data_1xnl_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1xnl _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.476 -1.893 1 N-CA-C 130.934 7.383 . . . . 0.0 130.934 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.45 ' O ' ' N ' ' A' ' 9' ' ' SER . . . -51.24 -49.63 29.44 Favored 'Isoleucine or valine' 0 C--O 1.186 -2.288 1 N-CA-C 92.301 -6.926 . . . . 0.0 92.301 137.708 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . . . -46.25 -47.45 18.08 Favored 'General case' 0 N--CA 1.487 1.399 3 CA-C-N 128.994 5.361 . . . . 0.0 124.951 -152.752 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -98.45 -35.03 10.4 Favored 'General case' 0 N--CA 1.409 -2.492 3 C-N-CA 154.948 13.299 . . . . 0.0 100.371 -165.413 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.45 ' N ' ' O ' ' A' ' 6' ' ' ILE . . . -74.42 -13.4 60.71 Favored 'General case' 0 CA--C 1.462 -2.429 2 O-C-N 111.18 -7.2 . . . . 0.0 129.307 144.063 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . . . -62.44 -43.3 98.11 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.835 1 CA-C-O 129.498 4.475 . . . . 0.0 114.7 166.462 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . . . -106.83 -52.27 2.8 Favored 'General case' 1 CA--C 1.351 -6.698 4 CA-C-N 97.785 -8.825 . . . . 0.0 124.788 -140.778 . . . . . . . . 3 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -78.13 -20.12 0.33 Allowed Pre-proline 1 CA--C 1.649 4.775 2 CA-C-N 102.878 -6.51 . . . . 0.0 109.708 168.487 . . . . . . . . 3 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -59.91 -29.42 89.4 Favored 'Trans proline' 0 CA--C 1.486 -1.91 2 O-C-N 106.516 -7.676 . . . . 0.0 127.416 134.868 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -70.89 -0.9 36.36 Favored Glycine 0 N--CA 1.506 3.329 2 O-C-N 132.617 6.198 . . . . 0.0 120.535 164.362 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.404 ' C ' ' N ' ' A' ' 17' ' ' ALA . . . -107.29 -73.83 0.59 Allowed 'Isoleucine or valine' 0 C--O 1.2 -1.549 2 CA-C-N 106.587 -4.806 . . . . 0.0 107.318 -165.3 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -28.52 -23.17 0.0 OUTLIER 'General case' 0 C--N 1.258 -3.379 0 CA-C-N 108.518 -3.946 . . . . 0.0 119.578 144.277 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.404 ' N ' ' C ' ' A' ' 15' ' ' VAL . . . -90.21 -33.38 16.21 Favored 'General case' 0 CA--C 1.549 0.907 1 N-CA-C 126.158 5.614 . . . . 0.0 126.158 156.858 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -41.73 -63.16 0.76 Allowed 'General case' 0 CA--C 1.576 1.967 0 CA-C-N 122.146 2.248 . . . . 0.0 115.071 145.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . . . -75.51 -56.3 4.83 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 113.759 -1.564 . . . . 0.0 109.649 -148.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -48.83 -44.45 39.38 Favored 'General case' 0 CA--C 1.577 1.987 0 N-CA-C 117.585 2.439 . . . . 0.0 117.585 163.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . . . -78.24 -13.65 59.77 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 117.33 -3.356 . . . . 0.0 117.773 -178.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . . . -96.5 -26.29 15.34 Favored 'General case' 0 N--CA 1.538 3.941 1 N-CA-C 126.129 5.603 . . . . 0.0 126.129 177.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . . . -37.81 -63.71 0.45 Allowed 'General case' 0 C--N 1.252 -3.638 2 CA-C-N 104.327 -5.851 . . . . 0.0 120.531 156.319 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . . . -39.32 -40.19 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.253 -3.615 4 O-C-N 134.218 7.199 . . . . 0.0 122.647 143.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . . . -94.92 3.57 54.81 Favored 'General case' 0 C--N 1.263 -3.171 0 N-CA-C 118.059 2.615 . . . . 0.0 118.059 167.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . . . -95.52 -60.45 1.66 Allowed 'General case' 0 N--CA 1.505 2.305 0 CA-C-N 109.546 -3.479 . . . . 0.0 111.178 177.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . . . -49.61 -41.69 42.78 Favored 'General case' 0 N--CA 1.501 2.097 0 C-N-CA 126.857 2.063 . . . . 0.0 115.503 163.346 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.505 2.311 0 CA-C-O 122.911 1.339 . . . . 0.0 112.398 159.688 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.421 -1.91 1 N-CA-C 144.599 12.444 . . . . 0.0 144.599 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.46 ' O ' ' CA ' ' A' ' 9' ' ' SER . . . -37.65 -49.9 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.434 -3.511 0 CA-C-N 111.716 -2.493 . . . . 0.0 106.019 117.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . . . -59.17 -51.89 68.05 Favored 'General case' 2 CA--C 1.378 -5.645 0 N-CA-C 119.355 3.094 . . . . 0.0 119.355 -143.799 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -104.47 44.28 1.04 Allowed 'General case' 1 N--CA 1.375 -4.222 2 N-CA-C 122.193 4.146 . . . . 0.0 122.193 146.707 . . . . . . . . 3 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.51 ' O ' ' CD ' ' A' ' 13' ' ' PRO . . . -93.3 17.2 11.61 Favored 'General case' 1 C--N 1.24 -4.162 1 N-CA-C 140.757 11.021 . . . . 0.0 140.757 95.158 . . . . . . . . 4 3 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.406 ' N ' ' O ' ' A' ' 6' ' ' ILE . . . -72.59 -33.89 46.2 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.802 2 CA-C-O 132.975 6.131 . . . . 0.0 125.162 156.453 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . . . -105.37 -32.34 8.62 Favored 'General case' 2 CA--C 1.368 -6.045 4 CA-C-N 93.656 -10.702 . . . . 0.0 131.033 -165.39 . . . . . . . . 3 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -89.1 -15.66 0.21 Allowed Pre-proline 0 CA--C 1.618 3.573 3 CA-C-N 101.894 -6.957 . . . . 0.0 114.273 161.515 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.51 ' CD ' ' O ' ' A' ' 9' ' ' SER . 0.0 OUTLIER -57.19 -24.09 57.12 Favored 'Trans proline' 0 C--N 1.291 -2.485 2 O-C-N 106.116 -7.886 . . . . 0.0 129.602 128.161 . . . . . . . . 4 4 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -76.77 2.1 60.42 Favored Glycine 0 N--CA 1.514 3.876 2 CA-C-N 103.849 -6.068 . . . . 0.0 120.945 162.081 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . . . -106.95 -77.79 0.42 Allowed 'Isoleucine or valine' 0 C--O 1.196 -1.713 2 CA-C-N 106.443 -4.879 . . . . 0.0 110.493 -169.6 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -28.77 -23.9 0.0 OUTLIER 'General case' 0 C--N 1.253 -3.588 1 CA-C-N 107.388 -4.46 . . . . 0.0 121.326 144.84 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -76.62 -46.2 26.94 Favored 'General case' 0 CA--C 1.553 1.09 1 N-CA-C 134.402 8.667 . . . . 0.0 134.402 146.557 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -37.64 -56.83 1.02 Allowed 'General case' 0 CA--C 1.573 1.846 0 N-CA-C 115.088 1.514 . . . . 0.0 115.088 147.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . . . -80.26 -63.41 1.42 Allowed 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.366 -0.833 . . . . 0.0 108.834 -148.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -46.93 -43.74 19.27 Favored 'General case' 0 CA--C 1.576 1.945 0 N-CA-C 117.292 2.331 . . . . 0.0 117.292 171.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . . . -94.73 -5.63 44.95 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 119.211 3.041 . . . . 0.0 119.211 -177.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . . . -85.01 -31.68 23.34 Favored 'General case' 1 N--CA 1.553 4.71 2 N-CA-C 127.488 6.107 . . . . 0.0 127.488 161.148 . . . . . . . . 3 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . . . -39.7 -60.4 0.99 Allowed 'General case' 1 C--N 1.219 -5.089 3 CA-C-N 100.176 -7.738 . . . . 0.0 124.601 164.121 . . . . . . . . 3 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . . . -31.92 -42.04 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.252 -3.657 2 CA-C-N 100.838 -7.437 . . . . 0.0 130.29 137.636 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . . . -93.78 -0.36 55.92 Favored 'General case' 0 C--N 1.275 -2.653 0 N-CA-C 121.535 3.902 . . . . 0.0 121.535 164.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . . . -87.33 -24.65 24.22 Favored 'General case' 0 CA--C 1.609 3.229 0 CA-C-N 109.041 -3.709 . . . . 0.0 114.416 173.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . . . -97.24 -57.74 2.19 Favored 'General case' 0 N--CA 1.505 2.321 1 C-N-CA 132.261 4.224 . . . . 0.0 111.061 -177.831 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.755 0 CA-C-N 112.0 -2.364 . . . . 0.0 116.154 139.498 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.464 -2.33 1 N-CA-C 136.754 9.539 . . . . 0.0 136.754 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . . . -50.16 -55.24 6.12 Favored 'Isoleucine or valine' 0 CA--C 1.434 -3.493 0 CA-C-N 111.383 -2.644 . . . . 0.0 107.923 129.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . . . -33.26 -42.55 0.09 Allowed 'General case' 1 C--N 1.231 -4.549 1 N-CA-C 131.661 7.652 . . . . 0.0 131.661 -162.509 . . . . . . . . 3 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -97.54 -49.81 4.74 Favored 'General case' 1 N--CA 1.32 -6.968 3 CA-C-N 89.772 -12.467 . . . . 0.0 113.709 -147.489 . . . . . . . . 3 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.465 ' O ' ' CD ' ' A' ' 13' ' ' PRO . . . -74.51 5.71 4.47 Favored 'General case' 0 C--N 1.375 1.682 2 N-CA-C 138.88 10.326 . . . . 0.0 138.88 129.766 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . . . -66.9 -31.23 52.53 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.079 2 CA-C-O 133.719 6.485 . . . . 0.0 125.265 158.154 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . . . -108.39 -61.52 1.58 Allowed 'General case' 2 CA--C 1.4 -4.824 4 CA-C-N 91.714 -11.584 . . . . 0.0 124.904 -141.411 . . . . . . . . 3 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -78.44 -9.1 0.13 Allowed Pre-proline 0 C--N 1.269 -2.928 2 CA-C-N 99.95 -7.841 . . . . 0.0 118.66 160.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.465 ' CD ' ' O ' ' A' ' 9' ' ' SER . 0.1 OUTLIER -68.35 -18.48 44.28 Favored 'Trans proline' 0 N--CA 1.502 1.978 2 N-CA-C 135.041 8.823 . . . . 0.0 135.041 123.639 . . . . . . . . 4 4 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -70.07 -14.01 70.49 Favored Glycine 1 N--CA 1.53 4.964 2 CA-C-N 107.613 -4.358 . . . . 0.0 121.2 156.1 . . . . . . . . 3 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . . . -101.74 -70.33 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.457 -2.634 3 C-N-CA 136.666 5.986 . . . . 0.0 108.097 -175.185 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -71.88 -1.62 14.94 Favored 'General case' 1 C--N 1.237 -4.303 0 CA-C-N 109.03 -3.713 . . . . 0.0 111.506 -177.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -54.37 -82.87 0.01 OUTLIER 'General case' 0 C--N 1.359 0.983 1 N-CA-C 128.361 6.43 . . . . 0.0 128.361 125.43 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -32.52 -52.51 0.3 Allowed 'General case' 0 CA--C 1.582 2.197 0 N-CA-C 116.976 2.213 . . . . 0.0 116.976 170.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . . . -68.7 -55.98 9.62 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 113.004 -1.907 . . . . 0.0 113.08 -173.028 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -52.42 -39.46 61.01 Favored 'General case' 0 CA--C 1.586 2.353 0 N-CA-C 118.788 2.884 . . . . 0.0 118.788 171.164 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . . . -91.25 -5.55 54.6 Favored 'General case' 0 N--CA 1.516 2.869 0 N-CA-C 120.011 3.337 . . . . 0.0 120.011 178.138 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . . . -88.72 -30.18 19.28 Favored 'General case' 1 N--CA 1.543 4.177 2 N-CA-C 127.092 5.96 . . . . 0.0 127.092 164.607 . . . . . . . . 3 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . . . -37.79 -63.38 0.47 Allowed 'General case' 1 C--N 1.215 -5.257 2 CA-C-N 101.835 -6.984 . . . . 0.0 124.732 157.637 . . . . . . . . 3 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . . . -33.45 -48.4 0.11 Allowed 'Isoleucine or valine' 1 C--N 1.242 -4.076 2 N-CA-C 130.358 7.17 . . . . 0.0 130.358 139.494 . . . . . . . . 3 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . . . -77.87 -5.72 51.9 Favored 'General case' 0 C--N 1.276 -2.598 1 N-CA-C 123.031 4.456 . . . . 0.0 123.031 163.232 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . . . -92.82 -67.93 0.83 Allowed 'General case' 0 N--CA 1.527 3.413 0 CA-C-N 111.724 -2.489 . . . . 0.0 115.948 -161.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . . . -46.01 -53.87 9.36 Favored 'General case' 0 N--CA 1.497 1.875 1 CA-C-N 108.041 -4.163 . . . . 0.0 117.082 146.565 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.852 0 CA-C-N 122.106 2.23 . . . . 0.0 109.943 171.968 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.572 1.82 1 N-CA-C 128.182 6.364 . . . . 0.0 128.182 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.533 ' O ' ' N ' ' A' ' 10' ' ' ILE . . . -37.27 -34.62 0.11 Allowed 'Isoleucine or valine' 1 CA--C 1.395 -4.984 1 C-N-CA 136.545 5.938 . . . . 0.0 114.4 129.174 . . . . . . . . 4 3 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . . . -78.24 -49.85 12.97 Favored 'General case' 2 CA--C 1.299 -8.696 2 CA-C-O 133.146 6.212 . . . . 0.0 119.297 171.886 . . . . . . . . 3 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -41.06 -26.09 0.04 OUTLIER 'General case' 1 N--CA 1.378 -4.063 2 N-CA-C 129.633 6.901 . . . . 0.0 129.633 139.706 . . . . . . . . 3 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . . . -90.7 -19.62 23.38 Favored 'General case' 1 CA--C 1.418 -4.12 3 N-CA-C 141.226 11.195 . . . . 0.0 141.226 140.419 . . . . . . . . 3 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.533 ' N ' ' O ' ' A' ' 6' ' ' ILE . . . -66.64 -58.72 5.47 Favored 'Isoleucine or valine' 0 CA--C 1.608 3.187 2 CA-C-N 104.286 -5.87 . . . . 0.0 108.281 -167.957 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . . . -106.19 -24.89 12.21 Favored 'General case' 1 CA--C 1.36 -6.35 4 CA-C-N 93.5 -10.773 . . . . 0.0 128.026 -165.109 . . . . . . . . 3 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -78.09 -19.25 0.3 Allowed Pre-proline 0 C--N 1.258 -3.407 1 O-C-N 129.573 4.295 . . . . 0.0 117.281 160.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 0.0 OUTLIER -50.3 -26.17 15.12 Favored 'Trans proline' 0 C--N 1.313 -1.296 1 N-CA-C 136.691 9.458 . . . . 0.0 136.691 125.212 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -74.2 -7.27 76.95 Favored Glycine 1 N--CA 1.531 5.002 3 O-C-N 130.378 4.799 . . . . 0.0 122.703 156.252 . . . . . . . . 3 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . . . -110.49 -57.88 3.88 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.761 2 CA-C-N 105.29 -5.455 . . . . 0.0 117.884 -168.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -28.05 -40.29 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.638 0 CA-C-N 108.506 -3.952 . . . . 0.0 117.217 139.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -73.69 -41.16 63.0 Favored 'General case' 0 N--CA 1.426 -1.66 1 CA-C-N 107.609 -4.359 . . . . 0.0 121.061 -173.573 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -37.28 -58.66 0.81 Allowed 'General case' 0 CA--C 1.574 1.868 0 CA-C-N 112.012 -2.358 . . . . 0.0 117.198 143.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . . . -77.04 -51.86 10.34 Favored 'General case' 0 N--CA 1.487 1.382 0 CA-C-O 126.625 3.107 . . . . 0.0 113.365 -147.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -43.91 -41.63 5.32 Favored 'General case' 0 CA--C 1.584 2.253 0 CA-C-N 109.348 -3.569 . . . . 0.0 117.591 157.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . . . -91.42 -2.46 57.27 Favored 'General case' 0 N--CA 1.501 2.078 1 N-CA-C 122.744 4.35 . . . . 0.0 122.744 174.77 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . . . -97.91 -3.74 37.92 Favored 'General case' 1 N--CA 1.548 4.462 1 N-CA-C 126.259 5.651 . . . . 0.0 126.259 164.032 . . . . . . . . 3 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . . . -90.48 -42.86 10.62 Favored 'General case' 1 C--N 1.232 -4.517 4 CA-C-N 102.845 -6.525 . . . . 0.0 126.962 -173.478 . . . . . . . . 3 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . . . -28.04 -88.52 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.291 -1.965 2 CA-C-N 98.062 -8.699 . . . . 0.0 119.904 110.107 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . . . -75.04 15.53 0.4 Allowed 'General case' 0 N--CA 1.534 3.73 2 O-C-N 113.994 -5.441 . . . . 0.0 120.54 -171.868 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . . . -93.0 -61.01 1.66 Allowed 'General case' 0 N--CA 1.502 2.162 1 CA-C-N 106.498 -4.865 . . . . 0.0 114.876 167.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . . . -48.06 -43.25 30.28 Favored 'General case' 0 N--CA 1.511 2.586 0 N-CA-C 117.002 2.223 . . . . 0.0 117.002 166.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.781 0 CA-C-N 111.889 -2.414 . . . . 0.0 113.06 157.993 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.499 -0.991 1 N-CA-C 124.356 4.947 . . . . 0.0 124.356 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.536 ' O ' ' N ' ' A' ' 10' ' ' ILE . . . -38.6 -45.09 0.4 Allowed 'Isoleucine or valine' 0 C--O 1.157 -3.786 2 CA-C-N 105.654 -5.248 . . . . 0.0 111.54 126.65 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.46 ' O ' ' N ' ' A' ' 11' ' ' LEU . . . -61.41 -60.55 3.55 Favored 'General case' 2 C--O 1.143 -4.543 2 CA-C-O 140.983 9.944 . . . . 0.0 113.306 -172.65 . . . . . . . . 4 3 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -36.81 -36.74 0.12 Allowed 'General case' 1 C--N 1.22 -5.031 2 CA-C-N 102.177 -6.829 . . . . 0.0 105.558 157.141 . . . . . . . . 3 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . . . -90.74 -12.67 35.88 Favored 'General case' 0 CA--C 1.431 -3.632 1 N-CA-C 134.001 8.519 . . . . 0.0 134.001 151.023 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.536 ' N ' ' O ' ' A' ' 6' ' ' ILE . . . -67.61 -57.47 9.48 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.317 0 CA-C-O 127.603 3.573 . . . . 0.0 109.122 174.529 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.46 ' N ' ' O ' ' A' ' 7' ' ' PHE . . . -112.69 -27.92 7.99 Favored 'General case' 1 CA--C 1.384 -5.421 1 CA-C-N 99.256 -8.156 . . . . 0.0 121.566 -156.162 . . . . . . . . 4 3 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -101.48 19.66 0.05 OUTLIER Pre-proline 0 C--N 1.266 -3.026 0 C-N-CA 113.203 -3.399 . . . . 0.0 118.735 159.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 0.0 OUTLIER -53.05 -31.29 53.22 Favored 'Trans proline' 0 N--CA 1.523 3.221 2 N-CA-C 132.654 7.905 . . . . 0.0 132.654 99.487 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -59.65 -25.71 61.45 Favored Glycine 3 N--CA 1.552 6.405 1 CA-C-O 129.219 4.788 . . . . 0.0 122.444 167.453 . . . . . . . . 3 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . . . -107.11 -69.86 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.28 -2.444 2 CA-C-N 101.512 -7.344 . . . . 0.0 113.698 -163.217 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -27.0 -32.43 0.0 OUTLIER 'General case' 0 C--N 1.277 -2.568 0 N-CA-C 119.676 3.213 . . . . 0.0 119.676 153.515 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -85.1 -46.01 11.55 Favored 'General case' 0 C--N 1.328 -0.363 2 N-CA-C 123.334 4.568 . . . . 0.0 123.334 167.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -39.18 -57.74 1.28 Allowed 'General case' 0 N--CA 1.508 2.425 0 CA-C-O 123.249 1.499 . . . . 0.0 114.302 151.126 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . . . -81.99 -55.76 4.38 Favored 'General case' 0 CA--C 1.553 1.083 0 CA-C-O 123.32 1.533 . . . . 0.0 109.123 -140.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -48.62 -56.35 8.71 Favored 'General case' 0 CA--C 1.567 1.603 0 CA-C-N 112.728 -2.033 . . . . 0.0 115.128 162.009 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . . . -90.24 13.26 15.73 Favored 'General case' 0 N--CA 1.532 3.672 1 O-C-N 116.052 -4.155 . . . . 0.0 119.216 -178.568 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . . . -87.48 -32.72 19.31 Favored 'General case' 0 CA--C 1.427 -3.761 0 N-CA-C 121.464 3.876 . . . . 0.0 121.464 158.019 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . . . -43.52 -59.11 2.3 Favored 'General case' 0 C--N 1.253 -3.598 0 CA-C-N 108.665 -3.88 . . . . 0.0 114.804 174.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . . . -36.23 -46.14 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.26 -3.284 2 CA-C-N 102.379 -6.737 . . . . 0.0 125.261 148.161 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . . . -72.13 -14.47 61.84 Favored 'General case' 0 C--N 1.278 -2.502 1 N-CA-C 121.991 4.071 . . . . 0.0 121.991 162.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . . . -91.01 -61.56 1.64 Allowed 'General case' 0 N--CA 1.511 2.602 0 CA-C-N 110.681 -2.963 . . . . 0.0 108.375 -160.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . . . -49.91 -42.58 48.41 Favored 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 128.659 2.784 . . . . 0.0 118.238 157.232 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.503 2.208 0 CA-C-O 124.159 1.933 . . . . 0.0 110.227 161.257 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.49 -1.337 1 N-CA-C 125.905 5.521 . . . . 0.0 125.905 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.428 ' O ' ' N ' ' A' ' 9' ' ' SER . . . -45.95 -51.69 3.39 Favored 'Isoleucine or valine' 0 C--O 1.192 -1.932 0 O-C-N 128.948 3.905 . . . . 0.0 106.128 136.752 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.436 ' O ' ' N ' ' A' ' 10' ' ' ILE . . . -45.32 -64.44 0.72 Allowed 'General case' 3 N--CA 1.561 5.098 0 O-C-N 126.551 2.407 . . . . 0.0 113.063 -155.942 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -39.38 -47.62 1.79 Allowed 'General case' 1 N--CA 1.373 -4.319 4 C-N-CA 153.271 12.628 . . . . 0.0 100.027 166.512 . . . . . . . . 3 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.471 ' O ' ' CG ' ' A' ' 13' ' ' PRO . . . -91.75 19.2 6.67 Favored 'General case' 0 N--CA 1.513 2.676 1 N-CA-C 132.711 8.041 . . . . 0.0 132.711 153.15 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.436 ' N ' ' O ' ' A' ' 7' ' ' PHE . . . -109.29 -49.65 7.09 Favored 'Isoleucine or valine' 2 CA--C 1.644 4.576 2 N-CA-C 98.912 -4.477 . . . . 0.0 98.912 -177.547 . . . . . . . . 4 3 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . . . -62.97 -52.78 61.66 Favored 'General case' 1 CA--C 1.361 -6.297 2 C-N-CA 138.429 6.692 . . . . 0.0 126.301 -177.71 . . . . . . . . 3 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -95.83 -15.52 0.2 Allowed Pre-proline 0 C--N 1.248 -3.844 2 O-C-N 135.102 7.751 . . . . 0.0 112.744 -177.212 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.471 ' CG ' ' O ' ' A' ' 9' ' ' SER . 0.1 OUTLIER -54.67 -24.55 37.8 Favored 'Trans proline' 0 N--CA 1.504 2.144 1 N-CA-C 128.56 6.331 . . . . 0.0 128.56 121.467 . . . . . . . . 4 4 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -85.83 -0.3 87.63 Favored Glycine 2 N--CA 1.533 5.157 1 CA-C-N 108.127 -4.124 . . . . 0.0 121.814 164.465 . . . . . . . . 3 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . . . -103.89 -69.36 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.642 2 CA-C-N 106.409 -4.896 . . . . 0.0 114.335 175.523 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -24.03 -41.4 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.714 0 CA-C-N 110.865 -2.88 . . . . 0.0 117.994 156.02 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.44 -81.66 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.716 1 CA-C-N 106.073 -5.058 . . . . 0.0 121.287 158.512 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -36.33 -60.12 0.59 Allowed 'General case' 0 CA--C 1.581 2.168 0 N-CA-C 117.182 2.29 . . . . 0.0 117.182 171.235 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . . . -58.69 -57.38 13.25 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 128.874 2.87 . . . . 0.0 112.347 -168.166 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -71.7 -36.48 70.58 Favored 'General case' 0 CA--C 1.574 1.893 0 C-N-CA 127.689 2.396 . . . . 0.0 115.667 -176.185 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . . . -85.88 -0.86 56.48 Favored 'General case' 0 N--CA 1.506 2.374 0 N-CA-C 117.598 2.444 . . . . 0.0 117.598 173.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . . . -104.67 -26.87 12.13 Favored 'General case' 1 N--CA 1.554 4.743 1 N-CA-C 125.376 5.325 . . . . 0.0 125.376 176.427 . . . . . . . . 3 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . . . -35.0 -68.89 0.11 Allowed 'General case' 0 C--N 1.258 -3.37 1 CA-C-N 102.823 -6.535 . . . . 0.0 118.625 146.805 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . . . -34.28 -41.0 0.09 OUTLIER 'Isoleucine or valine' 1 C--N 1.236 -4.335 2 CA-C-N 105.484 -5.325 . . . . 0.0 122.642 148.921 . . . . . . . . 3 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . . . -94.71 2.47 55.56 Favored 'General case' 0 C--N 1.275 -2.646 0 N-CA-C 120.837 3.643 . . . . 0.0 120.837 170.524 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . . . -91.2 -25.11 19.69 Favored 'General case' 0 CA--C 1.608 3.185 0 CA-C-N 108.552 -3.931 . . . . 0.0 113.977 169.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . . . -96.85 -59.3 1.83 Allowed 'General case' 0 N--CA 1.507 2.419 0 C-N-CA 131.157 3.783 . . . . 0.0 110.163 -176.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 1.886 0 CA-C-N 112.195 -2.275 . . . . 0.0 114.233 141.677 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.432 -1.331 1 N-CA-C 123.219 4.526 . . . . 0.0 123.219 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.423 ' O ' ' N ' ' A' ' 10' ' ' ILE . . . -39.28 -29.77 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.435 -3.457 1 CA-C-O 110.952 -4.356 . . . . 0.0 109.516 125.494 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . . . -72.34 -56.85 4.8 Favored 'General case' 1 N--CA 1.558 4.939 2 CA-C-O 131.312 5.339 . . . . 0.0 115.367 -173.013 . . . . . . . . 3 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -37.44 -49.24 1.01 Allowed 'General case' 1 C--N 1.233 -4.497 3 C-N-CA 142.179 8.192 . . . . 0.0 100.704 150.732 . . . . . . . . 3 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.484 ' O ' ' CG ' ' A' ' 13' ' ' PRO . . . -102.66 -6.46 22.69 Favored 'General case' 0 N--CA 1.52 3.065 1 N-CA-C 128.829 6.603 . . . . 0.0 128.829 174.957 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.423 ' N ' ' O ' ' A' ' 6' ' ' ILE . . . -84.85 -47.54 17.08 Favored 'Isoleucine or valine' 1 C--N 1.231 -4.562 2 CA-C-N 106.894 -4.685 . . . . 0.0 98.392 -179.455 . . . . . . . . 4 3 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . . . -106.13 -33.38 7.87 Favored 'General case' 1 CA--C 1.378 -5.64 1 N-CA-C 123.457 4.614 . . . . 0.0 123.457 -157.276 . . . . . . . . 3 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -76.41 -23.1 0.44 Allowed Pre-proline 0 C--N 1.246 -3.897 2 O-C-N 130.065 4.603 . . . . 0.0 113.343 166.808 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.484 ' CG ' ' O ' ' A' ' 9' ' ' SER . 0.0 OUTLIER -48.34 -27.45 9.9 Favored 'Trans proline' 0 CA--C 1.476 -2.416 1 N-CA-C 129.113 6.544 . . . . 0.0 129.113 127.895 . . . . . . . . 4 4 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -64.93 -21.03 67.29 Favored Glycine 2 N--CA 1.544 5.855 1 CA-C-O 128.106 4.17 . . . . 0.0 122.742 160.041 . . . . . . . . 3 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . . . -108.45 -68.99 0.95 Allowed 'Isoleucine or valine' 0 CA--C 1.462 -2.427 2 CA-C-N 103.262 -6.469 . . . . 0.0 111.936 -159.667 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -26.37 -32.92 0.0 OUTLIER 'General case' 0 C--N 1.269 -2.921 0 N-CA-C 119.937 3.31 . . . . 0.0 119.937 148.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -88.75 -41.46 12.53 Favored 'General case' 0 N--CA 1.466 0.326 2 N-CA-C 123.7 4.704 . . . . 0.0 123.7 167.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -39.01 -59.15 1.02 Allowed 'General case' 0 N--CA 1.511 2.593 0 CA-C-O 123.796 1.76 . . . . 0.0 114.881 148.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . . . -77.3 -56.46 4.53 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 114.714 -1.13 . . . . 0.0 108.316 -143.117 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -42.44 -45.4 4.38 Favored 'General case' 0 CA--C 1.582 2.204 0 C-N-CA 126.52 1.928 . . . . 0.0 115.741 159.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . . . -92.57 1.77 57.07 Favored 'General case' 0 CA--C 1.578 2.054 0 N-CA-C 119.251 3.056 . . . . 0.0 119.251 -176.015 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . . . -106.54 -15.7 14.72 Favored 'General case' 1 N--CA 1.56 5.064 1 N-CA-C 124.075 4.843 . . . . 0.0 124.075 157.521 . . . . . . . . 3 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . . . -36.68 -69.67 0.11 Allowed 'General case' 1 C--N 1.233 -4.468 0 CA-C-N 108.794 -3.821 . . . . 0.0 118.61 157.36 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . . . -35.47 -43.65 0.15 Allowed 'Isoleucine or valine' 1 C--N 1.224 -4.879 2 CA-C-N 102.526 -6.67 . . . . 0.0 123.099 149.961 . . . . . . . . 3 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . . . -92.29 1.82 57.0 Favored 'General case' 0 C--N 1.292 -1.893 0 N-CA-C 118.398 2.74 . . . . 0.0 118.398 171.163 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . . . -90.91 -32.57 15.95 Favored 'General case' 0 CA--C 1.612 3.328 0 CA-C-N 110.71 -2.95 . . . . 0.0 113.632 175.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . . . -97.05 -48.91 5.21 Favored 'General case' 0 N--CA 1.509 2.482 1 C-N-CA 131.968 4.107 . . . . 0.0 110.818 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.499 1.985 0 C-N-CA 117.586 -1.646 . . . . 0.0 113.419 140.428 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.437 -1.123 1 N-CA-C 128.466 6.469 . . . . 0.0 128.466 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . . . -37.16 -60.3 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.512 2.631 3 N-CA-C 89.576 -7.935 . . . . 0.0 89.576 142.834 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . . . -103.34 -32.04 9.75 Favored 'General case' 1 N--CA 1.371 -4.405 1 CA-C-O 130.934 5.159 . . . . 0.0 111.664 -128.603 . . . . . . . . 3 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -45.88 -36.27 5.22 Favored 'General case' 0 CA--C 1.446 -3.053 1 O-C-N 116.054 -4.154 . . . . 0.0 121.197 126.757 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.425 ' O ' ' CG ' ' A' ' 13' ' ' PRO . . . -90.7 10.6 25.2 Favored 'General case' 0 N--CA 1.524 3.258 1 N-CA-C 125.11 5.226 . . . . 0.0 125.11 176.094 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . . . -110.99 -42.39 4.74 Favored 'Isoleucine or valine' 1 CA--C 1.651 4.855 1 CA-C-N 106.817 -4.719 . . . . 0.0 102.094 -176.364 . . . . . . . . 3 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . . . -54.71 -59.33 4.86 Favored 'General case' 1 CA--C 1.373 -5.852 1 C-N-CA 138.069 6.548 . . . . 0.0 120.91 170.374 . . . . . . . . 3 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -81.89 -41.18 1.01 Allowed Pre-proline 1 N--CA 1.362 -4.857 1 CA-C-N 105.47 -5.332 . . . . 0.0 102.968 -172.42 . . . . . . . . 3 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.425 ' CG ' ' O ' ' A' ' 9' ' ' SER . 0.1 OUTLIER -37.56 -22.4 0.05 OUTLIER 'Trans proline' 0 N--CA 1.518 2.927 2 O-C-N 108.919 -6.411 . . . . 0.0 127.829 134.853 . . . . . . . . 4 4 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -80.33 -7.21 88.76 Favored Glycine 2 N--CA 1.529 4.851 1 CA-C-N 108.141 -4.118 . . . . 0.0 119.886 163.045 . . . . . . . . 3 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . . . -105.86 -76.53 0.46 Allowed 'Isoleucine or valine' 0 C--O 1.2 -1.521 2 C-N-CA 133.1 4.56 . . . . 0.0 110.89 -166.775 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -21.1 -34.71 0.0 OUTLIER 'General case' 0 C--N 1.26 -3.306 0 N-CA-C 120.367 3.469 . . . . 0.0 120.367 147.001 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -83.8 -45.29 13.46 Favored 'General case' 0 N--CA 1.476 0.827 1 N-CA-C 125.246 5.276 . . . . 0.0 125.246 160.531 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -36.4 -55.42 0.82 Allowed 'General case' 0 N--CA 1.517 2.878 0 CA-C-O 125.235 2.445 . . . . 0.0 116.276 154.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . . . -78.07 -50.25 12.42 Favored 'General case' 0 N--CA 1.48 1.047 0 CA-C-O 124.047 1.879 . . . . 0.0 111.327 -152.057 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -37.93 -48.98 1.21 Allowed 'General case' 0 N--CA 1.413 -2.29 0 C-N-CA 131.617 3.967 . . . . 0.0 120.836 149.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . . . -87.89 7.86 28.83 Favored 'General case' 0 N--CA 1.514 2.731 0 N-CA-C 119.901 3.297 . . . . 0.0 119.901 170.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . . . -104.08 -30.69 10.09 Favored 'General case' 0 N--CA 1.534 3.771 1 N-CA-C 124.429 4.974 . . . . 0.0 124.429 173.572 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . . . -37.82 -59.49 0.81 Allowed 'General case' 0 C--N 1.258 -3.404 2 CA-C-N 104.18 -5.918 . . . . 0.0 121.877 152.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . . . -36.13 -47.24 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.262 -3.205 3 O-C-N 134.567 7.417 . . . . 0.0 123.071 140.259 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . . . -91.89 4.81 52.09 Favored 'General case' 0 C--N 1.269 -2.902 0 O-C-N 119.128 -2.233 . . . . 0.0 116.437 170.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . . . -96.56 -60.0 1.7 Allowed 'General case' 0 N--CA 1.521 3.112 0 CA-C-N 110.475 -3.057 . . . . 0.0 113.572 -175.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . . . -47.16 -38.4 11.69 Favored 'General case' 0 N--CA 1.51 2.564 0 CA-C-N 109.06 -3.7 . . . . 0.0 115.053 158.175 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.489 0 CA-C-O 123.36 1.552 . . . . 0.0 108.411 164.202 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.635 1 N-CA-C 122.161 4.134 . . . . 0.0 122.161 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . . . -38.32 -55.09 0.35 Allowed 'Isoleucine or valine' 1 CA--C 1.418 -4.104 0 CA-C-N 108.428 -3.987 . . . . 0.0 111.262 131.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.414 ' O ' ' N ' ' A' ' 10' ' ' ILE . . . -45.87 -63.27 1.01 Allowed 'General case' 3 CA--C 1.299 -8.704 0 O-C-N 127.406 2.941 . . . . 0.0 111.007 -175.001 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -35.63 -49.1 0.55 Allowed 'General case' 0 C--N 1.273 -2.733 2 C-N-CA 141.414 7.886 . . . . 0.0 104.361 167.591 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.458 ' O ' ' CG ' ' A' ' 13' ' ' PRO . . . -76.44 -13.43 60.11 Favored 'General case' 1 N--CA 1.539 4.024 2 N-CA-C 134.667 8.765 . . . . 0.0 134.667 169.0 . . . . . . . . 4 3 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.414 ' N ' ' O ' ' A' ' 7' ' ' PHE . . . -103.84 -45.55 9.79 Favored 'Isoleucine or valine' 2 C--N 1.204 -5.731 2 CA-C-N 97.549 -8.932 . . . . 0.0 99.1 -161.293 . . . . . . . . 4 3 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . . . -94.77 -56.6 2.72 Favored 'General case' 1 CA--C 1.397 -4.931 1 C-N-CA 135.144 5.378 . . . . 0.0 118.402 -148.135 . . . . . . . . 3 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -86.26 -12.89 0.19 Allowed Pre-proline 0 C--N 1.262 -3.199 2 O-C-N 135.848 8.217 . . . . 0.0 113.32 178.766 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.458 ' CG ' ' O ' ' A' ' 9' ' ' SER . 0.1 OUTLIER -56.08 -27.7 66.09 Favored 'Trans proline' 0 N--CA 1.52 3.053 2 N-CA-C 131.501 7.462 . . . . 0.0 131.501 118.579 . . . . . . . . 4 4 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -77.97 -5.15 86.71 Favored Glycine 3 N--CA 1.562 7.051 2 CA-C-O 130.659 5.589 . . . . 0.0 123.301 164.845 . . . . . . . . 3 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . . . -105.61 -78.4 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.278 -2.514 2 C-N-CA 139.386 7.074 . . . . 0.0 117.819 179.616 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -29.6 -30.34 0.0 OUTLIER 'General case' 0 C--N 1.264 -3.139 0 N-CA-C 117.932 2.567 . . . . 0.0 117.932 152.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -53.19 -77.56 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.863 0 CA-C-N 109.21 -3.632 . . . . 0.0 120.627 150.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -33.68 -58.27 0.42 Allowed 'General case' 0 CA--C 1.571 1.788 0 N-CA-C 116.685 2.106 . . . . 0.0 116.685 169.425 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . . . -64.8 -41.37 95.85 Favored 'General case' 0 CA--C 1.552 1.04 0 CA-C-N 113.6 -1.636 . . . . 0.0 113.67 -164.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -83.43 -27.8 29.28 Favored 'General case' 0 CA--C 1.582 2.198 0 C-N-CA 129.142 2.977 . . . . 0.0 114.593 -178.317 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . . . -84.51 3.66 35.45 Favored 'General case' 0 N--CA 1.505 2.304 0 N-CA-C 120.034 3.346 . . . . 0.0 120.034 158.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . . . -103.39 -27.16 12.6 Favored 'General case' 1 N--CA 1.548 4.443 1 N-CA-C 124.534 5.012 . . . . 0.0 124.534 173.261 . . . . . . . . 3 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . . . -35.99 -67.41 0.16 Allowed 'General case' 0 C--N 1.257 -3.414 1 CA-C-N 103.779 -6.101 . . . . 0.0 119.048 149.065 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . . . -33.9 -41.86 0.09 OUTLIER 'Isoleucine or valine' 1 C--N 1.239 -4.219 2 CA-C-N 104.851 -5.613 . . . . 0.0 122.801 147.961 . . . . . . . . 3 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . . . -94.43 3.08 55.63 Favored 'General case' 0 C--N 1.274 -2.705 0 N-CA-C 120.838 3.644 . . . . 0.0 120.838 170.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . . . -90.97 -25.75 19.59 Favored 'General case' 0 CA--C 1.609 3.222 1 CA-C-N 108.381 -4.008 . . . . 0.0 113.831 169.34 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . . . -96.82 -59.11 1.87 Allowed 'General case' 0 N--CA 1.507 2.406 0 C-N-CA 131.266 3.826 . . . . 0.0 110.239 -176.264 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 1.929 0 CA-C-N 112.152 -2.295 . . . . 0.0 114.225 141.353 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.481 -1.693 1 N-CA-C 141.871 11.434 . . . . 0.0 141.871 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.438 ' O ' ' N ' ' A' ' 10' ' ' ILE . . . -46.01 -43.32 4.73 Favored 'Isoleucine or valine' 0 CA--C 1.465 -2.289 0 O-C-N 128.886 3.866 . . . . 0.0 106.763 126.095 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.434 ' O ' ' N ' ' A' ' 10' ' ' ILE . . . -67.08 -61.16 2.07 Favored 'General case' 0 N--CA 1.401 -2.919 1 CA-C-O 129.405 4.431 . . . . 0.0 118.194 -133.813 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -35.1 -27.18 0.01 OUTLIER 'General case' 2 C--N 1.195 -6.132 2 N-CA-C 136.562 9.467 . . . . 0.0 136.562 130.275 . . . . . . . . 3 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . . . -89.35 5.59 44.39 Favored 'General case' 0 C--N 1.255 -3.502 1 N-CA-C 135.188 8.958 . . . . 0.0 135.188 140.647 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.438 ' N ' ' O ' ' A' ' 6' ' ' ILE . . . -67.7 -43.29 86.71 Favored 'Isoleucine or valine' 0 C--N 1.255 -3.503 1 CA-C-O 129.246 4.355 . . . . 0.0 118.642 162.302 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . . . -116.82 -28.85 6.21 Favored 'General case' 1 CA--C 1.406 -4.584 3 CA-C-N 98.219 -8.628 . . . . 0.0 127.937 -149.486 . . . . . . . . 3 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -76.91 -23.93 0.45 Allowed Pre-proline 1 C--N 1.244 -4.003 3 O-C-N 135.077 7.736 . . . . 0.0 122.988 150.65 . . . . . . . . 3 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -59.36 -22.76 67.14 Favored 'Trans proline' 0 C--N 1.31 -1.486 1 N-CA-C 130.72 7.162 . . . . 0.0 130.72 128.365 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -80.66 4.91 66.75 Favored Glycine 1 N--CA 1.518 4.118 2 CA-C-N 104.567 -5.742 . . . . 0.0 120.26 159.043 . . . . . . . . 3 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . . . -113.39 -67.72 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 C-N-CA 131.127 3.771 . . . . 0.0 113.058 -174.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -26.96 -34.96 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 108.917 -3.765 . . . . 0.0 119.506 145.139 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.83 -70.4 0.21 Allowed 'General case' 0 N--CA 1.441 -0.91 2 N-CA-C 126.167 5.618 . . . . 0.0 126.167 155.335 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -38.22 -54.76 1.37 Allowed 'General case' 0 CA--C 1.583 2.232 0 N-CA-C 118.187 2.662 . . . . 0.0 118.187 163.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . . . -39.46 -56.47 1.6 Allowed 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 129.731 3.213 . . . . 0.0 115.507 174.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -80.9 -27.28 36.32 Favored 'General case' 0 CA--C 1.567 1.598 0 CA-C-N 109.998 -3.274 . . . . 0.0 113.757 -178.228 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . . . -98.49 10.52 40.73 Favored 'General case' 0 N--CA 1.525 3.297 1 N-CA-C 130.874 7.361 . . . . 0.0 130.874 160.018 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . . . -95.12 -28.37 15.11 Favored 'General case' 0 N--CA 1.538 3.934 2 N-CA-C 125.718 5.451 . . . . 0.0 125.718 157.715 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . . . -30.84 -56.75 0.22 Allowed 'General case' 2 N--CA 1.366 -4.645 2 CA-C-N 103.517 -6.22 . . . . 0.0 119.53 138.208 . . . . . . . . 3 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . . . -94.35 -8.88 9.67 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.239 0 C-N-CA 113.901 -3.12 . . . . 0.0 117.924 -171.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . . . -71.02 -14.52 62.37 Favored 'General case' 0 C--N 1.307 -1.252 1 N-CA-C 127.46 6.096 . . . . 0.0 127.46 148.531 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . . . -92.6 -48.36 6.65 Favored 'General case' 1 N--CA 1.548 4.465 0 N-CA-C 118.845 2.906 . . . . 0.0 118.845 -162.219 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . . . -46.19 -72.98 0.04 OUTLIER 'General case' 0 C--N 1.288 -2.076 1 CA-C-N 106.22 -4.991 . . . . 0.0 117.266 138.536 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.712 0 CA-C-O 124.802 2.239 . . . . 0.0 111.548 -172.98 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . . . . . . . . 0 C--O 1.225 -0.22 1 N-CA-C 124.967 5.173 . . . . 0.0 124.967 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.488 ' O ' ' N ' ' A' ' 10' ' ' ILE . . . -35.48 -61.11 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.425 -3.838 1 CA-C-N 106.682 -4.781 . . . . 0.0 114.599 113.43 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . . . -35.39 -41.01 0.17 Allowed 'General case' 3 CA--C 1.333 -7.403 2 N-CA-C 129.336 6.791 . . . . 0.0 129.336 -179.487 . . . . . . . . 3 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -57.03 -52.26 65.99 Favored 'General case' 1 N--CA 1.315 -7.192 4 O-C-N 145.693 14.37 . . . . 0.0 125.673 165.426 . . . . . . . . 3 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.436 ' O ' ' CG ' ' A' ' 13' ' ' PRO . . . -97.3 0.37 47.94 Favored 'General case' 0 N--CA 1.501 2.096 3 N-CA-C 132.805 8.076 . . . . 0.0 132.805 160.782 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.488 ' N ' ' O ' ' A' ' 6' ' ' ILE . . . -62.61 -39.72 85.68 Favored 'Isoleucine or valine' 0 C--N 1.246 -3.91 2 CA-C-N 101.757 -7.019 . . . . 0.0 120.202 150.418 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . . . -100.63 -52.58 3.3 Favored 'General case' 1 CA--C 1.416 -4.194 3 CA-C-N 99.029 -8.26 . . . . 0.0 125.736 -145.088 . . . . . . . . 3 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -81.29 -21.3 0.31 Allowed Pre-proline 0 N--CA 1.379 -3.99 2 O-C-N 136.935 8.897 . . . . 0.0 116.151 167.027 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.436 ' CG ' ' O ' ' A' ' 9' ' ' SER . 12.2 Cg_exo -52.53 -24.27 21.77 Favored 'Trans proline' 0 N--CA 1.51 2.474 2 N-CA-C 134.683 8.686 . . . . 0.0 134.683 118.13 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -78.41 -3.07 85.72 Favored Glycine 2 N--CA 1.543 5.793 2 CA-C-N 106.655 -4.793 . . . . 0.0 120.827 159.539 . . . . . . . . 3 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . . . -114.87 -77.81 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.467 -2.238 2 C-N-CA 134.852 5.261 . . . . 0.0 112.409 -169.513 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -29.29 -27.91 0.0 OUTLIER 'General case' 0 C--N 1.274 -2.71 0 N-CA-C 119.939 3.311 . . . . 0.0 119.939 150.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -57.76 -69.02 0.19 Allowed 'General case' 0 CA--C 1.549 0.923 1 N-CA-C 130.425 7.195 . . . . 0.0 130.425 145.697 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -35.54 -54.69 0.68 Allowed 'General case' 0 CA--C 1.578 2.03 0 N-CA-C 116.955 2.205 . . . . 0.0 116.955 159.648 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . . . -77.3 -55.15 5.66 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 113.653 -1.612 . . . . 0.0 111.555 -155.519 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -39.82 -41.9 1.21 Allowed 'General case' 0 CA--C 1.586 2.349 0 N-CA-C 117.522 2.415 . . . . 0.0 117.522 157.083 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . . . -95.22 14.17 23.09 Favored 'General case' 0 N--CA 1.502 2.165 1 N-CA-C 123.86 4.763 . . . . 0.0 123.86 175.031 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . . . -101.87 -6.68 23.25 Favored 'General case' 1 N--CA 1.555 4.78 1 N-CA-C 127.42 6.082 . . . . 0.0 127.42 151.009 . . . . . . . . 3 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . . . -81.13 -48.2 12.45 Favored 'General case' 1 C--N 1.221 -4.988 2 CA-C-N 102.955 -6.475 . . . . 0.0 123.262 -173.019 . . . . . . . . 3 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . . . -23.71 -52.74 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.283 -2.32 3 N-CA-C 131.404 7.557 . . . . 0.0 131.404 115.898 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . . . -90.66 8.81 32.46 Favored 'General case' 0 N--CA 1.521 3.097 0 O-C-N 118.12 -2.863 . . . . 0.0 117.085 169.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . . . -96.25 -61.8 1.38 Allowed 'General case' 0 N--CA 1.518 2.928 0 CA-C-N 108.768 -3.833 . . . . 0.0 116.215 -175.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . . . -46.34 -46.16 18.06 Favored 'General case' 0 N--CA 1.494 1.76 1 CA-C-N 108.006 -4.179 . . . . 0.0 115.431 156.547 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.258 0 CA-C-O 123.871 1.796 . . . . 0.0 108.788 166.792 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.439 -0.978 1 N-CA-C 138.529 10.196 . . . . 0.0 138.529 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.419 ' O ' ' N ' ' A' ' 10' ' ' ILE . . . -44.47 -49.47 2.23 Favored 'Isoleucine or valine' 0 C--O 1.184 -2.359 0 CA-C-N 109.757 -3.383 . . . . 0.0 105.485 124.157 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . . . -63.83 -61.4 2.32 Favored 'General case' 1 CA--C 1.385 -5.401 0 O-C-N 126.679 2.487 . . . . 0.0 114.646 -140.324 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -92.46 27.34 2.3 Favored 'General case' 0 N--CA 1.398 -3.059 1 CA-C-N 106.955 -4.657 . . . . 0.0 120.449 158.857 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . . . -100.58 7.78 43.83 Favored 'General case' 0 CA--C 1.461 -2.466 1 N-CA-C 142.619 11.711 . . . . 0.0 142.619 120.52 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.419 ' N ' ' O ' ' A' ' 6' ' ' ILE . . . -67.79 -54.2 24.76 Favored 'Isoleucine or valine' 0 C--N 1.249 -3.802 2 CA-C-N 105.276 -5.42 . . . . 0.0 114.938 165.182 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . . . -120.49 -26.37 5.38 Favored 'General case' 1 CA--C 1.397 -4.92 3 CA-C-N 96.754 -9.294 . . . . 0.0 130.205 -148.317 . . . . . . . . 3 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -90.65 -25.69 0.29 Allowed Pre-proline 1 N--CA 1.372 -4.374 2 CA-C-N 103.572 -6.195 . . . . 0.0 107.069 159.805 . . . . . . . . 3 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -39.57 -15.72 0.04 OUTLIER 'Trans proline' 0 N--CA 1.533 3.837 3 O-C-N 104.571 -8.699 . . . . 0.0 128.305 125.829 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -86.17 9.29 70.34 Favored Glycine 1 N--CA 1.539 5.521 1 CA-C-N 105.17 -5.468 . . . . 0.0 122.646 159.701 . . . . . . . . 3 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . . . -115.98 -83.98 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.795 3 CA-C-N 105.051 -5.575 . . . . 0.0 112.117 -167.54 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -28.99 -26.01 0.0 OUTLIER 'General case' 0 C--N 1.248 -3.819 1 CA-C-N 107.735 -4.302 . . . . 0.0 120.974 148.333 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -70.12 -58.75 3.44 Favored 'General case' 0 C--N 1.326 -0.451 1 N-CA-C 133.463 8.32 . . . . 0.0 133.463 143.485 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -35.24 -55.85 0.62 Allowed 'General case' 0 CA--C 1.586 2.364 0 N-CA-C 116.186 1.921 . . . . 0.0 116.186 159.064 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . . . -68.23 -56.98 6.75 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 113.113 -1.858 . . . . 0.0 111.714 -168.183 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -44.09 -38.61 3.73 Favored 'General case' 0 CA--C 1.585 2.308 0 N-CA-C 117.348 2.351 . . . . 0.0 117.348 162.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . . . -95.88 1.04 52.76 Favored 'General case' 0 N--CA 1.513 2.695 1 N-CA-C 125.494 5.368 . . . . 0.0 125.494 178.434 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . . . -100.19 3.73 43.91 Favored 'General case' 1 N--CA 1.557 4.896 2 N-CA-C 125.845 5.498 . . . . 0.0 125.845 155.902 . . . . . . . . 3 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . . . -87.33 -56.04 3.54 Favored 'General case' 1 C--N 1.214 -5.308 1 CA-C-N 103.929 -6.032 . . . . 0.0 119.363 -174.215 . . . . . . . . 3 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . . . -23.79 -46.21 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.268 -2.947 2 N-CA-C 132.484 7.957 . . . . 0.0 132.484 123.017 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . . . -78.72 -8.78 59.05 Favored 'General case' 0 C--N 1.28 -2.444 0 N-CA-C 121.358 3.836 . . . . 0.0 121.358 164.365 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . . . -94.05 -46.08 7.29 Favored 'General case' 1 N--CA 1.549 4.488 0 CA-C-N 108.924 -3.762 . . . . 0.0 118.981 -157.403 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . . . -46.36 -74.1 0.04 OUTLIER 'General case' 0 C--N 1.287 -2.141 1 CA-C-N 106.516 -4.856 . . . . 0.0 117.027 135.425 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.656 0 CA-C-O 124.778 2.227 . . . . 0.0 111.775 -169.09 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.5 2.072 1 N-CA-C 134.597 8.74 . . . . 0.0 134.597 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.504 ' O ' ' N ' ' A' ' 10' ' ' ILE . . . -33.24 -52.14 0.11 Allowed 'Isoleucine or valine' 1 CA--C 1.419 -4.065 1 CA-C-O 111.609 -4.043 . . . . 0.0 103.557 123.228 . . . . . . . . 4 3 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . . . -90.94 -52.06 5.04 Favored 'General case' 1 N--CA 1.334 -6.259 1 CA-C-O 130.8 5.095 . . . . 0.0 109.806 -122.366 . . . . . . . . 3 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -35.07 -37.15 0.06 Allowed 'General case' 2 C--N 1.215 -5.267 1 N-CA-C 123.502 4.63 . . . . 0.0 123.502 136.888 . . . . . . . . 3 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.542 ' O ' ' CD ' ' A' ' 13' ' ' PRO . . . -90.09 16.23 8.78 Favored 'General case' 0 CA--C 1.423 -3.915 2 N-CA-C 124.994 5.183 . . . . 0.0 124.994 157.33 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.504 ' N ' ' O ' ' A' ' 6' ' ' ILE . . . -79.82 -24.15 11.99 Favored 'Isoleucine or valine' 0 CA--C 1.602 2.962 0 CA-C-O 127.433 3.492 . . . . 0.0 112.881 160.42 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . . . -117.32 -28.31 6.18 Favored 'General case' 1 CA--C 1.383 -5.452 3 N-CA-C 126.288 5.662 . . . . 0.0 126.288 -160.645 . . . . . . . . 3 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -71.57 -18.67 0.39 Allowed Pre-proline 0 C--N 1.247 -3.868 2 O-C-N 134.504 7.378 . . . . 0.0 119.404 147.7 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.542 ' CD ' ' O ' ' A' ' 9' ' ' SER . 0.1 OUTLIER -63.31 -21.51 71.76 Favored 'Trans proline' 0 C--N 1.298 -2.09 2 N-CA-C 127.64 5.977 . . . . 0.0 127.64 130.297 . . . . . . . . 4 4 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -74.75 -3.23 66.87 Favored Glycine 2 N--CA 1.534 5.224 0 CA-C-N 108.969 -3.741 . . . . 0.0 121.372 157.833 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.406 ' C ' ' N ' ' A' ' 17' ' ' ALA . . . -113.79 -65.57 1.52 Allowed 'Isoleucine or valine' 0 CA--C 1.475 -1.907 2 C-N-CA 133.768 4.827 . . . . 0.0 112.221 -168.982 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -27.45 -33.27 0.0 OUTLIER 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 119.855 3.28 . . . . 0.0 119.855 148.201 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.406 ' N ' ' C ' ' A' ' 15' ' ' VAL . . . -90.49 -41.28 11.51 Favored 'General case' 0 CA--C 1.516 -0.364 2 CA-C-N 107.284 -4.507 . . . . 0.0 122.523 173.528 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -38.81 -62.31 0.63 Allowed 'General case' 0 CA--C 1.59 2.517 0 CA-C-O 123.015 1.388 . . . . 0.0 114.539 148.099 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . . . -77.43 -59.04 2.94 Favored 'General case' 0 CA--C 1.556 1.196 0 CA-C-O 124.443 2.068 . . . . 0.0 109.119 -143.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -41.39 -44.6 2.86 Favored 'General case' 0 CA--C 1.57 1.741 0 CA-C-N 111.5 -2.591 . . . . 0.0 115.931 160.479 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . . . -95.9 8.41 43.68 Favored 'General case' 0 N--CA 1.507 2.403 0 N-CA-C 118.794 2.887 . . . . 0.0 118.794 -174.481 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . . . -100.77 -28.21 12.94 Favored 'General case' 1 N--CA 1.551 4.603 1 N-CA-C 124.103 4.853 . . . . 0.0 124.103 160.275 . . . . . . . . 3 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . . . -39.36 -64.51 0.46 Allowed 'General case' 1 C--N 1.241 -4.138 1 CA-C-N 105.8 -5.182 . . . . 0.0 116.842 162.418 . . . . . . . . 3 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . . . -24.62 -50.92 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.252 -3.634 2 CA-C-N 104.509 -5.769 . . . . 0.0 124.642 139.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . . . -91.29 -0.22 57.63 Favored 'General case' 0 N--CA 1.505 2.317 0 N-CA-C 119.484 3.142 . . . . 0.0 119.484 170.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . . . -92.79 -37.19 12.46 Favored 'General case' 1 N--CA 1.553 4.699 0 CA-C-O 126.324 2.964 . . . . 0.0 117.33 -168.87 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . . . -93.47 -41.61 9.7 Favored 'General case' 0 N--CA 1.512 2.648 2 CA-C-N 107.295 -4.502 . . . . 0.0 111.146 171.791 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.738 0 C-N-CA 117.624 -1.63 . . . . 0.0 114.253 139.761 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.964 1 N-CA-C 126.019 5.563 . . . . 0.0 126.019 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.436 ' O ' ' N ' ' A' ' 10' ' ' ILE . . . -38.79 -33.06 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.447 -2.999 0 CA-C-O 111.968 -3.872 . . . . 0.0 110.735 135.081 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . . . -93.08 -41.96 9.67 Favored 'General case' 0 CA--C 1.435 -3.449 2 N-CA-C 131.122 7.453 . . . . 0.0 131.122 -156.165 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -34.68 -48.06 0.36 Allowed 'General case' 0 N--CA 1.394 -3.27 2 CA-C-N 96.899 -9.228 . . . . 0.0 107.649 127.597 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . . . -89.56 -2.34 58.31 Favored 'General case' 0 CA--C 1.479 -1.779 0 N-CA-C 121.277 3.806 . . . . 0.0 121.277 157.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.436 ' N ' ' O ' ' A' ' 6' ' ' ILE . . . -67.1 -26.01 35.48 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.137 1 CA-C-O 128.737 4.113 . . . . 0.0 118.03 167.881 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . . . -113.29 -55.2 2.55 Favored 'General case' 0 CA--C 1.435 -3.477 2 CA-C-N 101.232 -7.258 . . . . 0.0 126.057 -127.886 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -94.3 -21.87 0.24 Allowed Pre-proline 0 N--CA 1.38 -3.941 2 O-C-N 137.692 9.37 . . . . 0.0 112.564 171.909 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -62.49 -25.64 75.93 Favored 'Trans proline' 0 N--CA 1.49 1.294 1 N-CA-C 127.106 5.772 . . . . 0.0 127.106 126.873 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -76.07 2.31 56.47 Favored Glycine 1 N--CA 1.522 4.373 3 O-C-N 130.403 4.814 . . . . 0.0 121.68 160.015 . . . . . . . . 3 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . . . -113.11 -69.36 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.973 1 CA-C-N 106.687 -4.757 . . . . 0.0 110.206 -177.03 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -27.06 -28.75 0.0 OUTLIER 'General case' 0 C--N 1.29 -2.017 0 N-CA-C 120.044 3.35 . . . . 0.0 120.044 148.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -69.9 -56.99 5.59 Favored 'General case' 0 CA--C 1.549 0.924 1 N-CA-C 121.913 4.042 . . . . 0.0 121.913 160.162 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -36.69 -60.7 0.58 Allowed 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 115.747 1.758 . . . . 0.0 115.747 155.319 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . . . -77.69 -58.32 3.33 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-O 121.929 0.871 . . . . 0.0 110.072 -150.197 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -43.77 -31.67 0.87 Allowed 'General case' 0 CA--C 1.581 2.164 0 N-CA-C 116.448 2.018 . . . . 0.0 116.448 164.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . . . -90.14 -20.44 23.11 Favored 'General case' 0 CA--C 1.569 1.684 0 N-CA-C 116.53 2.048 . . . . 0.0 116.53 -178.51 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . . . -102.25 -13.58 17.33 Favored 'General case' 1 N--CA 1.574 5.725 1 N-CA-C 124.829 5.122 . . . . 0.0 124.829 170.391 . . . . . . . . 3 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . . . -30.29 -60.76 0.17 Allowed 'General case' 1 C--N 1.225 -4.814 1 CA-C-N 107.639 -4.346 . . . . 0.0 120.498 134.244 . . . . . . . . 3 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . . . -90.05 -18.77 7.54 Favored 'Isoleucine or valine' 1 C--N 1.241 -4.13 0 CA-C-N 110.022 -3.263 . . . . 0.0 114.743 -159.554 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . . . -66.47 -18.51 65.4 Favored 'General case' 0 C--N 1.307 -1.242 1 N-CA-C 123.855 4.761 . . . . 0.0 123.855 148.821 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . . . -90.49 -62.87 1.36 Allowed 'General case' 0 N--CA 1.522 3.144 0 CA-C-N 114.229 -1.351 . . . . 0.0 109.37 -163.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . . . -48.66 -47.7 40.37 Favored 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 128.489 2.716 . . . . 0.0 116.293 157.028 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.5 2.039 0 CA-C-O 124.324 2.011 . . . . 0.0 110.832 160.262 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.565 1 N-CA-C 128.086 6.328 . . . . 0.0 128.086 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.452 ' O ' ' N ' ' A' ' 9' ' ' SER . . . -42.71 -36.88 0.75 Allowed 'Isoleucine or valine' 0 C--O 1.206 -1.208 1 O-C-N 129.513 4.258 . . . . 0.0 107.652 125.055 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . . . -93.78 -1.81 54.5 Favored 'General case' 2 CA--C 1.392 -5.114 1 N-CA-C 135.918 9.229 . . . . 0.0 135.918 -171.063 . . . . . . . . 3 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.88 -39.21 93.65 Favored 'General case' 1 CA--C 1.389 -5.215 3 CA-C-N 94.437 -10.347 . . . . 0.0 132.684 117.779 . . . . . . . . 3 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.452 ' N ' ' O ' ' A' ' 6' ' ' ILE . . . -105.98 12.02 30.99 Favored 'General case' 0 C--N 1.253 -3.619 1 N-CA-C 125.501 5.371 . . . . 0.0 125.501 178.925 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . . . -95.03 -30.97 4.15 Favored 'Isoleucine or valine' 0 C--N 1.259 -3.35 1 CA-C-N 106.958 -4.656 . . . . 0.0 105.878 166.392 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . . . -86.65 -62.55 1.48 Allowed 'General case' 1 CA--C 1.408 -4.506 1 C-N-CA 136.424 5.89 . . . . 0.0 121.075 -158.928 . . . . . . . . 3 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -72.66 -21.65 0.48 Allowed Pre-proline 0 N--CA 1.391 -3.384 2 CA-C-N 102.198 -6.819 . . . . 0.0 113.134 167.404 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.449 ' CG ' ' O ' ' A' ' 9' ' ' SER . 0.1 OUTLIER -68.95 -20.39 38.76 Favored 'Trans proline' 0 CA--C 1.499 -1.258 1 N-CA-C 127.724 6.009 . . . . 0.0 127.724 139.567 . . . . . . . . 4 4 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -72.46 -4.39 60.61 Favored Glycine 0 N--CA 1.512 3.702 0 O-C-N 128.766 3.791 . . . . 0.0 118.368 157.066 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . . . -119.15 -56.72 3.53 Favored 'Isoleucine or valine' 0 CA--C 1.475 -1.926 0 CA-C-N 110.353 -2.924 . . . . 0.0 115.048 -161.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -26.91 -42.7 0.02 OUTLIER 'General case' 0 C--N 1.292 -1.905 1 CA-C-N 108.261 -4.063 . . . . 0.0 117.163 141.422 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.87 -73.02 0.16 Allowed 'General case' 0 CA--C 1.557 1.218 0 CA-C-N 108.461 -3.972 . . . . 0.0 118.179 172.508 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -38.69 -66.71 0.25 Allowed 'General case' 0 CA--C 1.583 2.217 0 N-CA-C 116.93 2.196 . . . . 0.0 116.93 164.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . . . -60.88 -59.98 4.52 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 128.435 2.694 . . . . 0.0 111.63 -161.281 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.33 -42.99 92.34 Favored 'General case' 0 CA--C 1.569 1.692 0 C-N-CA 126.587 1.955 . . . . 0.0 115.991 -175.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . . . -92.35 6.38 47.11 Favored 'General case' 0 N--CA 1.517 2.888 0 O-C-N 119.272 -2.143 . . . . 0.0 116.148 -179.284 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . . . -104.52 -30.78 9.81 Favored 'General case' 1 N--CA 1.542 4.151 1 N-CA-C 125.044 5.202 . . . . 0.0 125.044 174.517 . . . . . . . . 3 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . . . -34.9 -71.86 0.06 Allowed 'General case' 0 C--N 1.261 -3.275 2 CA-C-N 103.022 -6.444 . . . . 0.0 117.921 147.522 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . . . -25.98 -45.57 0.01 OUTLIER 'Isoleucine or valine' 1 C--N 1.234 -4.43 2 N-CA-C 124.303 4.927 . . . . 0.0 124.303 143.522 . . . . . . . . 3 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . . . -92.6 -0.76 57.27 Favored 'General case' 0 N--CA 1.505 2.315 0 N-CA-C 119.219 3.044 . . . . 0.0 119.219 170.745 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . . . -92.39 -36.22 13.26 Favored 'General case' 1 N--CA 1.55 4.551 0 CA-C-O 126.069 2.842 . . . . 0.0 117.12 -170.853 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . . . -94.36 -41.98 9.13 Favored 'General case' 0 N--CA 1.512 2.67 2 CA-C-N 107.796 -4.275 . . . . 0.0 111.014 173.377 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.726 0 C-N-CA 117.849 -1.54 . . . . 0.0 114.235 139.634 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.166 0 N-CA-C 119.937 3.31 . . . . 0.0 119.937 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.501 ' O ' ' N ' ' A' ' 10' ' ' ILE . . . -39.51 -40.25 0.41 Allowed 'Isoleucine or valine' 0 C--O 1.162 -3.522 1 CA-C-O 108.079 -5.724 . . . . 0.0 111.681 127.458 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.4 ' O ' ' N ' ' A' ' 11' ' ' LEU . . . -61.57 -53.13 60.42 Favored 'General case' 1 C--O 1.15 -4.147 1 CA-C-N 127.436 4.653 . . . . 0.0 119.397 -169.478 . . . . . . . . 4 3 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -38.94 -53.86 1.7 Allowed 'General case' 1 N--CA 1.379 -4.005 4 C-N-CA 146.633 9.973 . . . . 0.0 99.128 155.279 . . . . . . . . 3 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.409 ' O ' ' CG ' ' A' ' 13' ' ' PRO . . . -85.58 2.86 43.24 Favored 'General case' 0 N--CA 1.494 1.735 1 N-CA-C 125.675 5.435 . . . . 0.0 125.675 160.758 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.501 ' N ' ' O ' ' A' ' 6' ' ' ILE . . . -80.67 -47.89 20.15 Favored 'Isoleucine or valine' 0 CA--C 1.584 2.275 0 CA-C-O 126.072 2.844 . . . . 0.0 106.286 172.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.4 ' N ' ' O ' ' A' ' 7' ' ' PHE . . . -114.02 -23.83 9.35 Favored 'General case' 0 CA--C 1.439 -3.32 2 CA-C-N 106.794 -4.73 . . . . 0.0 123.581 -147.959 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -95.21 -7.78 0.12 Allowed Pre-proline 1 N--CA 1.374 -4.257 2 CA-C-N 104.327 -5.852 . . . . 0.0 110.882 160.967 . . . . . . . . 3 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.409 ' CG ' ' O ' ' A' ' 9' ' ' SER . 0.3 OUTLIER -77.39 -10.91 17.48 Favored 'Trans proline' 0 CA--C 1.475 -2.431 2 N-CA-C 124.44 4.746 . . . . 0.0 124.44 131.464 . . . . . . . . 4 4 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -87.45 9.4 73.51 Favored Glycine 1 N--CA 1.523 4.442 2 O-C-N 132.149 5.906 . . . . 0.0 121.477 163.57 . . . . . . . . 3 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . . . -115.31 -78.29 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.405 -2.678 2 CA-C-N 105.273 -5.464 . . . . 0.0 111.086 -175.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -28.26 -29.83 0.0 OUTLIER 'General case' 0 C--N 1.246 -3.899 0 CA-C-N 110.996 -2.82 . . . . 0.0 118.25 152.203 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -58.29 -71.7 0.11 Allowed 'General case' 0 CA--C 1.533 0.29 1 N-CA-C 123.617 4.673 . . . . 0.0 123.617 148.773 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -33.36 -60.45 0.35 Allowed 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 115.393 1.627 . . . . 0.0 115.393 165.118 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . . . -63.49 -45.36 91.09 Favored 'General case' 0 CA--C 1.545 0.783 0 CA-C-N 114.346 -1.297 . . . . 0.0 112.134 -161.622 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -84.99 -12.14 53.9 Favored 'General case' 0 N--CA 1.418 -2.044 0 C-N-CA 127.75 2.42 . . . . 0.0 115.526 -173.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . . . -90.15 -22.01 21.94 Favored 'General case' 0 N--CA 1.509 2.492 0 N-CA-C 118.891 2.923 . . . . 0.0 118.891 165.112 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . . . -93.34 -27.61 16.68 Favored 'General case' 1 N--CA 1.564 5.226 1 N-CA-C 126.433 5.716 . . . . 0.0 126.433 178.039 . . . . . . . . 3 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . . . -27.34 -81.97 0.01 OUTLIER 'General case' 1 CA--C 1.417 -4.146 2 CA-C-N 102.919 -6.491 . . . . 0.0 113.152 123.75 . . . . . . . . 3 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . . . -78.09 -12.67 13.76 Favored 'Isoleucine or valine' 0 C--N 1.257 -3.451 1 C-N-CA 110.571 -4.452 . . . . 0.0 116.904 -139.761 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . . . -91.31 -1.62 57.6 Favored 'General case' 0 C--N 1.306 -1.301 2 N-CA-C 126.896 5.887 . . . . 0.0 126.896 159.032 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . . . -88.71 -57.99 2.71 Favored 'General case' 1 N--CA 1.539 4.023 0 CA-C-O 125.416 2.531 . . . . 0.0 115.98 178.073 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . . . -71.03 -52.49 19.24 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-N 108.843 -3.799 . . . . 0.0 115.043 165.597 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.512 2.631 0 C-N-CA 116.069 -2.252 . . . . 0.0 112.623 148.367 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.502 -0.89 1 N-CA-C 123.523 4.638 . . . . 0.0 123.523 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.516 ' O ' ' N ' ' A' ' 10' ' ' ILE . . . -48.84 -50.92 13.2 Favored 'Isoleucine or valine' 1 C--O 1.135 -4.946 2 CA-C-N 106.808 -4.724 . . . . 0.0 106.907 137.706 . . . . . . . . 4 3 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.407 ' O ' ' N ' ' A' ' 10' ' ' ILE . . . -59.3 -55.23 37.49 Favored 'General case' 2 CA--C 1.365 -6.17 1 CA-C-O 140.191 9.567 . . . . 0.0 114.696 -163.484 . . . . . . . . 4 3 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -34.49 -43.31 0.16 Allowed 'General case' 0 N--CA 1.393 -3.298 1 CA-C-N 100.335 -7.666 . . . . 0.0 109.505 158.044 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.472 ' CA ' ' O ' ' A' ' 6' ' ' ILE . . . -88.67 -9.23 52.8 Favored 'General case' 0 CA--C 1.46 -2.502 1 N-CA-C 133.361 8.282 . . . . 0.0 133.361 152.485 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.516 ' N ' ' O ' ' A' ' 6' ' ' ILE . . . -66.47 -52.64 44.21 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.84 0 CA-C-O 126.613 3.102 . . . . 0.0 108.378 168.867 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . . . -119.31 -25.24 6.15 Favored 'General case' 1 CA--C 1.397 -4.937 1 CA-C-N 102.956 -6.475 . . . . 0.0 120.799 -146.002 . . . . . . . . 3 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -100.04 16.61 0.05 OUTLIER Pre-proline 0 C--N 1.265 -3.079 1 O-C-N 130.809 5.068 . . . . 0.0 120.142 155.897 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -67.3 -25.33 42.61 Favored 'Trans proline' 0 N--CA 1.509 2.406 2 N-CA-C 131.243 7.363 . . . . 0.0 131.243 105.925 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -74.96 -0.83 61.17 Favored Glycine 3 N--CA 1.552 6.378 1 CA-C-O 129.011 4.673 . . . . 0.0 121.746 167.319 . . . . . . . . 3 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . . . -112.86 -67.18 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.29 -1.994 2 CA-C-N 104.462 -5.869 . . . . 0.0 116.517 -179.892 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -26.44 -37.03 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 119.251 3.056 . . . . 0.0 119.251 153.612 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -56.12 -79.13 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.804 1 CA-C-N 105.978 -5.101 . . . . 0.0 120.726 157.625 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -37.19 -49.49 0.91 Allowed 'General case' 0 CA--C 1.582 2.185 0 N-CA-C 117.637 2.458 . . . . 0.0 117.637 167.365 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . . . -47.81 -71.96 0.06 Allowed 'General case' 0 CA--C 1.564 1.505 0 C-N-CA 129.345 3.058 . . . . 0.0 112.942 -179.167 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -51.63 -25.53 7.22 Favored 'General case' 0 CA--C 1.571 1.783 0 CA-C-N 108.541 -3.936 . . . . 0.0 116.401 173.287 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . . . -90.78 -29.92 17.32 Favored 'General case' 0 CA--C 1.564 1.484 0 CA-C-O 115.414 -2.232 . . . . 0.0 115.696 -179.349 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . . . -100.79 -10.7 20.52 Favored 'General case' 1 N--CA 1.581 6.088 1 N-CA-C 124.797 5.11 . . . . 0.0 124.797 174.698 . . . . . . . . 3 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . . . -30.54 -67.85 0.09 Allowed 'General case' 1 C--N 1.233 -4.471 1 CA-C-N 105.582 -5.281 . . . . 0.0 118.822 125.603 . . . . . . . . 3 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . . . -88.0 7.45 2.99 Favored 'Isoleucine or valine' 1 C--N 1.238 -4.282 0 C-N-CA 113.775 -3.17 . . . . 0.0 117.929 -157.261 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . . . -87.18 -32.4 19.85 Favored 'General case' 0 C--N 1.303 -1.431 3 C-N-CA 134.484 5.114 . . . . 0.0 124.008 161.44 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . . . -87.65 -34.07 18.59 Favored 'General case' 0 N--CA 1.534 3.737 1 CA-C-N 106.87 -4.695 . . . . 0.0 116.553 -172.457 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . . . -95.97 -38.79 10.08 Favored 'General case' 0 N--CA 1.511 2.613 2 C-N-CA 131.994 4.118 . . . . 0.0 110.008 173.174 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.499 1.989 0 C-N-CA 116.909 -1.917 . . . . 0.0 114.287 139.915 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.499 -1.016 1 N-CA-C 128.237 6.384 . . . . 0.0 128.237 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . . . -39.89 -58.49 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.426 -3.819 2 CA-C-N 107.144 -4.571 . . . . 0.0 103.878 125.587 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . . . -46.2 -41.29 12.55 Favored 'General case' 0 N--CA 1.492 1.672 2 N-CA-C 125.387 5.328 . . . . 0.0 125.387 -144.035 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -90.85 -40.38 11.79 Favored 'General case' 1 N--CA 1.372 -4.359 3 C-N-CA 150.495 11.518 . . . . 0.0 110.151 -162.129 . . . . . . . . 3 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . . . -70.95 -14.09 62.24 Favored 'General case' 0 CA--C 1.458 -2.559 1 N-CA-C 128.96 6.652 . . . . 0.0 128.96 140.43 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . . . -74.02 -23.52 18.84 Favored 'Isoleucine or valine' 0 C--N 1.253 -3.591 1 CA-C-O 129.335 4.397 . . . . 0.0 117.52 169.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . . . -110.92 -55.61 2.47 Favored 'General case' 1 CA--C 1.407 -4.524 1 CA-C-N 102.425 -6.716 . . . . 0.0 119.462 -138.666 . . . . . . . . 3 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -76.78 -21.78 0.4 Allowed Pre-proline 0 C--N 1.254 -3.553 2 O-C-N 132.958 6.411 . . . . 0.0 115.823 163.159 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_exo -60.58 -17.87 51.27 Favored 'Trans proline' 0 CA--C 1.479 -2.271 1 N-CA-C 128.007 6.118 . . . . 0.0 128.007 131.667 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -59.69 -22.46 57.01 Favored Glycine 2 N--CA 1.535 5.273 0 CA-C-O 126.199 3.11 . . . . 0.0 119.255 154.203 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . . . -119.54 -49.26 3.54 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.617 1 CA-C-N 106.441 -4.88 . . . . 0.0 118.811 -144.165 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -28.72 -52.8 0.1 Allowed 'General case' 0 C--N 1.298 -1.673 2 CA-C-N 106.808 -4.724 . . . . 0.0 114.34 135.309 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -77.22 -52.42 9.27 Favored 'General case' 0 CA--C 1.56 1.334 1 CA-C-N 107.495 -4.412 . . . . 0.0 112.563 -157.895 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -36.72 -66.46 0.22 Allowed 'General case' 0 CA--C 1.585 2.307 0 CA-C-N 110.83 -2.895 . . . . 0.0 115.324 146.38 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . . . -46.91 -61.29 1.93 Allowed 'General case' 0 N--CA 1.514 2.727 0 CA-C-O 125.243 2.449 . . . . 0.0 113.777 -159.368 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -77.72 -14.75 59.52 Favored 'General case' 0 CA--C 1.567 1.598 0 C-N-CA 129.405 3.082 . . . . 0.0 116.244 -174.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . . . -92.27 -24.47 18.98 Favored 'General case' 0 N--CA 1.523 3.184 0 N-CA-C 117.942 2.571 . . . . 0.0 117.942 174.236 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . . . -96.01 -27.25 15.21 Favored 'General case' 1 N--CA 1.561 5.106 1 N-CA-C 126.158 5.614 . . . . 0.0 126.158 179.723 . . . . . . . . 3 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . . . -27.89 -80.32 0.01 OUTLIER 'General case' 0 CA--C 1.423 -3.941 2 CA-C-N 103.064 -6.425 . . . . 0.0 113.338 123.459 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . . . -79.66 -12.35 13.11 Favored 'Isoleucine or valine' 0 C--N 1.254 -3.554 1 C-N-CA 110.693 -4.403 . . . . 0.0 116.552 -139.287 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . . . -91.42 1.52 57.06 Favored 'General case' 0 C--N 1.308 -1.219 2 N-CA-C 127.287 6.032 . . . . 0.0 127.287 157.186 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . . . -89.71 -62.17 1.53 Allowed 'General case' 0 N--CA 1.538 3.926 0 CA-C-O 125.323 2.487 . . . . 0.0 115.752 176.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . . . -57.26 -61.48 2.44 Favored 'General case' 0 N--CA 1.494 1.768 0 CA-C-N 109.257 -3.61 . . . . 0.0 115.705 157.78 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.517 2.883 0 C-N-CA 115.388 -2.525 . . . . 0.0 112.322 155.918 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . . . . . . . . 0 C--O 1.214 -0.769 0 N-CA-C 117.621 2.452 . . . . 0.0 117.621 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.426 ' O ' ' N ' ' A' ' 10' ' ' ILE . . . -37.12 -38.19 0.15 Allowed 'Isoleucine or valine' 2 CA--C 1.364 -6.179 1 CA-C-N 106.264 -4.971 . . . . 0.0 112.735 126.729 . . . . . . . . 4 3 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . . . -67.6 -60.35 2.62 Favored 'General case' 0 CA--C 1.423 -3.907 1 CA-C-O 137.041 8.067 . . . . 0.0 111.338 -173.343 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -36.26 -43.61 0.37 Allowed 'General case' 0 N--CA 1.407 -2.579 2 CA-C-N 100.51 -7.586 . . . . 0.0 105.36 159.694 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . . . -106.49 1.7 25.68 Favored 'General case' 0 CA--C 1.464 -2.345 1 N-CA-C 130.056 7.058 . . . . 0.0 130.056 176.356 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.426 ' N ' ' O ' ' A' ' 6' ' ' ILE . . . -91.93 -46.12 14.33 Favored 'Isoleucine or valine' 0 CA--C 1.621 3.695 2 N-CA-C 96.796 -5.261 . . . . 0.0 96.796 177.192 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . . . -112.91 -27.59 8.04 Favored 'General case' 1 CA--C 1.402 -4.726 1 N-CA-C 122.222 4.156 . . . . 0.0 122.222 -152.415 . . . . . . . . 3 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -99.78 14.58 0.05 OUTLIER Pre-proline 0 C--N 1.256 -3.48 1 O-C-N 130.19 4.681 . . . . 0.0 120.791 154.273 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 0.0 OUTLIER -71.57 -22.13 24.84 Favored 'Trans proline' 0 N--CA 1.507 2.289 2 N-CA-C 130.215 6.967 . . . . 0.0 130.215 110.115 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -82.32 2.28 85.2 Favored Glycine 2 N--CA 1.541 5.668 1 CA-C-O 127.849 4.027 . . . . 0.0 120.619 168.582 . . . . . . . . 3 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . . . -111.95 -64.3 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.71 2 CA-C-N 106.391 -4.905 . . . . 0.0 114.157 179.893 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -23.67 -42.32 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 111.56 -2.564 . . . . 0.0 117.612 152.519 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -56.8 -83.8 0.01 OUTLIER 'General case' 0 CA--C 1.556 1.201 1 CA-C-N 106.837 -4.71 . . . . 0.0 119.54 158.293 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -36.21 -60.8 0.54 Allowed 'General case' 0 CA--C 1.58 2.125 0 N-CA-C 118.615 2.82 . . . . 0.0 118.615 172.27 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . . . -52.65 -54.66 30.3 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 128.421 2.688 . . . . 0.0 112.824 -172.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.51 -53.06 61.32 Favored 'General case' 0 N--CA 1.399 -2.982 0 CA-C-N 112.693 -2.049 . . . . 0.0 111.602 173.117 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . . . -95.42 34.34 1.46 Allowed 'General case' 0 N--CA 1.518 2.96 0 N-CA-C 120.401 3.482 . . . . 0.0 120.401 175.337 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . . . -107.73 -5.71 17.23 Favored 'General case' 0 N--CA 1.533 3.714 0 N-CA-C 121.068 3.729 . . . . 0.0 121.068 141.444 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . . . -63.3 -55.02 28.13 Favored 'General case' 0 C--N 1.246 -3.897 0 N-CA-C 118.529 2.788 . . . . 0.0 118.529 -179.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . . . -28.18 -52.09 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.266 -3.063 4 CA-C-N 100.903 -7.408 . . . . 0.0 124.073 131.39 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . . . -92.29 7.52 42.39 Favored 'General case' 0 N--CA 1.519 2.98 0 N-CA-C 117.36 2.356 . . . . 0.0 117.36 171.478 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . . . -96.5 -60.97 1.5 Allowed 'General case' 0 N--CA 1.511 2.587 0 CA-C-N 109.317 -3.583 . . . . 0.0 110.699 179.077 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . . . -48.42 -38.61 20.14 Favored 'General case' 0 N--CA 1.503 2.209 0 C-N-CA 126.567 1.947 . . . . 0.0 115.937 162.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.834 0 CA-C-O 123.795 1.76 . . . . 0.0 110.639 160.491 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.176 0 N-CA-C 119.713 3.227 . . . . 0.0 119.713 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.434 ' O ' ' N ' ' A' ' 10' ' ' ILE . . . -38.1 -50.09 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.434 -3.51 1 CA-C-O 111.572 -4.061 . . . . 0.0 112.732 125.902 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . . . -48.03 -62.15 1.62 Allowed 'General case' 2 CA--C 1.387 -5.311 1 CA-C-O 132.597 5.951 . . . . 0.0 112.98 178.499 . . . . . . . . 3 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -37.77 -46.19 0.89 Allowed 'General case' 0 N--CA 1.4 -2.943 2 CA-C-N 102.314 -6.766 . . . . 0.0 106.153 168.044 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.417 ' O ' ' CG ' ' A' ' 13' ' ' PRO . . . -92.95 3.07 56.39 Favored 'General case' 0 CA--C 1.469 -2.158 1 N-CA-C 129.292 6.775 . . . . 0.0 129.292 166.522 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.434 ' N ' ' O ' ' A' ' 6' ' ' ILE . . . -93.78 -41.23 12.33 Favored 'Isoleucine or valine' 1 C--N 1.238 -4.275 0 N-CA-C 102.213 -3.254 . . . . 0.0 102.213 178.592 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . . . -111.29 -28.6 8.17 Favored 'General case' 1 CA--C 1.421 -4.016 1 N-CA-C 122.245 4.165 . . . . 0.0 122.245 -153.249 . . . . . . . . 3 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -82.46 -24.12 0.36 Allowed Pre-proline 0 C--N 1.256 -3.494 2 O-C-N 131.63 5.581 . . . . 0.0 114.064 158.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.417 ' CG ' ' O ' ' A' ' 9' ' ' SER . 0.1 OUTLIER -56.21 -16.89 18.57 Favored 'Trans proline' 0 CA--C 1.476 -2.38 1 N-CA-C 128.107 6.156 . . . . 0.0 128.107 129.9 . . . . . . . . 4 4 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -59.3 -24.03 58.49 Favored Glycine 2 N--CA 1.536 5.35 0 CA-C-O 127.05 3.583 . . . . 0.0 121.727 155.391 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . . . -120.03 -50.84 3.58 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.843 1 CA-C-N 104.187 -6.007 . . . . 0.0 118.236 -142.646 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -28.69 -52.45 0.1 Allowed 'General case' 0 CA--C 1.476 -1.879 2 CA-C-N 105.697 -5.228 . . . . 0.0 115.114 135.213 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -74.49 -59.78 2.58 Favored 'General case' 0 CA--C 1.553 1.09 1 CA-C-N 107.272 -4.513 . . . . 0.0 110.848 -161.571 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -35.16 -56.41 0.6 Allowed 'General case' 0 CA--C 1.574 1.872 0 CA-C-N 110.604 -2.998 . . . . 0.0 115.992 157.34 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . . . -43.37 -53.7 5.16 Favored 'General case' 0 N--CA 1.508 2.441 0 C-N-CA 128.18 2.592 . . . . 0.0 114.975 -167.573 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -80.51 -33.34 36.49 Favored 'General case' 0 N--CA 1.421 -1.905 0 C-N-CA 130.976 3.71 . . . . 0.0 114.439 -173.348 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . . . -90.31 -0.41 57.62 Favored 'General case' 0 N--CA 1.529 3.514 0 N-CA-C 117.039 2.237 . . . . 0.0 117.039 170.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . . . -88.87 -35.87 16.3 Favored 'General case' 1 N--CA 1.555 4.794 1 N-CA-C 123.619 4.674 . . . . 0.0 123.619 167.607 . . . . . . . . 3 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . . . -37.75 -64.49 0.39 Allowed 'General case' 0 C--N 1.26 -3.309 2 CA-C-N 102.513 -6.676 . . . . 0.0 114.969 167.068 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . . . -25.09 -51.02 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.268 -2.957 2 CA-C-N 104.354 -5.839 . . . . 0.0 124.695 142.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . . . -92.26 -2.73 56.28 Favored 'General case' 0 C--N 1.274 -2.679 0 N-CA-C 119.831 3.271 . . . . 0.0 119.831 170.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . . . -87.84 -24.24 23.76 Favored 'General case' 0 CA--C 1.609 3.241 0 CA-C-N 110.581 -3.009 . . . . 0.0 113.821 179.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . . . -96.09 -53.41 3.66 Favored 'General case' 0 N--CA 1.501 2.12 1 C-N-CA 132.831 4.453 . . . . 0.0 110.986 -178.672 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 1.918 0 CA-C-N 111.757 -2.474 . . . . 0.0 115.442 139.469 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.569 3.428 0 N-CA-C 117.264 1.666 . . . . 0.0 117.264 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . . . -109.9 -18.04 0.03 OUTLIER 'Trans proline' 1 CA--C 1.621 4.849 1 N-CA-C 125.558 5.176 . . . . 0.0 125.558 -149.791 . . . . . . . . 3 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . . . -29.33 -50.43 0.1 Allowed 'General case' 0 C--N 1.268 -2.958 3 C-N-CA 137.719 6.408 . . . . 0.0 123.255 119.236 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -91.22 -29.42 17.22 Favored 'General case' 0 N--CA 1.481 1.104 2 C-N-CA 132.995 4.518 . . . . 0.0 112.133 -169.39 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . . . -98.14 -38.03 9.48 Favored 'General case' 0 CA--C 1.476 -1.893 3 N-CA-C 130.934 7.383 . . . . 0.0 130.934 165.275 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.45 ' O ' ' N ' ' A' ' 9' ' ' SER . . . -51.24 -49.63 29.44 Favored 'Isoleucine or valine' 0 C--O 1.186 -2.288 1 N-CA-C 92.301 -6.926 . . . . 0.0 92.301 137.708 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . . . -46.25 -47.45 18.08 Favored 'General case' 0 N--CA 1.487 1.399 3 CA-C-N 128.994 5.361 . . . . 0.0 124.951 -152.752 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -98.45 -35.03 10.4 Favored 'General case' 0 N--CA 1.409 -2.492 3 C-N-CA 154.948 13.299 . . . . 0.0 100.371 -165.413 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.45 ' N ' ' O ' ' A' ' 6' ' ' ILE . . . -74.42 -13.4 60.71 Favored 'General case' 0 CA--C 1.462 -2.429 2 O-C-N 111.18 -7.2 . . . . 0.0 129.307 144.063 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . . . -62.44 -43.3 98.11 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.835 1 CA-C-O 129.498 4.475 . . . . 0.0 114.7 166.462 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . . . -106.83 -52.27 2.8 Favored 'General case' 1 CA--C 1.351 -6.698 4 CA-C-N 97.785 -8.825 . . . . 0.0 124.788 -140.778 . . . . . . . . 3 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -78.13 -20.12 0.33 Allowed Pre-proline 1 CA--C 1.649 4.775 2 CA-C-N 102.878 -6.51 . . . . 0.0 109.708 168.487 . . . . . . . . 3 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -59.91 -29.42 89.4 Favored 'Trans proline' 0 CA--C 1.486 -1.91 2 O-C-N 106.516 -7.676 . . . . 0.0 127.416 134.868 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -70.89 -0.9 36.36 Favored Glycine 0 N--CA 1.506 3.329 2 O-C-N 132.617 6.198 . . . . 0.0 120.535 164.362 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.404 ' C ' ' N ' ' A' ' 17' ' ' ALA . . . -107.29 -73.83 0.59 Allowed 'Isoleucine or valine' 0 C--O 1.2 -1.549 2 CA-C-N 106.587 -4.806 . . . . 0.0 107.318 -165.3 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -28.52 -23.17 0.0 OUTLIER 'General case' 0 C--N 1.258 -3.379 0 CA-C-N 108.518 -3.946 . . . . 0.0 119.578 144.277 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.404 ' N ' ' C ' ' A' ' 15' ' ' VAL . . . -90.21 -33.38 16.21 Favored 'General case' 0 CA--C 1.549 0.907 1 N-CA-C 126.158 5.614 . . . . 0.0 126.158 156.858 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -41.73 -63.16 0.76 Allowed 'General case' 0 CA--C 1.576 1.967 0 CA-C-N 122.146 2.248 . . . . 0.0 115.071 145.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . . . -75.51 -56.3 4.83 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 113.759 -1.564 . . . . 0.0 109.649 -148.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -48.83 -44.45 39.38 Favored 'General case' 0 CA--C 1.577 1.987 0 N-CA-C 117.585 2.439 . . . . 0.0 117.585 163.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . . . -78.24 -13.65 59.77 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 117.33 -3.356 . . . . 0.0 117.773 -178.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . . . -96.5 -26.29 15.34 Favored 'General case' 0 N--CA 1.538 3.941 1 N-CA-C 126.129 5.603 . . . . 0.0 126.129 177.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . . . -37.81 -63.71 0.45 Allowed 'General case' 0 C--N 1.252 -3.638 2 CA-C-N 104.327 -5.851 . . . . 0.0 120.531 156.319 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . . . -39.32 -40.19 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.253 -3.615 4 O-C-N 134.218 7.199 . . . . 0.0 122.647 143.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . . . -94.92 3.57 54.81 Favored 'General case' 0 C--N 1.263 -3.171 0 N-CA-C 118.059 2.615 . . . . 0.0 118.059 167.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . . . -95.52 -60.45 1.66 Allowed 'General case' 0 N--CA 1.505 2.305 0 CA-C-N 109.546 -3.479 . . . . 0.0 111.178 177.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . . . -49.61 -41.69 42.78 Favored 'General case' 0 N--CA 1.501 2.097 0 C-N-CA 126.857 2.063 . . . . 0.0 115.503 163.346 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -79.91 -41.74 25.53 Favored 'General case' 0 N--CA 1.505 2.311 0 CA-C-O 122.911 1.339 . . . . 0.0 112.398 159.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.3 -1.564 0 O-C-N 121.01 -1.057 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.565 3.209 0 N-CA-C 116.384 1.314 . . . . 0.0 116.384 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . . . -94.49 10.0 1.9 Allowed 'Trans proline' 0 CA--C 1.578 2.699 1 N-CA-C 125.132 5.012 . . . . 0.0 125.132 179.255 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . . . -39.6 -58.36 1.31 Allowed 'General case' 0 C--N 1.274 -2.697 2 C-N-CA 133.681 4.792 . . . . 0.0 121.361 125.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -93.9 -32.66 13.81 Favored 'General case' 0 N--CA 1.529 3.484 2 CA-C-O 135.442 7.306 . . . . 0.0 115.309 -151.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . . . -94.8 -24.36 17.1 Favored 'General case' 0 C--N 1.25 -3.728 3 N-CA-C 144.599 12.444 . . . . 0.0 144.599 140.38 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.46 ' O ' ' CA ' ' A' ' 9' ' ' SER . . . -37.65 -49.9 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.434 -3.511 0 CA-C-N 111.716 -2.493 . . . . 0.0 106.019 117.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . . . -59.17 -51.89 68.05 Favored 'General case' 2 CA--C 1.378 -5.645 0 N-CA-C 119.355 3.094 . . . . 0.0 119.355 -143.799 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -104.47 44.28 1.04 Allowed 'General case' 1 N--CA 1.375 -4.222 2 N-CA-C 122.193 4.146 . . . . 0.0 122.193 146.707 . . . . . . . . 3 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.51 ' O ' ' CD ' ' A' ' 13' ' ' PRO . . . -93.3 17.2 11.61 Favored 'General case' 1 C--N 1.24 -4.162 1 N-CA-C 140.757 11.021 . . . . 0.0 140.757 95.158 . . . . . . . . 4 3 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.406 ' N ' ' O ' ' A' ' 6' ' ' ILE . . . -72.59 -33.89 46.2 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.802 2 CA-C-O 132.975 6.131 . . . . 0.0 125.162 156.453 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . . . -105.37 -32.34 8.62 Favored 'General case' 2 CA--C 1.368 -6.045 4 CA-C-N 93.656 -10.702 . . . . 0.0 131.033 -165.39 . . . . . . . . 3 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -89.1 -15.66 0.21 Allowed Pre-proline 0 CA--C 1.618 3.573 3 CA-C-N 101.894 -6.957 . . . . 0.0 114.273 161.515 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.51 ' CD ' ' O ' ' A' ' 9' ' ' SER . 0.0 OUTLIER -57.19 -24.09 57.12 Favored 'Trans proline' 0 C--N 1.291 -2.485 2 O-C-N 106.116 -7.886 . . . . 0.0 129.602 128.161 . . . . . . . . 4 4 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -76.77 2.1 60.42 Favored Glycine 0 N--CA 1.514 3.876 2 CA-C-N 103.849 -6.068 . . . . 0.0 120.945 162.081 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . . . -106.95 -77.79 0.42 Allowed 'Isoleucine or valine' 0 C--O 1.196 -1.713 2 CA-C-N 106.443 -4.879 . . . . 0.0 110.493 -169.6 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -28.77 -23.9 0.0 OUTLIER 'General case' 0 C--N 1.253 -3.588 1 CA-C-N 107.388 -4.46 . . . . 0.0 121.326 144.84 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -76.62 -46.2 26.94 Favored 'General case' 0 CA--C 1.553 1.09 1 N-CA-C 134.402 8.667 . . . . 0.0 134.402 146.557 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -37.64 -56.83 1.02 Allowed 'General case' 0 CA--C 1.573 1.846 0 N-CA-C 115.088 1.514 . . . . 0.0 115.088 147.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . . . -80.26 -63.41 1.42 Allowed 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.366 -0.833 . . . . 0.0 108.834 -148.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -46.93 -43.74 19.27 Favored 'General case' 0 CA--C 1.576 1.945 0 N-CA-C 117.292 2.331 . . . . 0.0 117.292 171.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . . . -94.73 -5.63 44.95 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 119.211 3.041 . . . . 0.0 119.211 -177.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . . . -85.01 -31.68 23.34 Favored 'General case' 1 N--CA 1.553 4.71 2 N-CA-C 127.488 6.107 . . . . 0.0 127.488 161.148 . . . . . . . . 3 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . . . -39.7 -60.4 0.99 Allowed 'General case' 1 C--N 1.219 -5.089 3 CA-C-N 100.176 -7.738 . . . . 0.0 124.601 164.121 . . . . . . . . 3 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . . . -31.92 -42.04 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.252 -3.657 2 CA-C-N 100.838 -7.437 . . . . 0.0 130.29 137.636 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . . . -93.78 -0.36 55.92 Favored 'General case' 0 C--N 1.275 -2.653 0 N-CA-C 121.535 3.902 . . . . 0.0 121.535 164.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . . . -87.33 -24.65 24.22 Favored 'General case' 0 CA--C 1.609 3.229 0 CA-C-N 109.041 -3.709 . . . . 0.0 114.416 173.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . . . -97.24 -57.74 2.19 Favored 'General case' 0 N--CA 1.505 2.321 1 C-N-CA 132.261 4.224 . . . . 0.0 111.061 -177.831 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.22 18.01 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.755 0 CA-C-N 112.0 -2.364 . . . . 0.0 116.154 139.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.317 -0.821 0 O-C-N 119.598 -1.939 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.564 3.106 0 N-CA-C 114.76 0.664 . . . . 0.0 114.76 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . . . -102.63 6.7 0.43 Allowed 'Trans proline' 0 CA--C 1.576 2.602 1 N-CA-C 128.743 6.401 . . . . 0.0 128.743 -174.244 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . . . -33.15 -56.99 0.4 Allowed 'General case' 0 C--N 1.263 -3.172 4 C-N-CA 137.357 6.263 . . . . 0.0 124.55 118.893 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -96.7 -38.18 10.02 Favored 'General case' 0 N--CA 1.493 1.677 3 C-N-CA 135.348 5.459 . . . . 0.0 113.978 -158.085 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . . . -93.27 -21.04 19.84 Favored 'General case' 0 CA--C 1.464 -2.33 3 N-CA-C 136.754 9.539 . . . . 0.0 136.754 145.745 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . . . -50.16 -55.24 6.12 Favored 'Isoleucine or valine' 0 CA--C 1.434 -3.493 0 CA-C-N 111.383 -2.644 . . . . 0.0 107.923 129.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . . . -33.26 -42.55 0.09 Allowed 'General case' 1 C--N 1.231 -4.549 1 N-CA-C 131.661 7.652 . . . . 0.0 131.661 -162.509 . . . . . . . . 3 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -97.54 -49.81 4.74 Favored 'General case' 1 N--CA 1.32 -6.968 3 CA-C-N 89.772 -12.467 . . . . 0.0 113.709 -147.489 . . . . . . . . 3 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.465 ' O ' ' CD ' ' A' ' 13' ' ' PRO . . . -74.51 5.71 4.47 Favored 'General case' 0 C--N 1.375 1.682 2 N-CA-C 138.88 10.326 . . . . 0.0 138.88 129.766 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . . . -66.9 -31.23 52.53 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.079 2 CA-C-O 133.719 6.485 . . . . 0.0 125.265 158.154 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . . . -108.39 -61.52 1.58 Allowed 'General case' 2 CA--C 1.4 -4.824 4 CA-C-N 91.714 -11.584 . . . . 0.0 124.904 -141.411 . . . . . . . . 3 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -78.44 -9.1 0.13 Allowed Pre-proline 0 C--N 1.269 -2.928 2 CA-C-N 99.95 -7.841 . . . . 0.0 118.66 160.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.465 ' CD ' ' O ' ' A' ' 9' ' ' SER . 0.1 OUTLIER -68.35 -18.48 44.28 Favored 'Trans proline' 0 N--CA 1.502 1.978 2 N-CA-C 135.041 8.823 . . . . 0.0 135.041 123.639 . . . . . . . . 4 4 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -70.07 -14.01 70.49 Favored Glycine 1 N--CA 1.53 4.964 2 CA-C-N 107.613 -4.358 . . . . 0.0 121.2 156.1 . . . . . . . . 3 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . . . -101.74 -70.33 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.457 -2.634 3 C-N-CA 136.666 5.986 . . . . 0.0 108.097 -175.185 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -71.88 -1.62 14.94 Favored 'General case' 1 C--N 1.237 -4.303 0 CA-C-N 109.03 -3.713 . . . . 0.0 111.506 -177.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -54.37 -82.87 0.01 OUTLIER 'General case' 0 C--N 1.359 0.983 1 N-CA-C 128.361 6.43 . . . . 0.0 128.361 125.43 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -32.52 -52.51 0.3 Allowed 'General case' 0 CA--C 1.582 2.197 0 N-CA-C 116.976 2.213 . . . . 0.0 116.976 170.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . . . -68.7 -55.98 9.62 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 113.004 -1.907 . . . . 0.0 113.08 -173.028 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -52.42 -39.46 61.01 Favored 'General case' 0 CA--C 1.586 2.353 0 N-CA-C 118.788 2.884 . . . . 0.0 118.788 171.164 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . . . -91.25 -5.55 54.6 Favored 'General case' 0 N--CA 1.516 2.869 0 N-CA-C 120.011 3.337 . . . . 0.0 120.011 178.138 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . . . -88.72 -30.18 19.28 Favored 'General case' 1 N--CA 1.543 4.177 2 N-CA-C 127.092 5.96 . . . . 0.0 127.092 164.607 . . . . . . . . 3 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . . . -37.79 -63.38 0.47 Allowed 'General case' 1 C--N 1.215 -5.257 2 CA-C-N 101.835 -6.984 . . . . 0.0 124.732 157.637 . . . . . . . . 3 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . . . -33.45 -48.4 0.11 Allowed 'Isoleucine or valine' 1 C--N 1.242 -4.076 2 N-CA-C 130.358 7.17 . . . . 0.0 130.358 139.494 . . . . . . . . 3 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . . . -77.87 -5.72 51.9 Favored 'General case' 0 C--N 1.276 -2.598 1 N-CA-C 123.031 4.456 . . . . 0.0 123.031 163.232 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . . . -92.82 -67.93 0.83 Allowed 'General case' 0 N--CA 1.527 3.413 0 CA-C-N 111.724 -2.489 . . . . 0.0 115.948 -161.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . . . -46.01 -53.87 9.36 Favored 'General case' 0 N--CA 1.497 1.875 1 CA-C-N 108.041 -4.163 . . . . 0.0 117.082 146.565 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -77.98 -62.92 1.52 Allowed 'General case' 0 N--CA 1.496 1.852 0 CA-C-N 122.106 2.23 . . . . 0.0 109.943 171.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.299 -1.592 0 CA-C-N 112.172 -2.286 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.553 2.467 0 N-CA-C 103.186 -3.965 . . . . 0.0 103.186 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . . . -99.64 22.62 0.23 Allowed 'Trans proline' 0 N--CA 1.523 3.264 1 N-CA-C 125.337 5.091 . . . . 0.0 125.337 152.402 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.437 ' O ' ' N ' ' A' ' 5' ' ' ARG . . . -64.55 -71.65 0.17 Allowed 'General case' 0 C--O 1.169 -3.156 2 CA-C-N 103.211 -6.359 . . . . 0.0 107.453 117.574 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -37.92 2.26 0.0 OUTLIER 'General case' 1 N--CA 1.554 4.74 0 CA-C-O 128.295 3.902 . . . . 0.0 119.857 -168.718 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.437 ' N ' ' O ' ' A' ' 3' ' ' THR . . . -90.19 -58.03 2.64 Favored 'General case' 0 C--N 1.279 -2.461 3 C-N-CA 138.758 6.823 . . . . 0.0 128.182 170.166 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.533 ' O ' ' N ' ' A' ' 10' ' ' ILE . . . -37.27 -34.62 0.11 Allowed 'Isoleucine or valine' 1 CA--C 1.395 -4.984 1 C-N-CA 136.545 5.938 . . . . 0.0 114.4 129.174 . . . . . . . . 4 3 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . . . -78.24 -49.85 12.97 Favored 'General case' 2 CA--C 1.299 -8.696 2 CA-C-O 133.146 6.212 . . . . 0.0 119.297 171.886 . . . . . . . . 3 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -41.06 -26.09 0.04 OUTLIER 'General case' 1 N--CA 1.378 -4.063 2 N-CA-C 129.633 6.901 . . . . 0.0 129.633 139.706 . . . . . . . . 3 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . . . -90.7 -19.62 23.38 Favored 'General case' 1 CA--C 1.418 -4.12 3 N-CA-C 141.226 11.195 . . . . 0.0 141.226 140.419 . . . . . . . . 3 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.533 ' N ' ' O ' ' A' ' 6' ' ' ILE . . . -66.64 -58.72 5.47 Favored 'Isoleucine or valine' 0 CA--C 1.608 3.187 2 CA-C-N 104.286 -5.87 . . . . 0.0 108.281 -167.957 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . . . -106.19 -24.89 12.21 Favored 'General case' 1 CA--C 1.36 -6.35 4 CA-C-N 93.5 -10.773 . . . . 0.0 128.026 -165.109 . . . . . . . . 3 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -78.09 -19.25 0.3 Allowed Pre-proline 0 C--N 1.258 -3.407 1 O-C-N 129.573 4.295 . . . . 0.0 117.281 160.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 0.0 OUTLIER -50.3 -26.17 15.12 Favored 'Trans proline' 0 C--N 1.313 -1.296 1 N-CA-C 136.691 9.458 . . . . 0.0 136.691 125.212 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -74.2 -7.27 76.95 Favored Glycine 1 N--CA 1.531 5.002 3 O-C-N 130.378 4.799 . . . . 0.0 122.703 156.252 . . . . . . . . 3 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . . . -110.49 -57.88 3.88 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.761 2 CA-C-N 105.29 -5.455 . . . . 0.0 117.884 -168.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -28.05 -40.29 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.638 0 CA-C-N 108.506 -3.952 . . . . 0.0 117.217 139.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -73.69 -41.16 63.0 Favored 'General case' 0 N--CA 1.426 -1.66 1 CA-C-N 107.609 -4.359 . . . . 0.0 121.061 -173.573 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -37.28 -58.66 0.81 Allowed 'General case' 0 CA--C 1.574 1.868 0 CA-C-N 112.012 -2.358 . . . . 0.0 117.198 143.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . . . -77.04 -51.86 10.34 Favored 'General case' 0 N--CA 1.487 1.382 0 CA-C-O 126.625 3.107 . . . . 0.0 113.365 -147.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -43.91 -41.63 5.32 Favored 'General case' 0 CA--C 1.584 2.253 0 CA-C-N 109.348 -3.569 . . . . 0.0 117.591 157.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . . . -91.42 -2.46 57.27 Favored 'General case' 0 N--CA 1.501 2.078 1 N-CA-C 122.744 4.35 . . . . 0.0 122.744 174.77 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . . . -97.91 -3.74 37.92 Favored 'General case' 1 N--CA 1.548 4.462 1 N-CA-C 126.259 5.651 . . . . 0.0 126.259 164.032 . . . . . . . . 3 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . . . -90.48 -42.86 10.62 Favored 'General case' 1 C--N 1.232 -4.517 4 CA-C-N 102.845 -6.525 . . . . 0.0 126.962 -173.478 . . . . . . . . 3 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . . . -28.04 -88.52 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.291 -1.965 2 CA-C-N 98.062 -8.699 . . . . 0.0 119.904 110.107 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . . . -75.04 15.53 0.4 Allowed 'General case' 0 N--CA 1.534 3.73 2 O-C-N 113.994 -5.441 . . . . 0.0 120.54 -171.868 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . . . -93.0 -61.01 1.66 Allowed 'General case' 0 N--CA 1.502 2.162 1 CA-C-N 106.498 -4.865 . . . . 0.0 114.876 167.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . . . -48.06 -43.25 30.28 Favored 'General case' 0 N--CA 1.511 2.586 0 N-CA-C 117.002 2.223 . . . . 0.0 117.002 166.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.58 -60.16 2.37 Favored 'General case' 0 N--CA 1.495 1.781 0 CA-C-N 111.889 -2.414 . . . . 0.0 113.06 157.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.297 -1.683 0 CA-C-N 114.073 -1.422 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.561 2.926 0 CA-C-O 127.723 3.957 . . . . 0.0 114.389 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . . . -56.83 -45.6 35.3 Favored 'Trans proline' 1 CA--C 1.417 -5.363 0 CA-C-O 110.699 -3.959 . . . . 0.0 120.314 169.418 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . . . -101.65 51.19 0.84 Allowed 'General case' 0 C--N 1.257 -3.442 1 O-C-N 111.982 -6.699 . . . . 0.0 115.079 156.756 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -57.0 -27.87 61.95 Favored 'General case' 0 N--CA 1.521 3.092 1 N-CA-C 123.415 4.598 . . . . 0.0 123.415 110.261 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . . . -100.35 -56.46 2.35 Favored 'General case' 0 C--N 1.282 -2.366 2 N-CA-C 124.356 4.947 . . . . 0.0 124.356 -145.709 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.536 ' O ' ' N ' ' A' ' 10' ' ' ILE . . . -38.6 -45.09 0.4 Allowed 'Isoleucine or valine' 0 C--O 1.157 -3.786 2 CA-C-N 105.654 -5.248 . . . . 0.0 111.54 126.65 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.46 ' O ' ' N ' ' A' ' 11' ' ' LEU . . . -61.41 -60.55 3.55 Favored 'General case' 2 C--O 1.143 -4.543 2 CA-C-O 140.983 9.944 . . . . 0.0 113.306 -172.65 . . . . . . . . 4 3 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -36.81 -36.74 0.12 Allowed 'General case' 1 C--N 1.22 -5.031 2 CA-C-N 102.177 -6.829 . . . . 0.0 105.558 157.141 . . . . . . . . 3 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . . . -90.74 -12.67 35.88 Favored 'General case' 0 CA--C 1.431 -3.632 1 N-CA-C 134.001 8.519 . . . . 0.0 134.001 151.023 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.536 ' N ' ' O ' ' A' ' 6' ' ' ILE . . . -67.61 -57.47 9.48 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.317 0 CA-C-O 127.603 3.573 . . . . 0.0 109.122 174.529 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.46 ' N ' ' O ' ' A' ' 7' ' ' PHE . . . -112.69 -27.92 7.99 Favored 'General case' 1 CA--C 1.384 -5.421 1 CA-C-N 99.256 -8.156 . . . . 0.0 121.566 -156.162 . . . . . . . . 4 3 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -101.48 19.66 0.05 OUTLIER Pre-proline 0 C--N 1.266 -3.026 0 C-N-CA 113.203 -3.399 . . . . 0.0 118.735 159.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 0.0 OUTLIER -53.05 -31.29 53.22 Favored 'Trans proline' 0 N--CA 1.523 3.221 2 N-CA-C 132.654 7.905 . . . . 0.0 132.654 99.487 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -59.65 -25.71 61.45 Favored Glycine 3 N--CA 1.552 6.405 1 CA-C-O 129.219 4.788 . . . . 0.0 122.444 167.453 . . . . . . . . 3 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . . . -107.11 -69.86 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.28 -2.444 2 CA-C-N 101.512 -7.344 . . . . 0.0 113.698 -163.217 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -27.0 -32.43 0.0 OUTLIER 'General case' 0 C--N 1.277 -2.568 0 N-CA-C 119.676 3.213 . . . . 0.0 119.676 153.515 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -85.1 -46.01 11.55 Favored 'General case' 0 C--N 1.328 -0.363 2 N-CA-C 123.334 4.568 . . . . 0.0 123.334 167.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -39.18 -57.74 1.28 Allowed 'General case' 0 N--CA 1.508 2.425 0 CA-C-O 123.249 1.499 . . . . 0.0 114.302 151.126 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . . . -81.99 -55.76 4.38 Favored 'General case' 0 CA--C 1.553 1.083 0 CA-C-O 123.32 1.533 . . . . 0.0 109.123 -140.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -48.62 -56.35 8.71 Favored 'General case' 0 CA--C 1.567 1.603 0 CA-C-N 112.728 -2.033 . . . . 0.0 115.128 162.009 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . . . -90.24 13.26 15.73 Favored 'General case' 0 N--CA 1.532 3.672 1 O-C-N 116.052 -4.155 . . . . 0.0 119.216 -178.568 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . . . -87.48 -32.72 19.31 Favored 'General case' 0 CA--C 1.427 -3.761 0 N-CA-C 121.464 3.876 . . . . 0.0 121.464 158.019 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . . . -43.52 -59.11 2.3 Favored 'General case' 0 C--N 1.253 -3.598 0 CA-C-N 108.665 -3.88 . . . . 0.0 114.804 174.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . . . -36.23 -46.14 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.26 -3.284 2 CA-C-N 102.379 -6.737 . . . . 0.0 125.261 148.161 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . . . -72.13 -14.47 61.84 Favored 'General case' 0 C--N 1.278 -2.502 1 N-CA-C 121.991 4.071 . . . . 0.0 121.991 162.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . . . -91.01 -61.56 1.64 Allowed 'General case' 0 N--CA 1.511 2.602 0 CA-C-N 110.681 -2.963 . . . . 0.0 108.375 -160.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . . . -49.91 -42.58 48.41 Favored 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 128.659 2.784 . . . . 0.0 118.238 157.232 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.7 -50.19 46.09 Favored 'General case' 0 N--CA 1.503 2.208 0 CA-C-O 124.159 1.933 . . . . 0.0 110.227 161.257 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.301 -1.532 0 CA-C-N 113.05 -1.886 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.562 2.978 0 N-CA-C 118.375 2.11 . . . . 0.0 118.375 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . . . -96.34 -6.85 1.31 Allowed 'Trans proline' 1 CA--C 1.606 4.089 1 C-N-CA 125.855 4.37 . . . . 0.0 120.872 -177.064 . . . . . . . . 3 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.432 ' O ' ' N ' ' A' ' 7' ' ' PHE . . . -32.77 -68.32 0.1 Allowed 'General case' 1 C--O 1.148 -4.265 2 CA-C-N 106.772 -4.74 . . . . 0.0 119.442 117.856 . . . . . . . . 4 3 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -58.47 -21.46 51.49 Favored 'General case' 0 N--CA 1.503 2.181 0 CA-C-O 127.295 3.426 . . . . 0.0 116.887 179.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . . . -95.0 -42.43 8.64 Favored 'General case' 0 C--N 1.296 -1.743 3 CA-C-N 103.729 -6.123 . . . . 0.0 125.905 174.684 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.428 ' O ' ' N ' ' A' ' 9' ' ' SER . . . -45.95 -51.69 3.39 Favored 'Isoleucine or valine' 0 C--O 1.192 -1.932 0 O-C-N 128.948 3.905 . . . . 0.0 106.128 136.752 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.436 ' O ' ' N ' ' A' ' 10' ' ' ILE . . . -45.32 -64.44 0.72 Allowed 'General case' 3 N--CA 1.561 5.098 0 O-C-N 126.551 2.407 . . . . 0.0 113.063 -155.942 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -39.38 -47.62 1.79 Allowed 'General case' 1 N--CA 1.373 -4.319 4 C-N-CA 153.271 12.628 . . . . 0.0 100.027 166.512 . . . . . . . . 3 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.471 ' O ' ' CG ' ' A' ' 13' ' ' PRO . . . -91.75 19.2 6.67 Favored 'General case' 0 N--CA 1.513 2.676 1 N-CA-C 132.711 8.041 . . . . 0.0 132.711 153.15 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.436 ' N ' ' O ' ' A' ' 7' ' ' PHE . . . -109.29 -49.65 7.09 Favored 'Isoleucine or valine' 2 CA--C 1.644 4.576 2 N-CA-C 98.912 -4.477 . . . . 0.0 98.912 -177.547 . . . . . . . . 4 3 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . . . -62.97 -52.78 61.66 Favored 'General case' 1 CA--C 1.361 -6.297 2 C-N-CA 138.429 6.692 . . . . 0.0 126.301 -177.71 . . . . . . . . 3 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -95.83 -15.52 0.2 Allowed Pre-proline 0 C--N 1.248 -3.844 2 O-C-N 135.102 7.751 . . . . 0.0 112.744 -177.212 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.471 ' CG ' ' O ' ' A' ' 9' ' ' SER . 0.1 OUTLIER -54.67 -24.55 37.8 Favored 'Trans proline' 0 N--CA 1.504 2.144 1 N-CA-C 128.56 6.331 . . . . 0.0 128.56 121.467 . . . . . . . . 4 4 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -85.83 -0.3 87.63 Favored Glycine 2 N--CA 1.533 5.157 1 CA-C-N 108.127 -4.124 . . . . 0.0 121.814 164.465 . . . . . . . . 3 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . . . -103.89 -69.36 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.642 2 CA-C-N 106.409 -4.896 . . . . 0.0 114.335 175.523 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -24.03 -41.4 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.714 0 CA-C-N 110.865 -2.88 . . . . 0.0 117.994 156.02 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.44 -81.66 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.716 1 CA-C-N 106.073 -5.058 . . . . 0.0 121.287 158.512 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -36.33 -60.12 0.59 Allowed 'General case' 0 CA--C 1.581 2.168 0 N-CA-C 117.182 2.29 . . . . 0.0 117.182 171.235 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . . . -58.69 -57.38 13.25 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 128.874 2.87 . . . . 0.0 112.347 -168.166 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -71.7 -36.48 70.58 Favored 'General case' 0 CA--C 1.574 1.893 0 C-N-CA 127.689 2.396 . . . . 0.0 115.667 -176.185 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . . . -85.88 -0.86 56.48 Favored 'General case' 0 N--CA 1.506 2.374 0 N-CA-C 117.598 2.444 . . . . 0.0 117.598 173.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . . . -104.67 -26.87 12.13 Favored 'General case' 1 N--CA 1.554 4.743 1 N-CA-C 125.376 5.325 . . . . 0.0 125.376 176.427 . . . . . . . . 3 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . . . -35.0 -68.89 0.11 Allowed 'General case' 0 C--N 1.258 -3.37 1 CA-C-N 102.823 -6.535 . . . . 0.0 118.625 146.805 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . . . -34.28 -41.0 0.09 OUTLIER 'Isoleucine or valine' 1 C--N 1.236 -4.335 2 CA-C-N 105.484 -5.325 . . . . 0.0 122.642 148.921 . . . . . . . . 3 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . . . -94.71 2.47 55.56 Favored 'General case' 0 C--N 1.275 -2.646 0 N-CA-C 120.837 3.643 . . . . 0.0 120.837 170.524 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . . . -91.2 -25.11 19.69 Favored 'General case' 0 CA--C 1.608 3.185 0 CA-C-N 108.552 -3.931 . . . . 0.0 113.977 169.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . . . -96.85 -59.3 1.83 Allowed 'General case' 0 N--CA 1.507 2.419 0 C-N-CA 131.157 3.783 . . . . 0.0 110.163 -176.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.44 23.4 0.12 Allowed 'General case' 0 N--CA 1.497 1.886 0 CA-C-N 112.195 -2.275 . . . . 0.0 114.233 141.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.316 -0.87 0 O-C-N 119.359 -2.088 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.569 3.448 0 N-CA-C 117.691 1.837 . . . . 0.0 117.691 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . . . -120.96 14.59 0.02 OUTLIER 'Trans proline' 0 CA--C 1.561 1.848 1 N-CA-C 125.474 5.144 . . . . 0.0 125.474 -164.537 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . . . -55.56 -67.84 0.25 Allowed 'General case' 0 C--O 1.179 -2.642 2 CA-C-O 109.121 -5.228 . . . . 0.0 108.441 114.047 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -52.31 -1.14 0.02 OUTLIER 'General case' 1 N--CA 1.569 5.521 1 CA-C-O 131.128 5.251 . . . . 0.0 118.594 -147.739 . . . . . . . . 3 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . . . -93.29 -56.29 3.0 Favored 'General case' 0 C--N 1.269 -2.895 3 C-N-CA 142.114 8.166 . . . . 0.0 123.219 -176.515 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.423 ' O ' ' N ' ' A' ' 10' ' ' ILE . . . -39.28 -29.77 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.435 -3.457 1 CA-C-O 110.952 -4.356 . . . . 0.0 109.516 125.494 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . . . -72.34 -56.85 4.8 Favored 'General case' 1 N--CA 1.558 4.939 2 CA-C-O 131.312 5.339 . . . . 0.0 115.367 -173.013 . . . . . . . . 3 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -37.44 -49.24 1.01 Allowed 'General case' 1 C--N 1.233 -4.497 3 C-N-CA 142.179 8.192 . . . . 0.0 100.704 150.732 . . . . . . . . 3 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.484 ' O ' ' CG ' ' A' ' 13' ' ' PRO . . . -102.66 -6.46 22.69 Favored 'General case' 0 N--CA 1.52 3.065 1 N-CA-C 128.829 6.603 . . . . 0.0 128.829 174.957 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.423 ' N ' ' O ' ' A' ' 6' ' ' ILE . . . -84.85 -47.54 17.08 Favored 'Isoleucine or valine' 1 C--N 1.231 -4.562 2 CA-C-N 106.894 -4.685 . . . . 0.0 98.392 -179.455 . . . . . . . . 4 3 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . . . -106.13 -33.38 7.87 Favored 'General case' 1 CA--C 1.378 -5.64 1 N-CA-C 123.457 4.614 . . . . 0.0 123.457 -157.276 . . . . . . . . 3 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -76.41 -23.1 0.44 Allowed Pre-proline 0 C--N 1.246 -3.897 2 O-C-N 130.065 4.603 . . . . 0.0 113.343 166.808 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.484 ' CG ' ' O ' ' A' ' 9' ' ' SER . 0.0 OUTLIER -48.34 -27.45 9.9 Favored 'Trans proline' 0 CA--C 1.476 -2.416 1 N-CA-C 129.113 6.544 . . . . 0.0 129.113 127.895 . . . . . . . . 4 4 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -64.93 -21.03 67.29 Favored Glycine 2 N--CA 1.544 5.855 1 CA-C-O 128.106 4.17 . . . . 0.0 122.742 160.041 . . . . . . . . 3 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . . . -108.45 -68.99 0.95 Allowed 'Isoleucine or valine' 0 CA--C 1.462 -2.427 2 CA-C-N 103.262 -6.469 . . . . 0.0 111.936 -159.667 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -26.37 -32.92 0.0 OUTLIER 'General case' 0 C--N 1.269 -2.921 0 N-CA-C 119.937 3.31 . . . . 0.0 119.937 148.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -88.75 -41.46 12.53 Favored 'General case' 0 N--CA 1.466 0.326 2 N-CA-C 123.7 4.704 . . . . 0.0 123.7 167.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -39.01 -59.15 1.02 Allowed 'General case' 0 N--CA 1.511 2.593 0 CA-C-O 123.796 1.76 . . . . 0.0 114.881 148.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . . . -77.3 -56.46 4.53 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 114.714 -1.13 . . . . 0.0 108.316 -143.117 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -42.44 -45.4 4.38 Favored 'General case' 0 CA--C 1.582 2.204 0 C-N-CA 126.52 1.928 . . . . 0.0 115.741 159.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . . . -92.57 1.77 57.07 Favored 'General case' 0 CA--C 1.578 2.054 0 N-CA-C 119.251 3.056 . . . . 0.0 119.251 -176.015 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . . . -106.54 -15.7 14.72 Favored 'General case' 1 N--CA 1.56 5.064 1 N-CA-C 124.075 4.843 . . . . 0.0 124.075 157.521 . . . . . . . . 3 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . . . -36.68 -69.67 0.11 Allowed 'General case' 1 C--N 1.233 -4.468 0 CA-C-N 108.794 -3.821 . . . . 0.0 118.61 157.36 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . . . -35.47 -43.65 0.15 Allowed 'Isoleucine or valine' 1 C--N 1.224 -4.879 2 CA-C-N 102.526 -6.67 . . . . 0.0 123.099 149.961 . . . . . . . . 3 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . . . -92.29 1.82 57.0 Favored 'General case' 0 C--N 1.292 -1.893 0 N-CA-C 118.398 2.74 . . . . 0.0 118.398 171.163 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . . . -90.91 -32.57 15.95 Favored 'General case' 0 CA--C 1.612 3.328 0 CA-C-N 110.71 -2.95 . . . . 0.0 113.632 175.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . . . -97.05 -48.91 5.21 Favored 'General case' 0 N--CA 1.509 2.482 1 C-N-CA 131.968 4.107 . . . . 0.0 110.818 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -78.44 22.74 0.32 Allowed 'General case' 0 N--CA 1.499 1.985 0 C-N-CA 117.586 -1.646 . . . . 0.0 113.419 140.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.317 -0.807 0 O-C-N 119.622 -1.924 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.56 2.883 0 CA-C-O 119.151 -0.805 . . . . 0.0 112.022 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . . . -130.01 26.42 0.0 OUTLIER 'Trans proline' 0 N--CA 1.514 2.723 1 N-CA-C 125.119 5.007 . . . . 0.0 125.119 -163.673 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . . . -54.92 -81.51 0.01 OUTLIER 'General case' 0 C--O 1.189 -2.109 2 CA-C-N 104.679 -5.691 . . . . 0.0 100.148 109.012 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -61.03 -10.26 5.68 Favored 'General case' 0 N--CA 1.521 3.075 0 O-C-N 127.694 3.121 . . . . 0.0 118.458 -122.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . . . -95.13 -48.8 5.79 Favored 'General case' 0 C--N 1.301 -1.542 4 C-N-CA 141.899 8.08 . . . . 0.0 128.466 -176.226 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . . . -37.16 -60.3 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.512 2.631 3 N-CA-C 89.576 -7.935 . . . . 0.0 89.576 142.834 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . . . -103.34 -32.04 9.75 Favored 'General case' 1 N--CA 1.371 -4.405 1 CA-C-O 130.934 5.159 . . . . 0.0 111.664 -128.603 . . . . . . . . 3 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -45.88 -36.27 5.22 Favored 'General case' 0 CA--C 1.446 -3.053 1 O-C-N 116.054 -4.154 . . . . 0.0 121.197 126.757 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.425 ' O ' ' CG ' ' A' ' 13' ' ' PRO . . . -90.7 10.6 25.2 Favored 'General case' 0 N--CA 1.524 3.258 1 N-CA-C 125.11 5.226 . . . . 0.0 125.11 176.094 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . . . -110.99 -42.39 4.74 Favored 'Isoleucine or valine' 1 CA--C 1.651 4.855 1 CA-C-N 106.817 -4.719 . . . . 0.0 102.094 -176.364 . . . . . . . . 3 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . . . -54.71 -59.33 4.86 Favored 'General case' 1 CA--C 1.373 -5.852 1 C-N-CA 138.069 6.548 . . . . 0.0 120.91 170.374 . . . . . . . . 3 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -81.89 -41.18 1.01 Allowed Pre-proline 1 N--CA 1.362 -4.857 1 CA-C-N 105.47 -5.332 . . . . 0.0 102.968 -172.42 . . . . . . . . 3 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.425 ' CG ' ' O ' ' A' ' 9' ' ' SER . 0.1 OUTLIER -37.56 -22.4 0.05 OUTLIER 'Trans proline' 0 N--CA 1.518 2.927 2 O-C-N 108.919 -6.411 . . . . 0.0 127.829 134.853 . . . . . . . . 4 4 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -80.33 -7.21 88.76 Favored Glycine 2 N--CA 1.529 4.851 1 CA-C-N 108.141 -4.118 . . . . 0.0 119.886 163.045 . . . . . . . . 3 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . . . -105.86 -76.53 0.46 Allowed 'Isoleucine or valine' 0 C--O 1.2 -1.521 2 C-N-CA 133.1 4.56 . . . . 0.0 110.89 -166.775 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -21.1 -34.71 0.0 OUTLIER 'General case' 0 C--N 1.26 -3.306 0 N-CA-C 120.367 3.469 . . . . 0.0 120.367 147.001 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -83.8 -45.29 13.46 Favored 'General case' 0 N--CA 1.476 0.827 1 N-CA-C 125.246 5.276 . . . . 0.0 125.246 160.531 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -36.4 -55.42 0.82 Allowed 'General case' 0 N--CA 1.517 2.878 0 CA-C-O 125.235 2.445 . . . . 0.0 116.276 154.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . . . -78.07 -50.25 12.42 Favored 'General case' 0 N--CA 1.48 1.047 0 CA-C-O 124.047 1.879 . . . . 0.0 111.327 -152.057 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -37.93 -48.98 1.21 Allowed 'General case' 0 N--CA 1.413 -2.29 0 C-N-CA 131.617 3.967 . . . . 0.0 120.836 149.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . . . -87.89 7.86 28.83 Favored 'General case' 0 N--CA 1.514 2.731 0 N-CA-C 119.901 3.297 . . . . 0.0 119.901 170.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . . . -104.08 -30.69 10.09 Favored 'General case' 0 N--CA 1.534 3.771 1 N-CA-C 124.429 4.974 . . . . 0.0 124.429 173.572 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . . . -37.82 -59.49 0.81 Allowed 'General case' 0 C--N 1.258 -3.404 2 CA-C-N 104.18 -5.918 . . . . 0.0 121.877 152.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . . . -36.13 -47.24 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.262 -3.205 3 O-C-N 134.567 7.417 . . . . 0.0 123.071 140.259 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . . . -91.89 4.81 52.09 Favored 'General case' 0 C--N 1.269 -2.902 0 O-C-N 119.128 -2.233 . . . . 0.0 116.437 170.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . . . -96.56 -60.0 1.7 Allowed 'General case' 0 N--CA 1.521 3.112 0 CA-C-N 110.475 -3.057 . . . . 0.0 113.572 -175.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . . . -47.16 -38.4 11.69 Favored 'General case' 0 N--CA 1.51 2.564 0 CA-C-N 109.06 -3.7 . . . . 0.0 115.053 158.175 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -91.13 -83.19 0.28 Allowed 'General case' 0 N--CA 1.489 1.489 0 CA-C-O 123.36 1.552 . . . . 0.0 108.411 164.202 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.296 -1.741 0 O-C-N 121.224 -0.923 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.558 2.736 0 CA-C-O 123.645 1.692 . . . . 0.0 117.12 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . . . -65.5 -54.1 0.66 Allowed 'Trans proline' 1 CA--C 1.412 -5.587 0 CA-C-O 110.883 -3.882 . . . . 0.0 118.752 -172.021 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . . . -96.25 56.96 1.66 Allowed 'General case' 0 C--N 1.264 -3.126 2 O-C-N 111.859 -6.776 . . . . 0.0 112.104 149.558 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -75.56 -14.36 60.39 Favored 'General case' 0 N--CA 1.523 3.19 1 O-C-N 116.156 -4.09 . . . . 0.0 121.269 111.379 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . . . -97.47 -55.55 2.79 Favored 'General case' 0 N--CA 1.492 1.635 1 N-CA-C 122.161 4.134 . . . . 0.0 122.161 -155.803 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . . . -38.32 -55.09 0.35 Allowed 'Isoleucine or valine' 1 CA--C 1.418 -4.104 0 CA-C-N 108.428 -3.987 . . . . 0.0 111.262 131.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.414 ' O ' ' N ' ' A' ' 10' ' ' ILE . . . -45.87 -63.27 1.01 Allowed 'General case' 3 CA--C 1.299 -8.704 0 O-C-N 127.406 2.941 . . . . 0.0 111.007 -175.001 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -35.63 -49.1 0.55 Allowed 'General case' 0 C--N 1.273 -2.733 2 C-N-CA 141.414 7.886 . . . . 0.0 104.361 167.591 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.458 ' O ' ' CG ' ' A' ' 13' ' ' PRO . . . -76.44 -13.43 60.11 Favored 'General case' 1 N--CA 1.539 4.024 2 N-CA-C 134.667 8.765 . . . . 0.0 134.667 169.0 . . . . . . . . 4 3 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.414 ' N ' ' O ' ' A' ' 7' ' ' PHE . . . -103.84 -45.55 9.79 Favored 'Isoleucine or valine' 2 C--N 1.204 -5.731 2 CA-C-N 97.549 -8.932 . . . . 0.0 99.1 -161.293 . . . . . . . . 4 3 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . . . -94.77 -56.6 2.72 Favored 'General case' 1 CA--C 1.397 -4.931 1 C-N-CA 135.144 5.378 . . . . 0.0 118.402 -148.135 . . . . . . . . 3 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -86.26 -12.89 0.19 Allowed Pre-proline 0 C--N 1.262 -3.199 2 O-C-N 135.848 8.217 . . . . 0.0 113.32 178.766 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.458 ' CG ' ' O ' ' A' ' 9' ' ' SER . 0.1 OUTLIER -56.08 -27.7 66.09 Favored 'Trans proline' 0 N--CA 1.52 3.053 2 N-CA-C 131.501 7.462 . . . . 0.0 131.501 118.579 . . . . . . . . 4 4 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -77.97 -5.15 86.71 Favored Glycine 3 N--CA 1.562 7.051 2 CA-C-O 130.659 5.589 . . . . 0.0 123.301 164.845 . . . . . . . . 3 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . . . -105.61 -78.4 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.278 -2.514 2 C-N-CA 139.386 7.074 . . . . 0.0 117.819 179.616 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -29.6 -30.34 0.0 OUTLIER 'General case' 0 C--N 1.264 -3.139 0 N-CA-C 117.932 2.567 . . . . 0.0 117.932 152.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -53.19 -77.56 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.863 0 CA-C-N 109.21 -3.632 . . . . 0.0 120.627 150.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -33.68 -58.27 0.42 Allowed 'General case' 0 CA--C 1.571 1.788 0 N-CA-C 116.685 2.106 . . . . 0.0 116.685 169.425 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . . . -64.8 -41.37 95.85 Favored 'General case' 0 CA--C 1.552 1.04 0 CA-C-N 113.6 -1.636 . . . . 0.0 113.67 -164.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -83.43 -27.8 29.28 Favored 'General case' 0 CA--C 1.582 2.198 0 C-N-CA 129.142 2.977 . . . . 0.0 114.593 -178.317 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . . . -84.51 3.66 35.45 Favored 'General case' 0 N--CA 1.505 2.304 0 N-CA-C 120.034 3.346 . . . . 0.0 120.034 158.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . . . -103.39 -27.16 12.6 Favored 'General case' 1 N--CA 1.548 4.443 1 N-CA-C 124.534 5.012 . . . . 0.0 124.534 173.261 . . . . . . . . 3 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . . . -35.99 -67.41 0.16 Allowed 'General case' 0 C--N 1.257 -3.414 1 CA-C-N 103.779 -6.101 . . . . 0.0 119.048 149.065 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . . . -33.9 -41.86 0.09 OUTLIER 'Isoleucine or valine' 1 C--N 1.239 -4.219 2 CA-C-N 104.851 -5.613 . . . . 0.0 122.801 147.961 . . . . . . . . 3 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . . . -94.43 3.08 55.63 Favored 'General case' 0 C--N 1.274 -2.705 0 N-CA-C 120.838 3.644 . . . . 0.0 120.838 170.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . . . -90.97 -25.75 19.59 Favored 'General case' 0 CA--C 1.609 3.222 1 CA-C-N 108.381 -4.008 . . . . 0.0 113.831 169.34 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . . . -96.82 -59.11 1.87 Allowed 'General case' 0 N--CA 1.507 2.406 0 C-N-CA 131.266 3.826 . . . . 0.0 110.239 -176.264 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.14 23.62 0.1 Allowed 'General case' 0 N--CA 1.498 1.929 0 CA-C-N 112.152 -2.295 . . . . 0.0 114.225 141.353 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.316 -0.849 0 O-C-N 119.361 -2.087 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.572 3.632 0 N-CA-C 117.796 1.878 . . . . 0.0 117.796 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . . . -127.34 -7.92 0.0 OUTLIER 'Trans proline' 1 N--CA 1.538 4.106 1 N-CA-C 129.978 6.876 . . . . 0.0 129.978 -155.399 . . . . . . . . 3 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.467 ' O ' ' CA ' ' A' ' 7' ' ' PHE . . . -35.68 -61.72 0.45 Allowed 'General case' 0 C--O 1.161 -3.603 2 CA-C-N 100.892 -7.413 . . . . 0.0 110.959 119.192 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -93.54 -21.28 19.54 Favored 'General case' 0 N--CA 1.524 3.248 1 CA-C-O 129.78 4.609 . . . . 0.0 115.973 -137.223 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . . . -90.0 -22.43 21.9 Favored 'General case' 0 C--N 1.268 -2.95 3 N-CA-C 141.871 11.434 . . . . 0.0 141.871 136.498 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.438 ' O ' ' N ' ' A' ' 10' ' ' ILE . . . -46.01 -43.32 4.73 Favored 'Isoleucine or valine' 0 CA--C 1.465 -2.289 0 O-C-N 128.886 3.866 . . . . 0.0 106.763 126.095 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.467 ' CA ' ' O ' ' A' ' 3' ' ' THR . . . -67.08 -61.16 2.07 Favored 'General case' 0 N--CA 1.401 -2.919 1 CA-C-O 129.405 4.431 . . . . 0.0 118.194 -133.813 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -35.1 -27.18 0.01 OUTLIER 'General case' 2 C--N 1.195 -6.132 2 N-CA-C 136.562 9.467 . . . . 0.0 136.562 130.275 . . . . . . . . 3 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . . . -89.35 5.59 44.39 Favored 'General case' 0 C--N 1.255 -3.502 1 N-CA-C 135.188 8.958 . . . . 0.0 135.188 140.647 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.438 ' N ' ' O ' ' A' ' 6' ' ' ILE . . . -67.7 -43.29 86.71 Favored 'Isoleucine or valine' 0 C--N 1.255 -3.503 1 CA-C-O 129.246 4.355 . . . . 0.0 118.642 162.302 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . . . -116.82 -28.85 6.21 Favored 'General case' 1 CA--C 1.406 -4.584 3 CA-C-N 98.219 -8.628 . . . . 0.0 127.937 -149.486 . . . . . . . . 3 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -76.91 -23.93 0.45 Allowed Pre-proline 1 C--N 1.244 -4.003 3 O-C-N 135.077 7.736 . . . . 0.0 122.988 150.65 . . . . . . . . 3 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -59.36 -22.76 67.14 Favored 'Trans proline' 0 C--N 1.31 -1.486 1 N-CA-C 130.72 7.162 . . . . 0.0 130.72 128.365 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -80.66 4.91 66.75 Favored Glycine 1 N--CA 1.518 4.118 2 CA-C-N 104.567 -5.742 . . . . 0.0 120.26 159.043 . . . . . . . . 3 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . . . -113.39 -67.72 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 C-N-CA 131.127 3.771 . . . . 0.0 113.058 -174.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -26.96 -34.96 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 108.917 -3.765 . . . . 0.0 119.506 145.139 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.83 -70.4 0.21 Allowed 'General case' 0 N--CA 1.441 -0.91 2 N-CA-C 126.167 5.618 . . . . 0.0 126.167 155.335 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -38.22 -54.76 1.37 Allowed 'General case' 0 CA--C 1.583 2.232 0 N-CA-C 118.187 2.662 . . . . 0.0 118.187 163.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . . . -39.46 -56.47 1.6 Allowed 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 129.731 3.213 . . . . 0.0 115.507 174.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -80.9 -27.28 36.32 Favored 'General case' 0 CA--C 1.567 1.598 0 CA-C-N 109.998 -3.274 . . . . 0.0 113.757 -178.228 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . . . -98.49 10.52 40.73 Favored 'General case' 0 N--CA 1.525 3.297 1 N-CA-C 130.874 7.361 . . . . 0.0 130.874 160.018 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . . . -95.12 -28.37 15.11 Favored 'General case' 0 N--CA 1.538 3.934 2 N-CA-C 125.718 5.451 . . . . 0.0 125.718 157.715 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . . . -30.84 -56.75 0.22 Allowed 'General case' 2 N--CA 1.366 -4.645 2 CA-C-N 103.517 -6.22 . . . . 0.0 119.53 138.208 . . . . . . . . 3 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . . . -94.35 -8.88 9.67 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.239 0 C-N-CA 113.901 -3.12 . . . . 0.0 117.924 -171.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . . . -71.02 -14.52 62.37 Favored 'General case' 0 C--N 1.307 -1.252 1 N-CA-C 127.46 6.096 . . . . 0.0 127.46 148.531 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . . . -92.6 -48.36 6.65 Favored 'General case' 1 N--CA 1.548 4.465 0 N-CA-C 118.845 2.906 . . . . 0.0 118.845 -162.219 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . . . -46.19 -72.98 0.04 OUTLIER 'General case' 0 C--N 1.288 -2.076 1 CA-C-N 106.22 -4.991 . . . . 0.0 117.266 138.536 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -77.1 -58.77 3.09 Favored 'General case' 0 N--CA 1.493 1.712 0 CA-C-O 124.802 2.239 . . . . 0.0 111.548 -172.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.298 -1.673 0 CA-C-N 111.988 -2.369 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.557 2.685 0 CA-C-O 123.632 1.684 . . . . 0.0 115.952 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . . . -63.09 -45.4 12.62 Favored 'Trans proline' 1 CA--C 1.422 -5.101 0 N-CA-C 121.899 3.769 . . . . 0.0 121.899 -178.722 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . . . -95.7 47.98 1.12 Allowed 'General case' 0 C--N 1.267 -2.982 1 O-C-N 111.697 -6.877 . . . . 0.0 112.956 147.008 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -63.05 -17.92 62.78 Favored 'General case' 0 N--CA 1.521 3.116 1 N-CA-C 123.337 4.569 . . . . 0.0 123.337 117.684 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . . . -105.92 -56.89 2.12 Favored 'General case' 0 C--N 1.298 -1.656 3 N-CA-C 124.967 5.173 . . . . 0.0 124.967 -141.292 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.488 ' O ' ' N ' ' A' ' 10' ' ' ILE . . . -35.48 -61.11 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.425 -3.838 1 CA-C-N 106.682 -4.781 . . . . 0.0 114.599 113.43 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . . . -35.39 -41.01 0.17 Allowed 'General case' 3 CA--C 1.333 -7.403 2 N-CA-C 129.336 6.791 . . . . 0.0 129.336 -179.487 . . . . . . . . 3 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -57.03 -52.26 65.99 Favored 'General case' 1 N--CA 1.315 -7.192 4 O-C-N 145.693 14.37 . . . . 0.0 125.673 165.426 . . . . . . . . 3 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.436 ' O ' ' CG ' ' A' ' 13' ' ' PRO . . . -97.3 0.37 47.94 Favored 'General case' 0 N--CA 1.501 2.096 3 N-CA-C 132.805 8.076 . . . . 0.0 132.805 160.782 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.488 ' N ' ' O ' ' A' ' 6' ' ' ILE . . . -62.61 -39.72 85.68 Favored 'Isoleucine or valine' 0 C--N 1.246 -3.91 2 CA-C-N 101.757 -7.019 . . . . 0.0 120.202 150.418 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . . . -100.63 -52.58 3.3 Favored 'General case' 1 CA--C 1.416 -4.194 3 CA-C-N 99.029 -8.26 . . . . 0.0 125.736 -145.088 . . . . . . . . 3 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -81.29 -21.3 0.31 Allowed Pre-proline 0 N--CA 1.379 -3.99 2 O-C-N 136.935 8.897 . . . . 0.0 116.151 167.027 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.436 ' CG ' ' O ' ' A' ' 9' ' ' SER . 12.2 Cg_exo -52.53 -24.27 21.77 Favored 'Trans proline' 0 N--CA 1.51 2.474 2 N-CA-C 134.683 8.686 . . . . 0.0 134.683 118.13 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -78.41 -3.07 85.72 Favored Glycine 2 N--CA 1.543 5.793 2 CA-C-N 106.655 -4.793 . . . . 0.0 120.827 159.539 . . . . . . . . 3 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . . . -114.87 -77.81 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.467 -2.238 2 C-N-CA 134.852 5.261 . . . . 0.0 112.409 -169.513 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -29.29 -27.91 0.0 OUTLIER 'General case' 0 C--N 1.274 -2.71 0 N-CA-C 119.939 3.311 . . . . 0.0 119.939 150.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -57.76 -69.02 0.19 Allowed 'General case' 0 CA--C 1.549 0.923 1 N-CA-C 130.425 7.195 . . . . 0.0 130.425 145.697 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -35.54 -54.69 0.68 Allowed 'General case' 0 CA--C 1.578 2.03 0 N-CA-C 116.955 2.205 . . . . 0.0 116.955 159.648 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . . . -77.3 -55.15 5.66 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 113.653 -1.612 . . . . 0.0 111.555 -155.519 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -39.82 -41.9 1.21 Allowed 'General case' 0 CA--C 1.586 2.349 0 N-CA-C 117.522 2.415 . . . . 0.0 117.522 157.083 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . . . -95.22 14.17 23.09 Favored 'General case' 0 N--CA 1.502 2.165 1 N-CA-C 123.86 4.763 . . . . 0.0 123.86 175.031 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . . . -101.87 -6.68 23.25 Favored 'General case' 1 N--CA 1.555 4.78 1 N-CA-C 127.42 6.082 . . . . 0.0 127.42 151.009 . . . . . . . . 3 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . . . -81.13 -48.2 12.45 Favored 'General case' 1 C--N 1.221 -4.988 2 CA-C-N 102.955 -6.475 . . . . 0.0 123.262 -173.019 . . . . . . . . 3 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . . . -23.71 -52.74 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.283 -2.32 3 N-CA-C 131.404 7.557 . . . . 0.0 131.404 115.898 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . . . -90.66 8.81 32.46 Favored 'General case' 0 N--CA 1.521 3.097 0 O-C-N 118.12 -2.863 . . . . 0.0 117.085 169.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . . . -96.25 -61.8 1.38 Allowed 'General case' 0 N--CA 1.518 2.928 0 CA-C-N 108.768 -3.833 . . . . 0.0 116.215 -175.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . . . -46.34 -46.16 18.06 Favored 'General case' 0 N--CA 1.494 1.76 1 CA-C-N 108.006 -4.179 . . . . 0.0 115.431 156.547 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -91.29 -79.56 0.37 Allowed 'General case' 0 N--CA 1.484 1.258 0 CA-C-O 123.871 1.796 . . . . 0.0 108.788 166.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.297 -1.681 0 CA-C-N 114.228 -1.351 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.559 2.826 0 N-CA-C 119.032 2.373 . . . . 0.0 119.032 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . . . -130.79 -14.94 0.0 OUTLIER 'Trans proline' 0 CA--C 1.583 2.957 1 N-CA-C 124.056 4.599 . . . . 0.0 124.056 -151.069 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.492 ' O ' ' CA ' ' A' ' 7' ' ' PHE . . . -34.55 -56.62 0.53 Allowed 'General case' 0 C--O 1.182 -2.455 2 CA-C-O 106.696 -6.383 . . . . 0.0 112.697 122.583 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -96.02 -28.1 14.8 Favored 'General case' 0 N--CA 1.526 3.369 2 CA-C-O 132.009 5.671 . . . . 0.0 116.586 -141.012 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . . . -102.92 -17.65 15.4 Favored 'General case' 0 C--N 1.262 -3.225 3 N-CA-C 138.529 10.196 . . . . 0.0 138.529 141.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.419 ' O ' ' N ' ' A' ' 10' ' ' ILE . . . -44.47 -49.47 2.23 Favored 'Isoleucine or valine' 0 C--O 1.184 -2.359 0 CA-C-N 109.757 -3.383 . . . . 0.0 105.485 124.157 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.492 ' CA ' ' O ' ' A' ' 3' ' ' THR . . . -63.83 -61.4 2.32 Favored 'General case' 1 CA--C 1.385 -5.401 0 O-C-N 126.679 2.487 . . . . 0.0 114.646 -140.324 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -92.46 27.34 2.3 Favored 'General case' 0 N--CA 1.398 -3.059 1 CA-C-N 106.955 -4.657 . . . . 0.0 120.449 158.857 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . . . -100.58 7.78 43.83 Favored 'General case' 0 CA--C 1.461 -2.466 1 N-CA-C 142.619 11.711 . . . . 0.0 142.619 120.52 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.419 ' N ' ' O ' ' A' ' 6' ' ' ILE . . . -67.79 -54.2 24.76 Favored 'Isoleucine or valine' 0 C--N 1.249 -3.802 2 CA-C-N 105.276 -5.42 . . . . 0.0 114.938 165.182 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . . . -120.49 -26.37 5.38 Favored 'General case' 1 CA--C 1.397 -4.92 3 CA-C-N 96.754 -9.294 . . . . 0.0 130.205 -148.317 . . . . . . . . 3 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -90.65 -25.69 0.29 Allowed Pre-proline 1 N--CA 1.372 -4.374 2 CA-C-N 103.572 -6.195 . . . . 0.0 107.069 159.805 . . . . . . . . 3 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -39.57 -15.72 0.04 OUTLIER 'Trans proline' 0 N--CA 1.533 3.837 3 O-C-N 104.571 -8.699 . . . . 0.0 128.305 125.829 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -86.17 9.29 70.34 Favored Glycine 1 N--CA 1.539 5.521 1 CA-C-N 105.17 -5.468 . . . . 0.0 122.646 159.701 . . . . . . . . 3 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . . . -115.98 -83.98 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.795 3 CA-C-N 105.051 -5.575 . . . . 0.0 112.117 -167.54 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -28.99 -26.01 0.0 OUTLIER 'General case' 0 C--N 1.248 -3.819 1 CA-C-N 107.735 -4.302 . . . . 0.0 120.974 148.333 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -70.12 -58.75 3.44 Favored 'General case' 0 C--N 1.326 -0.451 1 N-CA-C 133.463 8.32 . . . . 0.0 133.463 143.485 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -35.24 -55.85 0.62 Allowed 'General case' 0 CA--C 1.586 2.364 0 N-CA-C 116.186 1.921 . . . . 0.0 116.186 159.064 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . . . -68.23 -56.98 6.75 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 113.113 -1.858 . . . . 0.0 111.714 -168.183 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -44.09 -38.61 3.73 Favored 'General case' 0 CA--C 1.585 2.308 0 N-CA-C 117.348 2.351 . . . . 0.0 117.348 162.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . . . -95.88 1.04 52.76 Favored 'General case' 0 N--CA 1.513 2.695 1 N-CA-C 125.494 5.368 . . . . 0.0 125.494 178.434 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . . . -100.19 3.73 43.91 Favored 'General case' 1 N--CA 1.557 4.896 2 N-CA-C 125.845 5.498 . . . . 0.0 125.845 155.902 . . . . . . . . 3 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . . . -87.33 -56.04 3.54 Favored 'General case' 1 C--N 1.214 -5.308 1 CA-C-N 103.929 -6.032 . . . . 0.0 119.363 -174.215 . . . . . . . . 3 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . . . -23.79 -46.21 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.268 -2.947 2 N-CA-C 132.484 7.957 . . . . 0.0 132.484 123.017 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . . . -78.72 -8.78 59.05 Favored 'General case' 0 C--N 1.28 -2.444 0 N-CA-C 121.358 3.836 . . . . 0.0 121.358 164.365 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . . . -94.05 -46.08 7.29 Favored 'General case' 1 N--CA 1.549 4.488 0 CA-C-N 108.924 -3.762 . . . . 0.0 118.981 -157.403 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . . . -46.36 -74.1 0.04 OUTLIER 'General case' 0 C--N 1.287 -2.141 1 CA-C-N 106.516 -4.856 . . . . 0.0 117.027 135.425 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -77.7 -58.89 3.02 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-O 124.778 2.227 . . . . 0.0 111.775 -169.09 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.297 -1.717 0 CA-C-N 112.109 -2.314 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.273 0 N-CA-C 118.167 2.027 . . . . 0.0 118.167 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . . . -136.02 16.6 0.0 OUTLIER 'Trans proline' 0 CA--C 1.586 3.108 0 N-CA-C 121.739 3.707 . . . . 0.0 121.739 169.524 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.497 ' O ' ' N ' ' A' ' 5' ' ' ARG . . . -51.84 -93.84 0.0 OUTLIER 'General case' 0 C--O 1.167 -3.253 2 CA-C-O 102.211 -8.519 . . . . 0.0 107.867 97.175 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -46.56 2.0 0.0 OUTLIER 'General case' 0 N--CA 1.528 3.457 2 CA-C-N 127.276 4.58 . . . . 0.0 118.656 -146.454 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.497 ' N ' ' O ' ' A' ' 3' ' ' THR . . . -103.62 -41.51 5.93 Favored 'General case' 0 N--CA 1.5 2.072 3 N-CA-C 134.597 8.74 . . . . 0.0 134.597 167.316 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.504 ' O ' ' N ' ' A' ' 10' ' ' ILE . . . -33.24 -52.14 0.11 Allowed 'Isoleucine or valine' 1 CA--C 1.419 -4.065 1 CA-C-O 111.609 -4.043 . . . . 0.0 103.557 123.228 . . . . . . . . 4 3 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . . . -90.94 -52.06 5.04 Favored 'General case' 1 N--CA 1.334 -6.259 1 CA-C-O 130.8 5.095 . . . . 0.0 109.806 -122.366 . . . . . . . . 3 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -35.07 -37.15 0.06 Allowed 'General case' 2 C--N 1.215 -5.267 1 N-CA-C 123.502 4.63 . . . . 0.0 123.502 136.888 . . . . . . . . 3 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.542 ' O ' ' CD ' ' A' ' 13' ' ' PRO . . . -90.09 16.23 8.78 Favored 'General case' 0 CA--C 1.423 -3.915 2 N-CA-C 124.994 5.183 . . . . 0.0 124.994 157.33 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.504 ' N ' ' O ' ' A' ' 6' ' ' ILE . . . -79.82 -24.15 11.99 Favored 'Isoleucine or valine' 0 CA--C 1.602 2.962 0 CA-C-O 127.433 3.492 . . . . 0.0 112.881 160.42 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . . . -117.32 -28.31 6.18 Favored 'General case' 1 CA--C 1.383 -5.452 3 N-CA-C 126.288 5.662 . . . . 0.0 126.288 -160.645 . . . . . . . . 3 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -71.57 -18.67 0.39 Allowed Pre-proline 0 C--N 1.247 -3.868 2 O-C-N 134.504 7.378 . . . . 0.0 119.404 147.7 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.542 ' CD ' ' O ' ' A' ' 9' ' ' SER . 0.1 OUTLIER -63.31 -21.51 71.76 Favored 'Trans proline' 0 C--N 1.298 -2.09 2 N-CA-C 127.64 5.977 . . . . 0.0 127.64 130.297 . . . . . . . . 4 4 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -74.75 -3.23 66.87 Favored Glycine 2 N--CA 1.534 5.224 0 CA-C-N 108.969 -3.741 . . . . 0.0 121.372 157.833 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.406 ' C ' ' N ' ' A' ' 17' ' ' ALA . . . -113.79 -65.57 1.52 Allowed 'Isoleucine or valine' 0 CA--C 1.475 -1.907 2 C-N-CA 133.768 4.827 . . . . 0.0 112.221 -168.982 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -27.45 -33.27 0.0 OUTLIER 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 119.855 3.28 . . . . 0.0 119.855 148.201 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.406 ' N ' ' C ' ' A' ' 15' ' ' VAL . . . -90.49 -41.28 11.51 Favored 'General case' 0 CA--C 1.516 -0.364 2 CA-C-N 107.284 -4.507 . . . . 0.0 122.523 173.528 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -38.81 -62.31 0.63 Allowed 'General case' 0 CA--C 1.59 2.517 0 CA-C-O 123.015 1.388 . . . . 0.0 114.539 148.099 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . . . -77.43 -59.04 2.94 Favored 'General case' 0 CA--C 1.556 1.196 0 CA-C-O 124.443 2.068 . . . . 0.0 109.119 -143.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -41.39 -44.6 2.86 Favored 'General case' 0 CA--C 1.57 1.741 0 CA-C-N 111.5 -2.591 . . . . 0.0 115.931 160.479 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . . . -95.9 8.41 43.68 Favored 'General case' 0 N--CA 1.507 2.403 0 N-CA-C 118.794 2.887 . . . . 0.0 118.794 -174.481 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . . . -100.77 -28.21 12.94 Favored 'General case' 1 N--CA 1.551 4.603 1 N-CA-C 124.103 4.853 . . . . 0.0 124.103 160.275 . . . . . . . . 3 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . . . -39.36 -64.51 0.46 Allowed 'General case' 1 C--N 1.241 -4.138 1 CA-C-N 105.8 -5.182 . . . . 0.0 116.842 162.418 . . . . . . . . 3 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . . . -24.62 -50.92 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.252 -3.634 2 CA-C-N 104.509 -5.769 . . . . 0.0 124.642 139.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . . . -91.29 -0.22 57.63 Favored 'General case' 0 N--CA 1.505 2.317 0 N-CA-C 119.484 3.142 . . . . 0.0 119.484 170.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . . . -92.79 -37.19 12.46 Favored 'General case' 1 N--CA 1.553 4.699 0 CA-C-O 126.324 2.964 . . . . 0.0 117.33 -168.87 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . . . -93.47 -41.61 9.7 Favored 'General case' 0 N--CA 1.512 2.648 2 CA-C-N 107.295 -4.502 . . . . 0.0 111.146 171.791 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -76.56 18.9 0.29 Allowed 'General case' 0 N--CA 1.494 1.738 0 C-N-CA 117.624 -1.63 . . . . 0.0 114.253 139.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.318 -0.764 0 O-C-N 119.307 -2.121 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.556 2.611 0 N-CA-C 115.661 1.024 . . . . 0.0 115.661 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . . . -139.71 18.57 0.0 OUTLIER 'Trans proline' 0 C--N 1.384 2.398 2 N-CA-C 128.678 6.376 . . . . 0.0 128.678 -149.566 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.43 ' O ' ' N ' ' A' ' 5' ' ' ARG . . . -57.34 -61.86 2.18 Favored 'General case' 0 C--O 1.199 -1.6 1 CA-C-O 109.257 -5.163 . . . . 0.0 109.085 103.863 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -54.89 8.94 0.0 OUTLIER 'General case' 0 CA--C 1.62 3.659 0 CA-C-O 125.373 2.511 . . . . 0.0 116.461 -157.075 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.43 ' N ' ' O ' ' A' ' 3' ' ' THR . . . -101.34 -51.89 3.38 Favored 'General case' 0 N--CA 1.478 0.964 3 C-N-CA 139.347 7.059 . . . . 0.0 126.019 172.937 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.436 ' O ' ' N ' ' A' ' 10' ' ' ILE . . . -38.79 -33.06 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.447 -2.999 0 CA-C-O 111.968 -3.872 . . . . 0.0 110.735 135.081 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . . . -93.08 -41.96 9.67 Favored 'General case' 0 CA--C 1.435 -3.449 2 N-CA-C 131.122 7.453 . . . . 0.0 131.122 -156.165 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -34.68 -48.06 0.36 Allowed 'General case' 0 N--CA 1.394 -3.27 2 CA-C-N 96.899 -9.228 . . . . 0.0 107.649 127.597 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . . . -89.56 -2.34 58.31 Favored 'General case' 0 CA--C 1.479 -1.779 0 N-CA-C 121.277 3.806 . . . . 0.0 121.277 157.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.436 ' N ' ' O ' ' A' ' 6' ' ' ILE . . . -67.1 -26.01 35.48 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.137 1 CA-C-O 128.737 4.113 . . . . 0.0 118.03 167.881 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . . . -113.29 -55.2 2.55 Favored 'General case' 0 CA--C 1.435 -3.477 2 CA-C-N 101.232 -7.258 . . . . 0.0 126.057 -127.886 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -94.3 -21.87 0.24 Allowed Pre-proline 0 N--CA 1.38 -3.941 2 O-C-N 137.692 9.37 . . . . 0.0 112.564 171.909 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -62.49 -25.64 75.93 Favored 'Trans proline' 0 N--CA 1.49 1.294 1 N-CA-C 127.106 5.772 . . . . 0.0 127.106 126.873 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -76.07 2.31 56.47 Favored Glycine 1 N--CA 1.522 4.373 3 O-C-N 130.403 4.814 . . . . 0.0 121.68 160.015 . . . . . . . . 3 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . . . -113.11 -69.36 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.973 1 CA-C-N 106.687 -4.757 . . . . 0.0 110.206 -177.03 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -27.06 -28.75 0.0 OUTLIER 'General case' 0 C--N 1.29 -2.017 0 N-CA-C 120.044 3.35 . . . . 0.0 120.044 148.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -69.9 -56.99 5.59 Favored 'General case' 0 CA--C 1.549 0.924 1 N-CA-C 121.913 4.042 . . . . 0.0 121.913 160.162 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -36.69 -60.7 0.58 Allowed 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 115.747 1.758 . . . . 0.0 115.747 155.319 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . . . -77.69 -58.32 3.33 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-O 121.929 0.871 . . . . 0.0 110.072 -150.197 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -43.77 -31.67 0.87 Allowed 'General case' 0 CA--C 1.581 2.164 0 N-CA-C 116.448 2.018 . . . . 0.0 116.448 164.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . . . -90.14 -20.44 23.11 Favored 'General case' 0 CA--C 1.569 1.684 0 N-CA-C 116.53 2.048 . . . . 0.0 116.53 -178.51 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . . . -102.25 -13.58 17.33 Favored 'General case' 1 N--CA 1.574 5.725 1 N-CA-C 124.829 5.122 . . . . 0.0 124.829 170.391 . . . . . . . . 3 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . . . -30.29 -60.76 0.17 Allowed 'General case' 1 C--N 1.225 -4.814 1 CA-C-N 107.639 -4.346 . . . . 0.0 120.498 134.244 . . . . . . . . 3 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . . . -90.05 -18.77 7.54 Favored 'Isoleucine or valine' 1 C--N 1.241 -4.13 0 CA-C-N 110.022 -3.263 . . . . 0.0 114.743 -159.554 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . . . -66.47 -18.51 65.4 Favored 'General case' 0 C--N 1.307 -1.242 1 N-CA-C 123.855 4.761 . . . . 0.0 123.855 148.821 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . . . -90.49 -62.87 1.36 Allowed 'General case' 0 N--CA 1.522 3.144 0 CA-C-N 114.229 -1.351 . . . . 0.0 109.37 -163.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . . . -48.66 -47.7 40.37 Favored 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 128.489 2.716 . . . . 0.0 116.293 157.028 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.02 -48.81 72.56 Favored 'General case' 0 N--CA 1.5 2.039 0 CA-C-O 124.324 2.011 . . . . 0.0 110.832 160.262 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.303 -1.434 0 CA-C-N 112.699 -2.046 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.407 ' O ' ' N ' ' A' ' 4' ' ' ALA . . . . . . . . 0 N--CA 1.486 1.999 0 N-CA-C 111.493 -0.643 . . . . 0.0 111.493 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . . . -68.75 40.33 0.25 Allowed 'Trans proline' 0 N--CA 1.535 3.949 2 CA-C-O 131.453 4.689 . . . . 0.0 123.548 170.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.429 ' O ' ' N ' ' A' ' 7' ' ' PHE . . . -92.95 -52.04 4.78 Favored 'General case' 1 C--N 1.24 -4.183 2 CA-C-N 98.415 -8.539 . . . . 0.0 117.122 148.804 . . . . . . . . 4 3 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.407 ' N ' ' O ' ' A' ' 1' ' ' GLY . . . -38.67 -15.38 0.01 OUTLIER 'General case' 0 N--CA 1.527 3.405 3 O-C-N 112.667 -6.271 . . . . 0.0 120.093 163.797 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . . . -101.76 -59.32 1.72 Allowed 'General case' 0 C--N 1.273 -2.751 3 CA-C-N 99.951 -7.841 . . . . 0.0 128.086 -174.68 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.452 ' O ' ' N ' ' A' ' 9' ' ' SER . . . -42.71 -36.88 0.75 Allowed 'Isoleucine or valine' 0 C--O 1.206 -1.208 1 O-C-N 129.513 4.258 . . . . 0.0 107.652 125.055 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.429 ' N ' ' O ' ' A' ' 3' ' ' THR . . . -93.78 -1.81 54.5 Favored 'General case' 2 CA--C 1.392 -5.114 1 N-CA-C 135.918 9.229 . . . . 0.0 135.918 -171.063 . . . . . . . . 4 3 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.88 -39.21 93.65 Favored 'General case' 1 CA--C 1.389 -5.215 3 CA-C-N 94.437 -10.347 . . . . 0.0 132.684 117.779 . . . . . . . . 3 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.452 ' N ' ' O ' ' A' ' 6' ' ' ILE . . . -105.98 12.02 30.99 Favored 'General case' 0 C--N 1.253 -3.619 1 N-CA-C 125.501 5.371 . . . . 0.0 125.501 178.925 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . . . -95.03 -30.97 4.15 Favored 'Isoleucine or valine' 0 C--N 1.259 -3.35 1 CA-C-N 106.958 -4.656 . . . . 0.0 105.878 166.392 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . . . -86.65 -62.55 1.48 Allowed 'General case' 1 CA--C 1.408 -4.506 1 C-N-CA 136.424 5.89 . . . . 0.0 121.075 -158.928 . . . . . . . . 3 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -72.66 -21.65 0.48 Allowed Pre-proline 0 N--CA 1.391 -3.384 2 CA-C-N 102.198 -6.819 . . . . 0.0 113.134 167.404 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.449 ' CG ' ' O ' ' A' ' 9' ' ' SER . 0.1 OUTLIER -68.95 -20.39 38.76 Favored 'Trans proline' 0 CA--C 1.499 -1.258 1 N-CA-C 127.724 6.009 . . . . 0.0 127.724 139.567 . . . . . . . . 4 4 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -72.46 -4.39 60.61 Favored Glycine 0 N--CA 1.512 3.702 0 O-C-N 128.766 3.791 . . . . 0.0 118.368 157.066 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . . . -119.15 -56.72 3.53 Favored 'Isoleucine or valine' 0 CA--C 1.475 -1.926 0 CA-C-N 110.353 -2.924 . . . . 0.0 115.048 -161.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -26.91 -42.7 0.02 OUTLIER 'General case' 0 C--N 1.292 -1.905 1 CA-C-N 108.261 -4.063 . . . . 0.0 117.163 141.422 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.87 -73.02 0.16 Allowed 'General case' 0 CA--C 1.557 1.218 0 CA-C-N 108.461 -3.972 . . . . 0.0 118.179 172.508 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -38.69 -66.71 0.25 Allowed 'General case' 0 CA--C 1.583 2.217 0 N-CA-C 116.93 2.196 . . . . 0.0 116.93 164.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . . . -60.88 -59.98 4.52 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 128.435 2.694 . . . . 0.0 111.63 -161.281 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.33 -42.99 92.34 Favored 'General case' 0 CA--C 1.569 1.692 0 C-N-CA 126.587 1.955 . . . . 0.0 115.991 -175.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . . . -92.35 6.38 47.11 Favored 'General case' 0 N--CA 1.517 2.888 0 O-C-N 119.272 -2.143 . . . . 0.0 116.148 -179.284 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . . . -104.52 -30.78 9.81 Favored 'General case' 1 N--CA 1.542 4.151 1 N-CA-C 125.044 5.202 . . . . 0.0 125.044 174.517 . . . . . . . . 3 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . . . -34.9 -71.86 0.06 Allowed 'General case' 0 C--N 1.261 -3.275 2 CA-C-N 103.022 -6.444 . . . . 0.0 117.921 147.522 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . . . -25.98 -45.57 0.01 OUTLIER 'Isoleucine or valine' 1 C--N 1.234 -4.43 2 N-CA-C 124.303 4.927 . . . . 0.0 124.303 143.522 . . . . . . . . 3 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . . . -92.6 -0.76 57.27 Favored 'General case' 0 N--CA 1.505 2.315 0 N-CA-C 119.219 3.044 . . . . 0.0 119.219 170.745 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . . . -92.39 -36.22 13.26 Favored 'General case' 1 N--CA 1.55 4.551 0 CA-C-O 126.069 2.842 . . . . 0.0 117.12 -170.853 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . . . -94.36 -41.98 9.13 Favored 'General case' 0 N--CA 1.512 2.67 2 CA-C-N 107.796 -4.275 . . . . 0.0 111.014 173.377 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -77.2 19.76 0.31 Allowed 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 117.849 -1.54 . . . . 0.0 114.235 139.634 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.317 -0.821 0 O-C-N 119.333 -2.104 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.558 2.719 0 CA-C-O 126.904 3.502 . . . . 0.0 120.382 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . . . -105.33 -33.97 0.02 OUTLIER 'Trans proline' 0 CA--C 1.472 -2.616 1 O-C-N 113.105 -4.208 . . . . 0.0 121.355 -135.427 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . . . -96.23 55.45 1.52 Allowed 'General case' 0 C--O 1.183 -2.41 0 N-CA-C 119.781 3.252 . . . . 0.0 119.781 114.64 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -68.17 -9.09 44.16 Favored 'General case' 0 N--CA 1.53 3.572 1 O-C-N 113.866 -5.521 . . . . 0.0 120.458 111.513 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . . . -105.3 -58.43 1.9 Allowed 'General case' 0 C--N 1.299 -1.596 1 CA-C-N 107.977 -4.192 . . . . 0.0 119.937 -153.422 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.501 ' O ' ' N ' ' A' ' 10' ' ' ILE . . . -39.51 -40.25 0.41 Allowed 'Isoleucine or valine' 0 C--O 1.162 -3.522 1 CA-C-O 108.079 -5.724 . . . . 0.0 111.681 127.458 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.4 ' O ' ' N ' ' A' ' 11' ' ' LEU . . . -61.57 -53.13 60.42 Favored 'General case' 1 C--O 1.15 -4.147 1 CA-C-N 127.436 4.653 . . . . 0.0 119.397 -169.478 . . . . . . . . 4 3 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -38.94 -53.86 1.7 Allowed 'General case' 1 N--CA 1.379 -4.005 4 C-N-CA 146.633 9.973 . . . . 0.0 99.128 155.279 . . . . . . . . 3 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.409 ' O ' ' CG ' ' A' ' 13' ' ' PRO . . . -85.58 2.86 43.24 Favored 'General case' 0 N--CA 1.494 1.735 1 N-CA-C 125.675 5.435 . . . . 0.0 125.675 160.758 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.501 ' N ' ' O ' ' A' ' 6' ' ' ILE . . . -80.67 -47.89 20.15 Favored 'Isoleucine or valine' 0 CA--C 1.584 2.275 0 CA-C-O 126.072 2.844 . . . . 0.0 106.286 172.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.4 ' N ' ' O ' ' A' ' 7' ' ' PHE . . . -114.02 -23.83 9.35 Favored 'General case' 0 CA--C 1.439 -3.32 2 CA-C-N 106.794 -4.73 . . . . 0.0 123.581 -147.959 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -95.21 -7.78 0.12 Allowed Pre-proline 1 N--CA 1.374 -4.257 2 CA-C-N 104.327 -5.852 . . . . 0.0 110.882 160.967 . . . . . . . . 3 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.409 ' CG ' ' O ' ' A' ' 9' ' ' SER . 0.3 OUTLIER -77.39 -10.91 17.48 Favored 'Trans proline' 0 CA--C 1.475 -2.431 2 N-CA-C 124.44 4.746 . . . . 0.0 124.44 131.464 . . . . . . . . 4 4 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -87.45 9.4 73.51 Favored Glycine 1 N--CA 1.523 4.442 2 O-C-N 132.149 5.906 . . . . 0.0 121.477 163.57 . . . . . . . . 3 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . . . -115.31 -78.29 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.405 -2.678 2 CA-C-N 105.273 -5.464 . . . . 0.0 111.086 -175.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -28.26 -29.83 0.0 OUTLIER 'General case' 0 C--N 1.246 -3.899 0 CA-C-N 110.996 -2.82 . . . . 0.0 118.25 152.203 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -58.29 -71.7 0.11 Allowed 'General case' 0 CA--C 1.533 0.29 1 N-CA-C 123.617 4.673 . . . . 0.0 123.617 148.773 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -33.36 -60.45 0.35 Allowed 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 115.393 1.627 . . . . 0.0 115.393 165.118 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . . . -63.49 -45.36 91.09 Favored 'General case' 0 CA--C 1.545 0.783 0 CA-C-N 114.346 -1.297 . . . . 0.0 112.134 -161.622 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -84.99 -12.14 53.9 Favored 'General case' 0 N--CA 1.418 -2.044 0 C-N-CA 127.75 2.42 . . . . 0.0 115.526 -173.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . . . -90.15 -22.01 21.94 Favored 'General case' 0 N--CA 1.509 2.492 0 N-CA-C 118.891 2.923 . . . . 0.0 118.891 165.112 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . . . -93.34 -27.61 16.68 Favored 'General case' 1 N--CA 1.564 5.226 1 N-CA-C 126.433 5.716 . . . . 0.0 126.433 178.039 . . . . . . . . 3 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . . . -27.34 -81.97 0.01 OUTLIER 'General case' 1 CA--C 1.417 -4.146 2 CA-C-N 102.919 -6.491 . . . . 0.0 113.152 123.75 . . . . . . . . 3 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . . . -78.09 -12.67 13.76 Favored 'Isoleucine or valine' 0 C--N 1.257 -3.451 1 C-N-CA 110.571 -4.452 . . . . 0.0 116.904 -139.761 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . . . -91.31 -1.62 57.6 Favored 'General case' 0 C--N 1.306 -1.301 2 N-CA-C 126.896 5.887 . . . . 0.0 126.896 159.032 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . . . -88.71 -57.99 2.71 Favored 'General case' 1 N--CA 1.539 4.023 0 CA-C-O 125.416 2.531 . . . . 0.0 115.98 178.073 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . . . -71.03 -52.49 19.24 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-N 108.843 -3.799 . . . . 0.0 115.043 165.597 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -81.29 22.74 0.65 Allowed 'General case' 0 N--CA 1.512 2.631 0 C-N-CA 116.069 -2.252 . . . . 0.0 112.623 148.367 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.315 -0.927 0 O-C-N 119.818 -1.801 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.563 3.069 0 N-CA-C 104.42 -3.472 . . . . 0.0 104.42 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . . . -113.49 11.43 0.05 OUTLIER 'Trans proline' 0 N--CA 1.508 2.36 0 C-N-CA 124.597 3.531 . . . . 0.0 118.922 168.721 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . . . -49.71 -86.53 0.0 OUTLIER 'General case' 0 C--O 1.165 -3.381 2 CA-C-O 105.639 -6.886 . . . . 0.0 108.243 110.126 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -41.52 -5.57 0.0 OUTLIER 'General case' 0 N--CA 1.535 3.782 0 CA-C-N 124.19 3.177 . . . . 0.0 118.954 -154.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . . . -102.43 -54.27 2.71 Favored 'General case' 0 C--N 1.291 -1.936 4 C-N-CA 138.666 6.786 . . . . 0.0 123.523 -170.061 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.516 ' O ' ' N ' ' A' ' 10' ' ' ILE . . . -48.84 -50.92 13.2 Favored 'Isoleucine or valine' 1 C--O 1.135 -4.946 2 CA-C-N 106.808 -4.724 . . . . 0.0 106.907 137.706 . . . . . . . . 4 3 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.407 ' O ' ' N ' ' A' ' 10' ' ' ILE . . . -59.3 -55.23 37.49 Favored 'General case' 2 CA--C 1.365 -6.17 1 CA-C-O 140.191 9.567 . . . . 0.0 114.696 -163.484 . . . . . . . . 4 3 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -34.49 -43.31 0.16 Allowed 'General case' 0 N--CA 1.393 -3.298 1 CA-C-N 100.335 -7.666 . . . . 0.0 109.505 158.044 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.472 ' CA ' ' O ' ' A' ' 6' ' ' ILE . . . -88.67 -9.23 52.8 Favored 'General case' 0 CA--C 1.46 -2.502 1 N-CA-C 133.361 8.282 . . . . 0.0 133.361 152.485 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.516 ' N ' ' O ' ' A' ' 6' ' ' ILE . . . -66.47 -52.64 44.21 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.84 0 CA-C-O 126.613 3.102 . . . . 0.0 108.378 168.867 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . . . -119.31 -25.24 6.15 Favored 'General case' 1 CA--C 1.397 -4.937 1 CA-C-N 102.956 -6.475 . . . . 0.0 120.799 -146.002 . . . . . . . . 3 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -100.04 16.61 0.05 OUTLIER Pre-proline 0 C--N 1.265 -3.079 1 O-C-N 130.809 5.068 . . . . 0.0 120.142 155.897 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -67.3 -25.33 42.61 Favored 'Trans proline' 0 N--CA 1.509 2.406 2 N-CA-C 131.243 7.363 . . . . 0.0 131.243 105.925 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -74.96 -0.83 61.17 Favored Glycine 3 N--CA 1.552 6.378 1 CA-C-O 129.011 4.673 . . . . 0.0 121.746 167.319 . . . . . . . . 3 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . . . -112.86 -67.18 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.29 -1.994 2 CA-C-N 104.462 -5.869 . . . . 0.0 116.517 -179.892 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -26.44 -37.03 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 119.251 3.056 . . . . 0.0 119.251 153.612 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -56.12 -79.13 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.804 1 CA-C-N 105.978 -5.101 . . . . 0.0 120.726 157.625 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -37.19 -49.49 0.91 Allowed 'General case' 0 CA--C 1.582 2.185 0 N-CA-C 117.637 2.458 . . . . 0.0 117.637 167.365 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . . . -47.81 -71.96 0.06 Allowed 'General case' 0 CA--C 1.564 1.505 0 C-N-CA 129.345 3.058 . . . . 0.0 112.942 -179.167 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -51.63 -25.53 7.22 Favored 'General case' 0 CA--C 1.571 1.783 0 CA-C-N 108.541 -3.936 . . . . 0.0 116.401 173.287 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . . . -90.78 -29.92 17.32 Favored 'General case' 0 CA--C 1.564 1.484 0 CA-C-O 115.414 -2.232 . . . . 0.0 115.696 -179.349 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . . . -100.79 -10.7 20.52 Favored 'General case' 1 N--CA 1.581 6.088 1 N-CA-C 124.797 5.11 . . . . 0.0 124.797 174.698 . . . . . . . . 3 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . . . -30.54 -67.85 0.09 Allowed 'General case' 1 C--N 1.233 -4.471 1 CA-C-N 105.582 -5.281 . . . . 0.0 118.822 125.603 . . . . . . . . 3 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . . . -88.0 7.45 2.99 Favored 'Isoleucine or valine' 1 C--N 1.238 -4.282 0 C-N-CA 113.775 -3.17 . . . . 0.0 117.929 -157.261 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . . . -87.18 -32.4 19.85 Favored 'General case' 0 C--N 1.303 -1.431 3 C-N-CA 134.484 5.114 . . . . 0.0 124.008 161.44 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . . . -87.65 -34.07 18.59 Favored 'General case' 0 N--CA 1.534 3.737 1 CA-C-N 106.87 -4.695 . . . . 0.0 116.553 -172.457 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . . . -95.97 -38.79 10.08 Favored 'General case' 0 N--CA 1.511 2.613 2 C-N-CA 131.994 4.118 . . . . 0.0 110.008 173.174 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -77.35 16.6 0.59 Allowed 'General case' 0 N--CA 1.499 1.989 0 C-N-CA 116.909 -1.917 . . . . 0.0 114.287 139.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.315 -0.895 0 O-C-N 119.096 -2.253 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.546 1.997 0 N-CA-C 116.648 1.419 . . . . 0.0 116.648 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . . . -113.96 -20.76 0.02 OUTLIER 'Trans proline' 0 N--CA 1.522 3.203 1 N-CA-C 122.776 4.106 . . . . 0.0 122.776 -150.217 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . . . -32.51 -49.63 0.22 Allowed 'General case' 0 C--N 1.252 -3.657 2 CA-C-N 100.52 -7.582 . . . . 0.0 121.231 126.93 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -92.47 -29.42 16.25 Favored 'General case' 0 N--CA 1.5 2.045 2 C-N-CA 132.834 4.454 . . . . 0.0 114.851 -163.259 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . . . -103.11 -39.16 6.99 Favored 'General case' 0 C--N 1.293 -1.868 3 C-N-CA 139.836 7.254 . . . . 0.0 128.237 171.739 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . . . -39.89 -58.49 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.426 -3.819 2 CA-C-N 107.144 -4.571 . . . . 0.0 103.878 125.587 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . . . -46.2 -41.29 12.55 Favored 'General case' 0 N--CA 1.492 1.672 2 N-CA-C 125.387 5.328 . . . . 0.0 125.387 -144.035 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -90.85 -40.38 11.79 Favored 'General case' 1 N--CA 1.372 -4.359 3 C-N-CA 150.495 11.518 . . . . 0.0 110.151 -162.129 . . . . . . . . 3 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . . . -70.95 -14.09 62.24 Favored 'General case' 0 CA--C 1.458 -2.559 1 N-CA-C 128.96 6.652 . . . . 0.0 128.96 140.43 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . . . -74.02 -23.52 18.84 Favored 'Isoleucine or valine' 0 C--N 1.253 -3.591 1 CA-C-O 129.335 4.397 . . . . 0.0 117.52 169.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . . . -110.92 -55.61 2.47 Favored 'General case' 1 CA--C 1.407 -4.524 1 CA-C-N 102.425 -6.716 . . . . 0.0 119.462 -138.666 . . . . . . . . 3 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -76.78 -21.78 0.4 Allowed Pre-proline 0 C--N 1.254 -3.553 2 O-C-N 132.958 6.411 . . . . 0.0 115.823 163.159 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_exo -60.58 -17.87 51.27 Favored 'Trans proline' 0 CA--C 1.479 -2.271 1 N-CA-C 128.007 6.118 . . . . 0.0 128.007 131.667 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -59.69 -22.46 57.01 Favored Glycine 2 N--CA 1.535 5.273 0 CA-C-O 126.199 3.11 . . . . 0.0 119.255 154.203 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . . . -119.54 -49.26 3.54 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.617 1 CA-C-N 106.441 -4.88 . . . . 0.0 118.811 -144.165 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -28.72 -52.8 0.1 Allowed 'General case' 0 C--N 1.298 -1.673 2 CA-C-N 106.808 -4.724 . . . . 0.0 114.34 135.309 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -77.22 -52.42 9.27 Favored 'General case' 0 CA--C 1.56 1.334 1 CA-C-N 107.495 -4.412 . . . . 0.0 112.563 -157.895 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -36.72 -66.46 0.22 Allowed 'General case' 0 CA--C 1.585 2.307 0 CA-C-N 110.83 -2.895 . . . . 0.0 115.324 146.38 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . . . -46.91 -61.29 1.93 Allowed 'General case' 0 N--CA 1.514 2.727 0 CA-C-O 125.243 2.449 . . . . 0.0 113.777 -159.368 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -77.72 -14.75 59.52 Favored 'General case' 0 CA--C 1.567 1.598 0 C-N-CA 129.405 3.082 . . . . 0.0 116.244 -174.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . . . -92.27 -24.47 18.98 Favored 'General case' 0 N--CA 1.523 3.184 0 N-CA-C 117.942 2.571 . . . . 0.0 117.942 174.236 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . . . -96.01 -27.25 15.21 Favored 'General case' 1 N--CA 1.561 5.106 1 N-CA-C 126.158 5.614 . . . . 0.0 126.158 179.723 . . . . . . . . 3 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . . . -27.89 -80.32 0.01 OUTLIER 'General case' 0 CA--C 1.423 -3.941 2 CA-C-N 103.064 -6.425 . . . . 0.0 113.338 123.459 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . . . -79.66 -12.35 13.11 Favored 'Isoleucine or valine' 0 C--N 1.254 -3.554 1 C-N-CA 110.693 -4.403 . . . . 0.0 116.552 -139.287 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . . . -91.42 1.52 57.06 Favored 'General case' 0 C--N 1.308 -1.219 2 N-CA-C 127.287 6.032 . . . . 0.0 127.287 157.186 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . . . -89.71 -62.17 1.53 Allowed 'General case' 0 N--CA 1.538 3.926 0 CA-C-O 125.323 2.487 . . . . 0.0 115.752 176.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . . . -57.26 -61.48 2.44 Favored 'General case' 0 N--CA 1.494 1.768 0 CA-C-N 109.257 -3.61 . . . . 0.0 115.705 157.78 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -79.99 22.28 0.52 Allowed 'General case' 0 N--CA 1.517 2.883 0 C-N-CA 115.388 -2.525 . . . . 0.0 112.322 155.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.317 -0.829 0 O-C-N 119.928 -1.732 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.556 2.656 0 CA-C-O 123.613 1.674 . . . . 0.0 117.061 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . . . -95.27 -40.31 0.02 OUTLIER 'Trans proline' 0 N--CA 1.503 2.058 1 O-C-N 112.802 -4.368 . . . . 0.0 121.396 -126.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . . . -102.42 46.92 0.91 Allowed 'General case' 0 C--N 1.28 -2.429 1 N-CA-C 122.097 4.11 . . . . 0.0 122.097 127.058 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -70.54 -8.45 51.49 Favored 'General case' 0 N--CA 1.536 3.859 1 N-CA-C 122.196 4.147 . . . . 0.0 122.196 130.071 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . . . -111.29 -55.1 2.54 Favored 'General case' 0 C--N 1.286 -2.18 2 CA-C-N 105.272 -5.422 . . . . 0.0 117.621 -140.062 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.426 ' O ' ' N ' ' A' ' 10' ' ' ILE . . . -37.12 -38.19 0.15 Allowed 'Isoleucine or valine' 2 CA--C 1.364 -6.179 1 CA-C-N 106.264 -4.971 . . . . 0.0 112.735 126.729 . . . . . . . . 4 3 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . . . -67.6 -60.35 2.62 Favored 'General case' 0 CA--C 1.423 -3.907 1 CA-C-O 137.041 8.067 . . . . 0.0 111.338 -173.343 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -36.26 -43.61 0.37 Allowed 'General case' 0 N--CA 1.407 -2.579 2 CA-C-N 100.51 -7.586 . . . . 0.0 105.36 159.694 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . . . -106.49 1.7 25.68 Favored 'General case' 0 CA--C 1.464 -2.345 1 N-CA-C 130.056 7.058 . . . . 0.0 130.056 176.356 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.426 ' N ' ' O ' ' A' ' 6' ' ' ILE . . . -91.93 -46.12 14.33 Favored 'Isoleucine or valine' 0 CA--C 1.621 3.695 2 N-CA-C 96.796 -5.261 . . . . 0.0 96.796 177.192 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . . . -112.91 -27.59 8.04 Favored 'General case' 1 CA--C 1.402 -4.726 1 N-CA-C 122.222 4.156 . . . . 0.0 122.222 -152.415 . . . . . . . . 3 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -99.78 14.58 0.05 OUTLIER Pre-proline 0 C--N 1.256 -3.48 1 O-C-N 130.19 4.681 . . . . 0.0 120.791 154.273 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 0.0 OUTLIER -71.57 -22.13 24.84 Favored 'Trans proline' 0 N--CA 1.507 2.289 2 N-CA-C 130.215 6.967 . . . . 0.0 130.215 110.115 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -82.32 2.28 85.2 Favored Glycine 2 N--CA 1.541 5.668 1 CA-C-O 127.849 4.027 . . . . 0.0 120.619 168.582 . . . . . . . . 3 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . . . -111.95 -64.3 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.71 2 CA-C-N 106.391 -4.905 . . . . 0.0 114.157 179.893 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -23.67 -42.32 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 111.56 -2.564 . . . . 0.0 117.612 152.519 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -56.8 -83.8 0.01 OUTLIER 'General case' 0 CA--C 1.556 1.201 1 CA-C-N 106.837 -4.71 . . . . 0.0 119.54 158.293 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -36.21 -60.8 0.54 Allowed 'General case' 0 CA--C 1.58 2.125 0 N-CA-C 118.615 2.82 . . . . 0.0 118.615 172.27 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . . . -52.65 -54.66 30.3 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 128.421 2.688 . . . . 0.0 112.824 -172.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.51 -53.06 61.32 Favored 'General case' 0 N--CA 1.399 -2.982 0 CA-C-N 112.693 -2.049 . . . . 0.0 111.602 173.117 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . . . -95.42 34.34 1.46 Allowed 'General case' 0 N--CA 1.518 2.96 0 N-CA-C 120.401 3.482 . . . . 0.0 120.401 175.337 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . . . -107.73 -5.71 17.23 Favored 'General case' 0 N--CA 1.533 3.714 0 N-CA-C 121.068 3.729 . . . . 0.0 121.068 141.444 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . . . -63.3 -55.02 28.13 Favored 'General case' 0 C--N 1.246 -3.897 0 N-CA-C 118.529 2.788 . . . . 0.0 118.529 -179.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . . . -28.18 -52.09 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.266 -3.063 4 CA-C-N 100.903 -7.408 . . . . 0.0 124.073 131.39 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . . . -92.29 7.52 42.39 Favored 'General case' 0 N--CA 1.519 2.98 0 N-CA-C 117.36 2.356 . . . . 0.0 117.36 171.478 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . . . -96.5 -60.97 1.5 Allowed 'General case' 0 N--CA 1.511 2.587 0 CA-C-N 109.317 -3.583 . . . . 0.0 110.699 179.077 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . . . -48.42 -38.61 20.14 Favored 'General case' 0 N--CA 1.503 2.209 0 C-N-CA 126.567 1.947 . . . . 0.0 115.937 162.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -76.54 -59.79 2.62 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-O 123.795 1.76 . . . . 0.0 110.639 160.491 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.299 -1.628 0 CA-C-N 114.127 -1.397 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.576 3.879 0 N-CA-C 119.964 2.746 . . . . 0.0 119.964 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . . . -97.9 -18.89 0.18 Allowed 'Trans proline' 0 CA--C 1.503 -1.053 0 N-CA-C 121.676 3.683 . . . . 0.0 121.676 -148.19 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . . . -99.94 55.38 0.93 Allowed 'General case' 0 C--O 1.188 -2.139 0 N-CA-C 119.545 3.165 . . . . 0.0 119.545 115.287 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -66.36 -5.25 10.07 Favored 'General case' 0 N--CA 1.528 3.433 1 O-C-N 113.554 -5.716 . . . . 0.0 120.271 113.843 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . . . -106.72 -60.48 1.66 Allowed 'General case' 0 C--N 1.306 -1.298 1 O-C-N 129.72 4.388 . . . . 0.0 119.713 -147.419 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.434 ' O ' ' N ' ' A' ' 10' ' ' ILE . . . -38.1 -50.09 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.434 -3.51 1 CA-C-O 111.572 -4.061 . . . . 0.0 112.732 125.902 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . . . -48.03 -62.15 1.62 Allowed 'General case' 2 CA--C 1.387 -5.311 1 CA-C-O 132.597 5.951 . . . . 0.0 112.98 178.499 . . . . . . . . 3 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -37.77 -46.19 0.89 Allowed 'General case' 0 N--CA 1.4 -2.943 2 CA-C-N 102.314 -6.766 . . . . 0.0 106.153 168.044 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.417 ' O ' ' CG ' ' A' ' 13' ' ' PRO . . . -92.95 3.07 56.39 Favored 'General case' 0 CA--C 1.469 -2.158 1 N-CA-C 129.292 6.775 . . . . 0.0 129.292 166.522 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.434 ' N ' ' O ' ' A' ' 6' ' ' ILE . . . -93.78 -41.23 12.33 Favored 'Isoleucine or valine' 1 C--N 1.238 -4.275 0 N-CA-C 102.213 -3.254 . . . . 0.0 102.213 178.592 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . . . -111.29 -28.6 8.17 Favored 'General case' 1 CA--C 1.421 -4.016 1 N-CA-C 122.245 4.165 . . . . 0.0 122.245 -153.249 . . . . . . . . 3 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -82.46 -24.12 0.36 Allowed Pre-proline 0 C--N 1.256 -3.494 2 O-C-N 131.63 5.581 . . . . 0.0 114.064 158.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.417 ' CG ' ' O ' ' A' ' 9' ' ' SER . 0.1 OUTLIER -56.21 -16.89 18.57 Favored 'Trans proline' 0 CA--C 1.476 -2.38 1 N-CA-C 128.107 6.156 . . . . 0.0 128.107 129.9 . . . . . . . . 4 4 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -59.3 -24.03 58.49 Favored Glycine 2 N--CA 1.536 5.35 0 CA-C-O 127.05 3.583 . . . . 0.0 121.727 155.391 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . . . -120.03 -50.84 3.58 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.843 1 CA-C-N 104.187 -6.007 . . . . 0.0 118.236 -142.646 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -28.69 -52.45 0.1 Allowed 'General case' 0 CA--C 1.476 -1.879 2 CA-C-N 105.697 -5.228 . . . . 0.0 115.114 135.213 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -74.49 -59.78 2.58 Favored 'General case' 0 CA--C 1.553 1.09 1 CA-C-N 107.272 -4.513 . . . . 0.0 110.848 -161.571 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -35.16 -56.41 0.6 Allowed 'General case' 0 CA--C 1.574 1.872 0 CA-C-N 110.604 -2.998 . . . . 0.0 115.992 157.34 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . . . -43.37 -53.7 5.16 Favored 'General case' 0 N--CA 1.508 2.441 0 C-N-CA 128.18 2.592 . . . . 0.0 114.975 -167.573 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -80.51 -33.34 36.49 Favored 'General case' 0 N--CA 1.421 -1.905 0 C-N-CA 130.976 3.71 . . . . 0.0 114.439 -173.348 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . . . -90.31 -0.41 57.62 Favored 'General case' 0 N--CA 1.529 3.514 0 N-CA-C 117.039 2.237 . . . . 0.0 117.039 170.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . . . -88.87 -35.87 16.3 Favored 'General case' 1 N--CA 1.555 4.794 1 N-CA-C 123.619 4.674 . . . . 0.0 123.619 167.607 . . . . . . . . 3 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . . . -37.75 -64.49 0.39 Allowed 'General case' 0 C--N 1.26 -3.309 2 CA-C-N 102.513 -6.676 . . . . 0.0 114.969 167.068 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . . . -25.09 -51.02 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.268 -2.957 2 CA-C-N 104.354 -5.839 . . . . 0.0 124.695 142.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . . . -92.26 -2.73 56.28 Favored 'General case' 0 C--N 1.274 -2.679 0 N-CA-C 119.831 3.271 . . . . 0.0 119.831 170.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . . . -87.84 -24.24 23.76 Favored 'General case' 0 CA--C 1.609 3.241 0 CA-C-N 110.581 -3.009 . . . . 0.0 113.821 179.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . . . -96.09 -53.41 3.66 Favored 'General case' 0 N--CA 1.501 2.12 1 C-N-CA 132.831 4.453 . . . . 0.0 110.986 -178.672 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.03 22.06 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.918 0 CA-C-N 111.757 -2.474 . . . . 0.0 115.442 139.469 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.319 -0.746 0 O-C-N 119.518 -1.988 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.528 ' N ' ' H ' ' A' ' 7' ' ' PHE . . . . . . . . 0 CA--C 1.476 -1.893 1 N-CA-C 130.934 7.383 . . . . 0.0 130.934 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.45 ' O ' ' N ' ' A' ' 9' ' ' SER . . . -51.24 -49.63 29.44 Favored 'Isoleucine or valine' 0 C--O 1.186 -2.288 1 N-CA-C 92.301 -6.926 . . . . 0.0 92.301 137.708 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.528 ' H ' ' N ' ' A' ' 5' ' ' ARG . . . -46.25 -47.45 18.08 Favored 'General case' 0 N--CA 1.487 1.399 3 CA-C-N 128.994 5.361 . . . . 0.0 124.951 -152.752 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -98.45 -35.03 10.4 Favored 'General case' 0 N--CA 1.409 -2.492 3 C-N-CA 154.948 13.299 . . . . 0.0 100.371 -165.413 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.46 ' O ' ' HG2' ' A' ' 13' ' ' PRO . . . -74.42 -13.4 60.71 Favored 'General case' 0 CA--C 1.462 -2.429 2 O-C-N 111.18 -7.2 . . . . 0.0 129.307 144.063 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . . . -62.44 -43.3 98.11 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.835 1 CA-C-O 129.498 4.475 . . . . 0.0 114.7 166.462 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . . . -106.83 -52.27 2.8 Favored 'General case' 1 CA--C 1.351 -6.698 4 CA-C-N 97.785 -8.825 . . . . 0.0 124.788 -140.778 . . . . . . . . 3 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -78.13 -20.12 0.33 Allowed Pre-proline 1 CA--C 1.649 4.775 2 CA-C-N 102.878 -6.51 . . . . 0.0 109.708 168.487 . . . . . . . . 3 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.46 ' HG2' ' O ' ' A' ' 9' ' ' SER . 0.1 OUTLIER -59.91 -29.42 89.4 Favored 'Trans proline' 0 CA--C 1.486 -1.91 2 O-C-N 106.516 -7.676 . . . . 0.0 127.416 134.868 . . . . . . . . 4 4 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -70.89 -0.9 36.36 Favored Glycine 0 N--CA 1.506 3.329 2 O-C-N 132.617 6.198 . . . . 0.0 120.535 164.362 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.404 ' C ' ' N ' ' A' ' 17' ' ' ALA . . . -107.29 -73.83 0.59 Allowed 'Isoleucine or valine' 0 C--O 1.2 -1.549 2 CA-C-N 106.587 -4.806 . . . . 0.0 107.318 -165.3 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -28.52 -23.17 0.0 OUTLIER 'General case' 0 C--N 1.258 -3.379 0 CA-C-N 108.518 -3.946 . . . . 0.0 119.578 144.277 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.404 ' N ' ' C ' ' A' ' 15' ' ' VAL . . . -90.21 -33.38 16.21 Favored 'General case' 0 CA--C 1.549 0.907 1 N-CA-C 126.158 5.614 . . . . 0.0 126.158 156.858 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -41.73 -63.16 0.76 Allowed 'General case' 0 CA--C 1.576 1.967 0 CA-C-N 122.146 2.248 . . . . 0.0 115.071 145.519 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . . . -75.51 -56.3 4.83 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 113.759 -1.564 . . . . 0.0 109.649 -148.736 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -48.83 -44.45 39.38 Favored 'General case' 0 CA--C 1.577 1.987 0 N-CA-C 117.585 2.439 . . . . 0.0 117.585 163.281 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . . . -78.24 -13.65 59.77 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 117.33 -3.356 . . . . 0.0 117.773 -178.528 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . . . -96.5 -26.29 15.34 Favored 'General case' 0 N--CA 1.538 3.941 1 N-CA-C 126.129 5.603 . . . . 0.0 126.129 177.934 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . . . -37.81 -63.71 0.45 Allowed 'General case' 0 C--N 1.252 -3.638 2 CA-C-N 104.327 -5.851 . . . . 0.0 120.531 156.319 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . . . -39.32 -40.19 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.253 -3.615 4 O-C-N 134.218 7.199 . . . . 0.0 122.647 143.99 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . . . -94.92 3.57 54.81 Favored 'General case' 0 C--N 1.263 -3.171 0 N-CA-C 118.059 2.615 . . . . 0.0 118.059 167.829 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . . . -95.52 -60.45 1.66 Allowed 'General case' 0 N--CA 1.505 2.305 0 CA-C-N 109.546 -3.479 . . . . 0.0 111.178 177.366 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . . . -49.61 -41.69 42.78 Favored 'General case' 0 N--CA 1.501 2.097 0 C-N-CA 126.857 2.063 . . . . 0.0 115.503 163.346 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.505 2.311 0 CA-C-O 122.911 1.339 . . . . 0.0 112.398 159.688 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.583 ' CA ' ' H ' ' A' ' 7' ' ' PHE . . . . . . . . 0 N--CA 1.421 -1.91 1 N-CA-C 144.599 12.444 . . . . 0.0 144.599 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.46 ' O ' ' CA ' ' A' ' 9' ' ' SER . . . -37.65 -49.9 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.434 -3.511 0 CA-C-N 111.716 -2.493 . . . . 0.0 106.019 117.883 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.583 ' H ' ' CA ' ' A' ' 5' ' ' ARG . . . -59.17 -51.89 68.05 Favored 'General case' 2 CA--C 1.378 -5.645 0 N-CA-C 119.355 3.094 . . . . 0.0 119.355 -143.799 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -104.47 44.28 1.04 Allowed 'General case' 1 N--CA 1.375 -4.222 2 N-CA-C 122.193 4.146 . . . . 0.0 122.193 146.707 . . . . . . . . 3 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.587 ' O ' ' HD2' ' A' ' 13' ' ' PRO . . . -93.3 17.2 11.61 Favored 'General case' 1 C--N 1.24 -4.162 1 N-CA-C 140.757 11.021 . . . . 0.0 140.757 95.158 . . . . . . . . 4 3 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.428 ' C ' ' HB2' ' A' ' 13' ' ' PRO . . . -72.59 -33.89 46.2 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.802 2 CA-C-O 132.975 6.131 . . . . 0.0 125.162 156.453 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . . . -105.37 -32.34 8.62 Favored 'General case' 2 CA--C 1.368 -6.045 4 CA-C-N 93.656 -10.702 . . . . 0.0 131.033 -165.39 . . . . . . . . 3 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -89.1 -15.66 0.21 Allowed Pre-proline 0 CA--C 1.618 3.573 3 CA-C-N 101.894 -6.957 . . . . 0.0 114.273 161.515 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.587 ' HD2' ' O ' ' A' ' 9' ' ' SER . 0.0 OUTLIER -57.19 -24.09 57.12 Favored 'Trans proline' 0 C--N 1.291 -2.485 2 O-C-N 106.116 -7.886 . . . . 0.0 129.602 128.161 . . . . . . . . 4 4 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -76.77 2.1 60.42 Favored Glycine 0 N--CA 1.514 3.876 2 CA-C-N 103.849 -6.068 . . . . 0.0 120.945 162.081 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . . . -106.95 -77.79 0.42 Allowed 'Isoleucine or valine' 0 C--O 1.196 -1.713 2 CA-C-N 106.443 -4.879 . . . . 0.0 110.493 -169.6 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -28.77 -23.9 0.0 OUTLIER 'General case' 0 C--N 1.253 -3.588 1 CA-C-N 107.388 -4.46 . . . . 0.0 121.326 144.84 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -76.62 -46.2 26.94 Favored 'General case' 0 CA--C 1.553 1.09 1 N-CA-C 134.402 8.667 . . . . 0.0 134.402 146.557 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -37.64 -56.83 1.02 Allowed 'General case' 0 CA--C 1.573 1.846 0 N-CA-C 115.088 1.514 . . . . 0.0 115.088 147.938 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . . . -80.26 -63.41 1.42 Allowed 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.366 -0.833 . . . . 0.0 108.834 -148.719 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -46.93 -43.74 19.27 Favored 'General case' 0 CA--C 1.576 1.945 0 N-CA-C 117.292 2.331 . . . . 0.0 117.292 171.887 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . . . -94.73 -5.63 44.95 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 119.211 3.041 . . . . 0.0 119.211 -177.586 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . . . -85.01 -31.68 23.34 Favored 'General case' 1 N--CA 1.553 4.71 2 N-CA-C 127.488 6.107 . . . . 0.0 127.488 161.148 . . . . . . . . 3 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . . . -39.7 -60.4 0.99 Allowed 'General case' 1 C--N 1.219 -5.089 3 CA-C-N 100.176 -7.738 . . . . 0.0 124.601 164.121 . . . . . . . . 3 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . . . -31.92 -42.04 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.252 -3.657 2 CA-C-N 100.838 -7.437 . . . . 0.0 130.29 137.636 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . . . -93.78 -0.36 55.92 Favored 'General case' 0 C--N 1.275 -2.653 0 N-CA-C 121.535 3.902 . . . . 0.0 121.535 164.841 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . . . -87.33 -24.65 24.22 Favored 'General case' 0 CA--C 1.609 3.229 0 CA-C-N 109.041 -3.709 . . . . 0.0 114.416 173.917 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . . . -97.24 -57.74 2.19 Favored 'General case' 0 N--CA 1.505 2.321 1 C-N-CA 132.261 4.224 . . . . 0.0 111.061 -177.831 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.755 0 CA-C-N 112.0 -2.364 . . . . 0.0 116.154 139.498 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.464 -2.33 1 N-CA-C 136.754 9.539 . . . . 0.0 136.754 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.598 ' C ' ' H ' ' A' ' 8' ' ' ALA . . . -50.16 -55.24 6.12 Favored 'Isoleucine or valine' 0 CA--C 1.434 -3.493 0 CA-C-N 111.383 -2.644 . . . . 0.0 107.923 129.947 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.457 ' C ' ' H ' ' A' ' 10' ' ' ILE . . . -33.26 -42.55 0.09 Allowed 'General case' 1 C--N 1.231 -4.549 1 N-CA-C 131.661 7.652 . . . . 0.0 131.661 -162.509 . . . . . . . . 4 3 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.598 ' H ' ' C ' ' A' ' 6' ' ' ILE . . . -97.54 -49.81 4.74 Favored 'General case' 1 N--CA 1.32 -6.968 3 CA-C-N 89.772 -12.467 . . . . 0.0 113.709 -147.489 . . . . . . . . 4 3 . 1 . 003 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.504 ' C ' ' HD2' ' A' ' 13' ' ' PRO . . . -74.51 5.71 4.47 Favored 'General case' 0 C--N 1.375 1.682 2 N-CA-C 138.88 10.326 . . . . 0.0 138.88 129.766 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.457 ' H ' ' C ' ' A' ' 7' ' ' PHE . . . -66.9 -31.23 52.53 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.079 2 CA-C-O 133.719 6.485 . . . . 0.0 125.265 158.154 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.44 ' C ' ' H ' ' A' ' 14' ' ' GLY . . . -108.39 -61.52 1.58 Allowed 'General case' 2 CA--C 1.4 -4.824 4 CA-C-N 91.714 -11.584 . . . . 0.0 124.904 -141.411 . . . . . . . . 4 3 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -78.44 -9.1 0.13 Allowed Pre-proline 0 C--N 1.269 -2.928 2 CA-C-N 99.95 -7.841 . . . . 0.0 118.66 160.862 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.504 ' HD2' ' C ' ' A' ' 9' ' ' SER . 0.1 OUTLIER -68.35 -18.48 44.28 Favored 'Trans proline' 0 N--CA 1.502 1.978 2 N-CA-C 135.041 8.823 . . . . 0.0 135.041 123.639 . . . . . . . . 4 4 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.44 ' H ' ' C ' ' A' ' 11' ' ' LEU . . . -70.07 -14.01 70.49 Favored Glycine 1 N--CA 1.53 4.964 2 CA-C-N 107.613 -4.358 . . . . 0.0 121.2 156.1 . . . . . . . . 4 3 . 1 . 003 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . . . -101.74 -70.33 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.457 -2.634 3 C-N-CA 136.666 5.986 . . . . 0.0 108.097 -175.185 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -71.88 -1.62 14.94 Favored 'General case' 1 C--N 1.237 -4.303 0 CA-C-N 109.03 -3.713 . . . . 0.0 111.506 -177.879 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -54.37 -82.87 0.01 OUTLIER 'General case' 0 C--N 1.359 0.983 1 N-CA-C 128.361 6.43 . . . . 0.0 128.361 125.43 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -32.52 -52.51 0.3 Allowed 'General case' 0 CA--C 1.582 2.197 0 N-CA-C 116.976 2.213 . . . . 0.0 116.976 170.596 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . . . -68.7 -55.98 9.62 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 113.004 -1.907 . . . . 0.0 113.08 -173.028 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -52.42 -39.46 61.01 Favored 'General case' 0 CA--C 1.586 2.353 0 N-CA-C 118.788 2.884 . . . . 0.0 118.788 171.164 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . . . -91.25 -5.55 54.6 Favored 'General case' 0 N--CA 1.516 2.869 0 N-CA-C 120.011 3.337 . . . . 0.0 120.011 178.138 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . . . -88.72 -30.18 19.28 Favored 'General case' 1 N--CA 1.543 4.177 2 N-CA-C 127.092 5.96 . . . . 0.0 127.092 164.607 . . . . . . . . 3 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . . . -37.79 -63.38 0.47 Allowed 'General case' 1 C--N 1.215 -5.257 2 CA-C-N 101.835 -6.984 . . . . 0.0 124.732 157.637 . . . . . . . . 3 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . . . -33.45 -48.4 0.11 Allowed 'Isoleucine or valine' 1 C--N 1.242 -4.076 2 N-CA-C 130.358 7.17 . . . . 0.0 130.358 139.494 . . . . . . . . 3 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . . . -77.87 -5.72 51.9 Favored 'General case' 0 C--N 1.276 -2.598 1 N-CA-C 123.031 4.456 . . . . 0.0 123.031 163.232 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . . . -92.82 -67.93 0.83 Allowed 'General case' 0 N--CA 1.527 3.413 0 CA-C-N 111.724 -2.489 . . . . 0.0 115.948 -161.588 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . . . -46.01 -53.87 9.36 Favored 'General case' 0 N--CA 1.497 1.875 1 CA-C-N 108.041 -4.163 . . . . 0.0 117.082 146.565 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.852 0 CA-C-N 122.106 2.23 . . . . 0.0 109.943 171.968 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.572 1.82 1 N-CA-C 128.182 6.364 . . . . 0.0 128.182 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.533 ' O ' ' N ' ' A' ' 10' ' ' ILE . . . -37.27 -34.62 0.11 Allowed 'Isoleucine or valine' 1 CA--C 1.395 -4.984 1 C-N-CA 136.545 5.938 . . . . 0.0 114.4 129.174 . . . . . . . . 4 3 . 1 . 004 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.551 ' C ' ' H ' ' A' ' 10' ' ' ILE . . . -78.24 -49.85 12.97 Favored 'General case' 2 CA--C 1.299 -8.696 2 CA-C-O 133.146 6.212 . . . . 0.0 119.297 171.886 . . . . . . . . 4 3 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -41.06 -26.09 0.04 OUTLIER 'General case' 1 N--CA 1.378 -4.063 2 N-CA-C 129.633 6.901 . . . . 0.0 129.633 139.706 . . . . . . . . 3 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.475 ' O ' ' HD2' ' A' ' 13' ' ' PRO . . . -90.7 -19.62 23.38 Favored 'General case' 1 CA--C 1.418 -4.12 3 N-CA-C 141.226 11.195 . . . . 0.0 141.226 140.419 . . . . . . . . 4 3 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.551 ' H ' ' C ' ' A' ' 7' ' ' PHE . . . -66.64 -58.72 5.47 Favored 'Isoleucine or valine' 0 CA--C 1.608 3.187 2 CA-C-N 104.286 -5.87 . . . . 0.0 108.281 -167.957 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.462 ' C ' ' H ' ' A' ' 14' ' ' GLY . . . -106.19 -24.89 12.21 Favored 'General case' 1 CA--C 1.36 -6.35 4 CA-C-N 93.5 -10.773 . . . . 0.0 128.026 -165.109 . . . . . . . . 4 3 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -78.09 -19.25 0.3 Allowed Pre-proline 0 C--N 1.258 -3.407 1 O-C-N 129.573 4.295 . . . . 0.0 117.281 160.853 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.475 ' HD2' ' O ' ' A' ' 9' ' ' SER . 0.0 OUTLIER -50.3 -26.17 15.12 Favored 'Trans proline' 0 C--N 1.313 -1.296 1 N-CA-C 136.691 9.458 . . . . 0.0 136.691 125.212 . . . . . . . . 4 4 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.462 ' H ' ' C ' ' A' ' 11' ' ' LEU . . . -74.2 -7.27 76.95 Favored Glycine 1 N--CA 1.531 5.002 3 O-C-N 130.378 4.799 . . . . 0.0 122.703 156.252 . . . . . . . . 4 3 . 1 . 004 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . . . -110.49 -57.88 3.88 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.761 2 CA-C-N 105.29 -5.455 . . . . 0.0 117.884 -168.925 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -28.05 -40.29 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.638 0 CA-C-N 108.506 -3.952 . . . . 0.0 117.217 139.678 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -73.69 -41.16 63.0 Favored 'General case' 0 N--CA 1.426 -1.66 1 CA-C-N 107.609 -4.359 . . . . 0.0 121.061 -173.573 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -37.28 -58.66 0.81 Allowed 'General case' 0 CA--C 1.574 1.868 0 CA-C-N 112.012 -2.358 . . . . 0.0 117.198 143.875 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . . . -77.04 -51.86 10.34 Favored 'General case' 0 N--CA 1.487 1.382 0 CA-C-O 126.625 3.107 . . . . 0.0 113.365 -147.761 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -43.91 -41.63 5.32 Favored 'General case' 0 CA--C 1.584 2.253 0 CA-C-N 109.348 -3.569 . . . . 0.0 117.591 157.371 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . . . -91.42 -2.46 57.27 Favored 'General case' 0 N--CA 1.501 2.078 1 N-CA-C 122.744 4.35 . . . . 0.0 122.744 174.77 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . . . -97.91 -3.74 37.92 Favored 'General case' 1 N--CA 1.548 4.462 1 N-CA-C 126.259 5.651 . . . . 0.0 126.259 164.032 . . . . . . . . 3 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . . . -90.48 -42.86 10.62 Favored 'General case' 1 C--N 1.232 -4.517 4 CA-C-N 102.845 -6.525 . . . . 0.0 126.962 -173.478 . . . . . . . . 3 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . . . -28.04 -88.52 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.291 -1.965 2 CA-C-N 98.062 -8.699 . . . . 0.0 119.904 110.107 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . . . -75.04 15.53 0.4 Allowed 'General case' 0 N--CA 1.534 3.73 2 O-C-N 113.994 -5.441 . . . . 0.0 120.54 -171.868 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . . . -93.0 -61.01 1.66 Allowed 'General case' 0 N--CA 1.502 2.162 1 CA-C-N 106.498 -4.865 . . . . 0.0 114.876 167.861 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . . . -48.06 -43.25 30.28 Favored 'General case' 0 N--CA 1.511 2.586 0 N-CA-C 117.002 2.223 . . . . 0.0 117.002 166.767 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.781 0 CA-C-N 111.889 -2.414 . . . . 0.0 113.06 157.993 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.478 ' N ' ' H ' ' A' ' 7' ' ' PHE . . . . . . . . 0 CA--C 1.499 -0.991 1 N-CA-C 124.356 4.947 . . . . 0.0 124.356 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.536 ' O ' ' N ' ' A' ' 10' ' ' ILE . . . -38.6 -45.09 0.4 Allowed 'Isoleucine or valine' 0 C--O 1.157 -3.786 2 CA-C-N 105.654 -5.248 . . . . 0.0 111.54 126.65 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.478 ' H ' ' N ' ' A' ' 5' ' ' ARG . . . -61.41 -60.55 3.55 Favored 'General case' 2 C--O 1.143 -4.543 2 CA-C-O 140.983 9.944 . . . . 0.0 113.306 -172.65 . . . . . . . . 4 3 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -36.81 -36.74 0.12 Allowed 'General case' 1 C--N 1.22 -5.031 2 CA-C-N 102.177 -6.829 . . . . 0.0 105.558 157.141 . . . . . . . . 3 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.528 ' C ' ' HD2' ' A' ' 13' ' ' PRO . . . -90.74 -12.67 35.88 Favored 'General case' 0 CA--C 1.431 -3.632 1 N-CA-C 134.001 8.519 . . . . 0.0 134.001 151.023 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.536 ' N ' ' O ' ' A' ' 6' ' ' ILE . . . -67.61 -57.47 9.48 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.317 0 CA-C-O 127.603 3.573 . . . . 0.0 109.122 174.529 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.573 ' C ' ' H ' ' A' ' 14' ' ' GLY . . . -112.69 -27.92 7.99 Favored 'General case' 1 CA--C 1.384 -5.421 1 CA-C-N 99.256 -8.156 . . . . 0.0 121.566 -156.162 . . . . . . . . 4 3 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -101.48 19.66 0.05 OUTLIER Pre-proline 0 C--N 1.266 -3.026 0 C-N-CA 113.203 -3.399 . . . . 0.0 118.735 159.798 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.528 ' HD2' ' C ' ' A' ' 9' ' ' SER . 0.0 OUTLIER -53.05 -31.29 53.22 Favored 'Trans proline' 0 N--CA 1.523 3.221 2 N-CA-C 132.654 7.905 . . . . 0.0 132.654 99.487 . . . . . . . . 4 4 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.573 ' H ' ' C ' ' A' ' 11' ' ' LEU . . . -59.65 -25.71 61.45 Favored Glycine 3 N--CA 1.552 6.405 1 CA-C-O 129.219 4.788 . . . . 0.0 122.444 167.453 . . . . . . . . 4 3 . 1 . 005 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . . . -107.11 -69.86 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.28 -2.444 2 CA-C-N 101.512 -7.344 . . . . 0.0 113.698 -163.217 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -27.0 -32.43 0.0 OUTLIER 'General case' 0 C--N 1.277 -2.568 0 N-CA-C 119.676 3.213 . . . . 0.0 119.676 153.515 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -85.1 -46.01 11.55 Favored 'General case' 0 C--N 1.328 -0.363 2 N-CA-C 123.334 4.568 . . . . 0.0 123.334 167.97 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -39.18 -57.74 1.28 Allowed 'General case' 0 N--CA 1.508 2.425 0 CA-C-O 123.249 1.499 . . . . 0.0 114.302 151.126 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . . . -81.99 -55.76 4.38 Favored 'General case' 0 CA--C 1.553 1.083 0 CA-C-O 123.32 1.533 . . . . 0.0 109.123 -140.9 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -48.62 -56.35 8.71 Favored 'General case' 0 CA--C 1.567 1.603 0 CA-C-N 112.728 -2.033 . . . . 0.0 115.128 162.009 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . . . -90.24 13.26 15.73 Favored 'General case' 0 N--CA 1.532 3.672 1 O-C-N 116.052 -4.155 . . . . 0.0 119.216 -178.568 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . . . -87.48 -32.72 19.31 Favored 'General case' 0 CA--C 1.427 -3.761 0 N-CA-C 121.464 3.876 . . . . 0.0 121.464 158.019 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . . . -43.52 -59.11 2.3 Favored 'General case' 0 C--N 1.253 -3.598 0 CA-C-N 108.665 -3.88 . . . . 0.0 114.804 174.757 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . . . -36.23 -46.14 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.26 -3.284 2 CA-C-N 102.379 -6.737 . . . . 0.0 125.261 148.161 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . . . -72.13 -14.47 61.84 Favored 'General case' 0 C--N 1.278 -2.502 1 N-CA-C 121.991 4.071 . . . . 0.0 121.991 162.818 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . . . -91.01 -61.56 1.64 Allowed 'General case' 0 N--CA 1.511 2.602 0 CA-C-N 110.681 -2.963 . . . . 0.0 108.375 -160.445 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . . . -49.91 -42.58 48.41 Favored 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 128.659 2.784 . . . . 0.0 118.238 157.232 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.503 2.208 0 CA-C-O 124.159 1.933 . . . . 0.0 110.227 161.257 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.49 -1.337 1 N-CA-C 125.905 5.521 . . . . 0.0 125.905 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.428 ' O ' ' N ' ' A' ' 9' ' ' SER . . . -45.95 -51.69 3.39 Favored 'Isoleucine or valine' 0 C--O 1.192 -1.932 0 O-C-N 128.948 3.905 . . . . 0.0 106.128 136.752 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.436 ' O ' ' N ' ' A' ' 10' ' ' ILE . . . -45.32 -64.44 0.72 Allowed 'General case' 3 N--CA 1.561 5.098 0 O-C-N 126.551 2.407 . . . . 0.0 113.063 -155.942 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -39.38 -47.62 1.79 Allowed 'General case' 1 N--CA 1.373 -4.319 4 C-N-CA 153.271 12.628 . . . . 0.0 100.027 166.512 . . . . . . . . 3 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.523 ' O ' ' HG2' ' A' ' 13' ' ' PRO . . . -91.75 19.2 6.67 Favored 'General case' 0 N--CA 1.513 2.676 1 N-CA-C 132.711 8.041 . . . . 0.0 132.711 153.15 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.436 ' N ' ' O ' ' A' ' 7' ' ' PHE . . . -109.29 -49.65 7.09 Favored 'Isoleucine or valine' 2 CA--C 1.644 4.576 2 N-CA-C 98.912 -4.477 . . . . 0.0 98.912 -177.547 . . . . . . . . 4 3 . 1 . 006 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.507 ' C ' ' H ' ' A' ' 14' ' ' GLY . . . -62.97 -52.78 61.66 Favored 'General case' 1 CA--C 1.361 -6.297 2 C-N-CA 138.429 6.692 . . . . 0.0 126.301 -177.71 . . . . . . . . 4 3 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -95.83 -15.52 0.2 Allowed Pre-proline 0 C--N 1.248 -3.844 2 O-C-N 135.102 7.751 . . . . 0.0 112.744 -177.212 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.523 ' HG2' ' O ' ' A' ' 9' ' ' SER . 0.1 OUTLIER -54.67 -24.55 37.8 Favored 'Trans proline' 0 N--CA 1.504 2.144 1 N-CA-C 128.56 6.331 . . . . 0.0 128.56 121.467 . . . . . . . . 4 4 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.507 ' H ' ' C ' ' A' ' 11' ' ' LEU . . . -85.83 -0.3 87.63 Favored Glycine 2 N--CA 1.533 5.157 1 CA-C-N 108.127 -4.124 . . . . 0.0 121.814 164.465 . . . . . . . . 4 3 . 1 . 006 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . . . -103.89 -69.36 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.642 2 CA-C-N 106.409 -4.896 . . . . 0.0 114.335 175.523 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -24.03 -41.4 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.714 0 CA-C-N 110.865 -2.88 . . . . 0.0 117.994 156.02 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.44 -81.66 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.716 1 CA-C-N 106.073 -5.058 . . . . 0.0 121.287 158.512 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -36.33 -60.12 0.59 Allowed 'General case' 0 CA--C 1.581 2.168 0 N-CA-C 117.182 2.29 . . . . 0.0 117.182 171.235 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . . . -58.69 -57.38 13.25 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 128.874 2.87 . . . . 0.0 112.347 -168.166 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -71.7 -36.48 70.58 Favored 'General case' 0 CA--C 1.574 1.893 0 C-N-CA 127.689 2.396 . . . . 0.0 115.667 -176.185 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . . . -85.88 -0.86 56.48 Favored 'General case' 0 N--CA 1.506 2.374 0 N-CA-C 117.598 2.444 . . . . 0.0 117.598 173.43 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . . . -104.67 -26.87 12.13 Favored 'General case' 1 N--CA 1.554 4.743 1 N-CA-C 125.376 5.325 . . . . 0.0 125.376 176.427 . . . . . . . . 3 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . . . -35.0 -68.89 0.11 Allowed 'General case' 0 C--N 1.258 -3.37 1 CA-C-N 102.823 -6.535 . . . . 0.0 118.625 146.805 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . . . -34.28 -41.0 0.09 OUTLIER 'Isoleucine or valine' 1 C--N 1.236 -4.335 2 CA-C-N 105.484 -5.325 . . . . 0.0 122.642 148.921 . . . . . . . . 3 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . . . -94.71 2.47 55.56 Favored 'General case' 0 C--N 1.275 -2.646 0 N-CA-C 120.837 3.643 . . . . 0.0 120.837 170.524 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . . . -91.2 -25.11 19.69 Favored 'General case' 0 CA--C 1.608 3.185 0 CA-C-N 108.552 -3.931 . . . . 0.0 113.977 169.33 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . . . -96.85 -59.3 1.83 Allowed 'General case' 0 N--CA 1.507 2.419 0 C-N-CA 131.157 3.783 . . . . 0.0 110.163 -176.659 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 1.886 0 CA-C-N 112.195 -2.275 . . . . 0.0 114.233 141.677 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.503 ' N ' ' H ' ' A' ' 7' ' ' PHE . . . . . . . . 0 N--CA 1.432 -1.331 1 N-CA-C 123.219 4.526 . . . . 0.0 123.219 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.565 ' C ' ' H ' ' A' ' 9' ' ' SER . . . -39.28 -29.77 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.435 -3.457 1 CA-C-O 110.952 -4.356 . . . . 0.0 109.516 125.494 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.503 ' H ' ' N ' ' A' ' 5' ' ' ARG . . . -72.34 -56.85 4.8 Favored 'General case' 1 N--CA 1.558 4.939 2 CA-C-O 131.312 5.339 . . . . 0.0 115.367 -173.013 . . . . . . . . 4 3 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -37.44 -49.24 1.01 Allowed 'General case' 1 C--N 1.233 -4.497 3 C-N-CA 142.179 8.192 . . . . 0.0 100.704 150.732 . . . . . . . . 3 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.565 ' H ' ' C ' ' A' ' 6' ' ' ILE . . . -102.66 -6.46 22.69 Favored 'General case' 0 N--CA 1.52 3.065 1 N-CA-C 128.829 6.603 . . . . 0.0 128.829 174.957 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.474 ' C ' ' HB2' ' A' ' 13' ' ' PRO . . . -84.85 -47.54 17.08 Favored 'Isoleucine or valine' 1 C--N 1.231 -4.562 2 CA-C-N 106.894 -4.685 . . . . 0.0 98.392 -179.455 . . . . . . . . 4 3 . 1 . 007 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.555 ' C ' ' H ' ' A' ' 14' ' ' GLY . . . -106.13 -33.38 7.87 Favored 'General case' 1 CA--C 1.378 -5.64 1 N-CA-C 123.457 4.614 . . . . 0.0 123.457 -157.276 . . . . . . . . 4 3 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -76.41 -23.1 0.44 Allowed Pre-proline 0 C--N 1.246 -3.897 2 O-C-N 130.065 4.603 . . . . 0.0 113.343 166.808 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.529 ' HG2' ' O ' ' A' ' 9' ' ' SER . 0.0 OUTLIER -48.34 -27.45 9.9 Favored 'Trans proline' 0 CA--C 1.476 -2.416 1 N-CA-C 129.113 6.544 . . . . 0.0 129.113 127.895 . . . . . . . . 4 4 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.555 ' H ' ' C ' ' A' ' 11' ' ' LEU . . . -64.93 -21.03 67.29 Favored Glycine 2 N--CA 1.544 5.855 1 CA-C-O 128.106 4.17 . . . . 0.0 122.742 160.041 . . . . . . . . 4 3 . 1 . 007 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . . . -108.45 -68.99 0.95 Allowed 'Isoleucine or valine' 0 CA--C 1.462 -2.427 2 CA-C-N 103.262 -6.469 . . . . 0.0 111.936 -159.667 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -26.37 -32.92 0.0 OUTLIER 'General case' 0 C--N 1.269 -2.921 0 N-CA-C 119.937 3.31 . . . . 0.0 119.937 148.712 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -88.75 -41.46 12.53 Favored 'General case' 0 N--CA 1.466 0.326 2 N-CA-C 123.7 4.704 . . . . 0.0 123.7 167.976 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -39.01 -59.15 1.02 Allowed 'General case' 0 N--CA 1.511 2.593 0 CA-C-O 123.796 1.76 . . . . 0.0 114.881 148.677 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . . . -77.3 -56.46 4.53 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 114.714 -1.13 . . . . 0.0 108.316 -143.117 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -42.44 -45.4 4.38 Favored 'General case' 0 CA--C 1.582 2.204 0 C-N-CA 126.52 1.928 . . . . 0.0 115.741 159.684 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . . . -92.57 1.77 57.07 Favored 'General case' 0 CA--C 1.578 2.054 0 N-CA-C 119.251 3.056 . . . . 0.0 119.251 -176.015 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . . . -106.54 -15.7 14.72 Favored 'General case' 1 N--CA 1.56 5.064 1 N-CA-C 124.075 4.843 . . . . 0.0 124.075 157.521 . . . . . . . . 3 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . . . -36.68 -69.67 0.11 Allowed 'General case' 1 C--N 1.233 -4.468 0 CA-C-N 108.794 -3.821 . . . . 0.0 118.61 157.36 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . . . -35.47 -43.65 0.15 Allowed 'Isoleucine or valine' 1 C--N 1.224 -4.879 2 CA-C-N 102.526 -6.67 . . . . 0.0 123.099 149.961 . . . . . . . . 3 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . . . -92.29 1.82 57.0 Favored 'General case' 0 C--N 1.292 -1.893 0 N-CA-C 118.398 2.74 . . . . 0.0 118.398 171.163 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . . . -90.91 -32.57 15.95 Favored 'General case' 0 CA--C 1.612 3.328 0 CA-C-N 110.71 -2.95 . . . . 0.0 113.632 175.772 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . . . -97.05 -48.91 5.21 Favored 'General case' 0 N--CA 1.509 2.482 1 C-N-CA 131.968 4.107 . . . . 0.0 110.818 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.499 1.985 0 C-N-CA 117.586 -1.646 . . . . 0.0 113.419 140.428 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.437 -1.123 1 N-CA-C 128.466 6.469 . . . . 0.0 128.466 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.649 ' C ' ' H ' ' A' ' 9' ' ' SER . . . -37.16 -60.3 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.512 2.631 3 N-CA-C 89.576 -7.935 . . . . 0.0 89.576 142.834 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . . . -103.34 -32.04 9.75 Favored 'General case' 1 N--CA 1.371 -4.405 1 CA-C-O 130.934 5.159 . . . . 0.0 111.664 -128.603 . . . . . . . . 3 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -45.88 -36.27 5.22 Favored 'General case' 0 CA--C 1.446 -3.053 1 O-C-N 116.054 -4.154 . . . . 0.0 121.197 126.757 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.649 ' H ' ' C ' ' A' ' 6' ' ' ILE . . . -90.7 10.6 25.2 Favored 'General case' 0 N--CA 1.524 3.258 1 N-CA-C 125.11 5.226 . . . . 0.0 125.11 176.094 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . . . -110.99 -42.39 4.74 Favored 'Isoleucine or valine' 1 CA--C 1.651 4.855 1 CA-C-N 106.817 -4.719 . . . . 0.0 102.094 -176.364 . . . . . . . . 3 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.541 ' C ' ' H ' ' A' ' 14' ' ' GLY . . . -54.71 -59.33 4.86 Favored 'General case' 1 CA--C 1.373 -5.852 1 C-N-CA 138.069 6.548 . . . . 0.0 120.91 170.374 . . . . . . . . 4 3 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -81.89 -41.18 1.01 Allowed Pre-proline 1 N--CA 1.362 -4.857 1 CA-C-N 105.47 -5.332 . . . . 0.0 102.968 -172.42 . . . . . . . . 3 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.535 ' HD2' ' C ' ' A' ' 9' ' ' SER . 0.1 OUTLIER -37.56 -22.4 0.05 OUTLIER 'Trans proline' 0 N--CA 1.518 2.927 2 O-C-N 108.919 -6.411 . . . . 0.0 127.829 134.853 . . . . . . . . 4 4 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.541 ' H ' ' C ' ' A' ' 11' ' ' LEU . . . -80.33 -7.21 88.76 Favored Glycine 2 N--CA 1.529 4.851 1 CA-C-N 108.141 -4.118 . . . . 0.0 119.886 163.045 . . . . . . . . 4 3 . 1 . 008 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . . . -105.86 -76.53 0.46 Allowed 'Isoleucine or valine' 0 C--O 1.2 -1.521 2 C-N-CA 133.1 4.56 . . . . 0.0 110.89 -166.775 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -21.1 -34.71 0.0 OUTLIER 'General case' 0 C--N 1.26 -3.306 0 N-CA-C 120.367 3.469 . . . . 0.0 120.367 147.001 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -83.8 -45.29 13.46 Favored 'General case' 0 N--CA 1.476 0.827 1 N-CA-C 125.246 5.276 . . . . 0.0 125.246 160.531 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -36.4 -55.42 0.82 Allowed 'General case' 0 N--CA 1.517 2.878 0 CA-C-O 125.235 2.445 . . . . 0.0 116.276 154.461 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . . . -78.07 -50.25 12.42 Favored 'General case' 0 N--CA 1.48 1.047 0 CA-C-O 124.047 1.879 . . . . 0.0 111.327 -152.057 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -37.93 -48.98 1.21 Allowed 'General case' 0 N--CA 1.413 -2.29 0 C-N-CA 131.617 3.967 . . . . 0.0 120.836 149.904 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . . . -87.89 7.86 28.83 Favored 'General case' 0 N--CA 1.514 2.731 0 N-CA-C 119.901 3.297 . . . . 0.0 119.901 170.53 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . . . -104.08 -30.69 10.09 Favored 'General case' 0 N--CA 1.534 3.771 1 N-CA-C 124.429 4.974 . . . . 0.0 124.429 173.572 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . . . -37.82 -59.49 0.81 Allowed 'General case' 0 C--N 1.258 -3.404 2 CA-C-N 104.18 -5.918 . . . . 0.0 121.877 152.902 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . . . -36.13 -47.24 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.262 -3.205 3 O-C-N 134.567 7.417 . . . . 0.0 123.071 140.259 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . . . -91.89 4.81 52.09 Favored 'General case' 0 C--N 1.269 -2.902 0 O-C-N 119.128 -2.233 . . . . 0.0 116.437 170.802 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . . . -96.56 -60.0 1.7 Allowed 'General case' 0 N--CA 1.521 3.112 0 CA-C-N 110.475 -3.057 . . . . 0.0 113.572 -175.914 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . . . -47.16 -38.4 11.69 Favored 'General case' 0 N--CA 1.51 2.564 0 CA-C-N 109.06 -3.7 . . . . 0.0 115.053 158.175 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.489 0 CA-C-O 123.36 1.552 . . . . 0.0 108.411 164.202 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.635 1 N-CA-C 122.161 4.134 . . . . 0.0 122.161 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . . . -38.32 -55.09 0.35 Allowed 'Isoleucine or valine' 1 CA--C 1.418 -4.104 0 CA-C-N 108.428 -3.987 . . . . 0.0 111.262 131.84 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . . . -45.87 -63.27 1.01 Allowed 'General case' 3 CA--C 1.299 -8.704 0 O-C-N 127.406 2.941 . . . . 0.0 111.007 -175.001 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -35.63 -49.1 0.55 Allowed 'General case' 0 C--N 1.273 -2.733 2 C-N-CA 141.414 7.886 . . . . 0.0 104.361 167.591 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.47 ' O ' ' HG2' ' A' ' 13' ' ' PRO . . . -76.44 -13.43 60.11 Favored 'General case' 1 N--CA 1.539 4.024 2 N-CA-C 134.667 8.765 . . . . 0.0 134.667 169.0 . . . . . . . . 4 3 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . . . -103.84 -45.55 9.79 Favored 'Isoleucine or valine' 2 C--N 1.204 -5.731 2 CA-C-N 97.549 -8.932 . . . . 0.0 99.1 -161.293 . . . . . . . . 3 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.521 ' C ' ' H ' ' A' ' 14' ' ' GLY . . . -94.77 -56.6 2.72 Favored 'General case' 1 CA--C 1.397 -4.931 1 C-N-CA 135.144 5.378 . . . . 0.0 118.402 -148.135 . . . . . . . . 4 3 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -86.26 -12.89 0.19 Allowed Pre-proline 0 C--N 1.262 -3.199 2 O-C-N 135.848 8.217 . . . . 0.0 113.32 178.766 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.47 ' HG2' ' O ' ' A' ' 9' ' ' SER . 0.1 OUTLIER -56.08 -27.7 66.09 Favored 'Trans proline' 0 N--CA 1.52 3.053 2 N-CA-C 131.501 7.462 . . . . 0.0 131.501 118.579 . . . . . . . . 4 4 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.521 ' H ' ' C ' ' A' ' 11' ' ' LEU . . . -77.97 -5.15 86.71 Favored Glycine 3 N--CA 1.562 7.051 2 CA-C-O 130.659 5.589 . . . . 0.0 123.301 164.845 . . . . . . . . 4 3 . 1 . 009 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . . . -105.61 -78.4 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.278 -2.514 2 C-N-CA 139.386 7.074 . . . . 0.0 117.819 179.616 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -29.6 -30.34 0.0 OUTLIER 'General case' 0 C--N 1.264 -3.139 0 N-CA-C 117.932 2.567 . . . . 0.0 117.932 152.862 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -53.19 -77.56 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.863 0 CA-C-N 109.21 -3.632 . . . . 0.0 120.627 150.446 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -33.68 -58.27 0.42 Allowed 'General case' 0 CA--C 1.571 1.788 0 N-CA-C 116.685 2.106 . . . . 0.0 116.685 169.425 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . . . -64.8 -41.37 95.85 Favored 'General case' 0 CA--C 1.552 1.04 0 CA-C-N 113.6 -1.636 . . . . 0.0 113.67 -164.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -83.43 -27.8 29.28 Favored 'General case' 0 CA--C 1.582 2.198 0 C-N-CA 129.142 2.977 . . . . 0.0 114.593 -178.317 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . . . -84.51 3.66 35.45 Favored 'General case' 0 N--CA 1.505 2.304 0 N-CA-C 120.034 3.346 . . . . 0.0 120.034 158.755 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . . . -103.39 -27.16 12.6 Favored 'General case' 1 N--CA 1.548 4.443 1 N-CA-C 124.534 5.012 . . . . 0.0 124.534 173.261 . . . . . . . . 3 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . . . -35.99 -67.41 0.16 Allowed 'General case' 0 C--N 1.257 -3.414 1 CA-C-N 103.779 -6.101 . . . . 0.0 119.048 149.065 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . . . -33.9 -41.86 0.09 OUTLIER 'Isoleucine or valine' 1 C--N 1.239 -4.219 2 CA-C-N 104.851 -5.613 . . . . 0.0 122.801 147.961 . . . . . . . . 3 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . . . -94.43 3.08 55.63 Favored 'General case' 0 C--N 1.274 -2.705 0 N-CA-C 120.838 3.644 . . . . 0.0 120.838 170.621 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . . . -90.97 -25.75 19.59 Favored 'General case' 0 CA--C 1.609 3.222 1 CA-C-N 108.381 -4.008 . . . . 0.0 113.831 169.34 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . . . -96.82 -59.11 1.87 Allowed 'General case' 0 N--CA 1.507 2.406 0 C-N-CA 131.266 3.826 . . . . 0.0 110.239 -176.264 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 1.929 0 CA-C-N 112.152 -2.295 . . . . 0.0 114.225 141.353 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.516 ' CA ' ' H ' ' A' ' 7' ' ' PHE . . . . . . . . 0 CA--C 1.481 -1.693 1 N-CA-C 141.871 11.434 . . . . 0.0 141.871 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.438 ' O ' ' N ' ' A' ' 10' ' ' ILE . . . -46.01 -43.32 4.73 Favored 'Isoleucine or valine' 0 CA--C 1.465 -2.289 0 O-C-N 128.886 3.866 . . . . 0.0 106.763 126.095 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.516 ' H ' ' CA ' ' A' ' 5' ' ' ARG . . . -67.08 -61.16 2.07 Favored 'General case' 0 N--CA 1.401 -2.919 1 CA-C-O 129.405 4.431 . . . . 0.0 118.194 -133.813 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -35.1 -27.18 0.01 OUTLIER 'General case' 2 C--N 1.195 -6.132 2 N-CA-C 136.562 9.467 . . . . 0.0 136.562 130.275 . . . . . . . . 3 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.477 ' O ' ' HD2' ' A' ' 13' ' ' PRO . . . -89.35 5.59 44.39 Favored 'General case' 0 C--N 1.255 -3.502 1 N-CA-C 135.188 8.958 . . . . 0.0 135.188 140.647 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.438 ' N ' ' O ' ' A' ' 6' ' ' ILE . . . -67.7 -43.29 86.71 Favored 'Isoleucine or valine' 0 C--N 1.255 -3.503 1 CA-C-O 129.246 4.355 . . . . 0.0 118.642 162.302 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . . . -116.82 -28.85 6.21 Favored 'General case' 1 CA--C 1.406 -4.584 3 CA-C-N 98.219 -8.628 . . . . 0.0 127.937 -149.486 . . . . . . . . 3 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -76.91 -23.93 0.45 Allowed Pre-proline 1 C--N 1.244 -4.003 3 O-C-N 135.077 7.736 . . . . 0.0 122.988 150.65 . . . . . . . . 3 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.477 ' HD2' ' O ' ' A' ' 9' ' ' SER . 0.1 OUTLIER -59.36 -22.76 67.14 Favored 'Trans proline' 0 C--N 1.31 -1.486 1 N-CA-C 130.72 7.162 . . . . 0.0 130.72 128.365 . . . . . . . . 4 4 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -80.66 4.91 66.75 Favored Glycine 1 N--CA 1.518 4.118 2 CA-C-N 104.567 -5.742 . . . . 0.0 120.26 159.043 . . . . . . . . 3 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . . . -113.39 -67.72 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 C-N-CA 131.127 3.771 . . . . 0.0 113.058 -174.872 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -26.96 -34.96 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 108.917 -3.765 . . . . 0.0 119.506 145.139 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.83 -70.4 0.21 Allowed 'General case' 0 N--CA 1.441 -0.91 2 N-CA-C 126.167 5.618 . . . . 0.0 126.167 155.335 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -38.22 -54.76 1.37 Allowed 'General case' 0 CA--C 1.583 2.232 0 N-CA-C 118.187 2.662 . . . . 0.0 118.187 163.642 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . . . -39.46 -56.47 1.6 Allowed 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 129.731 3.213 . . . . 0.0 115.507 174.691 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -80.9 -27.28 36.32 Favored 'General case' 0 CA--C 1.567 1.598 0 CA-C-N 109.998 -3.274 . . . . 0.0 113.757 -178.228 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . . . -98.49 10.52 40.73 Favored 'General case' 0 N--CA 1.525 3.297 1 N-CA-C 130.874 7.361 . . . . 0.0 130.874 160.018 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . . . -95.12 -28.37 15.11 Favored 'General case' 0 N--CA 1.538 3.934 2 N-CA-C 125.718 5.451 . . . . 0.0 125.718 157.715 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . . . -30.84 -56.75 0.22 Allowed 'General case' 2 N--CA 1.366 -4.645 2 CA-C-N 103.517 -6.22 . . . . 0.0 119.53 138.208 . . . . . . . . 3 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . . . -94.35 -8.88 9.67 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.239 0 C-N-CA 113.901 -3.12 . . . . 0.0 117.924 -171.945 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . . . -71.02 -14.52 62.37 Favored 'General case' 0 C--N 1.307 -1.252 1 N-CA-C 127.46 6.096 . . . . 0.0 127.46 148.531 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . . . -92.6 -48.36 6.65 Favored 'General case' 1 N--CA 1.548 4.465 0 N-CA-C 118.845 2.906 . . . . 0.0 118.845 -162.219 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . . . -46.19 -72.98 0.04 OUTLIER 'General case' 0 C--N 1.288 -2.076 1 CA-C-N 106.22 -4.991 . . . . 0.0 117.266 138.536 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.712 0 CA-C-O 124.802 2.239 . . . . 0.0 111.548 -172.98 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . . . . . . . . 0 C--O 1.225 -0.22 1 N-CA-C 124.967 5.173 . . . . 0.0 124.967 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . . . -35.48 -61.11 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.425 -3.838 1 CA-C-N 106.682 -4.781 . . . . 0.0 114.599 113.43 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . . . -35.39 -41.01 0.17 Allowed 'General case' 3 CA--C 1.333 -7.403 2 N-CA-C 129.336 6.791 . . . . 0.0 129.336 -179.487 . . . . . . . . 3 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -57.03 -52.26 65.99 Favored 'General case' 1 N--CA 1.315 -7.192 4 O-C-N 145.693 14.37 . . . . 0.0 125.673 165.426 . . . . . . . . 3 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.447 ' O ' ' HG2' ' A' ' 13' ' ' PRO . . . -97.3 0.37 47.94 Favored 'General case' 0 N--CA 1.501 2.096 3 N-CA-C 132.805 8.076 . . . . 0.0 132.805 160.782 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . . . -62.61 -39.72 85.68 Favored 'Isoleucine or valine' 0 C--N 1.246 -3.91 2 CA-C-N 101.757 -7.019 . . . . 0.0 120.202 150.418 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.472 ' C ' ' H ' ' A' ' 14' ' ' GLY . . . -100.63 -52.58 3.3 Favored 'General case' 1 CA--C 1.416 -4.194 3 CA-C-N 99.029 -8.26 . . . . 0.0 125.736 -145.088 . . . . . . . . 4 3 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -81.29 -21.3 0.31 Allowed Pre-proline 0 N--CA 1.379 -3.99 2 O-C-N 136.935 8.897 . . . . 0.0 116.151 167.027 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.447 ' HG2' ' O ' ' A' ' 9' ' ' SER . 12.2 Cg_exo -52.53 -24.27 21.77 Favored 'Trans proline' 0 N--CA 1.51 2.474 2 N-CA-C 134.683 8.686 . . . . 0.0 134.683 118.13 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.472 ' H ' ' C ' ' A' ' 11' ' ' LEU . . . -78.41 -3.07 85.72 Favored Glycine 2 N--CA 1.543 5.793 2 CA-C-N 106.655 -4.793 . . . . 0.0 120.827 159.539 . . . . . . . . 4 3 . 1 . 011 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . . . -114.87 -77.81 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.467 -2.238 2 C-N-CA 134.852 5.261 . . . . 0.0 112.409 -169.513 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -29.29 -27.91 0.0 OUTLIER 'General case' 0 C--N 1.274 -2.71 0 N-CA-C 119.939 3.311 . . . . 0.0 119.939 150.839 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -57.76 -69.02 0.19 Allowed 'General case' 0 CA--C 1.549 0.923 1 N-CA-C 130.425 7.195 . . . . 0.0 130.425 145.697 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -35.54 -54.69 0.68 Allowed 'General case' 0 CA--C 1.578 2.03 0 N-CA-C 116.955 2.205 . . . . 0.0 116.955 159.648 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . . . -77.3 -55.15 5.66 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 113.653 -1.612 . . . . 0.0 111.555 -155.519 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -39.82 -41.9 1.21 Allowed 'General case' 0 CA--C 1.586 2.349 0 N-CA-C 117.522 2.415 . . . . 0.0 117.522 157.083 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . . . -95.22 14.17 23.09 Favored 'General case' 0 N--CA 1.502 2.165 1 N-CA-C 123.86 4.763 . . . . 0.0 123.86 175.031 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.416 ' C ' ' H ' ' A' ' 25' ' ' GLU . . . -101.87 -6.68 23.25 Favored 'General case' 1 N--CA 1.555 4.78 1 N-CA-C 127.42 6.082 . . . . 0.0 127.42 151.009 . . . . . . . . 4 3 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . . . -81.13 -48.2 12.45 Favored 'General case' 1 C--N 1.221 -4.988 2 CA-C-N 102.955 -6.475 . . . . 0.0 123.262 -173.019 . . . . . . . . 3 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . . . -23.71 -52.74 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.283 -2.32 3 N-CA-C 131.404 7.557 . . . . 0.0 131.404 115.898 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.416 ' H ' ' C ' ' A' ' 22' ' ' ARG . . . -90.66 8.81 32.46 Favored 'General case' 0 N--CA 1.521 3.097 0 O-C-N 118.12 -2.863 . . . . 0.0 117.085 169.769 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . . . -96.25 -61.8 1.38 Allowed 'General case' 0 N--CA 1.518 2.928 0 CA-C-N 108.768 -3.833 . . . . 0.0 116.215 -175.849 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . . . -46.34 -46.16 18.06 Favored 'General case' 0 N--CA 1.494 1.76 1 CA-C-N 108.006 -4.179 . . . . 0.0 115.431 156.547 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.258 0 CA-C-O 123.871 1.796 . . . . 0.0 108.788 166.792 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.484 ' N ' ' H ' ' A' ' 7' ' ' PHE . . . . . . . . 0 N--CA 1.439 -0.978 1 N-CA-C 138.529 10.196 . . . . 0.0 138.529 . . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.419 ' O ' ' N ' ' A' ' 10' ' ' ILE . . . -44.47 -49.47 2.23 Favored 'Isoleucine or valine' 0 C--O 1.184 -2.359 0 CA-C-N 109.757 -3.383 . . . . 0.0 105.485 124.157 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.484 ' H ' ' N ' ' A' ' 5' ' ' ARG . . . -63.83 -61.4 2.32 Favored 'General case' 1 CA--C 1.385 -5.401 0 O-C-N 126.679 2.487 . . . . 0.0 114.646 -140.324 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -92.46 27.34 2.3 Favored 'General case' 0 N--CA 1.398 -3.059 1 CA-C-N 106.955 -4.657 . . . . 0.0 120.449 158.857 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.413 ' O ' ' HG2' ' A' ' 13' ' ' PRO . . . -100.58 7.78 43.83 Favored 'General case' 0 CA--C 1.461 -2.466 1 N-CA-C 142.619 11.711 . . . . 0.0 142.619 120.52 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.419 ' N ' ' O ' ' A' ' 6' ' ' ILE . . . -67.79 -54.2 24.76 Favored 'Isoleucine or valine' 0 C--N 1.249 -3.802 2 CA-C-N 105.276 -5.42 . . . . 0.0 114.938 165.182 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.443 ' C ' ' H ' ' A' ' 14' ' ' GLY . . . -120.49 -26.37 5.38 Favored 'General case' 1 CA--C 1.397 -4.92 3 CA-C-N 96.754 -9.294 . . . . 0.0 130.205 -148.317 . . . . . . . . 4 3 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -90.65 -25.69 0.29 Allowed Pre-proline 1 N--CA 1.372 -4.374 2 CA-C-N 103.572 -6.195 . . . . 0.0 107.069 159.805 . . . . . . . . 3 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.413 ' HG2' ' O ' ' A' ' 9' ' ' SER . 0.1 OUTLIER -39.57 -15.72 0.04 OUTLIER 'Trans proline' 0 N--CA 1.533 3.837 3 O-C-N 104.571 -8.699 . . . . 0.0 128.305 125.829 . . . . . . . . 4 4 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.443 ' H ' ' C ' ' A' ' 11' ' ' LEU . . . -86.17 9.29 70.34 Favored Glycine 1 N--CA 1.539 5.521 1 CA-C-N 105.17 -5.468 . . . . 0.0 122.646 159.701 . . . . . . . . 4 3 . 1 . 012 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . . . -115.98 -83.98 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.795 3 CA-C-N 105.051 -5.575 . . . . 0.0 112.117 -167.54 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -28.99 -26.01 0.0 OUTLIER 'General case' 0 C--N 1.248 -3.819 1 CA-C-N 107.735 -4.302 . . . . 0.0 120.974 148.333 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -70.12 -58.75 3.44 Favored 'General case' 0 C--N 1.326 -0.451 1 N-CA-C 133.463 8.32 . . . . 0.0 133.463 143.485 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -35.24 -55.85 0.62 Allowed 'General case' 0 CA--C 1.586 2.364 0 N-CA-C 116.186 1.921 . . . . 0.0 116.186 159.064 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . . . -68.23 -56.98 6.75 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 113.113 -1.858 . . . . 0.0 111.714 -168.183 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -44.09 -38.61 3.73 Favored 'General case' 0 CA--C 1.585 2.308 0 N-CA-C 117.348 2.351 . . . . 0.0 117.348 162.723 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . . . -95.88 1.04 52.76 Favored 'General case' 0 N--CA 1.513 2.695 1 N-CA-C 125.494 5.368 . . . . 0.0 125.494 178.434 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . . . -100.19 3.73 43.91 Favored 'General case' 1 N--CA 1.557 4.896 2 N-CA-C 125.845 5.498 . . . . 0.0 125.845 155.902 . . . . . . . . 3 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . . . -87.33 -56.04 3.54 Favored 'General case' 1 C--N 1.214 -5.308 1 CA-C-N 103.929 -6.032 . . . . 0.0 119.363 -174.215 . . . . . . . . 3 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . . . -23.79 -46.21 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.268 -2.947 2 N-CA-C 132.484 7.957 . . . . 0.0 132.484 123.017 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . . . -78.72 -8.78 59.05 Favored 'General case' 0 C--N 1.28 -2.444 0 N-CA-C 121.358 3.836 . . . . 0.0 121.358 164.365 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . . . -94.05 -46.08 7.29 Favored 'General case' 1 N--CA 1.549 4.488 0 CA-C-N 108.924 -3.762 . . . . 0.0 118.981 -157.403 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . . . -46.36 -74.1 0.04 OUTLIER 'General case' 0 C--N 1.287 -2.141 1 CA-C-N 106.516 -4.856 . . . . 0.0 117.027 135.425 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.656 0 CA-C-O 124.778 2.227 . . . . 0.0 111.775 -169.09 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.536 ' N ' ' H ' ' A' ' 7' ' ' PHE . . . . . . . . 0 N--CA 1.5 2.072 1 N-CA-C 134.597 8.74 . . . . 0.0 134.597 . . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.504 ' O ' ' N ' ' A' ' 10' ' ' ILE . . . -33.24 -52.14 0.11 Allowed 'Isoleucine or valine' 1 CA--C 1.419 -4.065 1 CA-C-O 111.609 -4.043 . . . . 0.0 103.557 123.228 . . . . . . . . 4 3 . 1 . 013 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.536 ' H ' ' N ' ' A' ' 5' ' ' ARG . . . -90.94 -52.06 5.04 Favored 'General case' 1 N--CA 1.334 -6.259 1 CA-C-O 130.8 5.095 . . . . 0.0 109.806 -122.366 . . . . . . . . 4 3 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -35.07 -37.15 0.06 Allowed 'General case' 2 C--N 1.215 -5.267 1 N-CA-C 123.502 4.63 . . . . 0.0 123.502 136.888 . . . . . . . . 3 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.64 ' O ' ' HD2' ' A' ' 13' ' ' PRO . . . -90.09 16.23 8.78 Favored 'General case' 0 CA--C 1.423 -3.915 2 N-CA-C 124.994 5.183 . . . . 0.0 124.994 157.33 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.504 ' N ' ' O ' ' A' ' 6' ' ' ILE . . . -79.82 -24.15 11.99 Favored 'Isoleucine or valine' 0 CA--C 1.602 2.962 0 CA-C-O 127.433 3.492 . . . . 0.0 112.881 160.42 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.461 ' CA ' ' H ' ' A' ' 14' ' ' GLY . . . -117.32 -28.31 6.18 Favored 'General case' 1 CA--C 1.383 -5.452 3 N-CA-C 126.288 5.662 . . . . 0.0 126.288 -160.645 . . . . . . . . 4 3 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -71.57 -18.67 0.39 Allowed Pre-proline 0 C--N 1.247 -3.868 2 O-C-N 134.504 7.378 . . . . 0.0 119.404 147.7 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.64 ' HD2' ' O ' ' A' ' 9' ' ' SER . 0.1 OUTLIER -63.31 -21.51 71.76 Favored 'Trans proline' 0 C--N 1.298 -2.09 2 N-CA-C 127.64 5.977 . . . . 0.0 127.64 130.297 . . . . . . . . 4 4 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.461 ' H ' ' CA ' ' A' ' 11' ' ' LEU . . . -74.75 -3.23 66.87 Favored Glycine 2 N--CA 1.534 5.224 0 CA-C-N 108.969 -3.741 . . . . 0.0 121.372 157.833 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.406 ' C ' ' N ' ' A' ' 17' ' ' ALA . . . -113.79 -65.57 1.52 Allowed 'Isoleucine or valine' 0 CA--C 1.475 -1.907 2 C-N-CA 133.768 4.827 . . . . 0.0 112.221 -168.982 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -27.45 -33.27 0.0 OUTLIER 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 119.855 3.28 . . . . 0.0 119.855 148.201 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.406 ' N ' ' C ' ' A' ' 15' ' ' VAL . . . -90.49 -41.28 11.51 Favored 'General case' 0 CA--C 1.516 -0.364 2 CA-C-N 107.284 -4.507 . . . . 0.0 122.523 173.528 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -38.81 -62.31 0.63 Allowed 'General case' 0 CA--C 1.59 2.517 0 CA-C-O 123.015 1.388 . . . . 0.0 114.539 148.099 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . . . -77.43 -59.04 2.94 Favored 'General case' 0 CA--C 1.556 1.196 0 CA-C-O 124.443 2.068 . . . . 0.0 109.119 -143.959 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -41.39 -44.6 2.86 Favored 'General case' 0 CA--C 1.57 1.741 0 CA-C-N 111.5 -2.591 . . . . 0.0 115.931 160.479 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . . . -95.9 8.41 43.68 Favored 'General case' 0 N--CA 1.507 2.403 0 N-CA-C 118.794 2.887 . . . . 0.0 118.794 -174.481 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . . . -100.77 -28.21 12.94 Favored 'General case' 1 N--CA 1.551 4.603 1 N-CA-C 124.103 4.853 . . . . 0.0 124.103 160.275 . . . . . . . . 3 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . . . -39.36 -64.51 0.46 Allowed 'General case' 1 C--N 1.241 -4.138 1 CA-C-N 105.8 -5.182 . . . . 0.0 116.842 162.418 . . . . . . . . 3 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . . . -24.62 -50.92 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.252 -3.634 2 CA-C-N 104.509 -5.769 . . . . 0.0 124.642 139.987 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . . . -91.29 -0.22 57.63 Favored 'General case' 0 N--CA 1.505 2.317 0 N-CA-C 119.484 3.142 . . . . 0.0 119.484 170.863 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . . . -92.79 -37.19 12.46 Favored 'General case' 1 N--CA 1.553 4.699 0 CA-C-O 126.324 2.964 . . . . 0.0 117.33 -168.87 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . . . -93.47 -41.61 9.7 Favored 'General case' 0 N--CA 1.512 2.648 2 CA-C-N 107.295 -4.502 . . . . 0.0 111.146 171.791 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.738 0 C-N-CA 117.624 -1.63 . . . . 0.0 114.253 139.761 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.964 1 N-CA-C 126.019 5.563 . . . . 0.0 126.019 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.44 ' C ' ' H ' ' A' ' 9' ' ' SER . . . -38.79 -33.06 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.447 -2.999 0 CA-C-O 111.968 -3.872 . . . . 0.0 110.735 135.081 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.582 ' C ' ' H ' ' A' ' 10' ' ' ILE . . . -93.08 -41.96 9.67 Favored 'General case' 0 CA--C 1.435 -3.449 2 N-CA-C 131.122 7.453 . . . . 0.0 131.122 -156.165 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -34.68 -48.06 0.36 Allowed 'General case' 0 N--CA 1.394 -3.27 2 CA-C-N 96.899 -9.228 . . . . 0.0 107.649 127.597 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.44 ' H ' ' C ' ' A' ' 6' ' ' ILE . . . -89.56 -2.34 58.31 Favored 'General case' 0 CA--C 1.479 -1.779 0 N-CA-C 121.277 3.806 . . . . 0.0 121.277 157.749 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.582 ' H ' ' C ' ' A' ' 7' ' ' PHE . . . -67.1 -26.01 35.48 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.137 1 CA-C-O 128.737 4.113 . . . . 0.0 118.03 167.881 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.584 ' H ' ' HD2' ' A' ' 13' ' ' PRO . . . -113.29 -55.2 2.55 Favored 'General case' 0 CA--C 1.435 -3.477 2 CA-C-N 101.232 -7.258 . . . . 0.0 126.057 -127.886 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -94.3 -21.87 0.24 Allowed Pre-proline 0 N--CA 1.38 -3.941 2 O-C-N 137.692 9.37 . . . . 0.0 112.564 171.909 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.584 ' HD2' ' H ' ' A' ' 11' ' ' LEU . 27.7 Cg_exo -62.49 -25.64 75.93 Favored 'Trans proline' 0 N--CA 1.49 1.294 1 N-CA-C 127.106 5.772 . . . . 0.0 127.106 126.873 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -76.07 2.31 56.47 Favored Glycine 1 N--CA 1.522 4.373 3 O-C-N 130.403 4.814 . . . . 0.0 121.68 160.015 . . . . . . . . 3 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . . . -113.11 -69.36 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.973 1 CA-C-N 106.687 -4.757 . . . . 0.0 110.206 -177.03 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -27.06 -28.75 0.0 OUTLIER 'General case' 0 C--N 1.29 -2.017 0 N-CA-C 120.044 3.35 . . . . 0.0 120.044 148.847 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -69.9 -56.99 5.59 Favored 'General case' 0 CA--C 1.549 0.924 1 N-CA-C 121.913 4.042 . . . . 0.0 121.913 160.162 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -36.69 -60.7 0.58 Allowed 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 115.747 1.758 . . . . 0.0 115.747 155.319 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . . . -77.69 -58.32 3.33 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-O 121.929 0.871 . . . . 0.0 110.072 -150.197 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -43.77 -31.67 0.87 Allowed 'General case' 0 CA--C 1.581 2.164 0 N-CA-C 116.448 2.018 . . . . 0.0 116.448 164.756 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . . . -90.14 -20.44 23.11 Favored 'General case' 0 CA--C 1.569 1.684 0 N-CA-C 116.53 2.048 . . . . 0.0 116.53 -178.51 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . . . -102.25 -13.58 17.33 Favored 'General case' 1 N--CA 1.574 5.725 1 N-CA-C 124.829 5.122 . . . . 0.0 124.829 170.391 . . . . . . . . 3 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . . . -30.29 -60.76 0.17 Allowed 'General case' 1 C--N 1.225 -4.814 1 CA-C-N 107.639 -4.346 . . . . 0.0 120.498 134.244 . . . . . . . . 3 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . . . -90.05 -18.77 7.54 Favored 'Isoleucine or valine' 1 C--N 1.241 -4.13 0 CA-C-N 110.022 -3.263 . . . . 0.0 114.743 -159.554 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . . . -66.47 -18.51 65.4 Favored 'General case' 0 C--N 1.307 -1.242 1 N-CA-C 123.855 4.761 . . . . 0.0 123.855 148.821 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . . . -90.49 -62.87 1.36 Allowed 'General case' 0 N--CA 1.522 3.144 0 CA-C-N 114.229 -1.351 . . . . 0.0 109.37 -163.953 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . . . -48.66 -47.7 40.37 Favored 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 128.489 2.716 . . . . 0.0 116.293 157.028 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.5 2.039 0 CA-C-O 124.324 2.011 . . . . 0.0 110.832 160.262 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.692 ' N ' ' H ' ' A' ' 7' ' ' PHE . . . . . . . . 0 N--CA 1.448 -0.565 1 N-CA-C 128.086 6.328 . . . . 0.0 128.086 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.748 ' C ' ' H ' ' A' ' 9' ' ' SER . . . -42.71 -36.88 0.75 Allowed 'Isoleucine or valine' 0 C--O 1.206 -1.208 1 O-C-N 129.513 4.258 . . . . 0.0 107.652 125.055 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.692 ' H ' ' N ' ' A' ' 5' ' ' ARG . . . -93.78 -1.81 54.5 Favored 'General case' 2 CA--C 1.392 -5.114 1 N-CA-C 135.918 9.229 . . . . 0.0 135.918 -171.063 . . . . . . . . 4 3 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.88 -39.21 93.65 Favored 'General case' 1 CA--C 1.389 -5.215 3 CA-C-N 94.437 -10.347 . . . . 0.0 132.684 117.779 . . . . . . . . 3 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.748 ' H ' ' C ' ' A' ' 6' ' ' ILE . . . -105.98 12.02 30.99 Favored 'General case' 0 C--N 1.253 -3.619 1 N-CA-C 125.501 5.371 . . . . 0.0 125.501 178.925 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . . . -95.03 -30.97 4.15 Favored 'Isoleucine or valine' 0 C--N 1.259 -3.35 1 CA-C-N 106.958 -4.656 . . . . 0.0 105.878 166.392 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . . . -86.65 -62.55 1.48 Allowed 'General case' 1 CA--C 1.408 -4.506 1 C-N-CA 136.424 5.89 . . . . 0.0 121.075 -158.928 . . . . . . . . 3 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -72.66 -21.65 0.48 Allowed Pre-proline 0 N--CA 1.391 -3.384 2 CA-C-N 102.198 -6.819 . . . . 0.0 113.134 167.404 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.502 ' HG2' ' O ' ' A' ' 9' ' ' SER . 0.1 OUTLIER -68.95 -20.39 38.76 Favored 'Trans proline' 0 CA--C 1.499 -1.258 1 N-CA-C 127.724 6.009 . . . . 0.0 127.724 139.567 . . . . . . . . 4 4 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -72.46 -4.39 60.61 Favored Glycine 0 N--CA 1.512 3.702 0 O-C-N 128.766 3.791 . . . . 0.0 118.368 157.066 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . . . -119.15 -56.72 3.53 Favored 'Isoleucine or valine' 0 CA--C 1.475 -1.926 0 CA-C-N 110.353 -2.924 . . . . 0.0 115.048 -161.648 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -26.91 -42.7 0.02 OUTLIER 'General case' 0 C--N 1.292 -1.905 1 CA-C-N 108.261 -4.063 . . . . 0.0 117.163 141.422 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.87 -73.02 0.16 Allowed 'General case' 0 CA--C 1.557 1.218 0 CA-C-N 108.461 -3.972 . . . . 0.0 118.179 172.508 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -38.69 -66.71 0.25 Allowed 'General case' 0 CA--C 1.583 2.217 0 N-CA-C 116.93 2.196 . . . . 0.0 116.93 164.951 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . . . -60.88 -59.98 4.52 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 128.435 2.694 . . . . 0.0 111.63 -161.281 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.33 -42.99 92.34 Favored 'General case' 0 CA--C 1.569 1.692 0 C-N-CA 126.587 1.955 . . . . 0.0 115.991 -175.63 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . . . -92.35 6.38 47.11 Favored 'General case' 0 N--CA 1.517 2.888 0 O-C-N 119.272 -2.143 . . . . 0.0 116.148 -179.284 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . . . -104.52 -30.78 9.81 Favored 'General case' 1 N--CA 1.542 4.151 1 N-CA-C 125.044 5.202 . . . . 0.0 125.044 174.517 . . . . . . . . 3 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . . . -34.9 -71.86 0.06 Allowed 'General case' 0 C--N 1.261 -3.275 2 CA-C-N 103.022 -6.444 . . . . 0.0 117.921 147.522 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . . . -25.98 -45.57 0.01 OUTLIER 'Isoleucine or valine' 1 C--N 1.234 -4.43 2 N-CA-C 124.303 4.927 . . . . 0.0 124.303 143.522 . . . . . . . . 3 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . . . -92.6 -0.76 57.27 Favored 'General case' 0 N--CA 1.505 2.315 0 N-CA-C 119.219 3.044 . . . . 0.0 119.219 170.745 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . . . -92.39 -36.22 13.26 Favored 'General case' 1 N--CA 1.55 4.551 0 CA-C-O 126.069 2.842 . . . . 0.0 117.12 -170.853 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . . . -94.36 -41.98 9.13 Favored 'General case' 0 N--CA 1.512 2.67 2 CA-C-N 107.796 -4.275 . . . . 0.0 111.014 173.377 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.726 0 C-N-CA 117.849 -1.54 . . . . 0.0 114.235 139.634 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.588 ' N ' ' H ' ' A' ' 7' ' ' PHE . . . . . . . . 0 N--CA 1.482 1.166 0 N-CA-C 119.937 3.31 . . . . 0.0 119.937 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.501 ' O ' ' N ' ' A' ' 10' ' ' ILE . . . -39.51 -40.25 0.41 Allowed 'Isoleucine or valine' 0 C--O 1.162 -3.522 1 CA-C-O 108.079 -5.724 . . . . 0.0 111.681 127.458 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.591 ' C ' ' H ' ' A' ' 10' ' ' ILE . . . -61.57 -53.13 60.42 Favored 'General case' 1 C--O 1.15 -4.147 1 CA-C-N 127.436 4.653 . . . . 0.0 119.397 -169.478 . . . . . . . . 4 3 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -38.94 -53.86 1.7 Allowed 'General case' 1 N--CA 1.379 -4.005 4 C-N-CA 146.633 9.973 . . . . 0.0 99.128 155.279 . . . . . . . . 3 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.441 ' O ' ' HG2' ' A' ' 13' ' ' PRO . . . -85.58 2.86 43.24 Favored 'General case' 0 N--CA 1.494 1.735 1 N-CA-C 125.675 5.435 . . . . 0.0 125.675 160.758 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.591 ' H ' ' C ' ' A' ' 7' ' ' PHE . . . -80.67 -47.89 20.15 Favored 'Isoleucine or valine' 0 CA--C 1.584 2.275 0 CA-C-O 126.072 2.844 . . . . 0.0 106.286 172.899 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.438 ' C ' ' H ' ' A' ' 14' ' ' GLY . . . -114.02 -23.83 9.35 Favored 'General case' 0 CA--C 1.439 -3.32 2 CA-C-N 106.794 -4.73 . . . . 0.0 123.581 -147.959 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -95.21 -7.78 0.12 Allowed Pre-proline 1 N--CA 1.374 -4.257 2 CA-C-N 104.327 -5.852 . . . . 0.0 110.882 160.967 . . . . . . . . 3 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.441 ' HG2' ' O ' ' A' ' 9' ' ' SER . 0.3 OUTLIER -77.39 -10.91 17.48 Favored 'Trans proline' 0 CA--C 1.475 -2.431 2 N-CA-C 124.44 4.746 . . . . 0.0 124.44 131.464 . . . . . . . . 4 4 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.438 ' H ' ' C ' ' A' ' 11' ' ' LEU . . . -87.45 9.4 73.51 Favored Glycine 1 N--CA 1.523 4.442 2 O-C-N 132.149 5.906 . . . . 0.0 121.477 163.57 . . . . . . . . 4 3 . 1 . 016 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . . . -115.31 -78.29 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.405 -2.678 2 CA-C-N 105.273 -5.464 . . . . 0.0 111.086 -175.967 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -28.26 -29.83 0.0 OUTLIER 'General case' 0 C--N 1.246 -3.899 0 CA-C-N 110.996 -2.82 . . . . 0.0 118.25 152.203 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -58.29 -71.7 0.11 Allowed 'General case' 0 CA--C 1.533 0.29 1 N-CA-C 123.617 4.673 . . . . 0.0 123.617 148.773 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -33.36 -60.45 0.35 Allowed 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 115.393 1.627 . . . . 0.0 115.393 165.118 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . . . -63.49 -45.36 91.09 Favored 'General case' 0 CA--C 1.545 0.783 0 CA-C-N 114.346 -1.297 . . . . 0.0 112.134 -161.622 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -84.99 -12.14 53.9 Favored 'General case' 0 N--CA 1.418 -2.044 0 C-N-CA 127.75 2.42 . . . . 0.0 115.526 -173.774 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . . . -90.15 -22.01 21.94 Favored 'General case' 0 N--CA 1.509 2.492 0 N-CA-C 118.891 2.923 . . . . 0.0 118.891 165.112 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . . . -93.34 -27.61 16.68 Favored 'General case' 1 N--CA 1.564 5.226 1 N-CA-C 126.433 5.716 . . . . 0.0 126.433 178.039 . . . . . . . . 3 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . . . -27.34 -81.97 0.01 OUTLIER 'General case' 1 CA--C 1.417 -4.146 2 CA-C-N 102.919 -6.491 . . . . 0.0 113.152 123.75 . . . . . . . . 3 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . . . -78.09 -12.67 13.76 Favored 'Isoleucine or valine' 0 C--N 1.257 -3.451 1 C-N-CA 110.571 -4.452 . . . . 0.0 116.904 -139.761 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . . . -91.31 -1.62 57.6 Favored 'General case' 0 C--N 1.306 -1.301 2 N-CA-C 126.896 5.887 . . . . 0.0 126.896 159.032 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . . . -88.71 -57.99 2.71 Favored 'General case' 1 N--CA 1.539 4.023 0 CA-C-O 125.416 2.531 . . . . 0.0 115.98 178.073 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . . . -71.03 -52.49 19.24 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-N 108.843 -3.799 . . . . 0.0 115.043 165.597 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.512 2.631 0 C-N-CA 116.069 -2.252 . . . . 0.0 112.623 148.367 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.502 -0.89 1 N-CA-C 123.523 4.638 . . . . 0.0 123.523 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.516 ' O ' ' N ' ' A' ' 10' ' ' ILE . . . -48.84 -50.92 13.2 Favored 'Isoleucine or valine' 1 C--O 1.135 -4.946 2 CA-C-N 106.808 -4.724 . . . . 0.0 106.907 137.706 . . . . . . . . 4 3 . 1 . 017 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.458 ' C ' ' H ' ' A' ' 10' ' ' ILE . . . -59.3 -55.23 37.49 Favored 'General case' 2 CA--C 1.365 -6.17 1 CA-C-O 140.191 9.567 . . . . 0.0 114.696 -163.484 . . . . . . . . 4 3 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -34.49 -43.31 0.16 Allowed 'General case' 0 N--CA 1.393 -3.298 1 CA-C-N 100.335 -7.666 . . . . 0.0 109.505 158.044 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.478 ' O ' ' HD2' ' A' ' 13' ' ' PRO . . . -88.67 -9.23 52.8 Favored 'General case' 0 CA--C 1.46 -2.502 1 N-CA-C 133.361 8.282 . . . . 0.0 133.361 152.485 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.516 ' N ' ' O ' ' A' ' 6' ' ' ILE . . . -66.47 -52.64 44.21 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.84 0 CA-C-O 126.613 3.102 . . . . 0.0 108.378 168.867 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.471 ' C ' ' H ' ' A' ' 14' ' ' GLY . . . -119.31 -25.24 6.15 Favored 'General case' 1 CA--C 1.397 -4.937 1 CA-C-N 102.956 -6.475 . . . . 0.0 120.799 -146.002 . . . . . . . . 4 3 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -100.04 16.61 0.05 OUTLIER Pre-proline 0 C--N 1.265 -3.079 1 O-C-N 130.809 5.068 . . . . 0.0 120.142 155.897 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.478 ' HD2' ' O ' ' A' ' 9' ' ' SER . 0.1 OUTLIER -67.3 -25.33 42.61 Favored 'Trans proline' 0 N--CA 1.509 2.406 2 N-CA-C 131.243 7.363 . . . . 0.0 131.243 105.925 . . . . . . . . 4 4 . 1 . 017 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.471 ' H ' ' C ' ' A' ' 11' ' ' LEU . . . -74.96 -0.83 61.17 Favored Glycine 3 N--CA 1.552 6.378 1 CA-C-O 129.011 4.673 . . . . 0.0 121.746 167.319 . . . . . . . . 4 3 . 1 . 017 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . . . -112.86 -67.18 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.29 -1.994 2 CA-C-N 104.462 -5.869 . . . . 0.0 116.517 -179.892 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -26.44 -37.03 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 119.251 3.056 . . . . 0.0 119.251 153.612 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -56.12 -79.13 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.804 1 CA-C-N 105.978 -5.101 . . . . 0.0 120.726 157.625 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -37.19 -49.49 0.91 Allowed 'General case' 0 CA--C 1.582 2.185 0 N-CA-C 117.637 2.458 . . . . 0.0 117.637 167.365 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . . . -47.81 -71.96 0.06 Allowed 'General case' 0 CA--C 1.564 1.505 0 C-N-CA 129.345 3.058 . . . . 0.0 112.942 -179.167 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -51.63 -25.53 7.22 Favored 'General case' 0 CA--C 1.571 1.783 0 CA-C-N 108.541 -3.936 . . . . 0.0 116.401 173.287 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . . . -90.78 -29.92 17.32 Favored 'General case' 0 CA--C 1.564 1.484 0 CA-C-O 115.414 -2.232 . . . . 0.0 115.696 -179.349 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . . . -100.79 -10.7 20.52 Favored 'General case' 1 N--CA 1.581 6.088 1 N-CA-C 124.797 5.11 . . . . 0.0 124.797 174.698 . . . . . . . . 3 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . . . -30.54 -67.85 0.09 Allowed 'General case' 1 C--N 1.233 -4.471 1 CA-C-N 105.582 -5.281 . . . . 0.0 118.822 125.603 . . . . . . . . 3 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . . . -88.0 7.45 2.99 Favored 'Isoleucine or valine' 1 C--N 1.238 -4.282 0 C-N-CA 113.775 -3.17 . . . . 0.0 117.929 -157.261 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . . . -87.18 -32.4 19.85 Favored 'General case' 0 C--N 1.303 -1.431 3 C-N-CA 134.484 5.114 . . . . 0.0 124.008 161.44 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . . . -87.65 -34.07 18.59 Favored 'General case' 0 N--CA 1.534 3.737 1 CA-C-N 106.87 -4.695 . . . . 0.0 116.553 -172.457 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . . . -95.97 -38.79 10.08 Favored 'General case' 0 N--CA 1.511 2.613 2 C-N-CA 131.994 4.118 . . . . 0.0 110.008 173.174 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.499 1.989 0 C-N-CA 116.909 -1.917 . . . . 0.0 114.287 139.915 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.656 ' N ' ' H ' ' A' ' 7' ' ' PHE . . . . . . . . 0 CA--C 1.499 -1.016 1 N-CA-C 128.237 6.384 . . . . 0.0 128.237 . . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . . . -39.89 -58.49 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.426 -3.819 2 CA-C-N 107.144 -4.571 . . . . 0.0 103.878 125.587 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.656 ' H ' ' N ' ' A' ' 5' ' ' ARG . . . -46.2 -41.29 12.55 Favored 'General case' 0 N--CA 1.492 1.672 2 N-CA-C 125.387 5.328 . . . . 0.0 125.387 -144.035 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -90.85 -40.38 11.79 Favored 'General case' 1 N--CA 1.372 -4.359 3 C-N-CA 150.495 11.518 . . . . 0.0 110.151 -162.129 . . . . . . . . 3 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.482 ' O ' ' HD2' ' A' ' 13' ' ' PRO . . . -70.95 -14.09 62.24 Favored 'General case' 0 CA--C 1.458 -2.559 1 N-CA-C 128.96 6.652 . . . . 0.0 128.96 140.43 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . . . -74.02 -23.52 18.84 Favored 'Isoleucine or valine' 0 C--N 1.253 -3.591 1 CA-C-O 129.335 4.397 . . . . 0.0 117.52 169.982 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . . . -110.92 -55.61 2.47 Favored 'General case' 1 CA--C 1.407 -4.524 1 CA-C-N 102.425 -6.716 . . . . 0.0 119.462 -138.666 . . . . . . . . 3 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -76.78 -21.78 0.4 Allowed Pre-proline 0 C--N 1.254 -3.553 2 O-C-N 132.958 6.411 . . . . 0.0 115.823 163.159 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.482 ' HD2' ' O ' ' A' ' 9' ' ' SER . 1.4 Cg_exo -60.58 -17.87 51.27 Favored 'Trans proline' 0 CA--C 1.479 -2.271 1 N-CA-C 128.007 6.118 . . . . 0.0 128.007 131.667 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -59.69 -22.46 57.01 Favored Glycine 2 N--CA 1.535 5.273 0 CA-C-O 126.199 3.11 . . . . 0.0 119.255 154.203 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.414 ' N ' ' H ' ' A' ' 17' ' ' ALA . . . -119.54 -49.26 3.54 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.617 1 CA-C-N 106.441 -4.88 . . . . 0.0 118.811 -144.165 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -28.72 -52.8 0.1 Allowed 'General case' 0 C--N 1.298 -1.673 2 CA-C-N 106.808 -4.724 . . . . 0.0 114.34 135.309 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.414 ' H ' ' N ' ' A' ' 15' ' ' VAL . . . -77.22 -52.42 9.27 Favored 'General case' 0 CA--C 1.56 1.334 1 CA-C-N 107.495 -4.412 . . . . 0.0 112.563 -157.895 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -36.72 -66.46 0.22 Allowed 'General case' 0 CA--C 1.585 2.307 0 CA-C-N 110.83 -2.895 . . . . 0.0 115.324 146.38 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . . . -46.91 -61.29 1.93 Allowed 'General case' 0 N--CA 1.514 2.727 0 CA-C-O 125.243 2.449 . . . . 0.0 113.777 -159.368 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -77.72 -14.75 59.52 Favored 'General case' 0 CA--C 1.567 1.598 0 C-N-CA 129.405 3.082 . . . . 0.0 116.244 -174.908 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . . . -92.27 -24.47 18.98 Favored 'General case' 0 N--CA 1.523 3.184 0 N-CA-C 117.942 2.571 . . . . 0.0 117.942 174.236 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . . . -96.01 -27.25 15.21 Favored 'General case' 1 N--CA 1.561 5.106 1 N-CA-C 126.158 5.614 . . . . 0.0 126.158 179.723 . . . . . . . . 3 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . . . -27.89 -80.32 0.01 OUTLIER 'General case' 0 CA--C 1.423 -3.941 2 CA-C-N 103.064 -6.425 . . . . 0.0 113.338 123.459 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . . . -79.66 -12.35 13.11 Favored 'Isoleucine or valine' 0 C--N 1.254 -3.554 1 C-N-CA 110.693 -4.403 . . . . 0.0 116.552 -139.287 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . . . -91.42 1.52 57.06 Favored 'General case' 0 C--N 1.308 -1.219 2 N-CA-C 127.287 6.032 . . . . 0.0 127.287 157.186 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . . . -89.71 -62.17 1.53 Allowed 'General case' 0 N--CA 1.538 3.926 0 CA-C-O 125.323 2.487 . . . . 0.0 115.752 176.877 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . . . -57.26 -61.48 2.44 Favored 'General case' 0 N--CA 1.494 1.768 0 CA-C-N 109.257 -3.61 . . . . 0.0 115.705 157.78 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.517 2.883 0 C-N-CA 115.388 -2.525 . . . . 0.0 112.322 155.918 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.679 ' N ' ' H ' ' A' ' 7' ' ' PHE . . . . . . . . 0 C--O 1.214 -0.769 0 N-CA-C 117.621 2.452 . . . . 0.0 117.621 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.502 ' C ' ' H ' ' A' ' 9' ' ' SER . . . -37.12 -38.19 0.15 Allowed 'Isoleucine or valine' 2 CA--C 1.364 -6.179 1 CA-C-N 106.264 -4.971 . . . . 0.0 112.735 126.729 . . . . . . . . 4 3 . 1 . 019 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.679 ' H ' ' N ' ' A' ' 5' ' ' ARG . . . -67.6 -60.35 2.62 Favored 'General case' 0 CA--C 1.423 -3.907 1 CA-C-O 137.041 8.067 . . . . 0.0 111.338 -173.343 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -36.26 -43.61 0.37 Allowed 'General case' 0 N--CA 1.407 -2.579 2 CA-C-N 100.51 -7.586 . . . . 0.0 105.36 159.694 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.51 ' C ' ' HD2' ' A' ' 13' ' ' PRO . . . -106.49 1.7 25.68 Favored 'General case' 0 CA--C 1.464 -2.345 1 N-CA-C 130.056 7.058 . . . . 0.0 130.056 176.356 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.426 ' N ' ' O ' ' A' ' 6' ' ' ILE . . . -91.93 -46.12 14.33 Favored 'Isoleucine or valine' 0 CA--C 1.621 3.695 2 N-CA-C 96.796 -5.261 . . . . 0.0 96.796 177.192 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.487 ' C ' ' H ' ' A' ' 14' ' ' GLY . . . -112.91 -27.59 8.04 Favored 'General case' 1 CA--C 1.402 -4.726 1 N-CA-C 122.222 4.156 . . . . 0.0 122.222 -152.415 . . . . . . . . 4 3 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -99.78 14.58 0.05 OUTLIER Pre-proline 0 C--N 1.256 -3.48 1 O-C-N 130.19 4.681 . . . . 0.0 120.791 154.273 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.51 ' HD2' ' C ' ' A' ' 9' ' ' SER . 0.0 OUTLIER -71.57 -22.13 24.84 Favored 'Trans proline' 0 N--CA 1.507 2.289 2 N-CA-C 130.215 6.967 . . . . 0.0 130.215 110.115 . . . . . . . . 4 4 . 1 . 019 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.487 ' H ' ' C ' ' A' ' 11' ' ' LEU . . . -82.32 2.28 85.2 Favored Glycine 2 N--CA 1.541 5.668 1 CA-C-O 127.849 4.027 . . . . 0.0 120.619 168.582 . . . . . . . . 4 3 . 1 . 019 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . . . -111.95 -64.3 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.71 2 CA-C-N 106.391 -4.905 . . . . 0.0 114.157 179.893 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -23.67 -42.32 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 111.56 -2.564 . . . . 0.0 117.612 152.519 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -56.8 -83.8 0.01 OUTLIER 'General case' 0 CA--C 1.556 1.201 1 CA-C-N 106.837 -4.71 . . . . 0.0 119.54 158.293 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -36.21 -60.8 0.54 Allowed 'General case' 0 CA--C 1.58 2.125 0 N-CA-C 118.615 2.82 . . . . 0.0 118.615 172.27 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . . . -52.65 -54.66 30.3 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 128.421 2.688 . . . . 0.0 112.824 -172.751 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.51 -53.06 61.32 Favored 'General case' 0 N--CA 1.399 -2.982 0 CA-C-N 112.693 -2.049 . . . . 0.0 111.602 173.117 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . . . -95.42 34.34 1.46 Allowed 'General case' 0 N--CA 1.518 2.96 0 N-CA-C 120.401 3.482 . . . . 0.0 120.401 175.337 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . . . -107.73 -5.71 17.23 Favored 'General case' 0 N--CA 1.533 3.714 0 N-CA-C 121.068 3.729 . . . . 0.0 121.068 141.444 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . . . -63.3 -55.02 28.13 Favored 'General case' 0 C--N 1.246 -3.897 0 N-CA-C 118.529 2.788 . . . . 0.0 118.529 -179.728 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . . . -28.18 -52.09 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.266 -3.063 4 CA-C-N 100.903 -7.408 . . . . 0.0 124.073 131.39 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . . . -92.29 7.52 42.39 Favored 'General case' 0 N--CA 1.519 2.98 0 N-CA-C 117.36 2.356 . . . . 0.0 117.36 171.478 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . . . -96.5 -60.97 1.5 Allowed 'General case' 0 N--CA 1.511 2.587 0 CA-C-N 109.317 -3.583 . . . . 0.0 110.699 179.077 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . . . -48.42 -38.61 20.14 Favored 'General case' 0 N--CA 1.503 2.209 0 C-N-CA 126.567 1.947 . . . . 0.0 115.937 162.942 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.834 0 CA-C-O 123.795 1.76 . . . . 0.0 110.639 160.491 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.176 0 N-CA-C 119.713 3.227 . . . . 0.0 119.713 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.434 ' O ' ' N ' ' A' ' 10' ' ' ILE . . . -38.1 -50.09 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.434 -3.51 1 CA-C-O 111.572 -4.061 . . . . 0.0 112.732 125.902 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . . . -48.03 -62.15 1.62 Allowed 'General case' 2 CA--C 1.387 -5.311 1 CA-C-O 132.597 5.951 . . . . 0.0 112.98 178.499 . . . . . . . . 3 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -37.77 -46.19 0.89 Allowed 'General case' 0 N--CA 1.4 -2.943 2 CA-C-N 102.314 -6.766 . . . . 0.0 106.153 168.044 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.574 ' O ' ' HG2' ' A' ' 13' ' ' PRO . . . -92.95 3.07 56.39 Favored 'General case' 0 CA--C 1.469 -2.158 1 N-CA-C 129.292 6.775 . . . . 0.0 129.292 166.522 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.434 ' N ' ' O ' ' A' ' 6' ' ' ILE . . . -93.78 -41.23 12.33 Favored 'Isoleucine or valine' 1 C--N 1.238 -4.275 0 N-CA-C 102.213 -3.254 . . . . 0.0 102.213 178.592 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.446 ' C ' ' H ' ' A' ' 14' ' ' GLY . . . -111.29 -28.6 8.17 Favored 'General case' 1 CA--C 1.421 -4.016 1 N-CA-C 122.245 4.165 . . . . 0.0 122.245 -153.249 . . . . . . . . 4 3 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -82.46 -24.12 0.36 Allowed Pre-proline 0 C--N 1.256 -3.494 2 O-C-N 131.63 5.581 . . . . 0.0 114.064 158.997 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.574 ' HG2' ' O ' ' A' ' 9' ' ' SER . 0.1 OUTLIER -56.21 -16.89 18.57 Favored 'Trans proline' 0 CA--C 1.476 -2.38 1 N-CA-C 128.107 6.156 . . . . 0.0 128.107 129.9 . . . . . . . . 4 4 . 1 . 020 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.446 ' H ' ' C ' ' A' ' 11' ' ' LEU . . . -59.3 -24.03 58.49 Favored Glycine 2 N--CA 1.536 5.35 0 CA-C-O 127.05 3.583 . . . . 0.0 121.727 155.391 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.41 ' N ' ' H ' ' A' ' 17' ' ' ALA . . . -120.03 -50.84 3.58 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.843 1 CA-C-N 104.187 -6.007 . . . . 0.0 118.236 -142.646 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -28.69 -52.45 0.1 Allowed 'General case' 0 CA--C 1.476 -1.879 2 CA-C-N 105.697 -5.228 . . . . 0.0 115.114 135.213 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.41 ' H ' ' N ' ' A' ' 15' ' ' VAL . . . -74.49 -59.78 2.58 Favored 'General case' 0 CA--C 1.553 1.09 1 CA-C-N 107.272 -4.513 . . . . 0.0 110.848 -161.571 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -35.16 -56.41 0.6 Allowed 'General case' 0 CA--C 1.574 1.872 0 CA-C-N 110.604 -2.998 . . . . 0.0 115.992 157.34 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . . . -43.37 -53.7 5.16 Favored 'General case' 0 N--CA 1.508 2.441 0 C-N-CA 128.18 2.592 . . . . 0.0 114.975 -167.573 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -80.51 -33.34 36.49 Favored 'General case' 0 N--CA 1.421 -1.905 0 C-N-CA 130.976 3.71 . . . . 0.0 114.439 -173.348 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . . . -90.31 -0.41 57.62 Favored 'General case' 0 N--CA 1.529 3.514 0 N-CA-C 117.039 2.237 . . . . 0.0 117.039 170.963 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . . . -88.87 -35.87 16.3 Favored 'General case' 1 N--CA 1.555 4.794 1 N-CA-C 123.619 4.674 . . . . 0.0 123.619 167.607 . . . . . . . . 3 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . . . -37.75 -64.49 0.39 Allowed 'General case' 0 C--N 1.26 -3.309 2 CA-C-N 102.513 -6.676 . . . . 0.0 114.969 167.068 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . . . -25.09 -51.02 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.268 -2.957 2 CA-C-N 104.354 -5.839 . . . . 0.0 124.695 142.957 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . . . -92.26 -2.73 56.28 Favored 'General case' 0 C--N 1.274 -2.679 0 N-CA-C 119.831 3.271 . . . . 0.0 119.831 170.831 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . . . -87.84 -24.24 23.76 Favored 'General case' 0 CA--C 1.609 3.241 0 CA-C-N 110.581 -3.009 . . . . 0.0 113.821 179.818 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . . . -96.09 -53.41 3.66 Favored 'General case' 0 N--CA 1.501 2.12 1 C-N-CA 132.831 4.453 . . . . 0.0 110.986 -178.672 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 1.918 0 CA-C-N 111.757 -2.474 . . . . 0.0 115.442 139.469 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.569 3.428 0 N-CA-C 117.264 1.666 . . . . 0.0 117.264 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.43 ' C ' ' H ' ' A' ' 6' ' ' ILE . . . -109.9 -18.04 0.03 OUTLIER 'Trans proline' 1 CA--C 1.621 4.849 1 N-CA-C 125.558 5.176 . . . . 0.0 125.558 -149.791 . . . . . . . . 4 3 . 1 . 001 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . . . -29.33 -50.43 0.1 Allowed 'General case' 0 C--N 1.268 -2.958 3 C-N-CA 137.719 6.408 . . . . 0.0 123.255 119.236 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.437 ' C ' ' H ' ' A' ' 7' ' ' PHE . . . -91.22 -29.42 17.22 Favored 'General case' 0 N--CA 1.481 1.104 2 C-N-CA 132.995 4.518 . . . . 0.0 112.133 -169.39 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.528 ' N ' ' H ' ' A' ' 7' ' ' PHE . . . -98.14 -38.03 9.48 Favored 'General case' 0 CA--C 1.476 -1.893 3 N-CA-C 130.934 7.383 . . . . 0.0 130.934 165.275 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.45 ' O ' ' N ' ' A' ' 9' ' ' SER . . . -51.24 -49.63 29.44 Favored 'Isoleucine or valine' 0 C--O 1.186 -2.288 1 N-CA-C 92.301 -6.926 . . . . 0.0 92.301 137.708 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.528 ' H ' ' N ' ' A' ' 5' ' ' ARG . . . -46.25 -47.45 18.08 Favored 'General case' 0 N--CA 1.487 1.399 3 CA-C-N 128.994 5.361 . . . . 0.0 124.951 -152.752 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -98.45 -35.03 10.4 Favored 'General case' 0 N--CA 1.409 -2.492 3 C-N-CA 154.948 13.299 . . . . 0.0 100.371 -165.413 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.46 ' O ' ' HG2' ' A' ' 13' ' ' PRO . . . -74.42 -13.4 60.71 Favored 'General case' 0 CA--C 1.462 -2.429 2 O-C-N 111.18 -7.2 . . . . 0.0 129.307 144.063 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . . . -62.44 -43.3 98.11 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.835 1 CA-C-O 129.498 4.475 . . . . 0.0 114.7 166.462 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . . . -106.83 -52.27 2.8 Favored 'General case' 1 CA--C 1.351 -6.698 4 CA-C-N 97.785 -8.825 . . . . 0.0 124.788 -140.778 . . . . . . . . 3 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -78.13 -20.12 0.33 Allowed Pre-proline 1 CA--C 1.649 4.775 2 CA-C-N 102.878 -6.51 . . . . 0.0 109.708 168.487 . . . . . . . . 3 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.46 ' HG2' ' O ' ' A' ' 9' ' ' SER . 0.1 OUTLIER -59.91 -29.42 89.4 Favored 'Trans proline' 0 CA--C 1.486 -1.91 2 O-C-N 106.516 -7.676 . . . . 0.0 127.416 134.868 . . . . . . . . 4 4 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -70.89 -0.9 36.36 Favored Glycine 0 N--CA 1.506 3.329 2 O-C-N 132.617 6.198 . . . . 0.0 120.535 164.362 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.404 ' C ' ' N ' ' A' ' 17' ' ' ALA . . . -107.29 -73.83 0.59 Allowed 'Isoleucine or valine' 0 C--O 1.2 -1.549 2 CA-C-N 106.587 -4.806 . . . . 0.0 107.318 -165.3 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -28.52 -23.17 0.0 OUTLIER 'General case' 0 C--N 1.258 -3.379 0 CA-C-N 108.518 -3.946 . . . . 0.0 119.578 144.277 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.404 ' N ' ' C ' ' A' ' 15' ' ' VAL . . . -90.21 -33.38 16.21 Favored 'General case' 0 CA--C 1.549 0.907 1 N-CA-C 126.158 5.614 . . . . 0.0 126.158 156.858 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -41.73 -63.16 0.76 Allowed 'General case' 0 CA--C 1.576 1.967 0 CA-C-N 122.146 2.248 . . . . 0.0 115.071 145.519 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . . . -75.51 -56.3 4.83 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 113.759 -1.564 . . . . 0.0 109.649 -148.736 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -48.83 -44.45 39.38 Favored 'General case' 0 CA--C 1.577 1.987 0 N-CA-C 117.585 2.439 . . . . 0.0 117.585 163.281 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . . . -78.24 -13.65 59.77 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 117.33 -3.356 . . . . 0.0 117.773 -178.528 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . . . -96.5 -26.29 15.34 Favored 'General case' 0 N--CA 1.538 3.941 1 N-CA-C 126.129 5.603 . . . . 0.0 126.129 177.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . . . -37.81 -63.71 0.45 Allowed 'General case' 0 C--N 1.252 -3.638 2 CA-C-N 104.327 -5.851 . . . . 0.0 120.531 156.319 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . . . -39.32 -40.19 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.253 -3.615 4 O-C-N 134.218 7.199 . . . . 0.0 122.647 143.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . . . -94.92 3.57 54.81 Favored 'General case' 0 C--N 1.263 -3.171 0 N-CA-C 118.059 2.615 . . . . 0.0 118.059 167.829 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . . . -95.52 -60.45 1.66 Allowed 'General case' 0 N--CA 1.505 2.305 0 CA-C-N 109.546 -3.479 . . . . 0.0 111.178 177.366 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . . . -49.61 -41.69 42.78 Favored 'General case' 0 N--CA 1.501 2.097 0 C-N-CA 126.857 2.063 . . . . 0.0 115.503 163.346 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -79.91 -41.74 25.53 Favored 'General case' 0 N--CA 1.505 2.311 0 CA-C-O 122.911 1.339 . . . . 0.0 112.398 159.688 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.3 -1.564 0 O-C-N 121.01 -1.057 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.565 3.209 0 N-CA-C 116.384 1.314 . . . . 0.0 116.384 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . . . -94.49 10.0 1.9 Allowed 'Trans proline' 0 CA--C 1.578 2.699 1 N-CA-C 125.132 5.012 . . . . 0.0 125.132 179.255 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . . . -39.6 -58.36 1.31 Allowed 'General case' 0 C--N 1.274 -2.697 2 C-N-CA 133.681 4.792 . . . . 0.0 121.361 125.817 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -93.9 -32.66 13.81 Favored 'General case' 0 N--CA 1.529 3.484 2 CA-C-O 135.442 7.306 . . . . 0.0 115.309 -151.903 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.583 ' CA ' ' H ' ' A' ' 7' ' ' PHE . . . -94.8 -24.36 17.1 Favored 'General case' 0 C--N 1.25 -3.728 3 N-CA-C 144.599 12.444 . . . . 0.0 144.599 140.38 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.46 ' O ' ' CA ' ' A' ' 9' ' ' SER . . . -37.65 -49.9 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.434 -3.511 0 CA-C-N 111.716 -2.493 . . . . 0.0 106.019 117.883 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.583 ' H ' ' CA ' ' A' ' 5' ' ' ARG . . . -59.17 -51.89 68.05 Favored 'General case' 2 CA--C 1.378 -5.645 0 N-CA-C 119.355 3.094 . . . . 0.0 119.355 -143.799 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -104.47 44.28 1.04 Allowed 'General case' 1 N--CA 1.375 -4.222 2 N-CA-C 122.193 4.146 . . . . 0.0 122.193 146.707 . . . . . . . . 3 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.587 ' O ' ' HD2' ' A' ' 13' ' ' PRO . . . -93.3 17.2 11.61 Favored 'General case' 1 C--N 1.24 -4.162 1 N-CA-C 140.757 11.021 . . . . 0.0 140.757 95.158 . . . . . . . . 4 3 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.428 ' C ' ' HB2' ' A' ' 13' ' ' PRO . . . -72.59 -33.89 46.2 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.802 2 CA-C-O 132.975 6.131 . . . . 0.0 125.162 156.453 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . . . -105.37 -32.34 8.62 Favored 'General case' 2 CA--C 1.368 -6.045 4 CA-C-N 93.656 -10.702 . . . . 0.0 131.033 -165.39 . . . . . . . . 3 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -89.1 -15.66 0.21 Allowed Pre-proline 0 CA--C 1.618 3.573 3 CA-C-N 101.894 -6.957 . . . . 0.0 114.273 161.515 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.587 ' HD2' ' O ' ' A' ' 9' ' ' SER . 0.0 OUTLIER -57.19 -24.09 57.12 Favored 'Trans proline' 0 C--N 1.291 -2.485 2 O-C-N 106.116 -7.886 . . . . 0.0 129.602 128.161 . . . . . . . . 4 4 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -76.77 2.1 60.42 Favored Glycine 0 N--CA 1.514 3.876 2 CA-C-N 103.849 -6.068 . . . . 0.0 120.945 162.081 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . . . -106.95 -77.79 0.42 Allowed 'Isoleucine or valine' 0 C--O 1.196 -1.713 2 CA-C-N 106.443 -4.879 . . . . 0.0 110.493 -169.6 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -28.77 -23.9 0.0 OUTLIER 'General case' 0 C--N 1.253 -3.588 1 CA-C-N 107.388 -4.46 . . . . 0.0 121.326 144.84 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -76.62 -46.2 26.94 Favored 'General case' 0 CA--C 1.553 1.09 1 N-CA-C 134.402 8.667 . . . . 0.0 134.402 146.557 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -37.64 -56.83 1.02 Allowed 'General case' 0 CA--C 1.573 1.846 0 N-CA-C 115.088 1.514 . . . . 0.0 115.088 147.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . . . -80.26 -63.41 1.42 Allowed 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.366 -0.833 . . . . 0.0 108.834 -148.719 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -46.93 -43.74 19.27 Favored 'General case' 0 CA--C 1.576 1.945 0 N-CA-C 117.292 2.331 . . . . 0.0 117.292 171.887 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . . . -94.73 -5.63 44.95 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 119.211 3.041 . . . . 0.0 119.211 -177.586 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . . . -85.01 -31.68 23.34 Favored 'General case' 1 N--CA 1.553 4.71 2 N-CA-C 127.488 6.107 . . . . 0.0 127.488 161.148 . . . . . . . . 3 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . . . -39.7 -60.4 0.99 Allowed 'General case' 1 C--N 1.219 -5.089 3 CA-C-N 100.176 -7.738 . . . . 0.0 124.601 164.121 . . . . . . . . 3 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . . . -31.92 -42.04 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.252 -3.657 2 CA-C-N 100.838 -7.437 . . . . 0.0 130.29 137.636 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . . . -93.78 -0.36 55.92 Favored 'General case' 0 C--N 1.275 -2.653 0 N-CA-C 121.535 3.902 . . . . 0.0 121.535 164.841 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . . . -87.33 -24.65 24.22 Favored 'General case' 0 CA--C 1.609 3.229 0 CA-C-N 109.041 -3.709 . . . . 0.0 114.416 173.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . . . -97.24 -57.74 2.19 Favored 'General case' 0 N--CA 1.505 2.321 1 C-N-CA 132.261 4.224 . . . . 0.0 111.061 -177.831 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.22 18.01 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.755 0 CA-C-N 112.0 -2.364 . . . . 0.0 116.154 139.498 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.317 -0.821 0 O-C-N 119.598 -1.939 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.564 3.106 0 N-CA-C 114.76 0.664 . . . . 0.0 114.76 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.447 ' C ' ' H ' ' A' ' 6' ' ' ILE . . . -102.63 6.7 0.43 Allowed 'Trans proline' 0 CA--C 1.576 2.602 1 N-CA-C 128.743 6.401 . . . . 0.0 128.743 -174.244 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.411 ' C ' ' H ' ' A' ' 7' ' ' PHE . . . -33.15 -56.99 0.4 Allowed 'General case' 0 C--N 1.263 -3.172 4 C-N-CA 137.357 6.263 . . . . 0.0 124.55 118.893 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -96.7 -38.18 10.02 Favored 'General case' 0 N--CA 1.493 1.677 3 C-N-CA 135.348 5.459 . . . . 0.0 113.978 -158.085 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . . . -93.27 -21.04 19.84 Favored 'General case' 0 CA--C 1.464 -2.33 3 N-CA-C 136.754 9.539 . . . . 0.0 136.754 145.745 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.598 ' C ' ' H ' ' A' ' 8' ' ' ALA . . . -50.16 -55.24 6.12 Favored 'Isoleucine or valine' 0 CA--C 1.434 -3.493 0 CA-C-N 111.383 -2.644 . . . . 0.0 107.923 129.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.457 ' C ' ' H ' ' A' ' 10' ' ' ILE . . . -33.26 -42.55 0.09 Allowed 'General case' 1 C--N 1.231 -4.549 1 N-CA-C 131.661 7.652 . . . . 0.0 131.661 -162.509 . . . . . . . . 4 3 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.598 ' H ' ' C ' ' A' ' 6' ' ' ILE . . . -97.54 -49.81 4.74 Favored 'General case' 1 N--CA 1.32 -6.968 3 CA-C-N 89.772 -12.467 . . . . 0.0 113.709 -147.489 . . . . . . . . 4 3 . 1 . 003 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.504 ' C ' ' HD2' ' A' ' 13' ' ' PRO . . . -74.51 5.71 4.47 Favored 'General case' 0 C--N 1.375 1.682 2 N-CA-C 138.88 10.326 . . . . 0.0 138.88 129.766 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.457 ' H ' ' C ' ' A' ' 7' ' ' PHE . . . -66.9 -31.23 52.53 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.079 2 CA-C-O 133.719 6.485 . . . . 0.0 125.265 158.154 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.44 ' C ' ' H ' ' A' ' 14' ' ' GLY . . . -108.39 -61.52 1.58 Allowed 'General case' 2 CA--C 1.4 -4.824 4 CA-C-N 91.714 -11.584 . . . . 0.0 124.904 -141.411 . . . . . . . . 4 3 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -78.44 -9.1 0.13 Allowed Pre-proline 0 C--N 1.269 -2.928 2 CA-C-N 99.95 -7.841 . . . . 0.0 118.66 160.862 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.504 ' HD2' ' C ' ' A' ' 9' ' ' SER . 0.1 OUTLIER -68.35 -18.48 44.28 Favored 'Trans proline' 0 N--CA 1.502 1.978 2 N-CA-C 135.041 8.823 . . . . 0.0 135.041 123.639 . . . . . . . . 4 4 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.44 ' H ' ' C ' ' A' ' 11' ' ' LEU . . . -70.07 -14.01 70.49 Favored Glycine 1 N--CA 1.53 4.964 2 CA-C-N 107.613 -4.358 . . . . 0.0 121.2 156.1 . . . . . . . . 4 3 . 1 . 003 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . . . -101.74 -70.33 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.457 -2.634 3 C-N-CA 136.666 5.986 . . . . 0.0 108.097 -175.185 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -71.88 -1.62 14.94 Favored 'General case' 1 C--N 1.237 -4.303 0 CA-C-N 109.03 -3.713 . . . . 0.0 111.506 -177.879 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -54.37 -82.87 0.01 OUTLIER 'General case' 0 C--N 1.359 0.983 1 N-CA-C 128.361 6.43 . . . . 0.0 128.361 125.43 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -32.52 -52.51 0.3 Allowed 'General case' 0 CA--C 1.582 2.197 0 N-CA-C 116.976 2.213 . . . . 0.0 116.976 170.596 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . . . -68.7 -55.98 9.62 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 113.004 -1.907 . . . . 0.0 113.08 -173.028 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -52.42 -39.46 61.01 Favored 'General case' 0 CA--C 1.586 2.353 0 N-CA-C 118.788 2.884 . . . . 0.0 118.788 171.164 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . . . -91.25 -5.55 54.6 Favored 'General case' 0 N--CA 1.516 2.869 0 N-CA-C 120.011 3.337 . . . . 0.0 120.011 178.138 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . . . -88.72 -30.18 19.28 Favored 'General case' 1 N--CA 1.543 4.177 2 N-CA-C 127.092 5.96 . . . . 0.0 127.092 164.607 . . . . . . . . 3 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . . . -37.79 -63.38 0.47 Allowed 'General case' 1 C--N 1.215 -5.257 2 CA-C-N 101.835 -6.984 . . . . 0.0 124.732 157.637 . . . . . . . . 3 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . . . -33.45 -48.4 0.11 Allowed 'Isoleucine or valine' 1 C--N 1.242 -4.076 2 N-CA-C 130.358 7.17 . . . . 0.0 130.358 139.494 . . . . . . . . 3 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . . . -77.87 -5.72 51.9 Favored 'General case' 0 C--N 1.276 -2.598 1 N-CA-C 123.031 4.456 . . . . 0.0 123.031 163.232 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . . . -92.82 -67.93 0.83 Allowed 'General case' 0 N--CA 1.527 3.413 0 CA-C-N 111.724 -2.489 . . . . 0.0 115.948 -161.588 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . . . -46.01 -53.87 9.36 Favored 'General case' 0 N--CA 1.497 1.875 1 CA-C-N 108.041 -4.163 . . . . 0.0 117.082 146.565 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -77.98 -62.92 1.52 Allowed 'General case' 0 N--CA 1.496 1.852 0 CA-C-N 122.106 2.23 . . . . 0.0 109.943 171.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.299 -1.592 0 CA-C-N 112.172 -2.286 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.553 2.467 0 N-CA-C 103.186 -3.965 . . . . 0.0 103.186 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . . . -99.64 22.62 0.23 Allowed 'Trans proline' 0 N--CA 1.523 3.264 1 N-CA-C 125.337 5.091 . . . . 0.0 125.337 152.402 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.738 ' C ' ' H ' ' A' ' 5' ' ' ARG . . . -64.55 -71.65 0.17 Allowed 'General case' 0 C--O 1.169 -3.156 2 CA-C-N 103.211 -6.359 . . . . 0.0 107.453 117.574 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -37.92 2.26 0.0 OUTLIER 'General case' 1 N--CA 1.554 4.74 0 CA-C-O 128.295 3.902 . . . . 0.0 119.857 -168.718 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.738 ' H ' ' C ' ' A' ' 3' ' ' THR . . . -90.19 -58.03 2.64 Favored 'General case' 0 C--N 1.279 -2.461 3 C-N-CA 138.758 6.823 . . . . 0.0 128.182 170.166 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.533 ' O ' ' N ' ' A' ' 10' ' ' ILE . . . -37.27 -34.62 0.11 Allowed 'Isoleucine or valine' 1 CA--C 1.395 -4.984 1 C-N-CA 136.545 5.938 . . . . 0.0 114.4 129.174 . . . . . . . . 4 3 . 1 . 004 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.551 ' C ' ' H ' ' A' ' 10' ' ' ILE . . . -78.24 -49.85 12.97 Favored 'General case' 2 CA--C 1.299 -8.696 2 CA-C-O 133.146 6.212 . . . . 0.0 119.297 171.886 . . . . . . . . 4 3 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -41.06 -26.09 0.04 OUTLIER 'General case' 1 N--CA 1.378 -4.063 2 N-CA-C 129.633 6.901 . . . . 0.0 129.633 139.706 . . . . . . . . 3 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.475 ' O ' ' HD2' ' A' ' 13' ' ' PRO . . . -90.7 -19.62 23.38 Favored 'General case' 1 CA--C 1.418 -4.12 3 N-CA-C 141.226 11.195 . . . . 0.0 141.226 140.419 . . . . . . . . 4 3 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.551 ' H ' ' C ' ' A' ' 7' ' ' PHE . . . -66.64 -58.72 5.47 Favored 'Isoleucine or valine' 0 CA--C 1.608 3.187 2 CA-C-N 104.286 -5.87 . . . . 0.0 108.281 -167.957 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.462 ' C ' ' H ' ' A' ' 14' ' ' GLY . . . -106.19 -24.89 12.21 Favored 'General case' 1 CA--C 1.36 -6.35 4 CA-C-N 93.5 -10.773 . . . . 0.0 128.026 -165.109 . . . . . . . . 4 3 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -78.09 -19.25 0.3 Allowed Pre-proline 0 C--N 1.258 -3.407 1 O-C-N 129.573 4.295 . . . . 0.0 117.281 160.853 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.475 ' HD2' ' O ' ' A' ' 9' ' ' SER . 0.0 OUTLIER -50.3 -26.17 15.12 Favored 'Trans proline' 0 C--N 1.313 -1.296 1 N-CA-C 136.691 9.458 . . . . 0.0 136.691 125.212 . . . . . . . . 4 4 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.462 ' H ' ' C ' ' A' ' 11' ' ' LEU . . . -74.2 -7.27 76.95 Favored Glycine 1 N--CA 1.531 5.002 3 O-C-N 130.378 4.799 . . . . 0.0 122.703 156.252 . . . . . . . . 4 3 . 1 . 004 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . . . -110.49 -57.88 3.88 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.761 2 CA-C-N 105.29 -5.455 . . . . 0.0 117.884 -168.925 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -28.05 -40.29 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.638 0 CA-C-N 108.506 -3.952 . . . . 0.0 117.217 139.678 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -73.69 -41.16 63.0 Favored 'General case' 0 N--CA 1.426 -1.66 1 CA-C-N 107.609 -4.359 . . . . 0.0 121.061 -173.573 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -37.28 -58.66 0.81 Allowed 'General case' 0 CA--C 1.574 1.868 0 CA-C-N 112.012 -2.358 . . . . 0.0 117.198 143.875 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . . . -77.04 -51.86 10.34 Favored 'General case' 0 N--CA 1.487 1.382 0 CA-C-O 126.625 3.107 . . . . 0.0 113.365 -147.761 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -43.91 -41.63 5.32 Favored 'General case' 0 CA--C 1.584 2.253 0 CA-C-N 109.348 -3.569 . . . . 0.0 117.591 157.371 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . . . -91.42 -2.46 57.27 Favored 'General case' 0 N--CA 1.501 2.078 1 N-CA-C 122.744 4.35 . . . . 0.0 122.744 174.77 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . . . -97.91 -3.74 37.92 Favored 'General case' 1 N--CA 1.548 4.462 1 N-CA-C 126.259 5.651 . . . . 0.0 126.259 164.032 . . . . . . . . 3 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . . . -90.48 -42.86 10.62 Favored 'General case' 1 C--N 1.232 -4.517 4 CA-C-N 102.845 -6.525 . . . . 0.0 126.962 -173.478 . . . . . . . . 3 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . . . -28.04 -88.52 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.291 -1.965 2 CA-C-N 98.062 -8.699 . . . . 0.0 119.904 110.107 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . . . -75.04 15.53 0.4 Allowed 'General case' 0 N--CA 1.534 3.73 2 O-C-N 113.994 -5.441 . . . . 0.0 120.54 -171.868 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . . . -93.0 -61.01 1.66 Allowed 'General case' 0 N--CA 1.502 2.162 1 CA-C-N 106.498 -4.865 . . . . 0.0 114.876 167.861 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . . . -48.06 -43.25 30.28 Favored 'General case' 0 N--CA 1.511 2.586 0 N-CA-C 117.002 2.223 . . . . 0.0 117.002 166.767 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.58 -60.16 2.37 Favored 'General case' 0 N--CA 1.495 1.781 0 CA-C-N 111.889 -2.414 . . . . 0.0 113.06 157.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.297 -1.683 0 CA-C-N 114.073 -1.422 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.561 2.926 0 CA-C-O 127.723 3.957 . . . . 0.0 114.389 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . . . -56.83 -45.6 35.3 Favored 'Trans proline' 1 CA--C 1.417 -5.363 0 CA-C-O 110.699 -3.959 . . . . 0.0 120.314 169.418 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.512 ' CA ' ' H ' ' A' ' 5' ' ' ARG . . . -101.65 51.19 0.84 Allowed 'General case' 0 C--N 1.257 -3.442 1 O-C-N 111.982 -6.699 . . . . 0.0 115.079 156.756 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -57.0 -27.87 61.95 Favored 'General case' 0 N--CA 1.521 3.092 1 N-CA-C 123.415 4.598 . . . . 0.0 123.415 110.261 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.512 ' H ' ' CA ' ' A' ' 3' ' ' THR . . . -100.35 -56.46 2.35 Favored 'General case' 0 C--N 1.282 -2.366 2 N-CA-C 124.356 4.947 . . . . 0.0 124.356 -145.709 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.536 ' O ' ' N ' ' A' ' 10' ' ' ILE . . . -38.6 -45.09 0.4 Allowed 'Isoleucine or valine' 0 C--O 1.157 -3.786 2 CA-C-N 105.654 -5.248 . . . . 0.0 111.54 126.65 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.478 ' H ' ' N ' ' A' ' 5' ' ' ARG . . . -61.41 -60.55 3.55 Favored 'General case' 2 C--O 1.143 -4.543 2 CA-C-O 140.983 9.944 . . . . 0.0 113.306 -172.65 . . . . . . . . 4 3 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -36.81 -36.74 0.12 Allowed 'General case' 1 C--N 1.22 -5.031 2 CA-C-N 102.177 -6.829 . . . . 0.0 105.558 157.141 . . . . . . . . 3 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.528 ' C ' ' HD2' ' A' ' 13' ' ' PRO . . . -90.74 -12.67 35.88 Favored 'General case' 0 CA--C 1.431 -3.632 1 N-CA-C 134.001 8.519 . . . . 0.0 134.001 151.023 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.536 ' N ' ' O ' ' A' ' 6' ' ' ILE . . . -67.61 -57.47 9.48 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.317 0 CA-C-O 127.603 3.573 . . . . 0.0 109.122 174.529 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.573 ' C ' ' H ' ' A' ' 14' ' ' GLY . . . -112.69 -27.92 7.99 Favored 'General case' 1 CA--C 1.384 -5.421 1 CA-C-N 99.256 -8.156 . . . . 0.0 121.566 -156.162 . . . . . . . . 4 3 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -101.48 19.66 0.05 OUTLIER Pre-proline 0 C--N 1.266 -3.026 0 C-N-CA 113.203 -3.399 . . . . 0.0 118.735 159.798 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.528 ' HD2' ' C ' ' A' ' 9' ' ' SER . 0.0 OUTLIER -53.05 -31.29 53.22 Favored 'Trans proline' 0 N--CA 1.523 3.221 2 N-CA-C 132.654 7.905 . . . . 0.0 132.654 99.487 . . . . . . . . 4 4 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.573 ' H ' ' C ' ' A' ' 11' ' ' LEU . . . -59.65 -25.71 61.45 Favored Glycine 3 N--CA 1.552 6.405 1 CA-C-O 129.219 4.788 . . . . 0.0 122.444 167.453 . . . . . . . . 4 3 . 1 . 005 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . . . -107.11 -69.86 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.28 -2.444 2 CA-C-N 101.512 -7.344 . . . . 0.0 113.698 -163.217 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -27.0 -32.43 0.0 OUTLIER 'General case' 0 C--N 1.277 -2.568 0 N-CA-C 119.676 3.213 . . . . 0.0 119.676 153.515 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -85.1 -46.01 11.55 Favored 'General case' 0 C--N 1.328 -0.363 2 N-CA-C 123.334 4.568 . . . . 0.0 123.334 167.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -39.18 -57.74 1.28 Allowed 'General case' 0 N--CA 1.508 2.425 0 CA-C-O 123.249 1.499 . . . . 0.0 114.302 151.126 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . . . -81.99 -55.76 4.38 Favored 'General case' 0 CA--C 1.553 1.083 0 CA-C-O 123.32 1.533 . . . . 0.0 109.123 -140.9 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -48.62 -56.35 8.71 Favored 'General case' 0 CA--C 1.567 1.603 0 CA-C-N 112.728 -2.033 . . . . 0.0 115.128 162.009 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . . . -90.24 13.26 15.73 Favored 'General case' 0 N--CA 1.532 3.672 1 O-C-N 116.052 -4.155 . . . . 0.0 119.216 -178.568 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . . . -87.48 -32.72 19.31 Favored 'General case' 0 CA--C 1.427 -3.761 0 N-CA-C 121.464 3.876 . . . . 0.0 121.464 158.019 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . . . -43.52 -59.11 2.3 Favored 'General case' 0 C--N 1.253 -3.598 0 CA-C-N 108.665 -3.88 . . . . 0.0 114.804 174.757 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . . . -36.23 -46.14 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.26 -3.284 2 CA-C-N 102.379 -6.737 . . . . 0.0 125.261 148.161 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . . . -72.13 -14.47 61.84 Favored 'General case' 0 C--N 1.278 -2.502 1 N-CA-C 121.991 4.071 . . . . 0.0 121.991 162.818 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . . . -91.01 -61.56 1.64 Allowed 'General case' 0 N--CA 1.511 2.602 0 CA-C-N 110.681 -2.963 . . . . 0.0 108.375 -160.445 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . . . -49.91 -42.58 48.41 Favored 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 128.659 2.784 . . . . 0.0 118.238 157.232 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.7 -50.19 46.09 Favored 'General case' 0 N--CA 1.503 2.208 0 CA-C-O 124.159 1.933 . . . . 0.0 110.227 161.257 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.301 -1.532 0 CA-C-N 113.05 -1.886 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.562 2.978 0 N-CA-C 118.375 2.11 . . . . 0.0 118.375 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . . . -96.34 -6.85 1.31 Allowed 'Trans proline' 1 CA--C 1.606 4.089 1 C-N-CA 125.855 4.37 . . . . 0.0 120.872 -177.064 . . . . . . . . 3 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.432 ' O ' ' N ' ' A' ' 7' ' ' PHE . . . -32.77 -68.32 0.1 Allowed 'General case' 1 C--O 1.148 -4.265 2 CA-C-N 106.772 -4.74 . . . . 0.0 119.442 117.856 . . . . . . . . 4 3 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -58.47 -21.46 51.49 Favored 'General case' 0 N--CA 1.503 2.181 0 CA-C-O 127.295 3.426 . . . . 0.0 116.887 179.284 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . . . -95.0 -42.43 8.64 Favored 'General case' 0 C--N 1.296 -1.743 3 CA-C-N 103.729 -6.123 . . . . 0.0 125.905 174.684 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.428 ' O ' ' N ' ' A' ' 9' ' ' SER . . . -45.95 -51.69 3.39 Favored 'Isoleucine or valine' 0 C--O 1.192 -1.932 0 O-C-N 128.948 3.905 . . . . 0.0 106.128 136.752 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.436 ' O ' ' N ' ' A' ' 10' ' ' ILE . . . -45.32 -64.44 0.72 Allowed 'General case' 3 N--CA 1.561 5.098 0 O-C-N 126.551 2.407 . . . . 0.0 113.063 -155.942 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -39.38 -47.62 1.79 Allowed 'General case' 1 N--CA 1.373 -4.319 4 C-N-CA 153.271 12.628 . . . . 0.0 100.027 166.512 . . . . . . . . 3 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.523 ' O ' ' HG2' ' A' ' 13' ' ' PRO . . . -91.75 19.2 6.67 Favored 'General case' 0 N--CA 1.513 2.676 1 N-CA-C 132.711 8.041 . . . . 0.0 132.711 153.15 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.436 ' N ' ' O ' ' A' ' 7' ' ' PHE . . . -109.29 -49.65 7.09 Favored 'Isoleucine or valine' 2 CA--C 1.644 4.576 2 N-CA-C 98.912 -4.477 . . . . 0.0 98.912 -177.547 . . . . . . . . 4 3 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.507 ' C ' ' H ' ' A' ' 14' ' ' GLY . . . -62.97 -52.78 61.66 Favored 'General case' 1 CA--C 1.361 -6.297 2 C-N-CA 138.429 6.692 . . . . 0.0 126.301 -177.71 . . . . . . . . 4 3 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -95.83 -15.52 0.2 Allowed Pre-proline 0 C--N 1.248 -3.844 2 O-C-N 135.102 7.751 . . . . 0.0 112.744 -177.212 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.523 ' HG2' ' O ' ' A' ' 9' ' ' SER . 0.1 OUTLIER -54.67 -24.55 37.8 Favored 'Trans proline' 0 N--CA 1.504 2.144 1 N-CA-C 128.56 6.331 . . . . 0.0 128.56 121.467 . . . . . . . . 4 4 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.507 ' H ' ' C ' ' A' ' 11' ' ' LEU . . . -85.83 -0.3 87.63 Favored Glycine 2 N--CA 1.533 5.157 1 CA-C-N 108.127 -4.124 . . . . 0.0 121.814 164.465 . . . . . . . . 4 3 . 1 . 006 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . . . -103.89 -69.36 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.642 2 CA-C-N 106.409 -4.896 . . . . 0.0 114.335 175.523 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -24.03 -41.4 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.714 0 CA-C-N 110.865 -2.88 . . . . 0.0 117.994 156.02 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.44 -81.66 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.716 1 CA-C-N 106.073 -5.058 . . . . 0.0 121.287 158.512 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -36.33 -60.12 0.59 Allowed 'General case' 0 CA--C 1.581 2.168 0 N-CA-C 117.182 2.29 . . . . 0.0 117.182 171.235 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . . . -58.69 -57.38 13.25 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 128.874 2.87 . . . . 0.0 112.347 -168.166 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -71.7 -36.48 70.58 Favored 'General case' 0 CA--C 1.574 1.893 0 C-N-CA 127.689 2.396 . . . . 0.0 115.667 -176.185 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . . . -85.88 -0.86 56.48 Favored 'General case' 0 N--CA 1.506 2.374 0 N-CA-C 117.598 2.444 . . . . 0.0 117.598 173.43 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . . . -104.67 -26.87 12.13 Favored 'General case' 1 N--CA 1.554 4.743 1 N-CA-C 125.376 5.325 . . . . 0.0 125.376 176.427 . . . . . . . . 3 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . . . -35.0 -68.89 0.11 Allowed 'General case' 0 C--N 1.258 -3.37 1 CA-C-N 102.823 -6.535 . . . . 0.0 118.625 146.805 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . . . -34.28 -41.0 0.09 OUTLIER 'Isoleucine or valine' 1 C--N 1.236 -4.335 2 CA-C-N 105.484 -5.325 . . . . 0.0 122.642 148.921 . . . . . . . . 3 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . . . -94.71 2.47 55.56 Favored 'General case' 0 C--N 1.275 -2.646 0 N-CA-C 120.837 3.643 . . . . 0.0 120.837 170.524 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . . . -91.2 -25.11 19.69 Favored 'General case' 0 CA--C 1.608 3.185 0 CA-C-N 108.552 -3.931 . . . . 0.0 113.977 169.33 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . . . -96.85 -59.3 1.83 Allowed 'General case' 0 N--CA 1.507 2.419 0 C-N-CA 131.157 3.783 . . . . 0.0 110.163 -176.659 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.44 23.4 0.12 Allowed 'General case' 0 N--CA 1.497 1.886 0 CA-C-N 112.195 -2.275 . . . . 0.0 114.233 141.677 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.316 -0.87 0 O-C-N 119.359 -2.088 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.569 3.448 0 N-CA-C 117.691 1.837 . . . . 0.0 117.691 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . . . -120.96 14.59 0.02 OUTLIER 'Trans proline' 0 CA--C 1.561 1.848 1 N-CA-C 125.474 5.144 . . . . 0.0 125.474 -164.537 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.727 ' C ' ' H ' ' A' ' 5' ' ' ARG . . . -55.56 -67.84 0.25 Allowed 'General case' 0 C--O 1.179 -2.642 2 CA-C-O 109.121 -5.228 . . . . 0.0 108.441 114.047 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -52.31 -1.14 0.02 OUTLIER 'General case' 1 N--CA 1.569 5.521 1 CA-C-O 131.128 5.251 . . . . 0.0 118.594 -147.739 . . . . . . . . 3 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.727 ' H ' ' C ' ' A' ' 3' ' ' THR . . . -93.29 -56.29 3.0 Favored 'General case' 0 C--N 1.269 -2.895 3 C-N-CA 142.114 8.166 . . . . 0.0 123.219 -176.515 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.565 ' C ' ' H ' ' A' ' 9' ' ' SER . . . -39.28 -29.77 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.435 -3.457 1 CA-C-O 110.952 -4.356 . . . . 0.0 109.516 125.494 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.503 ' H ' ' N ' ' A' ' 5' ' ' ARG . . . -72.34 -56.85 4.8 Favored 'General case' 1 N--CA 1.558 4.939 2 CA-C-O 131.312 5.339 . . . . 0.0 115.367 -173.013 . . . . . . . . 4 3 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -37.44 -49.24 1.01 Allowed 'General case' 1 C--N 1.233 -4.497 3 C-N-CA 142.179 8.192 . . . . 0.0 100.704 150.732 . . . . . . . . 3 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.565 ' H ' ' C ' ' A' ' 6' ' ' ILE . . . -102.66 -6.46 22.69 Favored 'General case' 0 N--CA 1.52 3.065 1 N-CA-C 128.829 6.603 . . . . 0.0 128.829 174.957 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.474 ' C ' ' HB2' ' A' ' 13' ' ' PRO . . . -84.85 -47.54 17.08 Favored 'Isoleucine or valine' 1 C--N 1.231 -4.562 2 CA-C-N 106.894 -4.685 . . . . 0.0 98.392 -179.455 . . . . . . . . 4 3 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.555 ' C ' ' H ' ' A' ' 14' ' ' GLY . . . -106.13 -33.38 7.87 Favored 'General case' 1 CA--C 1.378 -5.64 1 N-CA-C 123.457 4.614 . . . . 0.0 123.457 -157.276 . . . . . . . . 4 3 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -76.41 -23.1 0.44 Allowed Pre-proline 0 C--N 1.246 -3.897 2 O-C-N 130.065 4.603 . . . . 0.0 113.343 166.808 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.529 ' HG2' ' O ' ' A' ' 9' ' ' SER . 0.0 OUTLIER -48.34 -27.45 9.9 Favored 'Trans proline' 0 CA--C 1.476 -2.416 1 N-CA-C 129.113 6.544 . . . . 0.0 129.113 127.895 . . . . . . . . 4 4 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.555 ' H ' ' C ' ' A' ' 11' ' ' LEU . . . -64.93 -21.03 67.29 Favored Glycine 2 N--CA 1.544 5.855 1 CA-C-O 128.106 4.17 . . . . 0.0 122.742 160.041 . . . . . . . . 4 3 . 1 . 007 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . . . -108.45 -68.99 0.95 Allowed 'Isoleucine or valine' 0 CA--C 1.462 -2.427 2 CA-C-N 103.262 -6.469 . . . . 0.0 111.936 -159.667 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -26.37 -32.92 0.0 OUTLIER 'General case' 0 C--N 1.269 -2.921 0 N-CA-C 119.937 3.31 . . . . 0.0 119.937 148.712 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -88.75 -41.46 12.53 Favored 'General case' 0 N--CA 1.466 0.326 2 N-CA-C 123.7 4.704 . . . . 0.0 123.7 167.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -39.01 -59.15 1.02 Allowed 'General case' 0 N--CA 1.511 2.593 0 CA-C-O 123.796 1.76 . . . . 0.0 114.881 148.677 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . . . -77.3 -56.46 4.53 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 114.714 -1.13 . . . . 0.0 108.316 -143.117 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -42.44 -45.4 4.38 Favored 'General case' 0 CA--C 1.582 2.204 0 C-N-CA 126.52 1.928 . . . . 0.0 115.741 159.684 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . . . -92.57 1.77 57.07 Favored 'General case' 0 CA--C 1.578 2.054 0 N-CA-C 119.251 3.056 . . . . 0.0 119.251 -176.015 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . . . -106.54 -15.7 14.72 Favored 'General case' 1 N--CA 1.56 5.064 1 N-CA-C 124.075 4.843 . . . . 0.0 124.075 157.521 . . . . . . . . 3 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . . . -36.68 -69.67 0.11 Allowed 'General case' 1 C--N 1.233 -4.468 0 CA-C-N 108.794 -3.821 . . . . 0.0 118.61 157.36 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . . . -35.47 -43.65 0.15 Allowed 'Isoleucine or valine' 1 C--N 1.224 -4.879 2 CA-C-N 102.526 -6.67 . . . . 0.0 123.099 149.961 . . . . . . . . 3 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . . . -92.29 1.82 57.0 Favored 'General case' 0 C--N 1.292 -1.893 0 N-CA-C 118.398 2.74 . . . . 0.0 118.398 171.163 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . . . -90.91 -32.57 15.95 Favored 'General case' 0 CA--C 1.612 3.328 0 CA-C-N 110.71 -2.95 . . . . 0.0 113.632 175.772 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . . . -97.05 -48.91 5.21 Favored 'General case' 0 N--CA 1.509 2.482 1 C-N-CA 131.968 4.107 . . . . 0.0 110.818 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -78.44 22.74 0.32 Allowed 'General case' 0 N--CA 1.499 1.985 0 C-N-CA 117.586 -1.646 . . . . 0.0 113.419 140.428 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.317 -0.807 0 O-C-N 119.622 -1.924 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.56 2.883 0 CA-C-O 119.151 -0.805 . . . . 0.0 112.022 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . . . -130.01 26.42 0.0 OUTLIER 'Trans proline' 0 N--CA 1.514 2.723 1 N-CA-C 125.119 5.007 . . . . 0.0 125.119 -163.673 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.485 ' C ' ' H ' ' A' ' 5' ' ' ARG . . . -54.92 -81.51 0.01 OUTLIER 'General case' 0 C--O 1.189 -2.109 2 CA-C-N 104.679 -5.691 . . . . 0.0 100.148 109.012 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -61.03 -10.26 5.68 Favored 'General case' 0 N--CA 1.521 3.075 0 O-C-N 127.694 3.121 . . . . 0.0 118.458 -122.624 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.485 ' H ' ' C ' ' A' ' 3' ' ' THR . . . -95.13 -48.8 5.79 Favored 'General case' 0 C--N 1.301 -1.542 4 C-N-CA 141.899 8.08 . . . . 0.0 128.466 -176.226 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.649 ' C ' ' H ' ' A' ' 9' ' ' SER . . . -37.16 -60.3 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.512 2.631 3 N-CA-C 89.576 -7.935 . . . . 0.0 89.576 142.834 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . . . -103.34 -32.04 9.75 Favored 'General case' 1 N--CA 1.371 -4.405 1 CA-C-O 130.934 5.159 . . . . 0.0 111.664 -128.603 . . . . . . . . 3 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -45.88 -36.27 5.22 Favored 'General case' 0 CA--C 1.446 -3.053 1 O-C-N 116.054 -4.154 . . . . 0.0 121.197 126.757 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.649 ' H ' ' C ' ' A' ' 6' ' ' ILE . . . -90.7 10.6 25.2 Favored 'General case' 0 N--CA 1.524 3.258 1 N-CA-C 125.11 5.226 . . . . 0.0 125.11 176.094 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . . . -110.99 -42.39 4.74 Favored 'Isoleucine or valine' 1 CA--C 1.651 4.855 1 CA-C-N 106.817 -4.719 . . . . 0.0 102.094 -176.364 . . . . . . . . 3 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.541 ' C ' ' H ' ' A' ' 14' ' ' GLY . . . -54.71 -59.33 4.86 Favored 'General case' 1 CA--C 1.373 -5.852 1 C-N-CA 138.069 6.548 . . . . 0.0 120.91 170.374 . . . . . . . . 4 3 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -81.89 -41.18 1.01 Allowed Pre-proline 1 N--CA 1.362 -4.857 1 CA-C-N 105.47 -5.332 . . . . 0.0 102.968 -172.42 . . . . . . . . 3 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.535 ' HD2' ' C ' ' A' ' 9' ' ' SER . 0.1 OUTLIER -37.56 -22.4 0.05 OUTLIER 'Trans proline' 0 N--CA 1.518 2.927 2 O-C-N 108.919 -6.411 . . . . 0.0 127.829 134.853 . . . . . . . . 4 4 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.541 ' H ' ' C ' ' A' ' 11' ' ' LEU . . . -80.33 -7.21 88.76 Favored Glycine 2 N--CA 1.529 4.851 1 CA-C-N 108.141 -4.118 . . . . 0.0 119.886 163.045 . . . . . . . . 4 3 . 1 . 008 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . . . -105.86 -76.53 0.46 Allowed 'Isoleucine or valine' 0 C--O 1.2 -1.521 2 C-N-CA 133.1 4.56 . . . . 0.0 110.89 -166.775 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -21.1 -34.71 0.0 OUTLIER 'General case' 0 C--N 1.26 -3.306 0 N-CA-C 120.367 3.469 . . . . 0.0 120.367 147.001 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -83.8 -45.29 13.46 Favored 'General case' 0 N--CA 1.476 0.827 1 N-CA-C 125.246 5.276 . . . . 0.0 125.246 160.531 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -36.4 -55.42 0.82 Allowed 'General case' 0 N--CA 1.517 2.878 0 CA-C-O 125.235 2.445 . . . . 0.0 116.276 154.461 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . . . -78.07 -50.25 12.42 Favored 'General case' 0 N--CA 1.48 1.047 0 CA-C-O 124.047 1.879 . . . . 0.0 111.327 -152.057 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -37.93 -48.98 1.21 Allowed 'General case' 0 N--CA 1.413 -2.29 0 C-N-CA 131.617 3.967 . . . . 0.0 120.836 149.904 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . . . -87.89 7.86 28.83 Favored 'General case' 0 N--CA 1.514 2.731 0 N-CA-C 119.901 3.297 . . . . 0.0 119.901 170.53 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . . . -104.08 -30.69 10.09 Favored 'General case' 0 N--CA 1.534 3.771 1 N-CA-C 124.429 4.974 . . . . 0.0 124.429 173.572 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . . . -37.82 -59.49 0.81 Allowed 'General case' 0 C--N 1.258 -3.404 2 CA-C-N 104.18 -5.918 . . . . 0.0 121.877 152.902 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . . . -36.13 -47.24 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.262 -3.205 3 O-C-N 134.567 7.417 . . . . 0.0 123.071 140.259 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . . . -91.89 4.81 52.09 Favored 'General case' 0 C--N 1.269 -2.902 0 O-C-N 119.128 -2.233 . . . . 0.0 116.437 170.802 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . . . -96.56 -60.0 1.7 Allowed 'General case' 0 N--CA 1.521 3.112 0 CA-C-N 110.475 -3.057 . . . . 0.0 113.572 -175.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . . . -47.16 -38.4 11.69 Favored 'General case' 0 N--CA 1.51 2.564 0 CA-C-N 109.06 -3.7 . . . . 0.0 115.053 158.175 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -91.13 -83.19 0.28 Allowed 'General case' 0 N--CA 1.489 1.489 0 CA-C-O 123.36 1.552 . . . . 0.0 108.411 164.202 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.296 -1.741 0 O-C-N 121.224 -0.923 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.558 2.736 0 CA-C-O 123.645 1.692 . . . . 0.0 117.12 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . . . -65.5 -54.1 0.66 Allowed 'Trans proline' 1 CA--C 1.412 -5.587 0 CA-C-O 110.883 -3.882 . . . . 0.0 118.752 -172.021 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . . . -96.25 56.96 1.66 Allowed 'General case' 0 C--N 1.264 -3.126 2 O-C-N 111.859 -6.776 . . . . 0.0 112.104 149.558 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -75.56 -14.36 60.39 Favored 'General case' 0 N--CA 1.523 3.19 1 O-C-N 116.156 -4.09 . . . . 0.0 121.269 111.379 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . . . -97.47 -55.55 2.79 Favored 'General case' 0 N--CA 1.492 1.635 1 N-CA-C 122.161 4.134 . . . . 0.0 122.161 -155.803 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . . . -38.32 -55.09 0.35 Allowed 'Isoleucine or valine' 1 CA--C 1.418 -4.104 0 CA-C-N 108.428 -3.987 . . . . 0.0 111.262 131.84 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . . . -45.87 -63.27 1.01 Allowed 'General case' 3 CA--C 1.299 -8.704 0 O-C-N 127.406 2.941 . . . . 0.0 111.007 -175.001 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -35.63 -49.1 0.55 Allowed 'General case' 0 C--N 1.273 -2.733 2 C-N-CA 141.414 7.886 . . . . 0.0 104.361 167.591 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.47 ' O ' ' HG2' ' A' ' 13' ' ' PRO . . . -76.44 -13.43 60.11 Favored 'General case' 1 N--CA 1.539 4.024 2 N-CA-C 134.667 8.765 . . . . 0.0 134.667 169.0 . . . . . . . . 4 3 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . . . -103.84 -45.55 9.79 Favored 'Isoleucine or valine' 2 C--N 1.204 -5.731 2 CA-C-N 97.549 -8.932 . . . . 0.0 99.1 -161.293 . . . . . . . . 3 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.521 ' C ' ' H ' ' A' ' 14' ' ' GLY . . . -94.77 -56.6 2.72 Favored 'General case' 1 CA--C 1.397 -4.931 1 C-N-CA 135.144 5.378 . . . . 0.0 118.402 -148.135 . . . . . . . . 4 3 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -86.26 -12.89 0.19 Allowed Pre-proline 0 C--N 1.262 -3.199 2 O-C-N 135.848 8.217 . . . . 0.0 113.32 178.766 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.47 ' HG2' ' O ' ' A' ' 9' ' ' SER . 0.1 OUTLIER -56.08 -27.7 66.09 Favored 'Trans proline' 0 N--CA 1.52 3.053 2 N-CA-C 131.501 7.462 . . . . 0.0 131.501 118.579 . . . . . . . . 4 4 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.521 ' H ' ' C ' ' A' ' 11' ' ' LEU . . . -77.97 -5.15 86.71 Favored Glycine 3 N--CA 1.562 7.051 2 CA-C-O 130.659 5.589 . . . . 0.0 123.301 164.845 . . . . . . . . 4 3 . 1 . 009 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . . . -105.61 -78.4 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.278 -2.514 2 C-N-CA 139.386 7.074 . . . . 0.0 117.819 179.616 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -29.6 -30.34 0.0 OUTLIER 'General case' 0 C--N 1.264 -3.139 0 N-CA-C 117.932 2.567 . . . . 0.0 117.932 152.862 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -53.19 -77.56 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.863 0 CA-C-N 109.21 -3.632 . . . . 0.0 120.627 150.446 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -33.68 -58.27 0.42 Allowed 'General case' 0 CA--C 1.571 1.788 0 N-CA-C 116.685 2.106 . . . . 0.0 116.685 169.425 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . . . -64.8 -41.37 95.85 Favored 'General case' 0 CA--C 1.552 1.04 0 CA-C-N 113.6 -1.636 . . . . 0.0 113.67 -164.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -83.43 -27.8 29.28 Favored 'General case' 0 CA--C 1.582 2.198 0 C-N-CA 129.142 2.977 . . . . 0.0 114.593 -178.317 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . . . -84.51 3.66 35.45 Favored 'General case' 0 N--CA 1.505 2.304 0 N-CA-C 120.034 3.346 . . . . 0.0 120.034 158.755 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . . . -103.39 -27.16 12.6 Favored 'General case' 1 N--CA 1.548 4.443 1 N-CA-C 124.534 5.012 . . . . 0.0 124.534 173.261 . . . . . . . . 3 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . . . -35.99 -67.41 0.16 Allowed 'General case' 0 C--N 1.257 -3.414 1 CA-C-N 103.779 -6.101 . . . . 0.0 119.048 149.065 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . . . -33.9 -41.86 0.09 OUTLIER 'Isoleucine or valine' 1 C--N 1.239 -4.219 2 CA-C-N 104.851 -5.613 . . . . 0.0 122.801 147.961 . . . . . . . . 3 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . . . -94.43 3.08 55.63 Favored 'General case' 0 C--N 1.274 -2.705 0 N-CA-C 120.838 3.644 . . . . 0.0 120.838 170.621 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . . . -90.97 -25.75 19.59 Favored 'General case' 0 CA--C 1.609 3.222 1 CA-C-N 108.381 -4.008 . . . . 0.0 113.831 169.34 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . . . -96.82 -59.11 1.87 Allowed 'General case' 0 N--CA 1.507 2.406 0 C-N-CA 131.266 3.826 . . . . 0.0 110.239 -176.264 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.14 23.62 0.1 Allowed 'General case' 0 N--CA 1.498 1.929 0 CA-C-N 112.152 -2.295 . . . . 0.0 114.225 141.353 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.316 -0.849 0 O-C-N 119.361 -2.087 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.572 3.632 0 N-CA-C 117.796 1.878 . . . . 0.0 117.796 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . . . -127.34 -7.92 0.0 OUTLIER 'Trans proline' 1 N--CA 1.538 4.106 1 N-CA-C 129.978 6.876 . . . . 0.0 129.978 -155.399 . . . . . . . . 3 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.467 ' O ' ' CA ' ' A' ' 7' ' ' PHE . . . -35.68 -61.72 0.45 Allowed 'General case' 0 C--O 1.161 -3.603 2 CA-C-N 100.892 -7.413 . . . . 0.0 110.959 119.192 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -93.54 -21.28 19.54 Favored 'General case' 0 N--CA 1.524 3.248 1 CA-C-O 129.78 4.609 . . . . 0.0 115.973 -137.223 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.516 ' CA ' ' H ' ' A' ' 7' ' ' PHE . . . -90.0 -22.43 21.9 Favored 'General case' 0 C--N 1.268 -2.95 3 N-CA-C 141.871 11.434 . . . . 0.0 141.871 136.498 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.438 ' O ' ' N ' ' A' ' 10' ' ' ILE . . . -46.01 -43.32 4.73 Favored 'Isoleucine or valine' 0 CA--C 1.465 -2.289 0 O-C-N 128.886 3.866 . . . . 0.0 106.763 126.095 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.516 ' H ' ' CA ' ' A' ' 5' ' ' ARG . . . -67.08 -61.16 2.07 Favored 'General case' 0 N--CA 1.401 -2.919 1 CA-C-O 129.405 4.431 . . . . 0.0 118.194 -133.813 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -35.1 -27.18 0.01 OUTLIER 'General case' 2 C--N 1.195 -6.132 2 N-CA-C 136.562 9.467 . . . . 0.0 136.562 130.275 . . . . . . . . 3 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.477 ' O ' ' HD2' ' A' ' 13' ' ' PRO . . . -89.35 5.59 44.39 Favored 'General case' 0 C--N 1.255 -3.502 1 N-CA-C 135.188 8.958 . . . . 0.0 135.188 140.647 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.438 ' N ' ' O ' ' A' ' 6' ' ' ILE . . . -67.7 -43.29 86.71 Favored 'Isoleucine or valine' 0 C--N 1.255 -3.503 1 CA-C-O 129.246 4.355 . . . . 0.0 118.642 162.302 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . . . -116.82 -28.85 6.21 Favored 'General case' 1 CA--C 1.406 -4.584 3 CA-C-N 98.219 -8.628 . . . . 0.0 127.937 -149.486 . . . . . . . . 3 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -76.91 -23.93 0.45 Allowed Pre-proline 1 C--N 1.244 -4.003 3 O-C-N 135.077 7.736 . . . . 0.0 122.988 150.65 . . . . . . . . 3 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.477 ' HD2' ' O ' ' A' ' 9' ' ' SER . 0.1 OUTLIER -59.36 -22.76 67.14 Favored 'Trans proline' 0 C--N 1.31 -1.486 1 N-CA-C 130.72 7.162 . . . . 0.0 130.72 128.365 . . . . . . . . 4 4 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -80.66 4.91 66.75 Favored Glycine 1 N--CA 1.518 4.118 2 CA-C-N 104.567 -5.742 . . . . 0.0 120.26 159.043 . . . . . . . . 3 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . . . -113.39 -67.72 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 C-N-CA 131.127 3.771 . . . . 0.0 113.058 -174.872 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -26.96 -34.96 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 108.917 -3.765 . . . . 0.0 119.506 145.139 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.83 -70.4 0.21 Allowed 'General case' 0 N--CA 1.441 -0.91 2 N-CA-C 126.167 5.618 . . . . 0.0 126.167 155.335 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -38.22 -54.76 1.37 Allowed 'General case' 0 CA--C 1.583 2.232 0 N-CA-C 118.187 2.662 . . . . 0.0 118.187 163.642 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . . . -39.46 -56.47 1.6 Allowed 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 129.731 3.213 . . . . 0.0 115.507 174.691 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -80.9 -27.28 36.32 Favored 'General case' 0 CA--C 1.567 1.598 0 CA-C-N 109.998 -3.274 . . . . 0.0 113.757 -178.228 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . . . -98.49 10.52 40.73 Favored 'General case' 0 N--CA 1.525 3.297 1 N-CA-C 130.874 7.361 . . . . 0.0 130.874 160.018 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . . . -95.12 -28.37 15.11 Favored 'General case' 0 N--CA 1.538 3.934 2 N-CA-C 125.718 5.451 . . . . 0.0 125.718 157.715 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . . . -30.84 -56.75 0.22 Allowed 'General case' 2 N--CA 1.366 -4.645 2 CA-C-N 103.517 -6.22 . . . . 0.0 119.53 138.208 . . . . . . . . 3 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . . . -94.35 -8.88 9.67 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.239 0 C-N-CA 113.901 -3.12 . . . . 0.0 117.924 -171.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . . . -71.02 -14.52 62.37 Favored 'General case' 0 C--N 1.307 -1.252 1 N-CA-C 127.46 6.096 . . . . 0.0 127.46 148.531 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . . . -92.6 -48.36 6.65 Favored 'General case' 1 N--CA 1.548 4.465 0 N-CA-C 118.845 2.906 . . . . 0.0 118.845 -162.219 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . . . -46.19 -72.98 0.04 OUTLIER 'General case' 0 C--N 1.288 -2.076 1 CA-C-N 106.22 -4.991 . . . . 0.0 117.266 138.536 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -77.1 -58.77 3.09 Favored 'General case' 0 N--CA 1.493 1.712 0 CA-C-O 124.802 2.239 . . . . 0.0 111.548 -172.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.298 -1.673 0 CA-C-N 111.988 -2.369 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.557 2.685 0 CA-C-O 123.632 1.684 . . . . 0.0 115.952 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . . . -63.09 -45.4 12.62 Favored 'Trans proline' 1 CA--C 1.422 -5.101 0 N-CA-C 121.899 3.769 . . . . 0.0 121.899 -178.722 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.406 ' CA ' ' H ' ' A' ' 5' ' ' ARG . . . -95.7 47.98 1.12 Allowed 'General case' 0 C--N 1.267 -2.982 1 O-C-N 111.697 -6.877 . . . . 0.0 112.956 147.008 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -63.05 -17.92 62.78 Favored 'General case' 0 N--CA 1.521 3.116 1 N-CA-C 123.337 4.569 . . . . 0.0 123.337 117.684 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.406 ' H ' ' CA ' ' A' ' 3' ' ' THR . . . -105.92 -56.89 2.12 Favored 'General case' 0 C--N 1.298 -1.656 3 N-CA-C 124.967 5.173 . . . . 0.0 124.967 -141.292 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . . . -35.48 -61.11 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.425 -3.838 1 CA-C-N 106.682 -4.781 . . . . 0.0 114.599 113.43 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . . . -35.39 -41.01 0.17 Allowed 'General case' 3 CA--C 1.333 -7.403 2 N-CA-C 129.336 6.791 . . . . 0.0 129.336 -179.487 . . . . . . . . 3 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -57.03 -52.26 65.99 Favored 'General case' 1 N--CA 1.315 -7.192 4 O-C-N 145.693 14.37 . . . . 0.0 125.673 165.426 . . . . . . . . 3 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.447 ' O ' ' HG2' ' A' ' 13' ' ' PRO . . . -97.3 0.37 47.94 Favored 'General case' 0 N--CA 1.501 2.096 3 N-CA-C 132.805 8.076 . . . . 0.0 132.805 160.782 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . . . -62.61 -39.72 85.68 Favored 'Isoleucine or valine' 0 C--N 1.246 -3.91 2 CA-C-N 101.757 -7.019 . . . . 0.0 120.202 150.418 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.472 ' C ' ' H ' ' A' ' 14' ' ' GLY . . . -100.63 -52.58 3.3 Favored 'General case' 1 CA--C 1.416 -4.194 3 CA-C-N 99.029 -8.26 . . . . 0.0 125.736 -145.088 . . . . . . . . 4 3 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -81.29 -21.3 0.31 Allowed Pre-proline 0 N--CA 1.379 -3.99 2 O-C-N 136.935 8.897 . . . . 0.0 116.151 167.027 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.447 ' HG2' ' O ' ' A' ' 9' ' ' SER . 12.2 Cg_exo -52.53 -24.27 21.77 Favored 'Trans proline' 0 N--CA 1.51 2.474 2 N-CA-C 134.683 8.686 . . . . 0.0 134.683 118.13 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.472 ' H ' ' C ' ' A' ' 11' ' ' LEU . . . -78.41 -3.07 85.72 Favored Glycine 2 N--CA 1.543 5.793 2 CA-C-N 106.655 -4.793 . . . . 0.0 120.827 159.539 . . . . . . . . 4 3 . 1 . 011 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . . . -114.87 -77.81 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.467 -2.238 2 C-N-CA 134.852 5.261 . . . . 0.0 112.409 -169.513 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -29.29 -27.91 0.0 OUTLIER 'General case' 0 C--N 1.274 -2.71 0 N-CA-C 119.939 3.311 . . . . 0.0 119.939 150.839 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -57.76 -69.02 0.19 Allowed 'General case' 0 CA--C 1.549 0.923 1 N-CA-C 130.425 7.195 . . . . 0.0 130.425 145.697 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -35.54 -54.69 0.68 Allowed 'General case' 0 CA--C 1.578 2.03 0 N-CA-C 116.955 2.205 . . . . 0.0 116.955 159.648 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . . . -77.3 -55.15 5.66 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 113.653 -1.612 . . . . 0.0 111.555 -155.519 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -39.82 -41.9 1.21 Allowed 'General case' 0 CA--C 1.586 2.349 0 N-CA-C 117.522 2.415 . . . . 0.0 117.522 157.083 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . . . -95.22 14.17 23.09 Favored 'General case' 0 N--CA 1.502 2.165 1 N-CA-C 123.86 4.763 . . . . 0.0 123.86 175.031 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.416 ' C ' ' H ' ' A' ' 25' ' ' GLU . . . -101.87 -6.68 23.25 Favored 'General case' 1 N--CA 1.555 4.78 1 N-CA-C 127.42 6.082 . . . . 0.0 127.42 151.009 . . . . . . . . 4 3 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . . . -81.13 -48.2 12.45 Favored 'General case' 1 C--N 1.221 -4.988 2 CA-C-N 102.955 -6.475 . . . . 0.0 123.262 -173.019 . . . . . . . . 3 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . . . -23.71 -52.74 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.283 -2.32 3 N-CA-C 131.404 7.557 . . . . 0.0 131.404 115.898 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.416 ' H ' ' C ' ' A' ' 22' ' ' ARG . . . -90.66 8.81 32.46 Favored 'General case' 0 N--CA 1.521 3.097 0 O-C-N 118.12 -2.863 . . . . 0.0 117.085 169.769 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . . . -96.25 -61.8 1.38 Allowed 'General case' 0 N--CA 1.518 2.928 0 CA-C-N 108.768 -3.833 . . . . 0.0 116.215 -175.849 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . . . -46.34 -46.16 18.06 Favored 'General case' 0 N--CA 1.494 1.76 1 CA-C-N 108.006 -4.179 . . . . 0.0 115.431 156.547 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -91.29 -79.56 0.37 Allowed 'General case' 0 N--CA 1.484 1.258 0 CA-C-O 123.871 1.796 . . . . 0.0 108.788 166.792 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.297 -1.681 0 CA-C-N 114.228 -1.351 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.559 2.826 0 N-CA-C 119.032 2.373 . . . . 0.0 119.032 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . . . -130.79 -14.94 0.0 OUTLIER 'Trans proline' 0 CA--C 1.583 2.957 1 N-CA-C 124.056 4.599 . . . . 0.0 124.056 -151.069 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.492 ' O ' ' CA ' ' A' ' 7' ' ' PHE . . . -34.55 -56.62 0.53 Allowed 'General case' 0 C--O 1.182 -2.455 2 CA-C-O 106.696 -6.383 . . . . 0.0 112.697 122.583 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -96.02 -28.1 14.8 Favored 'General case' 0 N--CA 1.526 3.369 2 CA-C-O 132.009 5.671 . . . . 0.0 116.586 -141.012 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.484 ' N ' ' H ' ' A' ' 7' ' ' PHE . . . -102.92 -17.65 15.4 Favored 'General case' 0 C--N 1.262 -3.225 3 N-CA-C 138.529 10.196 . . . . 0.0 138.529 141.952 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.419 ' O ' ' N ' ' A' ' 10' ' ' ILE . . . -44.47 -49.47 2.23 Favored 'Isoleucine or valine' 0 C--O 1.184 -2.359 0 CA-C-N 109.757 -3.383 . . . . 0.0 105.485 124.157 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.492 ' CA ' ' O ' ' A' ' 3' ' ' THR . . . -63.83 -61.4 2.32 Favored 'General case' 1 CA--C 1.385 -5.401 0 O-C-N 126.679 2.487 . . . . 0.0 114.646 -140.324 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -92.46 27.34 2.3 Favored 'General case' 0 N--CA 1.398 -3.059 1 CA-C-N 106.955 -4.657 . . . . 0.0 120.449 158.857 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.413 ' O ' ' HG2' ' A' ' 13' ' ' PRO . . . -100.58 7.78 43.83 Favored 'General case' 0 CA--C 1.461 -2.466 1 N-CA-C 142.619 11.711 . . . . 0.0 142.619 120.52 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.419 ' N ' ' O ' ' A' ' 6' ' ' ILE . . . -67.79 -54.2 24.76 Favored 'Isoleucine or valine' 0 C--N 1.249 -3.802 2 CA-C-N 105.276 -5.42 . . . . 0.0 114.938 165.182 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.443 ' C ' ' H ' ' A' ' 14' ' ' GLY . . . -120.49 -26.37 5.38 Favored 'General case' 1 CA--C 1.397 -4.92 3 CA-C-N 96.754 -9.294 . . . . 0.0 130.205 -148.317 . . . . . . . . 4 3 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -90.65 -25.69 0.29 Allowed Pre-proline 1 N--CA 1.372 -4.374 2 CA-C-N 103.572 -6.195 . . . . 0.0 107.069 159.805 . . . . . . . . 3 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.413 ' HG2' ' O ' ' A' ' 9' ' ' SER . 0.1 OUTLIER -39.57 -15.72 0.04 OUTLIER 'Trans proline' 0 N--CA 1.533 3.837 3 O-C-N 104.571 -8.699 . . . . 0.0 128.305 125.829 . . . . . . . . 4 4 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.443 ' H ' ' C ' ' A' ' 11' ' ' LEU . . . -86.17 9.29 70.34 Favored Glycine 1 N--CA 1.539 5.521 1 CA-C-N 105.17 -5.468 . . . . 0.0 122.646 159.701 . . . . . . . . 4 3 . 1 . 012 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . . . -115.98 -83.98 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.795 3 CA-C-N 105.051 -5.575 . . . . 0.0 112.117 -167.54 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -28.99 -26.01 0.0 OUTLIER 'General case' 0 C--N 1.248 -3.819 1 CA-C-N 107.735 -4.302 . . . . 0.0 120.974 148.333 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -70.12 -58.75 3.44 Favored 'General case' 0 C--N 1.326 -0.451 1 N-CA-C 133.463 8.32 . . . . 0.0 133.463 143.485 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -35.24 -55.85 0.62 Allowed 'General case' 0 CA--C 1.586 2.364 0 N-CA-C 116.186 1.921 . . . . 0.0 116.186 159.064 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . . . -68.23 -56.98 6.75 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 113.113 -1.858 . . . . 0.0 111.714 -168.183 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -44.09 -38.61 3.73 Favored 'General case' 0 CA--C 1.585 2.308 0 N-CA-C 117.348 2.351 . . . . 0.0 117.348 162.723 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . . . -95.88 1.04 52.76 Favored 'General case' 0 N--CA 1.513 2.695 1 N-CA-C 125.494 5.368 . . . . 0.0 125.494 178.434 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . . . -100.19 3.73 43.91 Favored 'General case' 1 N--CA 1.557 4.896 2 N-CA-C 125.845 5.498 . . . . 0.0 125.845 155.902 . . . . . . . . 3 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . . . -87.33 -56.04 3.54 Favored 'General case' 1 C--N 1.214 -5.308 1 CA-C-N 103.929 -6.032 . . . . 0.0 119.363 -174.215 . . . . . . . . 3 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . . . -23.79 -46.21 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.268 -2.947 2 N-CA-C 132.484 7.957 . . . . 0.0 132.484 123.017 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . . . -78.72 -8.78 59.05 Favored 'General case' 0 C--N 1.28 -2.444 0 N-CA-C 121.358 3.836 . . . . 0.0 121.358 164.365 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . . . -94.05 -46.08 7.29 Favored 'General case' 1 N--CA 1.549 4.488 0 CA-C-N 108.924 -3.762 . . . . 0.0 118.981 -157.403 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . . . -46.36 -74.1 0.04 OUTLIER 'General case' 0 C--N 1.287 -2.141 1 CA-C-N 106.516 -4.856 . . . . 0.0 117.027 135.425 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -77.7 -58.89 3.02 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-O 124.778 2.227 . . . . 0.0 111.775 -169.09 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.297 -1.717 0 CA-C-N 112.109 -2.314 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.273 0 N-CA-C 118.167 2.027 . . . . 0.0 118.167 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . . . -136.02 16.6 0.0 OUTLIER 'Trans proline' 0 CA--C 1.586 3.108 0 N-CA-C 121.739 3.707 . . . . 0.0 121.739 169.524 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.619 ' C ' ' H ' ' A' ' 5' ' ' ARG . . . -51.84 -93.84 0.0 OUTLIER 'General case' 0 C--O 1.167 -3.253 2 CA-C-O 102.211 -8.519 . . . . 0.0 107.867 97.175 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -46.56 2.0 0.0 OUTLIER 'General case' 0 N--CA 1.528 3.457 2 CA-C-N 127.276 4.58 . . . . 0.0 118.656 -146.454 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.619 ' H ' ' C ' ' A' ' 3' ' ' THR . . . -103.62 -41.51 5.93 Favored 'General case' 0 N--CA 1.5 2.072 3 N-CA-C 134.597 8.74 . . . . 0.0 134.597 167.316 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.504 ' O ' ' N ' ' A' ' 10' ' ' ILE . . . -33.24 -52.14 0.11 Allowed 'Isoleucine or valine' 1 CA--C 1.419 -4.065 1 CA-C-O 111.609 -4.043 . . . . 0.0 103.557 123.228 . . . . . . . . 4 3 . 1 . 013 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.536 ' H ' ' N ' ' A' ' 5' ' ' ARG . . . -90.94 -52.06 5.04 Favored 'General case' 1 N--CA 1.334 -6.259 1 CA-C-O 130.8 5.095 . . . . 0.0 109.806 -122.366 . . . . . . . . 4 3 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -35.07 -37.15 0.06 Allowed 'General case' 2 C--N 1.215 -5.267 1 N-CA-C 123.502 4.63 . . . . 0.0 123.502 136.888 . . . . . . . . 3 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.64 ' O ' ' HD2' ' A' ' 13' ' ' PRO . . . -90.09 16.23 8.78 Favored 'General case' 0 CA--C 1.423 -3.915 2 N-CA-C 124.994 5.183 . . . . 0.0 124.994 157.33 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.504 ' N ' ' O ' ' A' ' 6' ' ' ILE . . . -79.82 -24.15 11.99 Favored 'Isoleucine or valine' 0 CA--C 1.602 2.962 0 CA-C-O 127.433 3.492 . . . . 0.0 112.881 160.42 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.461 ' CA ' ' H ' ' A' ' 14' ' ' GLY . . . -117.32 -28.31 6.18 Favored 'General case' 1 CA--C 1.383 -5.452 3 N-CA-C 126.288 5.662 . . . . 0.0 126.288 -160.645 . . . . . . . . 4 3 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -71.57 -18.67 0.39 Allowed Pre-proline 0 C--N 1.247 -3.868 2 O-C-N 134.504 7.378 . . . . 0.0 119.404 147.7 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.64 ' HD2' ' O ' ' A' ' 9' ' ' SER . 0.1 OUTLIER -63.31 -21.51 71.76 Favored 'Trans proline' 0 C--N 1.298 -2.09 2 N-CA-C 127.64 5.977 . . . . 0.0 127.64 130.297 . . . . . . . . 4 4 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.461 ' H ' ' CA ' ' A' ' 11' ' ' LEU . . . -74.75 -3.23 66.87 Favored Glycine 2 N--CA 1.534 5.224 0 CA-C-N 108.969 -3.741 . . . . 0.0 121.372 157.833 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.406 ' C ' ' N ' ' A' ' 17' ' ' ALA . . . -113.79 -65.57 1.52 Allowed 'Isoleucine or valine' 0 CA--C 1.475 -1.907 2 C-N-CA 133.768 4.827 . . . . 0.0 112.221 -168.982 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -27.45 -33.27 0.0 OUTLIER 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 119.855 3.28 . . . . 0.0 119.855 148.201 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.406 ' N ' ' C ' ' A' ' 15' ' ' VAL . . . -90.49 -41.28 11.51 Favored 'General case' 0 CA--C 1.516 -0.364 2 CA-C-N 107.284 -4.507 . . . . 0.0 122.523 173.528 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -38.81 -62.31 0.63 Allowed 'General case' 0 CA--C 1.59 2.517 0 CA-C-O 123.015 1.388 . . . . 0.0 114.539 148.099 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . . . -77.43 -59.04 2.94 Favored 'General case' 0 CA--C 1.556 1.196 0 CA-C-O 124.443 2.068 . . . . 0.0 109.119 -143.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -41.39 -44.6 2.86 Favored 'General case' 0 CA--C 1.57 1.741 0 CA-C-N 111.5 -2.591 . . . . 0.0 115.931 160.479 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . . . -95.9 8.41 43.68 Favored 'General case' 0 N--CA 1.507 2.403 0 N-CA-C 118.794 2.887 . . . . 0.0 118.794 -174.481 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . . . -100.77 -28.21 12.94 Favored 'General case' 1 N--CA 1.551 4.603 1 N-CA-C 124.103 4.853 . . . . 0.0 124.103 160.275 . . . . . . . . 3 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . . . -39.36 -64.51 0.46 Allowed 'General case' 1 C--N 1.241 -4.138 1 CA-C-N 105.8 -5.182 . . . . 0.0 116.842 162.418 . . . . . . . . 3 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . . . -24.62 -50.92 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.252 -3.634 2 CA-C-N 104.509 -5.769 . . . . 0.0 124.642 139.987 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . . . -91.29 -0.22 57.63 Favored 'General case' 0 N--CA 1.505 2.317 0 N-CA-C 119.484 3.142 . . . . 0.0 119.484 170.863 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . . . -92.79 -37.19 12.46 Favored 'General case' 1 N--CA 1.553 4.699 0 CA-C-O 126.324 2.964 . . . . 0.0 117.33 -168.87 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . . . -93.47 -41.61 9.7 Favored 'General case' 0 N--CA 1.512 2.648 2 CA-C-N 107.295 -4.502 . . . . 0.0 111.146 171.791 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -76.56 18.9 0.29 Allowed 'General case' 0 N--CA 1.494 1.738 0 C-N-CA 117.624 -1.63 . . . . 0.0 114.253 139.761 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.318 -0.764 0 O-C-N 119.307 -2.121 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.556 2.611 0 N-CA-C 115.661 1.024 . . . . 0.0 115.661 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . . . -139.71 18.57 0.0 OUTLIER 'Trans proline' 0 C--N 1.384 2.398 2 N-CA-C 128.678 6.376 . . . . 0.0 128.678 -149.566 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.711 ' C ' ' H ' ' A' ' 5' ' ' ARG . . . -57.34 -61.86 2.18 Favored 'General case' 0 C--O 1.199 -1.6 1 CA-C-O 109.257 -5.163 . . . . 0.0 109.085 103.863 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -54.89 8.94 0.0 OUTLIER 'General case' 0 CA--C 1.62 3.659 0 CA-C-O 125.373 2.511 . . . . 0.0 116.461 -157.075 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.711 ' H ' ' C ' ' A' ' 3' ' ' THR . . . -101.34 -51.89 3.38 Favored 'General case' 0 N--CA 1.478 0.964 3 C-N-CA 139.347 7.059 . . . . 0.0 126.019 172.937 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.44 ' C ' ' H ' ' A' ' 9' ' ' SER . . . -38.79 -33.06 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.447 -2.999 0 CA-C-O 111.968 -3.872 . . . . 0.0 110.735 135.081 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.582 ' C ' ' H ' ' A' ' 10' ' ' ILE . . . -93.08 -41.96 9.67 Favored 'General case' 0 CA--C 1.435 -3.449 2 N-CA-C 131.122 7.453 . . . . 0.0 131.122 -156.165 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -34.68 -48.06 0.36 Allowed 'General case' 0 N--CA 1.394 -3.27 2 CA-C-N 96.899 -9.228 . . . . 0.0 107.649 127.597 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.44 ' H ' ' C ' ' A' ' 6' ' ' ILE . . . -89.56 -2.34 58.31 Favored 'General case' 0 CA--C 1.479 -1.779 0 N-CA-C 121.277 3.806 . . . . 0.0 121.277 157.749 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.582 ' H ' ' C ' ' A' ' 7' ' ' PHE . . . -67.1 -26.01 35.48 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.137 1 CA-C-O 128.737 4.113 . . . . 0.0 118.03 167.881 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.584 ' H ' ' HD2' ' A' ' 13' ' ' PRO . . . -113.29 -55.2 2.55 Favored 'General case' 0 CA--C 1.435 -3.477 2 CA-C-N 101.232 -7.258 . . . . 0.0 126.057 -127.886 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -94.3 -21.87 0.24 Allowed Pre-proline 0 N--CA 1.38 -3.941 2 O-C-N 137.692 9.37 . . . . 0.0 112.564 171.909 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.584 ' HD2' ' H ' ' A' ' 11' ' ' LEU . 27.7 Cg_exo -62.49 -25.64 75.93 Favored 'Trans proline' 0 N--CA 1.49 1.294 1 N-CA-C 127.106 5.772 . . . . 0.0 127.106 126.873 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -76.07 2.31 56.47 Favored Glycine 1 N--CA 1.522 4.373 3 O-C-N 130.403 4.814 . . . . 0.0 121.68 160.015 . . . . . . . . 3 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . . . -113.11 -69.36 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.973 1 CA-C-N 106.687 -4.757 . . . . 0.0 110.206 -177.03 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -27.06 -28.75 0.0 OUTLIER 'General case' 0 C--N 1.29 -2.017 0 N-CA-C 120.044 3.35 . . . . 0.0 120.044 148.847 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -69.9 -56.99 5.59 Favored 'General case' 0 CA--C 1.549 0.924 1 N-CA-C 121.913 4.042 . . . . 0.0 121.913 160.162 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -36.69 -60.7 0.58 Allowed 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 115.747 1.758 . . . . 0.0 115.747 155.319 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . . . -77.69 -58.32 3.33 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-O 121.929 0.871 . . . . 0.0 110.072 -150.197 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -43.77 -31.67 0.87 Allowed 'General case' 0 CA--C 1.581 2.164 0 N-CA-C 116.448 2.018 . . . . 0.0 116.448 164.756 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . . . -90.14 -20.44 23.11 Favored 'General case' 0 CA--C 1.569 1.684 0 N-CA-C 116.53 2.048 . . . . 0.0 116.53 -178.51 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . . . -102.25 -13.58 17.33 Favored 'General case' 1 N--CA 1.574 5.725 1 N-CA-C 124.829 5.122 . . . . 0.0 124.829 170.391 . . . . . . . . 3 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . . . -30.29 -60.76 0.17 Allowed 'General case' 1 C--N 1.225 -4.814 1 CA-C-N 107.639 -4.346 . . . . 0.0 120.498 134.244 . . . . . . . . 3 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . . . -90.05 -18.77 7.54 Favored 'Isoleucine or valine' 1 C--N 1.241 -4.13 0 CA-C-N 110.022 -3.263 . . . . 0.0 114.743 -159.554 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . . . -66.47 -18.51 65.4 Favored 'General case' 0 C--N 1.307 -1.242 1 N-CA-C 123.855 4.761 . . . . 0.0 123.855 148.821 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . . . -90.49 -62.87 1.36 Allowed 'General case' 0 N--CA 1.522 3.144 0 CA-C-N 114.229 -1.351 . . . . 0.0 109.37 -163.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . . . -48.66 -47.7 40.37 Favored 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 128.489 2.716 . . . . 0.0 116.293 157.028 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.02 -48.81 72.56 Favored 'General case' 0 N--CA 1.5 2.039 0 CA-C-O 124.324 2.011 . . . . 0.0 110.832 160.262 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.303 -1.434 0 CA-C-N 112.699 -2.046 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.617 ' C ' ' H ' ' A' ' 3' ' ' THR . . . . . . . . 0 N--CA 1.486 1.999 0 N-CA-C 111.493 -0.643 . . . . 0.0 111.493 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . . . -68.75 40.33 0.25 Allowed 'Trans proline' 0 N--CA 1.535 3.949 2 CA-C-O 131.453 4.689 . . . . 0.0 123.548 170.968 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.617 ' H ' ' C ' ' A' ' 1' ' ' GLY . . . -92.95 -52.04 4.78 Favored 'General case' 1 C--N 1.24 -4.183 2 CA-C-N 98.415 -8.539 . . . . 0.0 117.122 148.804 . . . . . . . . 4 3 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.407 ' N ' ' O ' ' A' ' 1' ' ' GLY . . . -38.67 -15.38 0.01 OUTLIER 'General case' 0 N--CA 1.527 3.405 3 O-C-N 112.667 -6.271 . . . . 0.0 120.093 163.797 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.692 ' N ' ' H ' ' A' ' 7' ' ' PHE . . . -101.76 -59.32 1.72 Allowed 'General case' 0 C--N 1.273 -2.751 3 CA-C-N 99.951 -7.841 . . . . 0.0 128.086 -174.68 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.748 ' C ' ' H ' ' A' ' 9' ' ' SER . . . -42.71 -36.88 0.75 Allowed 'Isoleucine or valine' 0 C--O 1.206 -1.208 1 O-C-N 129.513 4.258 . . . . 0.0 107.652 125.055 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.692 ' H ' ' N ' ' A' ' 5' ' ' ARG . . . -93.78 -1.81 54.5 Favored 'General case' 2 CA--C 1.392 -5.114 1 N-CA-C 135.918 9.229 . . . . 0.0 135.918 -171.063 . . . . . . . . 4 3 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.88 -39.21 93.65 Favored 'General case' 1 CA--C 1.389 -5.215 3 CA-C-N 94.437 -10.347 . . . . 0.0 132.684 117.779 . . . . . . . . 3 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.748 ' H ' ' C ' ' A' ' 6' ' ' ILE . . . -105.98 12.02 30.99 Favored 'General case' 0 C--N 1.253 -3.619 1 N-CA-C 125.501 5.371 . . . . 0.0 125.501 178.925 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . . . -95.03 -30.97 4.15 Favored 'Isoleucine or valine' 0 C--N 1.259 -3.35 1 CA-C-N 106.958 -4.656 . . . . 0.0 105.878 166.392 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . . . -86.65 -62.55 1.48 Allowed 'General case' 1 CA--C 1.408 -4.506 1 C-N-CA 136.424 5.89 . . . . 0.0 121.075 -158.928 . . . . . . . . 3 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -72.66 -21.65 0.48 Allowed Pre-proline 0 N--CA 1.391 -3.384 2 CA-C-N 102.198 -6.819 . . . . 0.0 113.134 167.404 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.502 ' HG2' ' O ' ' A' ' 9' ' ' SER . 0.1 OUTLIER -68.95 -20.39 38.76 Favored 'Trans proline' 0 CA--C 1.499 -1.258 1 N-CA-C 127.724 6.009 . . . . 0.0 127.724 139.567 . . . . . . . . 4 4 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -72.46 -4.39 60.61 Favored Glycine 0 N--CA 1.512 3.702 0 O-C-N 128.766 3.791 . . . . 0.0 118.368 157.066 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . . . -119.15 -56.72 3.53 Favored 'Isoleucine or valine' 0 CA--C 1.475 -1.926 0 CA-C-N 110.353 -2.924 . . . . 0.0 115.048 -161.648 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -26.91 -42.7 0.02 OUTLIER 'General case' 0 C--N 1.292 -1.905 1 CA-C-N 108.261 -4.063 . . . . 0.0 117.163 141.422 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.87 -73.02 0.16 Allowed 'General case' 0 CA--C 1.557 1.218 0 CA-C-N 108.461 -3.972 . . . . 0.0 118.179 172.508 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -38.69 -66.71 0.25 Allowed 'General case' 0 CA--C 1.583 2.217 0 N-CA-C 116.93 2.196 . . . . 0.0 116.93 164.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . . . -60.88 -59.98 4.52 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 128.435 2.694 . . . . 0.0 111.63 -161.281 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.33 -42.99 92.34 Favored 'General case' 0 CA--C 1.569 1.692 0 C-N-CA 126.587 1.955 . . . . 0.0 115.991 -175.63 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . . . -92.35 6.38 47.11 Favored 'General case' 0 N--CA 1.517 2.888 0 O-C-N 119.272 -2.143 . . . . 0.0 116.148 -179.284 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . . . -104.52 -30.78 9.81 Favored 'General case' 1 N--CA 1.542 4.151 1 N-CA-C 125.044 5.202 . . . . 0.0 125.044 174.517 . . . . . . . . 3 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . . . -34.9 -71.86 0.06 Allowed 'General case' 0 C--N 1.261 -3.275 2 CA-C-N 103.022 -6.444 . . . . 0.0 117.921 147.522 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . . . -25.98 -45.57 0.01 OUTLIER 'Isoleucine or valine' 1 C--N 1.234 -4.43 2 N-CA-C 124.303 4.927 . . . . 0.0 124.303 143.522 . . . . . . . . 3 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . . . -92.6 -0.76 57.27 Favored 'General case' 0 N--CA 1.505 2.315 0 N-CA-C 119.219 3.044 . . . . 0.0 119.219 170.745 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . . . -92.39 -36.22 13.26 Favored 'General case' 1 N--CA 1.55 4.551 0 CA-C-O 126.069 2.842 . . . . 0.0 117.12 -170.853 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . . . -94.36 -41.98 9.13 Favored 'General case' 0 N--CA 1.512 2.67 2 CA-C-N 107.796 -4.275 . . . . 0.0 111.014 173.377 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -77.2 19.76 0.31 Allowed 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 117.849 -1.54 . . . . 0.0 114.235 139.634 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.317 -0.821 0 O-C-N 119.333 -2.104 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.55 ' C ' ' H ' ' A' ' 4' ' ' ALA . . . . . . . . 0 CA--C 1.558 2.719 0 CA-C-O 126.904 3.502 . . . . 0.0 120.382 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . . . -105.33 -33.97 0.02 OUTLIER 'Trans proline' 0 CA--C 1.472 -2.616 1 O-C-N 113.105 -4.208 . . . . 0.0 121.355 -135.427 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.531 ' CA ' ' H ' ' A' ' 5' ' ' ARG . . . -96.23 55.45 1.52 Allowed 'General case' 0 C--O 1.183 -2.41 0 N-CA-C 119.781 3.252 . . . . 0.0 119.781 114.64 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.55 ' H ' ' C ' ' A' ' 1' ' ' GLY . . . -68.17 -9.09 44.16 Favored 'General case' 0 N--CA 1.53 3.572 1 O-C-N 113.866 -5.521 . . . . 0.0 120.458 111.513 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.588 ' N ' ' H ' ' A' ' 7' ' ' PHE . . . -105.3 -58.43 1.9 Allowed 'General case' 0 C--N 1.299 -1.596 1 CA-C-N 107.977 -4.192 . . . . 0.0 119.937 -153.422 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.501 ' O ' ' N ' ' A' ' 10' ' ' ILE . . . -39.51 -40.25 0.41 Allowed 'Isoleucine or valine' 0 C--O 1.162 -3.522 1 CA-C-O 108.079 -5.724 . . . . 0.0 111.681 127.458 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.591 ' C ' ' H ' ' A' ' 10' ' ' ILE . . . -61.57 -53.13 60.42 Favored 'General case' 1 C--O 1.15 -4.147 1 CA-C-N 127.436 4.653 . . . . 0.0 119.397 -169.478 . . . . . . . . 4 3 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -38.94 -53.86 1.7 Allowed 'General case' 1 N--CA 1.379 -4.005 4 C-N-CA 146.633 9.973 . . . . 0.0 99.128 155.279 . . . . . . . . 3 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.441 ' O ' ' HG2' ' A' ' 13' ' ' PRO . . . -85.58 2.86 43.24 Favored 'General case' 0 N--CA 1.494 1.735 1 N-CA-C 125.675 5.435 . . . . 0.0 125.675 160.758 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.591 ' H ' ' C ' ' A' ' 7' ' ' PHE . . . -80.67 -47.89 20.15 Favored 'Isoleucine or valine' 0 CA--C 1.584 2.275 0 CA-C-O 126.072 2.844 . . . . 0.0 106.286 172.899 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.438 ' C ' ' H ' ' A' ' 14' ' ' GLY . . . -114.02 -23.83 9.35 Favored 'General case' 0 CA--C 1.439 -3.32 2 CA-C-N 106.794 -4.73 . . . . 0.0 123.581 -147.959 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -95.21 -7.78 0.12 Allowed Pre-proline 1 N--CA 1.374 -4.257 2 CA-C-N 104.327 -5.852 . . . . 0.0 110.882 160.967 . . . . . . . . 3 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.441 ' HG2' ' O ' ' A' ' 9' ' ' SER . 0.3 OUTLIER -77.39 -10.91 17.48 Favored 'Trans proline' 0 CA--C 1.475 -2.431 2 N-CA-C 124.44 4.746 . . . . 0.0 124.44 131.464 . . . . . . . . 4 4 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.438 ' H ' ' C ' ' A' ' 11' ' ' LEU . . . -87.45 9.4 73.51 Favored Glycine 1 N--CA 1.523 4.442 2 O-C-N 132.149 5.906 . . . . 0.0 121.477 163.57 . . . . . . . . 4 3 . 1 . 016 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . . . -115.31 -78.29 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.405 -2.678 2 CA-C-N 105.273 -5.464 . . . . 0.0 111.086 -175.967 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -28.26 -29.83 0.0 OUTLIER 'General case' 0 C--N 1.246 -3.899 0 CA-C-N 110.996 -2.82 . . . . 0.0 118.25 152.203 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -58.29 -71.7 0.11 Allowed 'General case' 0 CA--C 1.533 0.29 1 N-CA-C 123.617 4.673 . . . . 0.0 123.617 148.773 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -33.36 -60.45 0.35 Allowed 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 115.393 1.627 . . . . 0.0 115.393 165.118 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . . . -63.49 -45.36 91.09 Favored 'General case' 0 CA--C 1.545 0.783 0 CA-C-N 114.346 -1.297 . . . . 0.0 112.134 -161.622 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -84.99 -12.14 53.9 Favored 'General case' 0 N--CA 1.418 -2.044 0 C-N-CA 127.75 2.42 . . . . 0.0 115.526 -173.774 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . . . -90.15 -22.01 21.94 Favored 'General case' 0 N--CA 1.509 2.492 0 N-CA-C 118.891 2.923 . . . . 0.0 118.891 165.112 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . . . -93.34 -27.61 16.68 Favored 'General case' 1 N--CA 1.564 5.226 1 N-CA-C 126.433 5.716 . . . . 0.0 126.433 178.039 . . . . . . . . 3 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . . . -27.34 -81.97 0.01 OUTLIER 'General case' 1 CA--C 1.417 -4.146 2 CA-C-N 102.919 -6.491 . . . . 0.0 113.152 123.75 . . . . . . . . 3 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . . . -78.09 -12.67 13.76 Favored 'Isoleucine or valine' 0 C--N 1.257 -3.451 1 C-N-CA 110.571 -4.452 . . . . 0.0 116.904 -139.761 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . . . -91.31 -1.62 57.6 Favored 'General case' 0 C--N 1.306 -1.301 2 N-CA-C 126.896 5.887 . . . . 0.0 126.896 159.032 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . . . -88.71 -57.99 2.71 Favored 'General case' 1 N--CA 1.539 4.023 0 CA-C-O 125.416 2.531 . . . . 0.0 115.98 178.073 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . . . -71.03 -52.49 19.24 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-N 108.843 -3.799 . . . . 0.0 115.043 165.597 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -81.29 22.74 0.65 Allowed 'General case' 0 N--CA 1.512 2.631 0 C-N-CA 116.069 -2.252 . . . . 0.0 112.623 148.367 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.315 -0.927 0 O-C-N 119.818 -1.801 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.563 3.069 0 N-CA-C 104.42 -3.472 . . . . 0.0 104.42 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . . . -113.49 11.43 0.05 OUTLIER 'Trans proline' 0 N--CA 1.508 2.36 0 C-N-CA 124.597 3.531 . . . . 0.0 118.922 168.721 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.74 ' C ' ' H ' ' A' ' 5' ' ' ARG . . . -49.71 -86.53 0.0 OUTLIER 'General case' 0 C--O 1.165 -3.381 2 CA-C-O 105.639 -6.886 . . . . 0.0 108.243 110.126 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -41.52 -5.57 0.0 OUTLIER 'General case' 0 N--CA 1.535 3.782 0 CA-C-N 124.19 3.177 . . . . 0.0 118.954 -154.971 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.74 ' H ' ' C ' ' A' ' 3' ' ' THR . . . -102.43 -54.27 2.71 Favored 'General case' 0 C--N 1.291 -1.936 4 C-N-CA 138.666 6.786 . . . . 0.0 123.523 -170.061 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.516 ' O ' ' N ' ' A' ' 10' ' ' ILE . . . -48.84 -50.92 13.2 Favored 'Isoleucine or valine' 1 C--O 1.135 -4.946 2 CA-C-N 106.808 -4.724 . . . . 0.0 106.907 137.706 . . . . . . . . 4 3 . 1 . 017 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.458 ' C ' ' H ' ' A' ' 10' ' ' ILE . . . -59.3 -55.23 37.49 Favored 'General case' 2 CA--C 1.365 -6.17 1 CA-C-O 140.191 9.567 . . . . 0.0 114.696 -163.484 . . . . . . . . 4 3 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -34.49 -43.31 0.16 Allowed 'General case' 0 N--CA 1.393 -3.298 1 CA-C-N 100.335 -7.666 . . . . 0.0 109.505 158.044 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.478 ' O ' ' HD2' ' A' ' 13' ' ' PRO . . . -88.67 -9.23 52.8 Favored 'General case' 0 CA--C 1.46 -2.502 1 N-CA-C 133.361 8.282 . . . . 0.0 133.361 152.485 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.516 ' N ' ' O ' ' A' ' 6' ' ' ILE . . . -66.47 -52.64 44.21 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.84 0 CA-C-O 126.613 3.102 . . . . 0.0 108.378 168.867 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.471 ' C ' ' H ' ' A' ' 14' ' ' GLY . . . -119.31 -25.24 6.15 Favored 'General case' 1 CA--C 1.397 -4.937 1 CA-C-N 102.956 -6.475 . . . . 0.0 120.799 -146.002 . . . . . . . . 4 3 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -100.04 16.61 0.05 OUTLIER Pre-proline 0 C--N 1.265 -3.079 1 O-C-N 130.809 5.068 . . . . 0.0 120.142 155.897 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.478 ' HD2' ' O ' ' A' ' 9' ' ' SER . 0.1 OUTLIER -67.3 -25.33 42.61 Favored 'Trans proline' 0 N--CA 1.509 2.406 2 N-CA-C 131.243 7.363 . . . . 0.0 131.243 105.925 . . . . . . . . 4 4 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.471 ' H ' ' C ' ' A' ' 11' ' ' LEU . . . -74.96 -0.83 61.17 Favored Glycine 3 N--CA 1.552 6.378 1 CA-C-O 129.011 4.673 . . . . 0.0 121.746 167.319 . . . . . . . . 4 3 . 1 . 017 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . . . -112.86 -67.18 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.29 -1.994 2 CA-C-N 104.462 -5.869 . . . . 0.0 116.517 -179.892 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -26.44 -37.03 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 119.251 3.056 . . . . 0.0 119.251 153.612 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -56.12 -79.13 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.804 1 CA-C-N 105.978 -5.101 . . . . 0.0 120.726 157.625 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -37.19 -49.49 0.91 Allowed 'General case' 0 CA--C 1.582 2.185 0 N-CA-C 117.637 2.458 . . . . 0.0 117.637 167.365 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . . . -47.81 -71.96 0.06 Allowed 'General case' 0 CA--C 1.564 1.505 0 C-N-CA 129.345 3.058 . . . . 0.0 112.942 -179.167 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -51.63 -25.53 7.22 Favored 'General case' 0 CA--C 1.571 1.783 0 CA-C-N 108.541 -3.936 . . . . 0.0 116.401 173.287 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . . . -90.78 -29.92 17.32 Favored 'General case' 0 CA--C 1.564 1.484 0 CA-C-O 115.414 -2.232 . . . . 0.0 115.696 -179.349 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . . . -100.79 -10.7 20.52 Favored 'General case' 1 N--CA 1.581 6.088 1 N-CA-C 124.797 5.11 . . . . 0.0 124.797 174.698 . . . . . . . . 3 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . . . -30.54 -67.85 0.09 Allowed 'General case' 1 C--N 1.233 -4.471 1 CA-C-N 105.582 -5.281 . . . . 0.0 118.822 125.603 . . . . . . . . 3 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . . . -88.0 7.45 2.99 Favored 'Isoleucine or valine' 1 C--N 1.238 -4.282 0 C-N-CA 113.775 -3.17 . . . . 0.0 117.929 -157.261 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . . . -87.18 -32.4 19.85 Favored 'General case' 0 C--N 1.303 -1.431 3 C-N-CA 134.484 5.114 . . . . 0.0 124.008 161.44 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . . . -87.65 -34.07 18.59 Favored 'General case' 0 N--CA 1.534 3.737 1 CA-C-N 106.87 -4.695 . . . . 0.0 116.553 -172.457 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . . . -95.97 -38.79 10.08 Favored 'General case' 0 N--CA 1.511 2.613 2 C-N-CA 131.994 4.118 . . . . 0.0 110.008 173.174 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -77.35 16.6 0.59 Allowed 'General case' 0 N--CA 1.499 1.989 0 C-N-CA 116.909 -1.917 . . . . 0.0 114.287 139.915 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.315 -0.895 0 O-C-N 119.096 -2.253 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.546 1.997 0 N-CA-C 116.648 1.419 . . . . 0.0 116.648 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . . . -113.96 -20.76 0.02 OUTLIER 'Trans proline' 0 N--CA 1.522 3.203 1 N-CA-C 122.776 4.106 . . . . 0.0 122.776 -150.217 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . . . -32.51 -49.63 0.22 Allowed 'General case' 0 C--N 1.252 -3.657 2 CA-C-N 100.52 -7.582 . . . . 0.0 121.231 126.93 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.482 ' C ' ' H ' ' A' ' 7' ' ' PHE . . . -92.47 -29.42 16.25 Favored 'General case' 0 N--CA 1.5 2.045 2 C-N-CA 132.834 4.454 . . . . 0.0 114.851 -163.259 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.656 ' N ' ' H ' ' A' ' 7' ' ' PHE . . . -103.11 -39.16 6.99 Favored 'General case' 0 C--N 1.293 -1.868 3 C-N-CA 139.836 7.254 . . . . 0.0 128.237 171.739 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . . . -39.89 -58.49 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.426 -3.819 2 CA-C-N 107.144 -4.571 . . . . 0.0 103.878 125.587 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.656 ' H ' ' N ' ' A' ' 5' ' ' ARG . . . -46.2 -41.29 12.55 Favored 'General case' 0 N--CA 1.492 1.672 2 N-CA-C 125.387 5.328 . . . . 0.0 125.387 -144.035 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -90.85 -40.38 11.79 Favored 'General case' 1 N--CA 1.372 -4.359 3 C-N-CA 150.495 11.518 . . . . 0.0 110.151 -162.129 . . . . . . . . 3 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.482 ' O ' ' HD2' ' A' ' 13' ' ' PRO . . . -70.95 -14.09 62.24 Favored 'General case' 0 CA--C 1.458 -2.559 1 N-CA-C 128.96 6.652 . . . . 0.0 128.96 140.43 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . . . -74.02 -23.52 18.84 Favored 'Isoleucine or valine' 0 C--N 1.253 -3.591 1 CA-C-O 129.335 4.397 . . . . 0.0 117.52 169.982 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . . . -110.92 -55.61 2.47 Favored 'General case' 1 CA--C 1.407 -4.524 1 CA-C-N 102.425 -6.716 . . . . 0.0 119.462 -138.666 . . . . . . . . 3 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -76.78 -21.78 0.4 Allowed Pre-proline 0 C--N 1.254 -3.553 2 O-C-N 132.958 6.411 . . . . 0.0 115.823 163.159 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.482 ' HD2' ' O ' ' A' ' 9' ' ' SER . 1.4 Cg_exo -60.58 -17.87 51.27 Favored 'Trans proline' 0 CA--C 1.479 -2.271 1 N-CA-C 128.007 6.118 . . . . 0.0 128.007 131.667 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -59.69 -22.46 57.01 Favored Glycine 2 N--CA 1.535 5.273 0 CA-C-O 126.199 3.11 . . . . 0.0 119.255 154.203 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.414 ' N ' ' H ' ' A' ' 17' ' ' ALA . . . -119.54 -49.26 3.54 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.617 1 CA-C-N 106.441 -4.88 . . . . 0.0 118.811 -144.165 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -28.72 -52.8 0.1 Allowed 'General case' 0 C--N 1.298 -1.673 2 CA-C-N 106.808 -4.724 . . . . 0.0 114.34 135.309 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.414 ' H ' ' N ' ' A' ' 15' ' ' VAL . . . -77.22 -52.42 9.27 Favored 'General case' 0 CA--C 1.56 1.334 1 CA-C-N 107.495 -4.412 . . . . 0.0 112.563 -157.895 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -36.72 -66.46 0.22 Allowed 'General case' 0 CA--C 1.585 2.307 0 CA-C-N 110.83 -2.895 . . . . 0.0 115.324 146.38 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . . . -46.91 -61.29 1.93 Allowed 'General case' 0 N--CA 1.514 2.727 0 CA-C-O 125.243 2.449 . . . . 0.0 113.777 -159.368 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -77.72 -14.75 59.52 Favored 'General case' 0 CA--C 1.567 1.598 0 C-N-CA 129.405 3.082 . . . . 0.0 116.244 -174.908 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . . . -92.27 -24.47 18.98 Favored 'General case' 0 N--CA 1.523 3.184 0 N-CA-C 117.942 2.571 . . . . 0.0 117.942 174.236 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . . . -96.01 -27.25 15.21 Favored 'General case' 1 N--CA 1.561 5.106 1 N-CA-C 126.158 5.614 . . . . 0.0 126.158 179.723 . . . . . . . . 3 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . . . -27.89 -80.32 0.01 OUTLIER 'General case' 0 CA--C 1.423 -3.941 2 CA-C-N 103.064 -6.425 . . . . 0.0 113.338 123.459 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . . . -79.66 -12.35 13.11 Favored 'Isoleucine or valine' 0 C--N 1.254 -3.554 1 C-N-CA 110.693 -4.403 . . . . 0.0 116.552 -139.287 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . . . -91.42 1.52 57.06 Favored 'General case' 0 C--N 1.308 -1.219 2 N-CA-C 127.287 6.032 . . . . 0.0 127.287 157.186 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . . . -89.71 -62.17 1.53 Allowed 'General case' 0 N--CA 1.538 3.926 0 CA-C-O 125.323 2.487 . . . . 0.0 115.752 176.877 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . . . -57.26 -61.48 2.44 Favored 'General case' 0 N--CA 1.494 1.768 0 CA-C-N 109.257 -3.61 . . . . 0.0 115.705 157.78 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -79.99 22.28 0.52 Allowed 'General case' 0 N--CA 1.517 2.883 0 C-N-CA 115.388 -2.525 . . . . 0.0 112.322 155.918 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.317 -0.829 0 O-C-N 119.928 -1.732 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.556 2.656 0 CA-C-O 123.613 1.674 . . . . 0.0 117.061 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . . . -95.27 -40.31 0.02 OUTLIER 'Trans proline' 0 N--CA 1.503 2.058 1 O-C-N 112.802 -4.368 . . . . 0.0 121.396 -126.991 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . . . -102.42 46.92 0.91 Allowed 'General case' 0 C--N 1.28 -2.429 1 N-CA-C 122.097 4.11 . . . . 0.0 122.097 127.058 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -70.54 -8.45 51.49 Favored 'General case' 0 N--CA 1.536 3.859 1 N-CA-C 122.196 4.147 . . . . 0.0 122.196 130.071 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.679 ' N ' ' H ' ' A' ' 7' ' ' PHE . . . -111.29 -55.1 2.54 Favored 'General case' 0 C--N 1.286 -2.18 2 CA-C-N 105.272 -5.422 . . . . 0.0 117.621 -140.062 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.502 ' C ' ' H ' ' A' ' 9' ' ' SER . . . -37.12 -38.19 0.15 Allowed 'Isoleucine or valine' 2 CA--C 1.364 -6.179 1 CA-C-N 106.264 -4.971 . . . . 0.0 112.735 126.729 . . . . . . . . 4 3 . 1 . 019 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.679 ' H ' ' N ' ' A' ' 5' ' ' ARG . . . -67.6 -60.35 2.62 Favored 'General case' 0 CA--C 1.423 -3.907 1 CA-C-O 137.041 8.067 . . . . 0.0 111.338 -173.343 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -36.26 -43.61 0.37 Allowed 'General case' 0 N--CA 1.407 -2.579 2 CA-C-N 100.51 -7.586 . . . . 0.0 105.36 159.694 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.51 ' C ' ' HD2' ' A' ' 13' ' ' PRO . . . -106.49 1.7 25.68 Favored 'General case' 0 CA--C 1.464 -2.345 1 N-CA-C 130.056 7.058 . . . . 0.0 130.056 176.356 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.426 ' N ' ' O ' ' A' ' 6' ' ' ILE . . . -91.93 -46.12 14.33 Favored 'Isoleucine or valine' 0 CA--C 1.621 3.695 2 N-CA-C 96.796 -5.261 . . . . 0.0 96.796 177.192 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.487 ' C ' ' H ' ' A' ' 14' ' ' GLY . . . -112.91 -27.59 8.04 Favored 'General case' 1 CA--C 1.402 -4.726 1 N-CA-C 122.222 4.156 . . . . 0.0 122.222 -152.415 . . . . . . . . 4 3 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -99.78 14.58 0.05 OUTLIER Pre-proline 0 C--N 1.256 -3.48 1 O-C-N 130.19 4.681 . . . . 0.0 120.791 154.273 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.51 ' HD2' ' C ' ' A' ' 9' ' ' SER . 0.0 OUTLIER -71.57 -22.13 24.84 Favored 'Trans proline' 0 N--CA 1.507 2.289 2 N-CA-C 130.215 6.967 . . . . 0.0 130.215 110.115 . . . . . . . . 4 4 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.487 ' H ' ' C ' ' A' ' 11' ' ' LEU . . . -82.32 2.28 85.2 Favored Glycine 2 N--CA 1.541 5.668 1 CA-C-O 127.849 4.027 . . . . 0.0 120.619 168.582 . . . . . . . . 4 3 . 1 . 019 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . . . -111.95 -64.3 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.71 2 CA-C-N 106.391 -4.905 . . . . 0.0 114.157 179.893 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -23.67 -42.32 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 111.56 -2.564 . . . . 0.0 117.612 152.519 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -56.8 -83.8 0.01 OUTLIER 'General case' 0 CA--C 1.556 1.201 1 CA-C-N 106.837 -4.71 . . . . 0.0 119.54 158.293 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -36.21 -60.8 0.54 Allowed 'General case' 0 CA--C 1.58 2.125 0 N-CA-C 118.615 2.82 . . . . 0.0 118.615 172.27 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . . . -52.65 -54.66 30.3 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 128.421 2.688 . . . . 0.0 112.824 -172.751 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.51 -53.06 61.32 Favored 'General case' 0 N--CA 1.399 -2.982 0 CA-C-N 112.693 -2.049 . . . . 0.0 111.602 173.117 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . . . -95.42 34.34 1.46 Allowed 'General case' 0 N--CA 1.518 2.96 0 N-CA-C 120.401 3.482 . . . . 0.0 120.401 175.337 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . . . -107.73 -5.71 17.23 Favored 'General case' 0 N--CA 1.533 3.714 0 N-CA-C 121.068 3.729 . . . . 0.0 121.068 141.444 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . . . -63.3 -55.02 28.13 Favored 'General case' 0 C--N 1.246 -3.897 0 N-CA-C 118.529 2.788 . . . . 0.0 118.529 -179.728 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . . . -28.18 -52.09 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.266 -3.063 4 CA-C-N 100.903 -7.408 . . . . 0.0 124.073 131.39 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . . . -92.29 7.52 42.39 Favored 'General case' 0 N--CA 1.519 2.98 0 N-CA-C 117.36 2.356 . . . . 0.0 117.36 171.478 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . . . -96.5 -60.97 1.5 Allowed 'General case' 0 N--CA 1.511 2.587 0 CA-C-N 109.317 -3.583 . . . . 0.0 110.699 179.077 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . . . -48.42 -38.61 20.14 Favored 'General case' 0 N--CA 1.503 2.209 0 C-N-CA 126.567 1.947 . . . . 0.0 115.937 162.942 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -76.54 -59.79 2.62 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-O 123.795 1.76 . . . . 0.0 110.639 160.491 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.299 -1.628 0 CA-C-N 114.127 -1.397 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.434 ' C ' ' H ' ' A' ' 4' ' ' ALA . . . . . . . . 0 CA--C 1.576 3.879 0 N-CA-C 119.964 2.746 . . . . 0.0 119.964 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . . . -97.9 -18.89 0.18 Allowed 'Trans proline' 0 CA--C 1.503 -1.053 0 N-CA-C 121.676 3.683 . . . . 0.0 121.676 -148.19 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.529 ' CA ' ' H ' ' A' ' 5' ' ' ARG . . . -99.94 55.38 0.93 Allowed 'General case' 0 C--O 1.188 -2.139 0 N-CA-C 119.545 3.165 . . . . 0.0 119.545 115.287 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.434 ' H ' ' C ' ' A' ' 1' ' ' GLY . . . -66.36 -5.25 10.07 Favored 'General case' 0 N--CA 1.528 3.433 1 O-C-N 113.554 -5.716 . . . . 0.0 120.271 113.843 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.529 ' H ' ' CA ' ' A' ' 3' ' ' THR . . . -106.72 -60.48 1.66 Allowed 'General case' 0 C--N 1.306 -1.298 1 O-C-N 129.72 4.388 . . . . 0.0 119.713 -147.419 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.434 ' O ' ' N ' ' A' ' 10' ' ' ILE . . . -38.1 -50.09 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.434 -3.51 1 CA-C-O 111.572 -4.061 . . . . 0.0 112.732 125.902 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . . . -48.03 -62.15 1.62 Allowed 'General case' 2 CA--C 1.387 -5.311 1 CA-C-O 132.597 5.951 . . . . 0.0 112.98 178.499 . . . . . . . . 3 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -37.77 -46.19 0.89 Allowed 'General case' 0 N--CA 1.4 -2.943 2 CA-C-N 102.314 -6.766 . . . . 0.0 106.153 168.044 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.574 ' O ' ' HG2' ' A' ' 13' ' ' PRO . . . -92.95 3.07 56.39 Favored 'General case' 0 CA--C 1.469 -2.158 1 N-CA-C 129.292 6.775 . . . . 0.0 129.292 166.522 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.434 ' N ' ' O ' ' A' ' 6' ' ' ILE . . . -93.78 -41.23 12.33 Favored 'Isoleucine or valine' 1 C--N 1.238 -4.275 0 N-CA-C 102.213 -3.254 . . . . 0.0 102.213 178.592 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.446 ' C ' ' H ' ' A' ' 14' ' ' GLY . . . -111.29 -28.6 8.17 Favored 'General case' 1 CA--C 1.421 -4.016 1 N-CA-C 122.245 4.165 . . . . 0.0 122.245 -153.249 . . . . . . . . 4 3 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -82.46 -24.12 0.36 Allowed Pre-proline 0 C--N 1.256 -3.494 2 O-C-N 131.63 5.581 . . . . 0.0 114.064 158.997 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.574 ' HG2' ' O ' ' A' ' 9' ' ' SER . 0.1 OUTLIER -56.21 -16.89 18.57 Favored 'Trans proline' 0 CA--C 1.476 -2.38 1 N-CA-C 128.107 6.156 . . . . 0.0 128.107 129.9 . . . . . . . . 4 4 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.446 ' H ' ' C ' ' A' ' 11' ' ' LEU . . . -59.3 -24.03 58.49 Favored Glycine 2 N--CA 1.536 5.35 0 CA-C-O 127.05 3.583 . . . . 0.0 121.727 155.391 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.41 ' N ' ' H ' ' A' ' 17' ' ' ALA . . . -120.03 -50.84 3.58 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.843 1 CA-C-N 104.187 -6.007 . . . . 0.0 118.236 -142.646 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -28.69 -52.45 0.1 Allowed 'General case' 0 CA--C 1.476 -1.879 2 CA-C-N 105.697 -5.228 . . . . 0.0 115.114 135.213 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.41 ' H ' ' N ' ' A' ' 15' ' ' VAL . . . -74.49 -59.78 2.58 Favored 'General case' 0 CA--C 1.553 1.09 1 CA-C-N 107.272 -4.513 . . . . 0.0 110.848 -161.571 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -35.16 -56.41 0.6 Allowed 'General case' 0 CA--C 1.574 1.872 0 CA-C-N 110.604 -2.998 . . . . 0.0 115.992 157.34 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . . . -43.37 -53.7 5.16 Favored 'General case' 0 N--CA 1.508 2.441 0 C-N-CA 128.18 2.592 . . . . 0.0 114.975 -167.573 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -80.51 -33.34 36.49 Favored 'General case' 0 N--CA 1.421 -1.905 0 C-N-CA 130.976 3.71 . . . . 0.0 114.439 -173.348 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . . . -90.31 -0.41 57.62 Favored 'General case' 0 N--CA 1.529 3.514 0 N-CA-C 117.039 2.237 . . . . 0.0 117.039 170.963 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . . . -88.87 -35.87 16.3 Favored 'General case' 1 N--CA 1.555 4.794 1 N-CA-C 123.619 4.674 . . . . 0.0 123.619 167.607 . . . . . . . . 3 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . . . -37.75 -64.49 0.39 Allowed 'General case' 0 C--N 1.26 -3.309 2 CA-C-N 102.513 -6.676 . . . . 0.0 114.969 167.068 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . . . -25.09 -51.02 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.268 -2.957 2 CA-C-N 104.354 -5.839 . . . . 0.0 124.695 142.957 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . . . -92.26 -2.73 56.28 Favored 'General case' 0 C--N 1.274 -2.679 0 N-CA-C 119.831 3.271 . . . . 0.0 119.831 170.831 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . . . -87.84 -24.24 23.76 Favored 'General case' 0 CA--C 1.609 3.241 0 CA-C-N 110.581 -3.009 . . . . 0.0 113.821 179.818 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . . . -96.09 -53.41 3.66 Favored 'General case' 0 N--CA 1.501 2.12 1 C-N-CA 132.831 4.453 . . . . 0.0 110.986 -178.672 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.03 22.06 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.918 0 CA-C-N 111.757 -2.474 . . . . 0.0 115.442 139.469 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.319 -0.746 0 O-C-N 119.518 -1.988 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.528 ' N ' ' H ' ' A' ' 7' ' ' PHE . . . . . . . . 0 CA--C 1.476 -1.893 1 N-CA-C 130.934 7.383 . . . . 0.0 130.934 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.45 ' O ' ' N ' ' A' ' 9' ' ' SER . . . -51.24 -49.63 29.44 Favored 'Isoleucine or valine' 0 C--O 1.186 -2.288 1 N-CA-C 92.301 -6.926 . . . . 0.0 92.301 137.708 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.528 ' H ' ' N ' ' A' ' 5' ' ' ARG . . . -46.25 -47.45 18.08 Favored 'General case' 0 N--CA 1.487 1.399 3 CA-C-N 128.994 5.361 . . . . 0.0 124.951 -152.752 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -98.45 -35.03 10.4 Favored 'General case' 0 N--CA 1.409 -2.492 3 C-N-CA 154.948 13.299 . . . . 0.0 100.371 -165.413 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.46 ' O ' ' HG2' ' A' ' 13' ' ' PRO . . . -74.42 -13.4 60.71 Favored 'General case' 0 CA--C 1.462 -2.429 2 O-C-N 111.18 -7.2 . . . . 0.0 129.307 144.063 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . . . -62.44 -43.3 98.11 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.835 1 CA-C-O 129.498 4.475 . . . . 0.0 114.7 166.462 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . . . -106.83 -52.27 2.8 Favored 'General case' 1 CA--C 1.351 -6.698 4 CA-C-N 97.785 -8.825 . . . . 0.0 124.788 -140.778 . . . . . . . . 3 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -78.13 -20.12 0.33 Allowed Pre-proline 1 CA--C 1.649 4.775 2 CA-C-N 102.878 -6.51 . . . . 0.0 109.708 168.487 . . . . . . . . 3 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.46 ' HG2' ' O ' ' A' ' 9' ' ' SER . 0.1 OUTLIER -59.91 -29.42 89.4 Favored 'Trans proline' 0 CA--C 1.486 -1.91 2 O-C-N 106.516 -7.676 . . . . 0.0 127.416 134.868 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -70.89 -0.9 36.36 Favored Glycine 0 N--CA 1.506 3.329 2 O-C-N 132.617 6.198 . . . . 0.0 120.535 164.362 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.404 ' C ' ' N ' ' A' ' 17' ' ' ALA . . . -107.29 -73.83 0.59 Allowed 'Isoleucine or valine' 0 C--O 1.2 -1.549 2 CA-C-N 106.587 -4.806 . . . . 0.0 107.318 -165.3 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -28.52 -23.17 0.0 OUTLIER 'General case' 0 C--N 1.258 -3.379 0 CA-C-N 108.518 -3.946 . . . . 0.0 119.578 144.277 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.404 ' N ' ' C ' ' A' ' 15' ' ' VAL . . . -90.21 -33.38 16.21 Favored 'General case' 0 CA--C 1.549 0.907 1 N-CA-C 126.158 5.614 . . . . 0.0 126.158 156.858 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -41.73 -63.16 0.76 Allowed 'General case' 0 CA--C 1.576 1.967 0 CA-C-N 122.146 2.248 . . . . 0.0 115.071 145.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . . . -75.51 -56.3 4.83 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 113.759 -1.564 . . . . 0.0 109.649 -148.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -48.83 -44.45 39.38 Favored 'General case' 0 CA--C 1.577 1.987 0 N-CA-C 117.585 2.439 . . . . 0.0 117.585 163.281 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . . . -78.24 -13.65 59.77 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 117.33 -3.356 . . . . 0.0 117.773 -178.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . . . -96.5 -26.29 15.34 Favored 'General case' 0 N--CA 1.538 3.941 1 N-CA-C 126.129 5.603 . . . . 0.0 126.129 177.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . . . -37.81 -63.71 0.45 Allowed 'General case' 0 C--N 1.252 -3.638 2 CA-C-N 104.327 -5.851 . . . . 0.0 120.531 156.319 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . . . -39.32 -40.19 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.253 -3.615 4 O-C-N 134.218 7.199 . . . . 0.0 122.647 143.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . . . -94.92 3.57 54.81 Favored 'General case' 0 C--N 1.263 -3.171 0 N-CA-C 118.059 2.615 . . . . 0.0 118.059 167.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . . . -95.52 -60.45 1.66 Allowed 'General case' 0 N--CA 1.505 2.305 0 CA-C-N 109.546 -3.479 . . . . 0.0 111.178 177.366 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . . . -49.61 -41.69 42.78 Favored 'General case' 0 N--CA 1.501 2.097 0 C-N-CA 126.857 2.063 . . . . 0.0 115.503 163.346 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.505 2.311 0 CA-C-O 122.911 1.339 . . . . 0.0 112.398 159.688 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.583 ' CA ' ' H ' ' A' ' 7' ' ' PHE . . . . . . . . 0 N--CA 1.421 -1.91 1 N-CA-C 144.599 12.444 . . . . 0.0 144.599 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.46 ' O ' ' CA ' ' A' ' 9' ' ' SER . . . -37.65 -49.9 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.434 -3.511 0 CA-C-N 111.716 -2.493 . . . . 0.0 106.019 117.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.583 ' H ' ' CA ' ' A' ' 5' ' ' ARG . . . -59.17 -51.89 68.05 Favored 'General case' 2 CA--C 1.378 -5.645 0 N-CA-C 119.355 3.094 . . . . 0.0 119.355 -143.799 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -104.47 44.28 1.04 Allowed 'General case' 1 N--CA 1.375 -4.222 2 N-CA-C 122.193 4.146 . . . . 0.0 122.193 146.707 . . . . . . . . 3 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.587 ' O ' ' HD2' ' A' ' 13' ' ' PRO . . . -93.3 17.2 11.61 Favored 'General case' 1 C--N 1.24 -4.162 1 N-CA-C 140.757 11.021 . . . . 0.0 140.757 95.158 . . . . . . . . 4 3 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.428 ' C ' ' HB2' ' A' ' 13' ' ' PRO . . . -72.59 -33.89 46.2 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.802 2 CA-C-O 132.975 6.131 . . . . 0.0 125.162 156.453 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . . . -105.37 -32.34 8.62 Favored 'General case' 2 CA--C 1.368 -6.045 4 CA-C-N 93.656 -10.702 . . . . 0.0 131.033 -165.39 . . . . . . . . 3 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -89.1 -15.66 0.21 Allowed Pre-proline 0 CA--C 1.618 3.573 3 CA-C-N 101.894 -6.957 . . . . 0.0 114.273 161.515 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.587 ' HD2' ' O ' ' A' ' 9' ' ' SER . 0.0 OUTLIER -57.19 -24.09 57.12 Favored 'Trans proline' 0 C--N 1.291 -2.485 2 O-C-N 106.116 -7.886 . . . . 0.0 129.602 128.161 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -76.77 2.1 60.42 Favored Glycine 0 N--CA 1.514 3.876 2 CA-C-N 103.849 -6.068 . . . . 0.0 120.945 162.081 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . . . -106.95 -77.79 0.42 Allowed 'Isoleucine or valine' 0 C--O 1.196 -1.713 2 CA-C-N 106.443 -4.879 . . . . 0.0 110.493 -169.6 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -28.77 -23.9 0.0 OUTLIER 'General case' 0 C--N 1.253 -3.588 1 CA-C-N 107.388 -4.46 . . . . 0.0 121.326 144.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -76.62 -46.2 26.94 Favored 'General case' 0 CA--C 1.553 1.09 1 N-CA-C 134.402 8.667 . . . . 0.0 134.402 146.557 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -37.64 -56.83 1.02 Allowed 'General case' 0 CA--C 1.573 1.846 0 N-CA-C 115.088 1.514 . . . . 0.0 115.088 147.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . . . -80.26 -63.41 1.42 Allowed 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.366 -0.833 . . . . 0.0 108.834 -148.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -46.93 -43.74 19.27 Favored 'General case' 0 CA--C 1.576 1.945 0 N-CA-C 117.292 2.331 . . . . 0.0 117.292 171.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . . . -94.73 -5.63 44.95 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 119.211 3.041 . . . . 0.0 119.211 -177.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . . . -85.01 -31.68 23.34 Favored 'General case' 1 N--CA 1.553 4.71 2 N-CA-C 127.488 6.107 . . . . 0.0 127.488 161.148 . . . . . . . . 3 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . . . -39.7 -60.4 0.99 Allowed 'General case' 1 C--N 1.219 -5.089 3 CA-C-N 100.176 -7.738 . . . . 0.0 124.601 164.121 . . . . . . . . 3 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . . . -31.92 -42.04 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.252 -3.657 2 CA-C-N 100.838 -7.437 . . . . 0.0 130.29 137.636 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . . . -93.78 -0.36 55.92 Favored 'General case' 0 C--N 1.275 -2.653 0 N-CA-C 121.535 3.902 . . . . 0.0 121.535 164.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . . . -87.33 -24.65 24.22 Favored 'General case' 0 CA--C 1.609 3.229 0 CA-C-N 109.041 -3.709 . . . . 0.0 114.416 173.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . . . -97.24 -57.74 2.19 Favored 'General case' 0 N--CA 1.505 2.321 1 C-N-CA 132.261 4.224 . . . . 0.0 111.061 -177.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.755 0 CA-C-N 112.0 -2.364 . . . . 0.0 116.154 139.498 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.464 -2.33 1 N-CA-C 136.754 9.539 . . . . 0.0 136.754 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.598 ' C ' ' H ' ' A' ' 8' ' ' ALA . . . -50.16 -55.24 6.12 Favored 'Isoleucine or valine' 0 CA--C 1.434 -3.493 0 CA-C-N 111.383 -2.644 . . . . 0.0 107.923 129.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.457 ' C ' ' H ' ' A' ' 10' ' ' ILE . . . -33.26 -42.55 0.09 Allowed 'General case' 1 C--N 1.231 -4.549 1 N-CA-C 131.661 7.652 . . . . 0.0 131.661 -162.509 . . . . . . . . 4 3 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.598 ' H ' ' C ' ' A' ' 6' ' ' ILE . . . -97.54 -49.81 4.74 Favored 'General case' 1 N--CA 1.32 -6.968 3 CA-C-N 89.772 -12.467 . . . . 0.0 113.709 -147.489 . . . . . . . . 4 3 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.504 ' C ' ' HD2' ' A' ' 13' ' ' PRO . . . -74.51 5.71 4.47 Favored 'General case' 0 C--N 1.375 1.682 2 N-CA-C 138.88 10.326 . . . . 0.0 138.88 129.766 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.457 ' H ' ' C ' ' A' ' 7' ' ' PHE . . . -66.9 -31.23 52.53 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.079 2 CA-C-O 133.719 6.485 . . . . 0.0 125.265 158.154 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.44 ' C ' ' H ' ' A' ' 14' ' ' GLY . . . -108.39 -61.52 1.58 Allowed 'General case' 2 CA--C 1.4 -4.824 4 CA-C-N 91.714 -11.584 . . . . 0.0 124.904 -141.411 . . . . . . . . 4 3 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -78.44 -9.1 0.13 Allowed Pre-proline 0 C--N 1.269 -2.928 2 CA-C-N 99.95 -7.841 . . . . 0.0 118.66 160.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.504 ' HD2' ' C ' ' A' ' 9' ' ' SER . 0.1 OUTLIER -68.35 -18.48 44.28 Favored 'Trans proline' 0 N--CA 1.502 1.978 2 N-CA-C 135.041 8.823 . . . . 0.0 135.041 123.639 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.44 ' H ' ' C ' ' A' ' 11' ' ' LEU . . . -70.07 -14.01 70.49 Favored Glycine 1 N--CA 1.53 4.964 2 CA-C-N 107.613 -4.358 . . . . 0.0 121.2 156.1 . . . . . . . . 4 3 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . . . -101.74 -70.33 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.457 -2.634 3 C-N-CA 136.666 5.986 . . . . 0.0 108.097 -175.185 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -71.88 -1.62 14.94 Favored 'General case' 1 C--N 1.237 -4.303 0 CA-C-N 109.03 -3.713 . . . . 0.0 111.506 -177.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -54.37 -82.87 0.01 OUTLIER 'General case' 0 C--N 1.359 0.983 1 N-CA-C 128.361 6.43 . . . . 0.0 128.361 125.43 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -32.52 -52.51 0.3 Allowed 'General case' 0 CA--C 1.582 2.197 0 N-CA-C 116.976 2.213 . . . . 0.0 116.976 170.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . . . -68.7 -55.98 9.62 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 113.004 -1.907 . . . . 0.0 113.08 -173.028 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -52.42 -39.46 61.01 Favored 'General case' 0 CA--C 1.586 2.353 0 N-CA-C 118.788 2.884 . . . . 0.0 118.788 171.164 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . . . -91.25 -5.55 54.6 Favored 'General case' 0 N--CA 1.516 2.869 0 N-CA-C 120.011 3.337 . . . . 0.0 120.011 178.138 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . . . -88.72 -30.18 19.28 Favored 'General case' 1 N--CA 1.543 4.177 2 N-CA-C 127.092 5.96 . . . . 0.0 127.092 164.607 . . . . . . . . 3 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . . . -37.79 -63.38 0.47 Allowed 'General case' 1 C--N 1.215 -5.257 2 CA-C-N 101.835 -6.984 . . . . 0.0 124.732 157.637 . . . . . . . . 3 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . . . -33.45 -48.4 0.11 Allowed 'Isoleucine or valine' 1 C--N 1.242 -4.076 2 N-CA-C 130.358 7.17 . . . . 0.0 130.358 139.494 . . . . . . . . 3 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . . . -77.87 -5.72 51.9 Favored 'General case' 0 C--N 1.276 -2.598 1 N-CA-C 123.031 4.456 . . . . 0.0 123.031 163.232 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . . . -92.82 -67.93 0.83 Allowed 'General case' 0 N--CA 1.527 3.413 0 CA-C-N 111.724 -2.489 . . . . 0.0 115.948 -161.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . . . -46.01 -53.87 9.36 Favored 'General case' 0 N--CA 1.497 1.875 1 CA-C-N 108.041 -4.163 . . . . 0.0 117.082 146.565 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.852 0 CA-C-N 122.106 2.23 . . . . 0.0 109.943 171.968 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.572 1.82 1 N-CA-C 128.182 6.364 . . . . 0.0 128.182 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.533 ' O ' ' N ' ' A' ' 10' ' ' ILE . . . -37.27 -34.62 0.11 Allowed 'Isoleucine or valine' 1 CA--C 1.395 -4.984 1 C-N-CA 136.545 5.938 . . . . 0.0 114.4 129.174 . . . . . . . . 4 3 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.551 ' C ' ' H ' ' A' ' 10' ' ' ILE . . . -78.24 -49.85 12.97 Favored 'General case' 2 CA--C 1.299 -8.696 2 CA-C-O 133.146 6.212 . . . . 0.0 119.297 171.886 . . . . . . . . 4 3 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -41.06 -26.09 0.04 OUTLIER 'General case' 1 N--CA 1.378 -4.063 2 N-CA-C 129.633 6.901 . . . . 0.0 129.633 139.706 . . . . . . . . 3 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.475 ' O ' ' HD2' ' A' ' 13' ' ' PRO . . . -90.7 -19.62 23.38 Favored 'General case' 1 CA--C 1.418 -4.12 3 N-CA-C 141.226 11.195 . . . . 0.0 141.226 140.419 . . . . . . . . 4 3 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.551 ' H ' ' C ' ' A' ' 7' ' ' PHE . . . -66.64 -58.72 5.47 Favored 'Isoleucine or valine' 0 CA--C 1.608 3.187 2 CA-C-N 104.286 -5.87 . . . . 0.0 108.281 -167.957 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.462 ' C ' ' H ' ' A' ' 14' ' ' GLY . . . -106.19 -24.89 12.21 Favored 'General case' 1 CA--C 1.36 -6.35 4 CA-C-N 93.5 -10.773 . . . . 0.0 128.026 -165.109 . . . . . . . . 4 3 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -78.09 -19.25 0.3 Allowed Pre-proline 0 C--N 1.258 -3.407 1 O-C-N 129.573 4.295 . . . . 0.0 117.281 160.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.475 ' HD2' ' O ' ' A' ' 9' ' ' SER . 0.0 OUTLIER -50.3 -26.17 15.12 Favored 'Trans proline' 0 C--N 1.313 -1.296 1 N-CA-C 136.691 9.458 . . . . 0.0 136.691 125.212 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.462 ' H ' ' C ' ' A' ' 11' ' ' LEU . . . -74.2 -7.27 76.95 Favored Glycine 1 N--CA 1.531 5.002 3 O-C-N 130.378 4.799 . . . . 0.0 122.703 156.252 . . . . . . . . 4 3 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . . . -110.49 -57.88 3.88 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.761 2 CA-C-N 105.29 -5.455 . . . . 0.0 117.884 -168.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -28.05 -40.29 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.638 0 CA-C-N 108.506 -3.952 . . . . 0.0 117.217 139.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -73.69 -41.16 63.0 Favored 'General case' 0 N--CA 1.426 -1.66 1 CA-C-N 107.609 -4.359 . . . . 0.0 121.061 -173.573 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -37.28 -58.66 0.81 Allowed 'General case' 0 CA--C 1.574 1.868 0 CA-C-N 112.012 -2.358 . . . . 0.0 117.198 143.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . . . -77.04 -51.86 10.34 Favored 'General case' 0 N--CA 1.487 1.382 0 CA-C-O 126.625 3.107 . . . . 0.0 113.365 -147.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -43.91 -41.63 5.32 Favored 'General case' 0 CA--C 1.584 2.253 0 CA-C-N 109.348 -3.569 . . . . 0.0 117.591 157.371 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . . . -91.42 -2.46 57.27 Favored 'General case' 0 N--CA 1.501 2.078 1 N-CA-C 122.744 4.35 . . . . 0.0 122.744 174.77 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . . . -97.91 -3.74 37.92 Favored 'General case' 1 N--CA 1.548 4.462 1 N-CA-C 126.259 5.651 . . . . 0.0 126.259 164.032 . . . . . . . . 3 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . . . -90.48 -42.86 10.62 Favored 'General case' 1 C--N 1.232 -4.517 4 CA-C-N 102.845 -6.525 . . . . 0.0 126.962 -173.478 . . . . . . . . 3 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . . . -28.04 -88.52 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.291 -1.965 2 CA-C-N 98.062 -8.699 . . . . 0.0 119.904 110.107 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . . . -75.04 15.53 0.4 Allowed 'General case' 0 N--CA 1.534 3.73 2 O-C-N 113.994 -5.441 . . . . 0.0 120.54 -171.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . . . -93.0 -61.01 1.66 Allowed 'General case' 0 N--CA 1.502 2.162 1 CA-C-N 106.498 -4.865 . . . . 0.0 114.876 167.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . . . -48.06 -43.25 30.28 Favored 'General case' 0 N--CA 1.511 2.586 0 N-CA-C 117.002 2.223 . . . . 0.0 117.002 166.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.781 0 CA-C-N 111.889 -2.414 . . . . 0.0 113.06 157.993 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.478 ' N ' ' H ' ' A' ' 7' ' ' PHE . . . . . . . . 0 CA--C 1.499 -0.991 1 N-CA-C 124.356 4.947 . . . . 0.0 124.356 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.536 ' O ' ' N ' ' A' ' 10' ' ' ILE . . . -38.6 -45.09 0.4 Allowed 'Isoleucine or valine' 0 C--O 1.157 -3.786 2 CA-C-N 105.654 -5.248 . . . . 0.0 111.54 126.65 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.478 ' H ' ' N ' ' A' ' 5' ' ' ARG . . . -61.41 -60.55 3.55 Favored 'General case' 2 C--O 1.143 -4.543 2 CA-C-O 140.983 9.944 . . . . 0.0 113.306 -172.65 . . . . . . . . 4 3 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -36.81 -36.74 0.12 Allowed 'General case' 1 C--N 1.22 -5.031 2 CA-C-N 102.177 -6.829 . . . . 0.0 105.558 157.141 . . . . . . . . 3 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.528 ' C ' ' HD2' ' A' ' 13' ' ' PRO . . . -90.74 -12.67 35.88 Favored 'General case' 0 CA--C 1.431 -3.632 1 N-CA-C 134.001 8.519 . . . . 0.0 134.001 151.023 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.536 ' N ' ' O ' ' A' ' 6' ' ' ILE . . . -67.61 -57.47 9.48 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.317 0 CA-C-O 127.603 3.573 . . . . 0.0 109.122 174.529 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.573 ' C ' ' H ' ' A' ' 14' ' ' GLY . . . -112.69 -27.92 7.99 Favored 'General case' 1 CA--C 1.384 -5.421 1 CA-C-N 99.256 -8.156 . . . . 0.0 121.566 -156.162 . . . . . . . . 4 3 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -101.48 19.66 0.05 OUTLIER Pre-proline 0 C--N 1.266 -3.026 0 C-N-CA 113.203 -3.399 . . . . 0.0 118.735 159.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.528 ' HD2' ' C ' ' A' ' 9' ' ' SER . 0.0 OUTLIER -53.05 -31.29 53.22 Favored 'Trans proline' 0 N--CA 1.523 3.221 2 N-CA-C 132.654 7.905 . . . . 0.0 132.654 99.487 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.573 ' H ' ' C ' ' A' ' 11' ' ' LEU . . . -59.65 -25.71 61.45 Favored Glycine 3 N--CA 1.552 6.405 1 CA-C-O 129.219 4.788 . . . . 0.0 122.444 167.453 . . . . . . . . 4 3 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . . . -107.11 -69.86 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.28 -2.444 2 CA-C-N 101.512 -7.344 . . . . 0.0 113.698 -163.217 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -27.0 -32.43 0.0 OUTLIER 'General case' 0 C--N 1.277 -2.568 0 N-CA-C 119.676 3.213 . . . . 0.0 119.676 153.515 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -85.1 -46.01 11.55 Favored 'General case' 0 C--N 1.328 -0.363 2 N-CA-C 123.334 4.568 . . . . 0.0 123.334 167.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -39.18 -57.74 1.28 Allowed 'General case' 0 N--CA 1.508 2.425 0 CA-C-O 123.249 1.499 . . . . 0.0 114.302 151.126 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . . . -81.99 -55.76 4.38 Favored 'General case' 0 CA--C 1.553 1.083 0 CA-C-O 123.32 1.533 . . . . 0.0 109.123 -140.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -48.62 -56.35 8.71 Favored 'General case' 0 CA--C 1.567 1.603 0 CA-C-N 112.728 -2.033 . . . . 0.0 115.128 162.009 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . . . -90.24 13.26 15.73 Favored 'General case' 0 N--CA 1.532 3.672 1 O-C-N 116.052 -4.155 . . . . 0.0 119.216 -178.568 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . . . -87.48 -32.72 19.31 Favored 'General case' 0 CA--C 1.427 -3.761 0 N-CA-C 121.464 3.876 . . . . 0.0 121.464 158.019 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . . . -43.52 -59.11 2.3 Favored 'General case' 0 C--N 1.253 -3.598 0 CA-C-N 108.665 -3.88 . . . . 0.0 114.804 174.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . . . -36.23 -46.14 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.26 -3.284 2 CA-C-N 102.379 -6.737 . . . . 0.0 125.261 148.161 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . . . -72.13 -14.47 61.84 Favored 'General case' 0 C--N 1.278 -2.502 1 N-CA-C 121.991 4.071 . . . . 0.0 121.991 162.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . . . -91.01 -61.56 1.64 Allowed 'General case' 0 N--CA 1.511 2.602 0 CA-C-N 110.681 -2.963 . . . . 0.0 108.375 -160.445 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . . . -49.91 -42.58 48.41 Favored 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 128.659 2.784 . . . . 0.0 118.238 157.232 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.503 2.208 0 CA-C-O 124.159 1.933 . . . . 0.0 110.227 161.257 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.49 -1.337 1 N-CA-C 125.905 5.521 . . . . 0.0 125.905 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.428 ' O ' ' N ' ' A' ' 9' ' ' SER . . . -45.95 -51.69 3.39 Favored 'Isoleucine or valine' 0 C--O 1.192 -1.932 0 O-C-N 128.948 3.905 . . . . 0.0 106.128 136.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.436 ' O ' ' N ' ' A' ' 10' ' ' ILE . . . -45.32 -64.44 0.72 Allowed 'General case' 3 N--CA 1.561 5.098 0 O-C-N 126.551 2.407 . . . . 0.0 113.063 -155.942 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -39.38 -47.62 1.79 Allowed 'General case' 1 N--CA 1.373 -4.319 4 C-N-CA 153.271 12.628 . . . . 0.0 100.027 166.512 . . . . . . . . 3 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.523 ' O ' ' HG2' ' A' ' 13' ' ' PRO . . . -91.75 19.2 6.67 Favored 'General case' 0 N--CA 1.513 2.676 1 N-CA-C 132.711 8.041 . . . . 0.0 132.711 153.15 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.436 ' N ' ' O ' ' A' ' 7' ' ' PHE . . . -109.29 -49.65 7.09 Favored 'Isoleucine or valine' 2 CA--C 1.644 4.576 2 N-CA-C 98.912 -4.477 . . . . 0.0 98.912 -177.547 . . . . . . . . 4 3 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.507 ' C ' ' H ' ' A' ' 14' ' ' GLY . . . -62.97 -52.78 61.66 Favored 'General case' 1 CA--C 1.361 -6.297 2 C-N-CA 138.429 6.692 . . . . 0.0 126.301 -177.71 . . . . . . . . 4 3 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -95.83 -15.52 0.2 Allowed Pre-proline 0 C--N 1.248 -3.844 2 O-C-N 135.102 7.751 . . . . 0.0 112.744 -177.212 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.523 ' HG2' ' O ' ' A' ' 9' ' ' SER . 0.1 OUTLIER -54.67 -24.55 37.8 Favored 'Trans proline' 0 N--CA 1.504 2.144 1 N-CA-C 128.56 6.331 . . . . 0.0 128.56 121.467 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.507 ' H ' ' C ' ' A' ' 11' ' ' LEU . . . -85.83 -0.3 87.63 Favored Glycine 2 N--CA 1.533 5.157 1 CA-C-N 108.127 -4.124 . . . . 0.0 121.814 164.465 . . . . . . . . 4 3 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . . . -103.89 -69.36 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.642 2 CA-C-N 106.409 -4.896 . . . . 0.0 114.335 175.523 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -24.03 -41.4 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.714 0 CA-C-N 110.865 -2.88 . . . . 0.0 117.994 156.02 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.44 -81.66 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.716 1 CA-C-N 106.073 -5.058 . . . . 0.0 121.287 158.512 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -36.33 -60.12 0.59 Allowed 'General case' 0 CA--C 1.581 2.168 0 N-CA-C 117.182 2.29 . . . . 0.0 117.182 171.235 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . . . -58.69 -57.38 13.25 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 128.874 2.87 . . . . 0.0 112.347 -168.166 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -71.7 -36.48 70.58 Favored 'General case' 0 CA--C 1.574 1.893 0 C-N-CA 127.689 2.396 . . . . 0.0 115.667 -176.185 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . . . -85.88 -0.86 56.48 Favored 'General case' 0 N--CA 1.506 2.374 0 N-CA-C 117.598 2.444 . . . . 0.0 117.598 173.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . . . -104.67 -26.87 12.13 Favored 'General case' 1 N--CA 1.554 4.743 1 N-CA-C 125.376 5.325 . . . . 0.0 125.376 176.427 . . . . . . . . 3 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . . . -35.0 -68.89 0.11 Allowed 'General case' 0 C--N 1.258 -3.37 1 CA-C-N 102.823 -6.535 . . . . 0.0 118.625 146.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . . . -34.28 -41.0 0.09 OUTLIER 'Isoleucine or valine' 1 C--N 1.236 -4.335 2 CA-C-N 105.484 -5.325 . . . . 0.0 122.642 148.921 . . . . . . . . 3 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . . . -94.71 2.47 55.56 Favored 'General case' 0 C--N 1.275 -2.646 0 N-CA-C 120.837 3.643 . . . . 0.0 120.837 170.524 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . . . -91.2 -25.11 19.69 Favored 'General case' 0 CA--C 1.608 3.185 0 CA-C-N 108.552 -3.931 . . . . 0.0 113.977 169.33 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . . . -96.85 -59.3 1.83 Allowed 'General case' 0 N--CA 1.507 2.419 0 C-N-CA 131.157 3.783 . . . . 0.0 110.163 -176.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 1.886 0 CA-C-N 112.195 -2.275 . . . . 0.0 114.233 141.677 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.503 ' N ' ' H ' ' A' ' 7' ' ' PHE . . . . . . . . 0 N--CA 1.432 -1.331 1 N-CA-C 123.219 4.526 . . . . 0.0 123.219 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.565 ' C ' ' H ' ' A' ' 9' ' ' SER . . . -39.28 -29.77 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.435 -3.457 1 CA-C-O 110.952 -4.356 . . . . 0.0 109.516 125.494 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.503 ' H ' ' N ' ' A' ' 5' ' ' ARG . . . -72.34 -56.85 4.8 Favored 'General case' 1 N--CA 1.558 4.939 2 CA-C-O 131.312 5.339 . . . . 0.0 115.367 -173.013 . . . . . . . . 4 3 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -37.44 -49.24 1.01 Allowed 'General case' 1 C--N 1.233 -4.497 3 C-N-CA 142.179 8.192 . . . . 0.0 100.704 150.732 . . . . . . . . 3 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.565 ' H ' ' C ' ' A' ' 6' ' ' ILE . . . -102.66 -6.46 22.69 Favored 'General case' 0 N--CA 1.52 3.065 1 N-CA-C 128.829 6.603 . . . . 0.0 128.829 174.957 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.474 ' C ' ' HB2' ' A' ' 13' ' ' PRO . . . -84.85 -47.54 17.08 Favored 'Isoleucine or valine' 1 C--N 1.231 -4.562 2 CA-C-N 106.894 -4.685 . . . . 0.0 98.392 -179.455 . . . . . . . . 4 3 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.555 ' C ' ' H ' ' A' ' 14' ' ' GLY . . . -106.13 -33.38 7.87 Favored 'General case' 1 CA--C 1.378 -5.64 1 N-CA-C 123.457 4.614 . . . . 0.0 123.457 -157.276 . . . . . . . . 4 3 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -76.41 -23.1 0.44 Allowed Pre-proline 0 C--N 1.246 -3.897 2 O-C-N 130.065 4.603 . . . . 0.0 113.343 166.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.529 ' HG2' ' O ' ' A' ' 9' ' ' SER . 0.0 OUTLIER -48.34 -27.45 9.9 Favored 'Trans proline' 0 CA--C 1.476 -2.416 1 N-CA-C 129.113 6.544 . . . . 0.0 129.113 127.895 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.555 ' H ' ' C ' ' A' ' 11' ' ' LEU . . . -64.93 -21.03 67.29 Favored Glycine 2 N--CA 1.544 5.855 1 CA-C-O 128.106 4.17 . . . . 0.0 122.742 160.041 . . . . . . . . 4 3 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . . . -108.45 -68.99 0.95 Allowed 'Isoleucine or valine' 0 CA--C 1.462 -2.427 2 CA-C-N 103.262 -6.469 . . . . 0.0 111.936 -159.667 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -26.37 -32.92 0.0 OUTLIER 'General case' 0 C--N 1.269 -2.921 0 N-CA-C 119.937 3.31 . . . . 0.0 119.937 148.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -88.75 -41.46 12.53 Favored 'General case' 0 N--CA 1.466 0.326 2 N-CA-C 123.7 4.704 . . . . 0.0 123.7 167.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -39.01 -59.15 1.02 Allowed 'General case' 0 N--CA 1.511 2.593 0 CA-C-O 123.796 1.76 . . . . 0.0 114.881 148.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . . . -77.3 -56.46 4.53 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 114.714 -1.13 . . . . 0.0 108.316 -143.117 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -42.44 -45.4 4.38 Favored 'General case' 0 CA--C 1.582 2.204 0 C-N-CA 126.52 1.928 . . . . 0.0 115.741 159.684 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . . . -92.57 1.77 57.07 Favored 'General case' 0 CA--C 1.578 2.054 0 N-CA-C 119.251 3.056 . . . . 0.0 119.251 -176.015 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . . . -106.54 -15.7 14.72 Favored 'General case' 1 N--CA 1.56 5.064 1 N-CA-C 124.075 4.843 . . . . 0.0 124.075 157.521 . . . . . . . . 3 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . . . -36.68 -69.67 0.11 Allowed 'General case' 1 C--N 1.233 -4.468 0 CA-C-N 108.794 -3.821 . . . . 0.0 118.61 157.36 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . . . -35.47 -43.65 0.15 Allowed 'Isoleucine or valine' 1 C--N 1.224 -4.879 2 CA-C-N 102.526 -6.67 . . . . 0.0 123.099 149.961 . . . . . . . . 3 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . . . -92.29 1.82 57.0 Favored 'General case' 0 C--N 1.292 -1.893 0 N-CA-C 118.398 2.74 . . . . 0.0 118.398 171.163 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . . . -90.91 -32.57 15.95 Favored 'General case' 0 CA--C 1.612 3.328 0 CA-C-N 110.71 -2.95 . . . . 0.0 113.632 175.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . . . -97.05 -48.91 5.21 Favored 'General case' 0 N--CA 1.509 2.482 1 C-N-CA 131.968 4.107 . . . . 0.0 110.818 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.499 1.985 0 C-N-CA 117.586 -1.646 . . . . 0.0 113.419 140.428 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.437 -1.123 1 N-CA-C 128.466 6.469 . . . . 0.0 128.466 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.649 ' C ' ' H ' ' A' ' 9' ' ' SER . . . -37.16 -60.3 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.512 2.631 3 N-CA-C 89.576 -7.935 . . . . 0.0 89.576 142.834 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . . . -103.34 -32.04 9.75 Favored 'General case' 1 N--CA 1.371 -4.405 1 CA-C-O 130.934 5.159 . . . . 0.0 111.664 -128.603 . . . . . . . . 3 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -45.88 -36.27 5.22 Favored 'General case' 0 CA--C 1.446 -3.053 1 O-C-N 116.054 -4.154 . . . . 0.0 121.197 126.757 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.649 ' H ' ' C ' ' A' ' 6' ' ' ILE . . . -90.7 10.6 25.2 Favored 'General case' 0 N--CA 1.524 3.258 1 N-CA-C 125.11 5.226 . . . . 0.0 125.11 176.094 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . . . -110.99 -42.39 4.74 Favored 'Isoleucine or valine' 1 CA--C 1.651 4.855 1 CA-C-N 106.817 -4.719 . . . . 0.0 102.094 -176.364 . . . . . . . . 3 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.541 ' C ' ' H ' ' A' ' 14' ' ' GLY . . . -54.71 -59.33 4.86 Favored 'General case' 1 CA--C 1.373 -5.852 1 C-N-CA 138.069 6.548 . . . . 0.0 120.91 170.374 . . . . . . . . 4 3 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -81.89 -41.18 1.01 Allowed Pre-proline 1 N--CA 1.362 -4.857 1 CA-C-N 105.47 -5.332 . . . . 0.0 102.968 -172.42 . . . . . . . . 3 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.535 ' HD2' ' C ' ' A' ' 9' ' ' SER . 0.1 OUTLIER -37.56 -22.4 0.05 OUTLIER 'Trans proline' 0 N--CA 1.518 2.927 2 O-C-N 108.919 -6.411 . . . . 0.0 127.829 134.853 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.541 ' H ' ' C ' ' A' ' 11' ' ' LEU . . . -80.33 -7.21 88.76 Favored Glycine 2 N--CA 1.529 4.851 1 CA-C-N 108.141 -4.118 . . . . 0.0 119.886 163.045 . . . . . . . . 4 3 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . . . -105.86 -76.53 0.46 Allowed 'Isoleucine or valine' 0 C--O 1.2 -1.521 2 C-N-CA 133.1 4.56 . . . . 0.0 110.89 -166.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -21.1 -34.71 0.0 OUTLIER 'General case' 0 C--N 1.26 -3.306 0 N-CA-C 120.367 3.469 . . . . 0.0 120.367 147.001 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -83.8 -45.29 13.46 Favored 'General case' 0 N--CA 1.476 0.827 1 N-CA-C 125.246 5.276 . . . . 0.0 125.246 160.531 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -36.4 -55.42 0.82 Allowed 'General case' 0 N--CA 1.517 2.878 0 CA-C-O 125.235 2.445 . . . . 0.0 116.276 154.461 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . . . -78.07 -50.25 12.42 Favored 'General case' 0 N--CA 1.48 1.047 0 CA-C-O 124.047 1.879 . . . . 0.0 111.327 -152.057 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -37.93 -48.98 1.21 Allowed 'General case' 0 N--CA 1.413 -2.29 0 C-N-CA 131.617 3.967 . . . . 0.0 120.836 149.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . . . -87.89 7.86 28.83 Favored 'General case' 0 N--CA 1.514 2.731 0 N-CA-C 119.901 3.297 . . . . 0.0 119.901 170.53 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . . . -104.08 -30.69 10.09 Favored 'General case' 0 N--CA 1.534 3.771 1 N-CA-C 124.429 4.974 . . . . 0.0 124.429 173.572 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . . . -37.82 -59.49 0.81 Allowed 'General case' 0 C--N 1.258 -3.404 2 CA-C-N 104.18 -5.918 . . . . 0.0 121.877 152.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . . . -36.13 -47.24 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.262 -3.205 3 O-C-N 134.567 7.417 . . . . 0.0 123.071 140.259 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . . . -91.89 4.81 52.09 Favored 'General case' 0 C--N 1.269 -2.902 0 O-C-N 119.128 -2.233 . . . . 0.0 116.437 170.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . . . -96.56 -60.0 1.7 Allowed 'General case' 0 N--CA 1.521 3.112 0 CA-C-N 110.475 -3.057 . . . . 0.0 113.572 -175.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . . . -47.16 -38.4 11.69 Favored 'General case' 0 N--CA 1.51 2.564 0 CA-C-N 109.06 -3.7 . . . . 0.0 115.053 158.175 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.489 0 CA-C-O 123.36 1.552 . . . . 0.0 108.411 164.202 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.635 1 N-CA-C 122.161 4.134 . . . . 0.0 122.161 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . . . -38.32 -55.09 0.35 Allowed 'Isoleucine or valine' 1 CA--C 1.418 -4.104 0 CA-C-N 108.428 -3.987 . . . . 0.0 111.262 131.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . . . -45.87 -63.27 1.01 Allowed 'General case' 3 CA--C 1.299 -8.704 0 O-C-N 127.406 2.941 . . . . 0.0 111.007 -175.001 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -35.63 -49.1 0.55 Allowed 'General case' 0 C--N 1.273 -2.733 2 C-N-CA 141.414 7.886 . . . . 0.0 104.361 167.591 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.47 ' O ' ' HG2' ' A' ' 13' ' ' PRO . . . -76.44 -13.43 60.11 Favored 'General case' 1 N--CA 1.539 4.024 2 N-CA-C 134.667 8.765 . . . . 0.0 134.667 169.0 . . . . . . . . 4 3 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . . . -103.84 -45.55 9.79 Favored 'Isoleucine or valine' 2 C--N 1.204 -5.731 2 CA-C-N 97.549 -8.932 . . . . 0.0 99.1 -161.293 . . . . . . . . 3 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.521 ' C ' ' H ' ' A' ' 14' ' ' GLY . . . -94.77 -56.6 2.72 Favored 'General case' 1 CA--C 1.397 -4.931 1 C-N-CA 135.144 5.378 . . . . 0.0 118.402 -148.135 . . . . . . . . 4 3 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -86.26 -12.89 0.19 Allowed Pre-proline 0 C--N 1.262 -3.199 2 O-C-N 135.848 8.217 . . . . 0.0 113.32 178.766 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.47 ' HG2' ' O ' ' A' ' 9' ' ' SER . 0.1 OUTLIER -56.08 -27.7 66.09 Favored 'Trans proline' 0 N--CA 1.52 3.053 2 N-CA-C 131.501 7.462 . . . . 0.0 131.501 118.579 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.521 ' H ' ' C ' ' A' ' 11' ' ' LEU . . . -77.97 -5.15 86.71 Favored Glycine 3 N--CA 1.562 7.051 2 CA-C-O 130.659 5.589 . . . . 0.0 123.301 164.845 . . . . . . . . 4 3 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . . . -105.61 -78.4 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.278 -2.514 2 C-N-CA 139.386 7.074 . . . . 0.0 117.819 179.616 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -29.6 -30.34 0.0 OUTLIER 'General case' 0 C--N 1.264 -3.139 0 N-CA-C 117.932 2.567 . . . . 0.0 117.932 152.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -53.19 -77.56 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.863 0 CA-C-N 109.21 -3.632 . . . . 0.0 120.627 150.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -33.68 -58.27 0.42 Allowed 'General case' 0 CA--C 1.571 1.788 0 N-CA-C 116.685 2.106 . . . . 0.0 116.685 169.425 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . . . -64.8 -41.37 95.85 Favored 'General case' 0 CA--C 1.552 1.04 0 CA-C-N 113.6 -1.636 . . . . 0.0 113.67 -164.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -83.43 -27.8 29.28 Favored 'General case' 0 CA--C 1.582 2.198 0 C-N-CA 129.142 2.977 . . . . 0.0 114.593 -178.317 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . . . -84.51 3.66 35.45 Favored 'General case' 0 N--CA 1.505 2.304 0 N-CA-C 120.034 3.346 . . . . 0.0 120.034 158.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . . . -103.39 -27.16 12.6 Favored 'General case' 1 N--CA 1.548 4.443 1 N-CA-C 124.534 5.012 . . . . 0.0 124.534 173.261 . . . . . . . . 3 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . . . -35.99 -67.41 0.16 Allowed 'General case' 0 C--N 1.257 -3.414 1 CA-C-N 103.779 -6.101 . . . . 0.0 119.048 149.065 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . . . -33.9 -41.86 0.09 OUTLIER 'Isoleucine or valine' 1 C--N 1.239 -4.219 2 CA-C-N 104.851 -5.613 . . . . 0.0 122.801 147.961 . . . . . . . . 3 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . . . -94.43 3.08 55.63 Favored 'General case' 0 C--N 1.274 -2.705 0 N-CA-C 120.838 3.644 . . . . 0.0 120.838 170.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . . . -90.97 -25.75 19.59 Favored 'General case' 0 CA--C 1.609 3.222 1 CA-C-N 108.381 -4.008 . . . . 0.0 113.831 169.34 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . . . -96.82 -59.11 1.87 Allowed 'General case' 0 N--CA 1.507 2.406 0 C-N-CA 131.266 3.826 . . . . 0.0 110.239 -176.264 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 1.929 0 CA-C-N 112.152 -2.295 . . . . 0.0 114.225 141.353 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.516 ' CA ' ' H ' ' A' ' 7' ' ' PHE . . . . . . . . 0 CA--C 1.481 -1.693 1 N-CA-C 141.871 11.434 . . . . 0.0 141.871 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.438 ' O ' ' N ' ' A' ' 10' ' ' ILE . . . -46.01 -43.32 4.73 Favored 'Isoleucine or valine' 0 CA--C 1.465 -2.289 0 O-C-N 128.886 3.866 . . . . 0.0 106.763 126.095 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.516 ' H ' ' CA ' ' A' ' 5' ' ' ARG . . . -67.08 -61.16 2.07 Favored 'General case' 0 N--CA 1.401 -2.919 1 CA-C-O 129.405 4.431 . . . . 0.0 118.194 -133.813 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -35.1 -27.18 0.01 OUTLIER 'General case' 2 C--N 1.195 -6.132 2 N-CA-C 136.562 9.467 . . . . 0.0 136.562 130.275 . . . . . . . . 3 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.477 ' O ' ' HD2' ' A' ' 13' ' ' PRO . . . -89.35 5.59 44.39 Favored 'General case' 0 C--N 1.255 -3.502 1 N-CA-C 135.188 8.958 . . . . 0.0 135.188 140.647 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.438 ' N ' ' O ' ' A' ' 6' ' ' ILE . . . -67.7 -43.29 86.71 Favored 'Isoleucine or valine' 0 C--N 1.255 -3.503 1 CA-C-O 129.246 4.355 . . . . 0.0 118.642 162.302 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . . . -116.82 -28.85 6.21 Favored 'General case' 1 CA--C 1.406 -4.584 3 CA-C-N 98.219 -8.628 . . . . 0.0 127.937 -149.486 . . . . . . . . 3 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -76.91 -23.93 0.45 Allowed Pre-proline 1 C--N 1.244 -4.003 3 O-C-N 135.077 7.736 . . . . 0.0 122.988 150.65 . . . . . . . . 3 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.477 ' HD2' ' O ' ' A' ' 9' ' ' SER . 0.1 OUTLIER -59.36 -22.76 67.14 Favored 'Trans proline' 0 C--N 1.31 -1.486 1 N-CA-C 130.72 7.162 . . . . 0.0 130.72 128.365 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -80.66 4.91 66.75 Favored Glycine 1 N--CA 1.518 4.118 2 CA-C-N 104.567 -5.742 . . . . 0.0 120.26 159.043 . . . . . . . . 3 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . . . -113.39 -67.72 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 C-N-CA 131.127 3.771 . . . . 0.0 113.058 -174.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -26.96 -34.96 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 108.917 -3.765 . . . . 0.0 119.506 145.139 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.83 -70.4 0.21 Allowed 'General case' 0 N--CA 1.441 -0.91 2 N-CA-C 126.167 5.618 . . . . 0.0 126.167 155.335 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -38.22 -54.76 1.37 Allowed 'General case' 0 CA--C 1.583 2.232 0 N-CA-C 118.187 2.662 . . . . 0.0 118.187 163.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . . . -39.46 -56.47 1.6 Allowed 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 129.731 3.213 . . . . 0.0 115.507 174.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -80.9 -27.28 36.32 Favored 'General case' 0 CA--C 1.567 1.598 0 CA-C-N 109.998 -3.274 . . . . 0.0 113.757 -178.228 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . . . -98.49 10.52 40.73 Favored 'General case' 0 N--CA 1.525 3.297 1 N-CA-C 130.874 7.361 . . . . 0.0 130.874 160.018 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . . . -95.12 -28.37 15.11 Favored 'General case' 0 N--CA 1.538 3.934 2 N-CA-C 125.718 5.451 . . . . 0.0 125.718 157.715 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . . . -30.84 -56.75 0.22 Allowed 'General case' 2 N--CA 1.366 -4.645 2 CA-C-N 103.517 -6.22 . . . . 0.0 119.53 138.208 . . . . . . . . 3 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . . . -94.35 -8.88 9.67 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.239 0 C-N-CA 113.901 -3.12 . . . . 0.0 117.924 -171.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . . . -71.02 -14.52 62.37 Favored 'General case' 0 C--N 1.307 -1.252 1 N-CA-C 127.46 6.096 . . . . 0.0 127.46 148.531 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . . . -92.6 -48.36 6.65 Favored 'General case' 1 N--CA 1.548 4.465 0 N-CA-C 118.845 2.906 . . . . 0.0 118.845 -162.219 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . . . -46.19 -72.98 0.04 OUTLIER 'General case' 0 C--N 1.288 -2.076 1 CA-C-N 106.22 -4.991 . . . . 0.0 117.266 138.536 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.712 0 CA-C-O 124.802 2.239 . . . . 0.0 111.548 -172.98 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . . . . . . . . 0 C--O 1.225 -0.22 1 N-CA-C 124.967 5.173 . . . . 0.0 124.967 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . . . -35.48 -61.11 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.425 -3.838 1 CA-C-N 106.682 -4.781 . . . . 0.0 114.599 113.43 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . . . -35.39 -41.01 0.17 Allowed 'General case' 3 CA--C 1.333 -7.403 2 N-CA-C 129.336 6.791 . . . . 0.0 129.336 -179.487 . . . . . . . . 3 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -57.03 -52.26 65.99 Favored 'General case' 1 N--CA 1.315 -7.192 4 O-C-N 145.693 14.37 . . . . 0.0 125.673 165.426 . . . . . . . . 3 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.447 ' O ' ' HG2' ' A' ' 13' ' ' PRO . . . -97.3 0.37 47.94 Favored 'General case' 0 N--CA 1.501 2.096 3 N-CA-C 132.805 8.076 . . . . 0.0 132.805 160.782 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . . . -62.61 -39.72 85.68 Favored 'Isoleucine or valine' 0 C--N 1.246 -3.91 2 CA-C-N 101.757 -7.019 . . . . 0.0 120.202 150.418 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.472 ' C ' ' H ' ' A' ' 14' ' ' GLY . . . -100.63 -52.58 3.3 Favored 'General case' 1 CA--C 1.416 -4.194 3 CA-C-N 99.029 -8.26 . . . . 0.0 125.736 -145.088 . . . . . . . . 4 3 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -81.29 -21.3 0.31 Allowed Pre-proline 0 N--CA 1.379 -3.99 2 O-C-N 136.935 8.897 . . . . 0.0 116.151 167.027 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.447 ' HG2' ' O ' ' A' ' 9' ' ' SER . 12.2 Cg_exo -52.53 -24.27 21.77 Favored 'Trans proline' 0 N--CA 1.51 2.474 2 N-CA-C 134.683 8.686 . . . . 0.0 134.683 118.13 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.472 ' H ' ' C ' ' A' ' 11' ' ' LEU . . . -78.41 -3.07 85.72 Favored Glycine 2 N--CA 1.543 5.793 2 CA-C-N 106.655 -4.793 . . . . 0.0 120.827 159.539 . . . . . . . . 4 3 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . . . -114.87 -77.81 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.467 -2.238 2 C-N-CA 134.852 5.261 . . . . 0.0 112.409 -169.513 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -29.29 -27.91 0.0 OUTLIER 'General case' 0 C--N 1.274 -2.71 0 N-CA-C 119.939 3.311 . . . . 0.0 119.939 150.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -57.76 -69.02 0.19 Allowed 'General case' 0 CA--C 1.549 0.923 1 N-CA-C 130.425 7.195 . . . . 0.0 130.425 145.697 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -35.54 -54.69 0.68 Allowed 'General case' 0 CA--C 1.578 2.03 0 N-CA-C 116.955 2.205 . . . . 0.0 116.955 159.648 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . . . -77.3 -55.15 5.66 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 113.653 -1.612 . . . . 0.0 111.555 -155.519 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -39.82 -41.9 1.21 Allowed 'General case' 0 CA--C 1.586 2.349 0 N-CA-C 117.522 2.415 . . . . 0.0 117.522 157.083 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . . . -95.22 14.17 23.09 Favored 'General case' 0 N--CA 1.502 2.165 1 N-CA-C 123.86 4.763 . . . . 0.0 123.86 175.031 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.416 ' C ' ' H ' ' A' ' 25' ' ' GLU . . . -101.87 -6.68 23.25 Favored 'General case' 1 N--CA 1.555 4.78 1 N-CA-C 127.42 6.082 . . . . 0.0 127.42 151.009 . . . . . . . . 4 3 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . . . -81.13 -48.2 12.45 Favored 'General case' 1 C--N 1.221 -4.988 2 CA-C-N 102.955 -6.475 . . . . 0.0 123.262 -173.019 . . . . . . . . 3 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . . . -23.71 -52.74 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.283 -2.32 3 N-CA-C 131.404 7.557 . . . . 0.0 131.404 115.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.416 ' H ' ' C ' ' A' ' 22' ' ' ARG . . . -90.66 8.81 32.46 Favored 'General case' 0 N--CA 1.521 3.097 0 O-C-N 118.12 -2.863 . . . . 0.0 117.085 169.769 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . . . -96.25 -61.8 1.38 Allowed 'General case' 0 N--CA 1.518 2.928 0 CA-C-N 108.768 -3.833 . . . . 0.0 116.215 -175.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . . . -46.34 -46.16 18.06 Favored 'General case' 0 N--CA 1.494 1.76 1 CA-C-N 108.006 -4.179 . . . . 0.0 115.431 156.547 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.258 0 CA-C-O 123.871 1.796 . . . . 0.0 108.788 166.792 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.484 ' N ' ' H ' ' A' ' 7' ' ' PHE . . . . . . . . 0 N--CA 1.439 -0.978 1 N-CA-C 138.529 10.196 . . . . 0.0 138.529 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.419 ' O ' ' N ' ' A' ' 10' ' ' ILE . . . -44.47 -49.47 2.23 Favored 'Isoleucine or valine' 0 C--O 1.184 -2.359 0 CA-C-N 109.757 -3.383 . . . . 0.0 105.485 124.157 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.484 ' H ' ' N ' ' A' ' 5' ' ' ARG . . . -63.83 -61.4 2.32 Favored 'General case' 1 CA--C 1.385 -5.401 0 O-C-N 126.679 2.487 . . . . 0.0 114.646 -140.324 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -92.46 27.34 2.3 Favored 'General case' 0 N--CA 1.398 -3.059 1 CA-C-N 106.955 -4.657 . . . . 0.0 120.449 158.857 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.413 ' O ' ' HG2' ' A' ' 13' ' ' PRO . . . -100.58 7.78 43.83 Favored 'General case' 0 CA--C 1.461 -2.466 1 N-CA-C 142.619 11.711 . . . . 0.0 142.619 120.52 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.419 ' N ' ' O ' ' A' ' 6' ' ' ILE . . . -67.79 -54.2 24.76 Favored 'Isoleucine or valine' 0 C--N 1.249 -3.802 2 CA-C-N 105.276 -5.42 . . . . 0.0 114.938 165.182 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.443 ' C ' ' H ' ' A' ' 14' ' ' GLY . . . -120.49 -26.37 5.38 Favored 'General case' 1 CA--C 1.397 -4.92 3 CA-C-N 96.754 -9.294 . . . . 0.0 130.205 -148.317 . . . . . . . . 4 3 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -90.65 -25.69 0.29 Allowed Pre-proline 1 N--CA 1.372 -4.374 2 CA-C-N 103.572 -6.195 . . . . 0.0 107.069 159.805 . . . . . . . . 3 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.413 ' HG2' ' O ' ' A' ' 9' ' ' SER . 0.1 OUTLIER -39.57 -15.72 0.04 OUTLIER 'Trans proline' 0 N--CA 1.533 3.837 3 O-C-N 104.571 -8.699 . . . . 0.0 128.305 125.829 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.443 ' H ' ' C ' ' A' ' 11' ' ' LEU . . . -86.17 9.29 70.34 Favored Glycine 1 N--CA 1.539 5.521 1 CA-C-N 105.17 -5.468 . . . . 0.0 122.646 159.701 . . . . . . . . 4 3 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . . . -115.98 -83.98 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.795 3 CA-C-N 105.051 -5.575 . . . . 0.0 112.117 -167.54 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -28.99 -26.01 0.0 OUTLIER 'General case' 0 C--N 1.248 -3.819 1 CA-C-N 107.735 -4.302 . . . . 0.0 120.974 148.333 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -70.12 -58.75 3.44 Favored 'General case' 0 C--N 1.326 -0.451 1 N-CA-C 133.463 8.32 . . . . 0.0 133.463 143.485 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -35.24 -55.85 0.62 Allowed 'General case' 0 CA--C 1.586 2.364 0 N-CA-C 116.186 1.921 . . . . 0.0 116.186 159.064 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . . . -68.23 -56.98 6.75 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 113.113 -1.858 . . . . 0.0 111.714 -168.183 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -44.09 -38.61 3.73 Favored 'General case' 0 CA--C 1.585 2.308 0 N-CA-C 117.348 2.351 . . . . 0.0 117.348 162.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . . . -95.88 1.04 52.76 Favored 'General case' 0 N--CA 1.513 2.695 1 N-CA-C 125.494 5.368 . . . . 0.0 125.494 178.434 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . . . -100.19 3.73 43.91 Favored 'General case' 1 N--CA 1.557 4.896 2 N-CA-C 125.845 5.498 . . . . 0.0 125.845 155.902 . . . . . . . . 3 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . . . -87.33 -56.04 3.54 Favored 'General case' 1 C--N 1.214 -5.308 1 CA-C-N 103.929 -6.032 . . . . 0.0 119.363 -174.215 . . . . . . . . 3 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . . . -23.79 -46.21 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.268 -2.947 2 N-CA-C 132.484 7.957 . . . . 0.0 132.484 123.017 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . . . -78.72 -8.78 59.05 Favored 'General case' 0 C--N 1.28 -2.444 0 N-CA-C 121.358 3.836 . . . . 0.0 121.358 164.365 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . . . -94.05 -46.08 7.29 Favored 'General case' 1 N--CA 1.549 4.488 0 CA-C-N 108.924 -3.762 . . . . 0.0 118.981 -157.403 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . . . -46.36 -74.1 0.04 OUTLIER 'General case' 0 C--N 1.287 -2.141 1 CA-C-N 106.516 -4.856 . . . . 0.0 117.027 135.425 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.656 0 CA-C-O 124.778 2.227 . . . . 0.0 111.775 -169.09 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.536 ' N ' ' H ' ' A' ' 7' ' ' PHE . . . . . . . . 0 N--CA 1.5 2.072 1 N-CA-C 134.597 8.74 . . . . 0.0 134.597 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.504 ' O ' ' N ' ' A' ' 10' ' ' ILE . . . -33.24 -52.14 0.11 Allowed 'Isoleucine or valine' 1 CA--C 1.419 -4.065 1 CA-C-O 111.609 -4.043 . . . . 0.0 103.557 123.228 . . . . . . . . 4 3 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.536 ' H ' ' N ' ' A' ' 5' ' ' ARG . . . -90.94 -52.06 5.04 Favored 'General case' 1 N--CA 1.334 -6.259 1 CA-C-O 130.8 5.095 . . . . 0.0 109.806 -122.366 . . . . . . . . 4 3 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -35.07 -37.15 0.06 Allowed 'General case' 2 C--N 1.215 -5.267 1 N-CA-C 123.502 4.63 . . . . 0.0 123.502 136.888 . . . . . . . . 3 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.64 ' O ' ' HD2' ' A' ' 13' ' ' PRO . . . -90.09 16.23 8.78 Favored 'General case' 0 CA--C 1.423 -3.915 2 N-CA-C 124.994 5.183 . . . . 0.0 124.994 157.33 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.504 ' N ' ' O ' ' A' ' 6' ' ' ILE . . . -79.82 -24.15 11.99 Favored 'Isoleucine or valine' 0 CA--C 1.602 2.962 0 CA-C-O 127.433 3.492 . . . . 0.0 112.881 160.42 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.461 ' CA ' ' H ' ' A' ' 14' ' ' GLY . . . -117.32 -28.31 6.18 Favored 'General case' 1 CA--C 1.383 -5.452 3 N-CA-C 126.288 5.662 . . . . 0.0 126.288 -160.645 . . . . . . . . 4 3 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -71.57 -18.67 0.39 Allowed Pre-proline 0 C--N 1.247 -3.868 2 O-C-N 134.504 7.378 . . . . 0.0 119.404 147.7 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.64 ' HD2' ' O ' ' A' ' 9' ' ' SER . 0.1 OUTLIER -63.31 -21.51 71.76 Favored 'Trans proline' 0 C--N 1.298 -2.09 2 N-CA-C 127.64 5.977 . . . . 0.0 127.64 130.297 . . . . . . . . 4 4 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.461 ' H ' ' CA ' ' A' ' 11' ' ' LEU . . . -74.75 -3.23 66.87 Favored Glycine 2 N--CA 1.534 5.224 0 CA-C-N 108.969 -3.741 . . . . 0.0 121.372 157.833 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.406 ' C ' ' N ' ' A' ' 17' ' ' ALA . . . -113.79 -65.57 1.52 Allowed 'Isoleucine or valine' 0 CA--C 1.475 -1.907 2 C-N-CA 133.768 4.827 . . . . 0.0 112.221 -168.982 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -27.45 -33.27 0.0 OUTLIER 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 119.855 3.28 . . . . 0.0 119.855 148.201 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.406 ' N ' ' C ' ' A' ' 15' ' ' VAL . . . -90.49 -41.28 11.51 Favored 'General case' 0 CA--C 1.516 -0.364 2 CA-C-N 107.284 -4.507 . . . . 0.0 122.523 173.528 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -38.81 -62.31 0.63 Allowed 'General case' 0 CA--C 1.59 2.517 0 CA-C-O 123.015 1.388 . . . . 0.0 114.539 148.099 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . . . -77.43 -59.04 2.94 Favored 'General case' 0 CA--C 1.556 1.196 0 CA-C-O 124.443 2.068 . . . . 0.0 109.119 -143.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -41.39 -44.6 2.86 Favored 'General case' 0 CA--C 1.57 1.741 0 CA-C-N 111.5 -2.591 . . . . 0.0 115.931 160.479 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . . . -95.9 8.41 43.68 Favored 'General case' 0 N--CA 1.507 2.403 0 N-CA-C 118.794 2.887 . . . . 0.0 118.794 -174.481 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . . . -100.77 -28.21 12.94 Favored 'General case' 1 N--CA 1.551 4.603 1 N-CA-C 124.103 4.853 . . . . 0.0 124.103 160.275 . . . . . . . . 3 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . . . -39.36 -64.51 0.46 Allowed 'General case' 1 C--N 1.241 -4.138 1 CA-C-N 105.8 -5.182 . . . . 0.0 116.842 162.418 . . . . . . . . 3 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . . . -24.62 -50.92 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.252 -3.634 2 CA-C-N 104.509 -5.769 . . . . 0.0 124.642 139.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . . . -91.29 -0.22 57.63 Favored 'General case' 0 N--CA 1.505 2.317 0 N-CA-C 119.484 3.142 . . . . 0.0 119.484 170.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . . . -92.79 -37.19 12.46 Favored 'General case' 1 N--CA 1.553 4.699 0 CA-C-O 126.324 2.964 . . . . 0.0 117.33 -168.87 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . . . -93.47 -41.61 9.7 Favored 'General case' 0 N--CA 1.512 2.648 2 CA-C-N 107.295 -4.502 . . . . 0.0 111.146 171.791 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.738 0 C-N-CA 117.624 -1.63 . . . . 0.0 114.253 139.761 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.964 1 N-CA-C 126.019 5.563 . . . . 0.0 126.019 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.44 ' C ' ' H ' ' A' ' 9' ' ' SER . . . -38.79 -33.06 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.447 -2.999 0 CA-C-O 111.968 -3.872 . . . . 0.0 110.735 135.081 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.582 ' C ' ' H ' ' A' ' 10' ' ' ILE . . . -93.08 -41.96 9.67 Favored 'General case' 0 CA--C 1.435 -3.449 2 N-CA-C 131.122 7.453 . . . . 0.0 131.122 -156.165 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -34.68 -48.06 0.36 Allowed 'General case' 0 N--CA 1.394 -3.27 2 CA-C-N 96.899 -9.228 . . . . 0.0 107.649 127.597 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.44 ' H ' ' C ' ' A' ' 6' ' ' ILE . . . -89.56 -2.34 58.31 Favored 'General case' 0 CA--C 1.479 -1.779 0 N-CA-C 121.277 3.806 . . . . 0.0 121.277 157.749 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.582 ' H ' ' C ' ' A' ' 7' ' ' PHE . . . -67.1 -26.01 35.48 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.137 1 CA-C-O 128.737 4.113 . . . . 0.0 118.03 167.881 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.584 ' H ' ' HD2' ' A' ' 13' ' ' PRO . . . -113.29 -55.2 2.55 Favored 'General case' 0 CA--C 1.435 -3.477 2 CA-C-N 101.232 -7.258 . . . . 0.0 126.057 -127.886 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -94.3 -21.87 0.24 Allowed Pre-proline 0 N--CA 1.38 -3.941 2 O-C-N 137.692 9.37 . . . . 0.0 112.564 171.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.584 ' HD2' ' H ' ' A' ' 11' ' ' LEU . 27.7 Cg_exo -62.49 -25.64 75.93 Favored 'Trans proline' 0 N--CA 1.49 1.294 1 N-CA-C 127.106 5.772 . . . . 0.0 127.106 126.873 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -76.07 2.31 56.47 Favored Glycine 1 N--CA 1.522 4.373 3 O-C-N 130.403 4.814 . . . . 0.0 121.68 160.015 . . . . . . . . 3 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . . . -113.11 -69.36 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.973 1 CA-C-N 106.687 -4.757 . . . . 0.0 110.206 -177.03 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -27.06 -28.75 0.0 OUTLIER 'General case' 0 C--N 1.29 -2.017 0 N-CA-C 120.044 3.35 . . . . 0.0 120.044 148.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -69.9 -56.99 5.59 Favored 'General case' 0 CA--C 1.549 0.924 1 N-CA-C 121.913 4.042 . . . . 0.0 121.913 160.162 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -36.69 -60.7 0.58 Allowed 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 115.747 1.758 . . . . 0.0 115.747 155.319 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . . . -77.69 -58.32 3.33 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-O 121.929 0.871 . . . . 0.0 110.072 -150.197 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -43.77 -31.67 0.87 Allowed 'General case' 0 CA--C 1.581 2.164 0 N-CA-C 116.448 2.018 . . . . 0.0 116.448 164.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . . . -90.14 -20.44 23.11 Favored 'General case' 0 CA--C 1.569 1.684 0 N-CA-C 116.53 2.048 . . . . 0.0 116.53 -178.51 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . . . -102.25 -13.58 17.33 Favored 'General case' 1 N--CA 1.574 5.725 1 N-CA-C 124.829 5.122 . . . . 0.0 124.829 170.391 . . . . . . . . 3 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . . . -30.29 -60.76 0.17 Allowed 'General case' 1 C--N 1.225 -4.814 1 CA-C-N 107.639 -4.346 . . . . 0.0 120.498 134.244 . . . . . . . . 3 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . . . -90.05 -18.77 7.54 Favored 'Isoleucine or valine' 1 C--N 1.241 -4.13 0 CA-C-N 110.022 -3.263 . . . . 0.0 114.743 -159.554 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . . . -66.47 -18.51 65.4 Favored 'General case' 0 C--N 1.307 -1.242 1 N-CA-C 123.855 4.761 . . . . 0.0 123.855 148.821 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . . . -90.49 -62.87 1.36 Allowed 'General case' 0 N--CA 1.522 3.144 0 CA-C-N 114.229 -1.351 . . . . 0.0 109.37 -163.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . . . -48.66 -47.7 40.37 Favored 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 128.489 2.716 . . . . 0.0 116.293 157.028 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.5 2.039 0 CA-C-O 124.324 2.011 . . . . 0.0 110.832 160.262 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.692 ' N ' ' H ' ' A' ' 7' ' ' PHE . . . . . . . . 0 N--CA 1.448 -0.565 1 N-CA-C 128.086 6.328 . . . . 0.0 128.086 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.748 ' C ' ' H ' ' A' ' 9' ' ' SER . . . -42.71 -36.88 0.75 Allowed 'Isoleucine or valine' 0 C--O 1.206 -1.208 1 O-C-N 129.513 4.258 . . . . 0.0 107.652 125.055 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.692 ' H ' ' N ' ' A' ' 5' ' ' ARG . . . -93.78 -1.81 54.5 Favored 'General case' 2 CA--C 1.392 -5.114 1 N-CA-C 135.918 9.229 . . . . 0.0 135.918 -171.063 . . . . . . . . 4 3 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.88 -39.21 93.65 Favored 'General case' 1 CA--C 1.389 -5.215 3 CA-C-N 94.437 -10.347 . . . . 0.0 132.684 117.779 . . . . . . . . 3 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.748 ' H ' ' C ' ' A' ' 6' ' ' ILE . . . -105.98 12.02 30.99 Favored 'General case' 0 C--N 1.253 -3.619 1 N-CA-C 125.501 5.371 . . . . 0.0 125.501 178.925 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . . . -95.03 -30.97 4.15 Favored 'Isoleucine or valine' 0 C--N 1.259 -3.35 1 CA-C-N 106.958 -4.656 . . . . 0.0 105.878 166.392 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . . . -86.65 -62.55 1.48 Allowed 'General case' 1 CA--C 1.408 -4.506 1 C-N-CA 136.424 5.89 . . . . 0.0 121.075 -158.928 . . . . . . . . 3 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -72.66 -21.65 0.48 Allowed Pre-proline 0 N--CA 1.391 -3.384 2 CA-C-N 102.198 -6.819 . . . . 0.0 113.134 167.404 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.502 ' HG2' ' O ' ' A' ' 9' ' ' SER . 0.1 OUTLIER -68.95 -20.39 38.76 Favored 'Trans proline' 0 CA--C 1.499 -1.258 1 N-CA-C 127.724 6.009 . . . . 0.0 127.724 139.567 . . . . . . . . 4 4 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -72.46 -4.39 60.61 Favored Glycine 0 N--CA 1.512 3.702 0 O-C-N 128.766 3.791 . . . . 0.0 118.368 157.066 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . . . -119.15 -56.72 3.53 Favored 'Isoleucine or valine' 0 CA--C 1.475 -1.926 0 CA-C-N 110.353 -2.924 . . . . 0.0 115.048 -161.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -26.91 -42.7 0.02 OUTLIER 'General case' 0 C--N 1.292 -1.905 1 CA-C-N 108.261 -4.063 . . . . 0.0 117.163 141.422 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.87 -73.02 0.16 Allowed 'General case' 0 CA--C 1.557 1.218 0 CA-C-N 108.461 -3.972 . . . . 0.0 118.179 172.508 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -38.69 -66.71 0.25 Allowed 'General case' 0 CA--C 1.583 2.217 0 N-CA-C 116.93 2.196 . . . . 0.0 116.93 164.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . . . -60.88 -59.98 4.52 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 128.435 2.694 . . . . 0.0 111.63 -161.281 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.33 -42.99 92.34 Favored 'General case' 0 CA--C 1.569 1.692 0 C-N-CA 126.587 1.955 . . . . 0.0 115.991 -175.63 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . . . -92.35 6.38 47.11 Favored 'General case' 0 N--CA 1.517 2.888 0 O-C-N 119.272 -2.143 . . . . 0.0 116.148 -179.284 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . . . -104.52 -30.78 9.81 Favored 'General case' 1 N--CA 1.542 4.151 1 N-CA-C 125.044 5.202 . . . . 0.0 125.044 174.517 . . . . . . . . 3 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . . . -34.9 -71.86 0.06 Allowed 'General case' 0 C--N 1.261 -3.275 2 CA-C-N 103.022 -6.444 . . . . 0.0 117.921 147.522 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . . . -25.98 -45.57 0.01 OUTLIER 'Isoleucine or valine' 1 C--N 1.234 -4.43 2 N-CA-C 124.303 4.927 . . . . 0.0 124.303 143.522 . . . . . . . . 3 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . . . -92.6 -0.76 57.27 Favored 'General case' 0 N--CA 1.505 2.315 0 N-CA-C 119.219 3.044 . . . . 0.0 119.219 170.745 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . . . -92.39 -36.22 13.26 Favored 'General case' 1 N--CA 1.55 4.551 0 CA-C-O 126.069 2.842 . . . . 0.0 117.12 -170.853 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . . . -94.36 -41.98 9.13 Favored 'General case' 0 N--CA 1.512 2.67 2 CA-C-N 107.796 -4.275 . . . . 0.0 111.014 173.377 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.726 0 C-N-CA 117.849 -1.54 . . . . 0.0 114.235 139.634 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.588 ' N ' ' H ' ' A' ' 7' ' ' PHE . . . . . . . . 0 N--CA 1.482 1.166 0 N-CA-C 119.937 3.31 . . . . 0.0 119.937 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.501 ' O ' ' N ' ' A' ' 10' ' ' ILE . . . -39.51 -40.25 0.41 Allowed 'Isoleucine or valine' 0 C--O 1.162 -3.522 1 CA-C-O 108.079 -5.724 . . . . 0.0 111.681 127.458 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.591 ' C ' ' H ' ' A' ' 10' ' ' ILE . . . -61.57 -53.13 60.42 Favored 'General case' 1 C--O 1.15 -4.147 1 CA-C-N 127.436 4.653 . . . . 0.0 119.397 -169.478 . . . . . . . . 4 3 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -38.94 -53.86 1.7 Allowed 'General case' 1 N--CA 1.379 -4.005 4 C-N-CA 146.633 9.973 . . . . 0.0 99.128 155.279 . . . . . . . . 3 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.441 ' O ' ' HG2' ' A' ' 13' ' ' PRO . . . -85.58 2.86 43.24 Favored 'General case' 0 N--CA 1.494 1.735 1 N-CA-C 125.675 5.435 . . . . 0.0 125.675 160.758 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.591 ' H ' ' C ' ' A' ' 7' ' ' PHE . . . -80.67 -47.89 20.15 Favored 'Isoleucine or valine' 0 CA--C 1.584 2.275 0 CA-C-O 126.072 2.844 . . . . 0.0 106.286 172.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.438 ' C ' ' H ' ' A' ' 14' ' ' GLY . . . -114.02 -23.83 9.35 Favored 'General case' 0 CA--C 1.439 -3.32 2 CA-C-N 106.794 -4.73 . . . . 0.0 123.581 -147.959 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -95.21 -7.78 0.12 Allowed Pre-proline 1 N--CA 1.374 -4.257 2 CA-C-N 104.327 -5.852 . . . . 0.0 110.882 160.967 . . . . . . . . 3 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.441 ' HG2' ' O ' ' A' ' 9' ' ' SER . 0.3 OUTLIER -77.39 -10.91 17.48 Favored 'Trans proline' 0 CA--C 1.475 -2.431 2 N-CA-C 124.44 4.746 . . . . 0.0 124.44 131.464 . . . . . . . . 4 4 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.438 ' H ' ' C ' ' A' ' 11' ' ' LEU . . . -87.45 9.4 73.51 Favored Glycine 1 N--CA 1.523 4.442 2 O-C-N 132.149 5.906 . . . . 0.0 121.477 163.57 . . . . . . . . 4 3 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . . . -115.31 -78.29 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.405 -2.678 2 CA-C-N 105.273 -5.464 . . . . 0.0 111.086 -175.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -28.26 -29.83 0.0 OUTLIER 'General case' 0 C--N 1.246 -3.899 0 CA-C-N 110.996 -2.82 . . . . 0.0 118.25 152.203 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -58.29 -71.7 0.11 Allowed 'General case' 0 CA--C 1.533 0.29 1 N-CA-C 123.617 4.673 . . . . 0.0 123.617 148.773 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -33.36 -60.45 0.35 Allowed 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 115.393 1.627 . . . . 0.0 115.393 165.118 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . . . -63.49 -45.36 91.09 Favored 'General case' 0 CA--C 1.545 0.783 0 CA-C-N 114.346 -1.297 . . . . 0.0 112.134 -161.622 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -84.99 -12.14 53.9 Favored 'General case' 0 N--CA 1.418 -2.044 0 C-N-CA 127.75 2.42 . . . . 0.0 115.526 -173.774 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . . . -90.15 -22.01 21.94 Favored 'General case' 0 N--CA 1.509 2.492 0 N-CA-C 118.891 2.923 . . . . 0.0 118.891 165.112 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . . . -93.34 -27.61 16.68 Favored 'General case' 1 N--CA 1.564 5.226 1 N-CA-C 126.433 5.716 . . . . 0.0 126.433 178.039 . . . . . . . . 3 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . . . -27.34 -81.97 0.01 OUTLIER 'General case' 1 CA--C 1.417 -4.146 2 CA-C-N 102.919 -6.491 . . . . 0.0 113.152 123.75 . . . . . . . . 3 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . . . -78.09 -12.67 13.76 Favored 'Isoleucine or valine' 0 C--N 1.257 -3.451 1 C-N-CA 110.571 -4.452 . . . . 0.0 116.904 -139.761 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . . . -91.31 -1.62 57.6 Favored 'General case' 0 C--N 1.306 -1.301 2 N-CA-C 126.896 5.887 . . . . 0.0 126.896 159.032 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . . . -88.71 -57.99 2.71 Favored 'General case' 1 N--CA 1.539 4.023 0 CA-C-O 125.416 2.531 . . . . 0.0 115.98 178.073 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . . . -71.03 -52.49 19.24 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-N 108.843 -3.799 . . . . 0.0 115.043 165.597 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.512 2.631 0 C-N-CA 116.069 -2.252 . . . . 0.0 112.623 148.367 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.502 -0.89 1 N-CA-C 123.523 4.638 . . . . 0.0 123.523 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.516 ' O ' ' N ' ' A' ' 10' ' ' ILE . . . -48.84 -50.92 13.2 Favored 'Isoleucine or valine' 1 C--O 1.135 -4.946 2 CA-C-N 106.808 -4.724 . . . . 0.0 106.907 137.706 . . . . . . . . 4 3 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.458 ' C ' ' H ' ' A' ' 10' ' ' ILE . . . -59.3 -55.23 37.49 Favored 'General case' 2 CA--C 1.365 -6.17 1 CA-C-O 140.191 9.567 . . . . 0.0 114.696 -163.484 . . . . . . . . 4 3 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -34.49 -43.31 0.16 Allowed 'General case' 0 N--CA 1.393 -3.298 1 CA-C-N 100.335 -7.666 . . . . 0.0 109.505 158.044 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.478 ' O ' ' HD2' ' A' ' 13' ' ' PRO . . . -88.67 -9.23 52.8 Favored 'General case' 0 CA--C 1.46 -2.502 1 N-CA-C 133.361 8.282 . . . . 0.0 133.361 152.485 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.516 ' N ' ' O ' ' A' ' 6' ' ' ILE . . . -66.47 -52.64 44.21 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.84 0 CA-C-O 126.613 3.102 . . . . 0.0 108.378 168.867 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.471 ' C ' ' H ' ' A' ' 14' ' ' GLY . . . -119.31 -25.24 6.15 Favored 'General case' 1 CA--C 1.397 -4.937 1 CA-C-N 102.956 -6.475 . . . . 0.0 120.799 -146.002 . . . . . . . . 4 3 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -100.04 16.61 0.05 OUTLIER Pre-proline 0 C--N 1.265 -3.079 1 O-C-N 130.809 5.068 . . . . 0.0 120.142 155.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.478 ' HD2' ' O ' ' A' ' 9' ' ' SER . 0.1 OUTLIER -67.3 -25.33 42.61 Favored 'Trans proline' 0 N--CA 1.509 2.406 2 N-CA-C 131.243 7.363 . . . . 0.0 131.243 105.925 . . . . . . . . 4 4 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.471 ' H ' ' C ' ' A' ' 11' ' ' LEU . . . -74.96 -0.83 61.17 Favored Glycine 3 N--CA 1.552 6.378 1 CA-C-O 129.011 4.673 . . . . 0.0 121.746 167.319 . . . . . . . . 4 3 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . . . -112.86 -67.18 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.29 -1.994 2 CA-C-N 104.462 -5.869 . . . . 0.0 116.517 -179.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -26.44 -37.03 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 119.251 3.056 . . . . 0.0 119.251 153.612 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -56.12 -79.13 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.804 1 CA-C-N 105.978 -5.101 . . . . 0.0 120.726 157.625 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -37.19 -49.49 0.91 Allowed 'General case' 0 CA--C 1.582 2.185 0 N-CA-C 117.637 2.458 . . . . 0.0 117.637 167.365 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . . . -47.81 -71.96 0.06 Allowed 'General case' 0 CA--C 1.564 1.505 0 C-N-CA 129.345 3.058 . . . . 0.0 112.942 -179.167 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -51.63 -25.53 7.22 Favored 'General case' 0 CA--C 1.571 1.783 0 CA-C-N 108.541 -3.936 . . . . 0.0 116.401 173.287 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . . . -90.78 -29.92 17.32 Favored 'General case' 0 CA--C 1.564 1.484 0 CA-C-O 115.414 -2.232 . . . . 0.0 115.696 -179.349 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . . . -100.79 -10.7 20.52 Favored 'General case' 1 N--CA 1.581 6.088 1 N-CA-C 124.797 5.11 . . . . 0.0 124.797 174.698 . . . . . . . . 3 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . . . -30.54 -67.85 0.09 Allowed 'General case' 1 C--N 1.233 -4.471 1 CA-C-N 105.582 -5.281 . . . . 0.0 118.822 125.603 . . . . . . . . 3 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . . . -88.0 7.45 2.99 Favored 'Isoleucine or valine' 1 C--N 1.238 -4.282 0 C-N-CA 113.775 -3.17 . . . . 0.0 117.929 -157.261 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . . . -87.18 -32.4 19.85 Favored 'General case' 0 C--N 1.303 -1.431 3 C-N-CA 134.484 5.114 . . . . 0.0 124.008 161.44 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . . . -87.65 -34.07 18.59 Favored 'General case' 0 N--CA 1.534 3.737 1 CA-C-N 106.87 -4.695 . . . . 0.0 116.553 -172.457 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . . . -95.97 -38.79 10.08 Favored 'General case' 0 N--CA 1.511 2.613 2 C-N-CA 131.994 4.118 . . . . 0.0 110.008 173.174 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.499 1.989 0 C-N-CA 116.909 -1.917 . . . . 0.0 114.287 139.915 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.656 ' N ' ' H ' ' A' ' 7' ' ' PHE . . . . . . . . 0 CA--C 1.499 -1.016 1 N-CA-C 128.237 6.384 . . . . 0.0 128.237 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . . . -39.89 -58.49 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.426 -3.819 2 CA-C-N 107.144 -4.571 . . . . 0.0 103.878 125.587 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.656 ' H ' ' N ' ' A' ' 5' ' ' ARG . . . -46.2 -41.29 12.55 Favored 'General case' 0 N--CA 1.492 1.672 2 N-CA-C 125.387 5.328 . . . . 0.0 125.387 -144.035 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -90.85 -40.38 11.79 Favored 'General case' 1 N--CA 1.372 -4.359 3 C-N-CA 150.495 11.518 . . . . 0.0 110.151 -162.129 . . . . . . . . 3 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.482 ' O ' ' HD2' ' A' ' 13' ' ' PRO . . . -70.95 -14.09 62.24 Favored 'General case' 0 CA--C 1.458 -2.559 1 N-CA-C 128.96 6.652 . . . . 0.0 128.96 140.43 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . . . -74.02 -23.52 18.84 Favored 'Isoleucine or valine' 0 C--N 1.253 -3.591 1 CA-C-O 129.335 4.397 . . . . 0.0 117.52 169.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . . . -110.92 -55.61 2.47 Favored 'General case' 1 CA--C 1.407 -4.524 1 CA-C-N 102.425 -6.716 . . . . 0.0 119.462 -138.666 . . . . . . . . 3 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -76.78 -21.78 0.4 Allowed Pre-proline 0 C--N 1.254 -3.553 2 O-C-N 132.958 6.411 . . . . 0.0 115.823 163.159 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.482 ' HD2' ' O ' ' A' ' 9' ' ' SER . 1.4 Cg_exo -60.58 -17.87 51.27 Favored 'Trans proline' 0 CA--C 1.479 -2.271 1 N-CA-C 128.007 6.118 . . . . 0.0 128.007 131.667 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -59.69 -22.46 57.01 Favored Glycine 2 N--CA 1.535 5.273 0 CA-C-O 126.199 3.11 . . . . 0.0 119.255 154.203 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.414 ' N ' ' H ' ' A' ' 17' ' ' ALA . . . -119.54 -49.26 3.54 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.617 1 CA-C-N 106.441 -4.88 . . . . 0.0 118.811 -144.165 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -28.72 -52.8 0.1 Allowed 'General case' 0 C--N 1.298 -1.673 2 CA-C-N 106.808 -4.724 . . . . 0.0 114.34 135.309 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.414 ' H ' ' N ' ' A' ' 15' ' ' VAL . . . -77.22 -52.42 9.27 Favored 'General case' 0 CA--C 1.56 1.334 1 CA-C-N 107.495 -4.412 . . . . 0.0 112.563 -157.895 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -36.72 -66.46 0.22 Allowed 'General case' 0 CA--C 1.585 2.307 0 CA-C-N 110.83 -2.895 . . . . 0.0 115.324 146.38 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . . . -46.91 -61.29 1.93 Allowed 'General case' 0 N--CA 1.514 2.727 0 CA-C-O 125.243 2.449 . . . . 0.0 113.777 -159.368 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -77.72 -14.75 59.52 Favored 'General case' 0 CA--C 1.567 1.598 0 C-N-CA 129.405 3.082 . . . . 0.0 116.244 -174.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . . . -92.27 -24.47 18.98 Favored 'General case' 0 N--CA 1.523 3.184 0 N-CA-C 117.942 2.571 . . . . 0.0 117.942 174.236 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . . . -96.01 -27.25 15.21 Favored 'General case' 1 N--CA 1.561 5.106 1 N-CA-C 126.158 5.614 . . . . 0.0 126.158 179.723 . . . . . . . . 3 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . . . -27.89 -80.32 0.01 OUTLIER 'General case' 0 CA--C 1.423 -3.941 2 CA-C-N 103.064 -6.425 . . . . 0.0 113.338 123.459 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . . . -79.66 -12.35 13.11 Favored 'Isoleucine or valine' 0 C--N 1.254 -3.554 1 C-N-CA 110.693 -4.403 . . . . 0.0 116.552 -139.287 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . . . -91.42 1.52 57.06 Favored 'General case' 0 C--N 1.308 -1.219 2 N-CA-C 127.287 6.032 . . . . 0.0 127.287 157.186 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . . . -89.71 -62.17 1.53 Allowed 'General case' 0 N--CA 1.538 3.926 0 CA-C-O 125.323 2.487 . . . . 0.0 115.752 176.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . . . -57.26 -61.48 2.44 Favored 'General case' 0 N--CA 1.494 1.768 0 CA-C-N 109.257 -3.61 . . . . 0.0 115.705 157.78 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.517 2.883 0 C-N-CA 115.388 -2.525 . . . . 0.0 112.322 155.918 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.679 ' N ' ' H ' ' A' ' 7' ' ' PHE . . . . . . . . 0 C--O 1.214 -0.769 0 N-CA-C 117.621 2.452 . . . . 0.0 117.621 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.502 ' C ' ' H ' ' A' ' 9' ' ' SER . . . -37.12 -38.19 0.15 Allowed 'Isoleucine or valine' 2 CA--C 1.364 -6.179 1 CA-C-N 106.264 -4.971 . . . . 0.0 112.735 126.729 . . . . . . . . 4 3 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.679 ' H ' ' N ' ' A' ' 5' ' ' ARG . . . -67.6 -60.35 2.62 Favored 'General case' 0 CA--C 1.423 -3.907 1 CA-C-O 137.041 8.067 . . . . 0.0 111.338 -173.343 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -36.26 -43.61 0.37 Allowed 'General case' 0 N--CA 1.407 -2.579 2 CA-C-N 100.51 -7.586 . . . . 0.0 105.36 159.694 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.51 ' C ' ' HD2' ' A' ' 13' ' ' PRO . . . -106.49 1.7 25.68 Favored 'General case' 0 CA--C 1.464 -2.345 1 N-CA-C 130.056 7.058 . . . . 0.0 130.056 176.356 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.426 ' N ' ' O ' ' A' ' 6' ' ' ILE . . . -91.93 -46.12 14.33 Favored 'Isoleucine or valine' 0 CA--C 1.621 3.695 2 N-CA-C 96.796 -5.261 . . . . 0.0 96.796 177.192 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.487 ' C ' ' H ' ' A' ' 14' ' ' GLY . . . -112.91 -27.59 8.04 Favored 'General case' 1 CA--C 1.402 -4.726 1 N-CA-C 122.222 4.156 . . . . 0.0 122.222 -152.415 . . . . . . . . 4 3 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -99.78 14.58 0.05 OUTLIER Pre-proline 0 C--N 1.256 -3.48 1 O-C-N 130.19 4.681 . . . . 0.0 120.791 154.273 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.51 ' HD2' ' C ' ' A' ' 9' ' ' SER . 0.0 OUTLIER -71.57 -22.13 24.84 Favored 'Trans proline' 0 N--CA 1.507 2.289 2 N-CA-C 130.215 6.967 . . . . 0.0 130.215 110.115 . . . . . . . . 4 4 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.487 ' H ' ' C ' ' A' ' 11' ' ' LEU . . . -82.32 2.28 85.2 Favored Glycine 2 N--CA 1.541 5.668 1 CA-C-O 127.849 4.027 . . . . 0.0 120.619 168.582 . . . . . . . . 4 3 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . . . -111.95 -64.3 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.71 2 CA-C-N 106.391 -4.905 . . . . 0.0 114.157 179.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -23.67 -42.32 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 111.56 -2.564 . . . . 0.0 117.612 152.519 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -56.8 -83.8 0.01 OUTLIER 'General case' 0 CA--C 1.556 1.201 1 CA-C-N 106.837 -4.71 . . . . 0.0 119.54 158.293 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -36.21 -60.8 0.54 Allowed 'General case' 0 CA--C 1.58 2.125 0 N-CA-C 118.615 2.82 . . . . 0.0 118.615 172.27 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . . . -52.65 -54.66 30.3 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 128.421 2.688 . . . . 0.0 112.824 -172.751 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.51 -53.06 61.32 Favored 'General case' 0 N--CA 1.399 -2.982 0 CA-C-N 112.693 -2.049 . . . . 0.0 111.602 173.117 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . . . -95.42 34.34 1.46 Allowed 'General case' 0 N--CA 1.518 2.96 0 N-CA-C 120.401 3.482 . . . . 0.0 120.401 175.337 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . . . -107.73 -5.71 17.23 Favored 'General case' 0 N--CA 1.533 3.714 0 N-CA-C 121.068 3.729 . . . . 0.0 121.068 141.444 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . . . -63.3 -55.02 28.13 Favored 'General case' 0 C--N 1.246 -3.897 0 N-CA-C 118.529 2.788 . . . . 0.0 118.529 -179.728 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . . . -28.18 -52.09 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.266 -3.063 4 CA-C-N 100.903 -7.408 . . . . 0.0 124.073 131.39 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . . . -92.29 7.52 42.39 Favored 'General case' 0 N--CA 1.519 2.98 0 N-CA-C 117.36 2.356 . . . . 0.0 117.36 171.478 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . . . -96.5 -60.97 1.5 Allowed 'General case' 0 N--CA 1.511 2.587 0 CA-C-N 109.317 -3.583 . . . . 0.0 110.699 179.077 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . . . -48.42 -38.61 20.14 Favored 'General case' 0 N--CA 1.503 2.209 0 C-N-CA 126.567 1.947 . . . . 0.0 115.937 162.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.834 0 CA-C-O 123.795 1.76 . . . . 0.0 110.639 160.491 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.176 0 N-CA-C 119.713 3.227 . . . . 0.0 119.713 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.434 ' O ' ' N ' ' A' ' 10' ' ' ILE . . . -38.1 -50.09 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.434 -3.51 1 CA-C-O 111.572 -4.061 . . . . 0.0 112.732 125.902 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . . . -48.03 -62.15 1.62 Allowed 'General case' 2 CA--C 1.387 -5.311 1 CA-C-O 132.597 5.951 . . . . 0.0 112.98 178.499 . . . . . . . . 3 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -37.77 -46.19 0.89 Allowed 'General case' 0 N--CA 1.4 -2.943 2 CA-C-N 102.314 -6.766 . . . . 0.0 106.153 168.044 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.574 ' O ' ' HG2' ' A' ' 13' ' ' PRO . . . -92.95 3.07 56.39 Favored 'General case' 0 CA--C 1.469 -2.158 1 N-CA-C 129.292 6.775 . . . . 0.0 129.292 166.522 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.434 ' N ' ' O ' ' A' ' 6' ' ' ILE . . . -93.78 -41.23 12.33 Favored 'Isoleucine or valine' 1 C--N 1.238 -4.275 0 N-CA-C 102.213 -3.254 . . . . 0.0 102.213 178.592 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.446 ' C ' ' H ' ' A' ' 14' ' ' GLY . . . -111.29 -28.6 8.17 Favored 'General case' 1 CA--C 1.421 -4.016 1 N-CA-C 122.245 4.165 . . . . 0.0 122.245 -153.249 . . . . . . . . 4 3 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -82.46 -24.12 0.36 Allowed Pre-proline 0 C--N 1.256 -3.494 2 O-C-N 131.63 5.581 . . . . 0.0 114.064 158.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.574 ' HG2' ' O ' ' A' ' 9' ' ' SER . 0.1 OUTLIER -56.21 -16.89 18.57 Favored 'Trans proline' 0 CA--C 1.476 -2.38 1 N-CA-C 128.107 6.156 . . . . 0.0 128.107 129.9 . . . . . . . . 4 4 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.446 ' H ' ' C ' ' A' ' 11' ' ' LEU . . . -59.3 -24.03 58.49 Favored Glycine 2 N--CA 1.536 5.35 0 CA-C-O 127.05 3.583 . . . . 0.0 121.727 155.391 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.41 ' N ' ' H ' ' A' ' 17' ' ' ALA . . . -120.03 -50.84 3.58 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.843 1 CA-C-N 104.187 -6.007 . . . . 0.0 118.236 -142.646 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -28.69 -52.45 0.1 Allowed 'General case' 0 CA--C 1.476 -1.879 2 CA-C-N 105.697 -5.228 . . . . 0.0 115.114 135.213 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.41 ' H ' ' N ' ' A' ' 15' ' ' VAL . . . -74.49 -59.78 2.58 Favored 'General case' 0 CA--C 1.553 1.09 1 CA-C-N 107.272 -4.513 . . . . 0.0 110.848 -161.571 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -35.16 -56.41 0.6 Allowed 'General case' 0 CA--C 1.574 1.872 0 CA-C-N 110.604 -2.998 . . . . 0.0 115.992 157.34 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . . . -43.37 -53.7 5.16 Favored 'General case' 0 N--CA 1.508 2.441 0 C-N-CA 128.18 2.592 . . . . 0.0 114.975 -167.573 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -80.51 -33.34 36.49 Favored 'General case' 0 N--CA 1.421 -1.905 0 C-N-CA 130.976 3.71 . . . . 0.0 114.439 -173.348 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . . . -90.31 -0.41 57.62 Favored 'General case' 0 N--CA 1.529 3.514 0 N-CA-C 117.039 2.237 . . . . 0.0 117.039 170.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . . . -88.87 -35.87 16.3 Favored 'General case' 1 N--CA 1.555 4.794 1 N-CA-C 123.619 4.674 . . . . 0.0 123.619 167.607 . . . . . . . . 3 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . . . -37.75 -64.49 0.39 Allowed 'General case' 0 C--N 1.26 -3.309 2 CA-C-N 102.513 -6.676 . . . . 0.0 114.969 167.068 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . . . -25.09 -51.02 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.268 -2.957 2 CA-C-N 104.354 -5.839 . . . . 0.0 124.695 142.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . . . -92.26 -2.73 56.28 Favored 'General case' 0 C--N 1.274 -2.679 0 N-CA-C 119.831 3.271 . . . . 0.0 119.831 170.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . . . -87.84 -24.24 23.76 Favored 'General case' 0 CA--C 1.609 3.241 0 CA-C-N 110.581 -3.009 . . . . 0.0 113.821 179.818 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . . . -96.09 -53.41 3.66 Favored 'General case' 0 N--CA 1.501 2.12 1 C-N-CA 132.831 4.453 . . . . 0.0 110.986 -178.672 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 1.918 0 CA-C-N 111.757 -2.474 . . . . 0.0 115.442 139.469 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.569 3.428 0 N-CA-C 117.264 1.666 . . . . 0.0 117.264 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.43 ' C ' ' H ' ' A' ' 6' ' ' ILE . . . -109.9 -18.04 0.03 OUTLIER 'Trans proline' 1 CA--C 1.621 4.849 1 N-CA-C 125.558 5.176 . . . . 0.0 125.558 -149.791 . . . . . . . . 4 3 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . . . -29.33 -50.43 0.1 Allowed 'General case' 0 C--N 1.268 -2.958 3 C-N-CA 137.719 6.408 . . . . 0.0 123.255 119.236 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.437 ' C ' ' H ' ' A' ' 7' ' ' PHE . . . -91.22 -29.42 17.22 Favored 'General case' 0 N--CA 1.481 1.104 2 C-N-CA 132.995 4.518 . . . . 0.0 112.133 -169.39 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.528 ' N ' ' H ' ' A' ' 7' ' ' PHE . . . -98.14 -38.03 9.48 Favored 'General case' 0 CA--C 1.476 -1.893 3 N-CA-C 130.934 7.383 . . . . 0.0 130.934 165.275 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.45 ' O ' ' N ' ' A' ' 9' ' ' SER . . . -51.24 -49.63 29.44 Favored 'Isoleucine or valine' 0 C--O 1.186 -2.288 1 N-CA-C 92.301 -6.926 . . . . 0.0 92.301 137.708 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.528 ' H ' ' N ' ' A' ' 5' ' ' ARG . . . -46.25 -47.45 18.08 Favored 'General case' 0 N--CA 1.487 1.399 3 CA-C-N 128.994 5.361 . . . . 0.0 124.951 -152.752 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -98.45 -35.03 10.4 Favored 'General case' 0 N--CA 1.409 -2.492 3 C-N-CA 154.948 13.299 . . . . 0.0 100.371 -165.413 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.46 ' O ' ' HG2' ' A' ' 13' ' ' PRO . . . -74.42 -13.4 60.71 Favored 'General case' 0 CA--C 1.462 -2.429 2 O-C-N 111.18 -7.2 . . . . 0.0 129.307 144.063 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . . . -62.44 -43.3 98.11 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.835 1 CA-C-O 129.498 4.475 . . . . 0.0 114.7 166.462 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . . . -106.83 -52.27 2.8 Favored 'General case' 1 CA--C 1.351 -6.698 4 CA-C-N 97.785 -8.825 . . . . 0.0 124.788 -140.778 . . . . . . . . 3 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -78.13 -20.12 0.33 Allowed Pre-proline 1 CA--C 1.649 4.775 2 CA-C-N 102.878 -6.51 . . . . 0.0 109.708 168.487 . . . . . . . . 3 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.46 ' HG2' ' O ' ' A' ' 9' ' ' SER . 0.1 OUTLIER -59.91 -29.42 89.4 Favored 'Trans proline' 0 CA--C 1.486 -1.91 2 O-C-N 106.516 -7.676 . . . . 0.0 127.416 134.868 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -70.89 -0.9 36.36 Favored Glycine 0 N--CA 1.506 3.329 2 O-C-N 132.617 6.198 . . . . 0.0 120.535 164.362 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.404 ' C ' ' N ' ' A' ' 17' ' ' ALA . . . -107.29 -73.83 0.59 Allowed 'Isoleucine or valine' 0 C--O 1.2 -1.549 2 CA-C-N 106.587 -4.806 . . . . 0.0 107.318 -165.3 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -28.52 -23.17 0.0 OUTLIER 'General case' 0 C--N 1.258 -3.379 0 CA-C-N 108.518 -3.946 . . . . 0.0 119.578 144.277 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.404 ' N ' ' C ' ' A' ' 15' ' ' VAL . . . -90.21 -33.38 16.21 Favored 'General case' 0 CA--C 1.549 0.907 1 N-CA-C 126.158 5.614 . . . . 0.0 126.158 156.858 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -41.73 -63.16 0.76 Allowed 'General case' 0 CA--C 1.576 1.967 0 CA-C-N 122.146 2.248 . . . . 0.0 115.071 145.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . . . -75.51 -56.3 4.83 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 113.759 -1.564 . . . . 0.0 109.649 -148.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -48.83 -44.45 39.38 Favored 'General case' 0 CA--C 1.577 1.987 0 N-CA-C 117.585 2.439 . . . . 0.0 117.585 163.281 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . . . -78.24 -13.65 59.77 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 117.33 -3.356 . . . . 0.0 117.773 -178.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . . . -96.5 -26.29 15.34 Favored 'General case' 0 N--CA 1.538 3.941 1 N-CA-C 126.129 5.603 . . . . 0.0 126.129 177.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . . . -37.81 -63.71 0.45 Allowed 'General case' 0 C--N 1.252 -3.638 2 CA-C-N 104.327 -5.851 . . . . 0.0 120.531 156.319 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . . . -39.32 -40.19 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.253 -3.615 4 O-C-N 134.218 7.199 . . . . 0.0 122.647 143.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . . . -94.92 3.57 54.81 Favored 'General case' 0 C--N 1.263 -3.171 0 N-CA-C 118.059 2.615 . . . . 0.0 118.059 167.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . . . -95.52 -60.45 1.66 Allowed 'General case' 0 N--CA 1.505 2.305 0 CA-C-N 109.546 -3.479 . . . . 0.0 111.178 177.366 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . . . -49.61 -41.69 42.78 Favored 'General case' 0 N--CA 1.501 2.097 0 C-N-CA 126.857 2.063 . . . . 0.0 115.503 163.346 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -79.91 -41.74 25.53 Favored 'General case' 0 N--CA 1.505 2.311 0 CA-C-O 122.911 1.339 . . . . 0.0 112.398 159.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.3 -1.564 0 O-C-N 121.01 -1.057 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.565 3.209 0 N-CA-C 116.384 1.314 . . . . 0.0 116.384 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . . . -94.49 10.0 1.9 Allowed 'Trans proline' 0 CA--C 1.578 2.699 1 N-CA-C 125.132 5.012 . . . . 0.0 125.132 179.255 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . . . -39.6 -58.36 1.31 Allowed 'General case' 0 C--N 1.274 -2.697 2 C-N-CA 133.681 4.792 . . . . 0.0 121.361 125.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -93.9 -32.66 13.81 Favored 'General case' 0 N--CA 1.529 3.484 2 CA-C-O 135.442 7.306 . . . . 0.0 115.309 -151.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.583 ' CA ' ' H ' ' A' ' 7' ' ' PHE . . . -94.8 -24.36 17.1 Favored 'General case' 0 C--N 1.25 -3.728 3 N-CA-C 144.599 12.444 . . . . 0.0 144.599 140.38 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.46 ' O ' ' CA ' ' A' ' 9' ' ' SER . . . -37.65 -49.9 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.434 -3.511 0 CA-C-N 111.716 -2.493 . . . . 0.0 106.019 117.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.583 ' H ' ' CA ' ' A' ' 5' ' ' ARG . . . -59.17 -51.89 68.05 Favored 'General case' 2 CA--C 1.378 -5.645 0 N-CA-C 119.355 3.094 . . . . 0.0 119.355 -143.799 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -104.47 44.28 1.04 Allowed 'General case' 1 N--CA 1.375 -4.222 2 N-CA-C 122.193 4.146 . . . . 0.0 122.193 146.707 . . . . . . . . 3 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.587 ' O ' ' HD2' ' A' ' 13' ' ' PRO . . . -93.3 17.2 11.61 Favored 'General case' 1 C--N 1.24 -4.162 1 N-CA-C 140.757 11.021 . . . . 0.0 140.757 95.158 . . . . . . . . 4 3 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.428 ' C ' ' HB2' ' A' ' 13' ' ' PRO . . . -72.59 -33.89 46.2 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.802 2 CA-C-O 132.975 6.131 . . . . 0.0 125.162 156.453 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . . . -105.37 -32.34 8.62 Favored 'General case' 2 CA--C 1.368 -6.045 4 CA-C-N 93.656 -10.702 . . . . 0.0 131.033 -165.39 . . . . . . . . 3 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -89.1 -15.66 0.21 Allowed Pre-proline 0 CA--C 1.618 3.573 3 CA-C-N 101.894 -6.957 . . . . 0.0 114.273 161.515 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.587 ' HD2' ' O ' ' A' ' 9' ' ' SER . 0.0 OUTLIER -57.19 -24.09 57.12 Favored 'Trans proline' 0 C--N 1.291 -2.485 2 O-C-N 106.116 -7.886 . . . . 0.0 129.602 128.161 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -76.77 2.1 60.42 Favored Glycine 0 N--CA 1.514 3.876 2 CA-C-N 103.849 -6.068 . . . . 0.0 120.945 162.081 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . . . -106.95 -77.79 0.42 Allowed 'Isoleucine or valine' 0 C--O 1.196 -1.713 2 CA-C-N 106.443 -4.879 . . . . 0.0 110.493 -169.6 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -28.77 -23.9 0.0 OUTLIER 'General case' 0 C--N 1.253 -3.588 1 CA-C-N 107.388 -4.46 . . . . 0.0 121.326 144.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -76.62 -46.2 26.94 Favored 'General case' 0 CA--C 1.553 1.09 1 N-CA-C 134.402 8.667 . . . . 0.0 134.402 146.557 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -37.64 -56.83 1.02 Allowed 'General case' 0 CA--C 1.573 1.846 0 N-CA-C 115.088 1.514 . . . . 0.0 115.088 147.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . . . -80.26 -63.41 1.42 Allowed 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.366 -0.833 . . . . 0.0 108.834 -148.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -46.93 -43.74 19.27 Favored 'General case' 0 CA--C 1.576 1.945 0 N-CA-C 117.292 2.331 . . . . 0.0 117.292 171.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . . . -94.73 -5.63 44.95 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 119.211 3.041 . . . . 0.0 119.211 -177.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . . . -85.01 -31.68 23.34 Favored 'General case' 1 N--CA 1.553 4.71 2 N-CA-C 127.488 6.107 . . . . 0.0 127.488 161.148 . . . . . . . . 3 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . . . -39.7 -60.4 0.99 Allowed 'General case' 1 C--N 1.219 -5.089 3 CA-C-N 100.176 -7.738 . . . . 0.0 124.601 164.121 . . . . . . . . 3 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . . . -31.92 -42.04 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.252 -3.657 2 CA-C-N 100.838 -7.437 . . . . 0.0 130.29 137.636 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . . . -93.78 -0.36 55.92 Favored 'General case' 0 C--N 1.275 -2.653 0 N-CA-C 121.535 3.902 . . . . 0.0 121.535 164.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . . . -87.33 -24.65 24.22 Favored 'General case' 0 CA--C 1.609 3.229 0 CA-C-N 109.041 -3.709 . . . . 0.0 114.416 173.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . . . -97.24 -57.74 2.19 Favored 'General case' 0 N--CA 1.505 2.321 1 C-N-CA 132.261 4.224 . . . . 0.0 111.061 -177.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.22 18.01 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.755 0 CA-C-N 112.0 -2.364 . . . . 0.0 116.154 139.498 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.317 -0.821 0 O-C-N 119.598 -1.939 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.564 3.106 0 N-CA-C 114.76 0.664 . . . . 0.0 114.76 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.447 ' C ' ' H ' ' A' ' 6' ' ' ILE . . . -102.63 6.7 0.43 Allowed 'Trans proline' 0 CA--C 1.576 2.602 1 N-CA-C 128.743 6.401 . . . . 0.0 128.743 -174.244 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.411 ' C ' ' H ' ' A' ' 7' ' ' PHE . . . -33.15 -56.99 0.4 Allowed 'General case' 0 C--N 1.263 -3.172 4 C-N-CA 137.357 6.263 . . . . 0.0 124.55 118.893 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -96.7 -38.18 10.02 Favored 'General case' 0 N--CA 1.493 1.677 3 C-N-CA 135.348 5.459 . . . . 0.0 113.978 -158.085 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . . . -93.27 -21.04 19.84 Favored 'General case' 0 CA--C 1.464 -2.33 3 N-CA-C 136.754 9.539 . . . . 0.0 136.754 145.745 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.598 ' C ' ' H ' ' A' ' 8' ' ' ALA . . . -50.16 -55.24 6.12 Favored 'Isoleucine or valine' 0 CA--C 1.434 -3.493 0 CA-C-N 111.383 -2.644 . . . . 0.0 107.923 129.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.457 ' C ' ' H ' ' A' ' 10' ' ' ILE . . . -33.26 -42.55 0.09 Allowed 'General case' 1 C--N 1.231 -4.549 1 N-CA-C 131.661 7.652 . . . . 0.0 131.661 -162.509 . . . . . . . . 4 3 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.598 ' H ' ' C ' ' A' ' 6' ' ' ILE . . . -97.54 -49.81 4.74 Favored 'General case' 1 N--CA 1.32 -6.968 3 CA-C-N 89.772 -12.467 . . . . 0.0 113.709 -147.489 . . . . . . . . 4 3 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.504 ' C ' ' HD2' ' A' ' 13' ' ' PRO . . . -74.51 5.71 4.47 Favored 'General case' 0 C--N 1.375 1.682 2 N-CA-C 138.88 10.326 . . . . 0.0 138.88 129.766 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.457 ' H ' ' C ' ' A' ' 7' ' ' PHE . . . -66.9 -31.23 52.53 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.079 2 CA-C-O 133.719 6.485 . . . . 0.0 125.265 158.154 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.44 ' C ' ' H ' ' A' ' 14' ' ' GLY . . . -108.39 -61.52 1.58 Allowed 'General case' 2 CA--C 1.4 -4.824 4 CA-C-N 91.714 -11.584 . . . . 0.0 124.904 -141.411 . . . . . . . . 4 3 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -78.44 -9.1 0.13 Allowed Pre-proline 0 C--N 1.269 -2.928 2 CA-C-N 99.95 -7.841 . . . . 0.0 118.66 160.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.504 ' HD2' ' C ' ' A' ' 9' ' ' SER . 0.1 OUTLIER -68.35 -18.48 44.28 Favored 'Trans proline' 0 N--CA 1.502 1.978 2 N-CA-C 135.041 8.823 . . . . 0.0 135.041 123.639 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.44 ' H ' ' C ' ' A' ' 11' ' ' LEU . . . -70.07 -14.01 70.49 Favored Glycine 1 N--CA 1.53 4.964 2 CA-C-N 107.613 -4.358 . . . . 0.0 121.2 156.1 . . . . . . . . 4 3 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . . . -101.74 -70.33 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.457 -2.634 3 C-N-CA 136.666 5.986 . . . . 0.0 108.097 -175.185 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -71.88 -1.62 14.94 Favored 'General case' 1 C--N 1.237 -4.303 0 CA-C-N 109.03 -3.713 . . . . 0.0 111.506 -177.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -54.37 -82.87 0.01 OUTLIER 'General case' 0 C--N 1.359 0.983 1 N-CA-C 128.361 6.43 . . . . 0.0 128.361 125.43 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -32.52 -52.51 0.3 Allowed 'General case' 0 CA--C 1.582 2.197 0 N-CA-C 116.976 2.213 . . . . 0.0 116.976 170.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . . . -68.7 -55.98 9.62 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 113.004 -1.907 . . . . 0.0 113.08 -173.028 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -52.42 -39.46 61.01 Favored 'General case' 0 CA--C 1.586 2.353 0 N-CA-C 118.788 2.884 . . . . 0.0 118.788 171.164 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . . . -91.25 -5.55 54.6 Favored 'General case' 0 N--CA 1.516 2.869 0 N-CA-C 120.011 3.337 . . . . 0.0 120.011 178.138 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . . . -88.72 -30.18 19.28 Favored 'General case' 1 N--CA 1.543 4.177 2 N-CA-C 127.092 5.96 . . . . 0.0 127.092 164.607 . . . . . . . . 3 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . . . -37.79 -63.38 0.47 Allowed 'General case' 1 C--N 1.215 -5.257 2 CA-C-N 101.835 -6.984 . . . . 0.0 124.732 157.637 . . . . . . . . 3 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . . . -33.45 -48.4 0.11 Allowed 'Isoleucine or valine' 1 C--N 1.242 -4.076 2 N-CA-C 130.358 7.17 . . . . 0.0 130.358 139.494 . . . . . . . . 3 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . . . -77.87 -5.72 51.9 Favored 'General case' 0 C--N 1.276 -2.598 1 N-CA-C 123.031 4.456 . . . . 0.0 123.031 163.232 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . . . -92.82 -67.93 0.83 Allowed 'General case' 0 N--CA 1.527 3.413 0 CA-C-N 111.724 -2.489 . . . . 0.0 115.948 -161.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . . . -46.01 -53.87 9.36 Favored 'General case' 0 N--CA 1.497 1.875 1 CA-C-N 108.041 -4.163 . . . . 0.0 117.082 146.565 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -77.98 -62.92 1.52 Allowed 'General case' 0 N--CA 1.496 1.852 0 CA-C-N 122.106 2.23 . . . . 0.0 109.943 171.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.299 -1.592 0 CA-C-N 112.172 -2.286 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.553 2.467 0 N-CA-C 103.186 -3.965 . . . . 0.0 103.186 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . . . -99.64 22.62 0.23 Allowed 'Trans proline' 0 N--CA 1.523 3.264 1 N-CA-C 125.337 5.091 . . . . 0.0 125.337 152.402 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.738 ' C ' ' H ' ' A' ' 5' ' ' ARG . . . -64.55 -71.65 0.17 Allowed 'General case' 0 C--O 1.169 -3.156 2 CA-C-N 103.211 -6.359 . . . . 0.0 107.453 117.574 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -37.92 2.26 0.0 OUTLIER 'General case' 1 N--CA 1.554 4.74 0 CA-C-O 128.295 3.902 . . . . 0.0 119.857 -168.718 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.738 ' H ' ' C ' ' A' ' 3' ' ' THR . . . -90.19 -58.03 2.64 Favored 'General case' 0 C--N 1.279 -2.461 3 C-N-CA 138.758 6.823 . . . . 0.0 128.182 170.166 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.533 ' O ' ' N ' ' A' ' 10' ' ' ILE . . . -37.27 -34.62 0.11 Allowed 'Isoleucine or valine' 1 CA--C 1.395 -4.984 1 C-N-CA 136.545 5.938 . . . . 0.0 114.4 129.174 . . . . . . . . 4 3 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.551 ' C ' ' H ' ' A' ' 10' ' ' ILE . . . -78.24 -49.85 12.97 Favored 'General case' 2 CA--C 1.299 -8.696 2 CA-C-O 133.146 6.212 . . . . 0.0 119.297 171.886 . . . . . . . . 4 3 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -41.06 -26.09 0.04 OUTLIER 'General case' 1 N--CA 1.378 -4.063 2 N-CA-C 129.633 6.901 . . . . 0.0 129.633 139.706 . . . . . . . . 3 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.475 ' O ' ' HD2' ' A' ' 13' ' ' PRO . . . -90.7 -19.62 23.38 Favored 'General case' 1 CA--C 1.418 -4.12 3 N-CA-C 141.226 11.195 . . . . 0.0 141.226 140.419 . . . . . . . . 4 3 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.551 ' H ' ' C ' ' A' ' 7' ' ' PHE . . . -66.64 -58.72 5.47 Favored 'Isoleucine or valine' 0 CA--C 1.608 3.187 2 CA-C-N 104.286 -5.87 . . . . 0.0 108.281 -167.957 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.462 ' C ' ' H ' ' A' ' 14' ' ' GLY . . . -106.19 -24.89 12.21 Favored 'General case' 1 CA--C 1.36 -6.35 4 CA-C-N 93.5 -10.773 . . . . 0.0 128.026 -165.109 . . . . . . . . 4 3 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -78.09 -19.25 0.3 Allowed Pre-proline 0 C--N 1.258 -3.407 1 O-C-N 129.573 4.295 . . . . 0.0 117.281 160.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.475 ' HD2' ' O ' ' A' ' 9' ' ' SER . 0.0 OUTLIER -50.3 -26.17 15.12 Favored 'Trans proline' 0 C--N 1.313 -1.296 1 N-CA-C 136.691 9.458 . . . . 0.0 136.691 125.212 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.462 ' H ' ' C ' ' A' ' 11' ' ' LEU . . . -74.2 -7.27 76.95 Favored Glycine 1 N--CA 1.531 5.002 3 O-C-N 130.378 4.799 . . . . 0.0 122.703 156.252 . . . . . . . . 4 3 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . . . -110.49 -57.88 3.88 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.761 2 CA-C-N 105.29 -5.455 . . . . 0.0 117.884 -168.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -28.05 -40.29 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.638 0 CA-C-N 108.506 -3.952 . . . . 0.0 117.217 139.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -73.69 -41.16 63.0 Favored 'General case' 0 N--CA 1.426 -1.66 1 CA-C-N 107.609 -4.359 . . . . 0.0 121.061 -173.573 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -37.28 -58.66 0.81 Allowed 'General case' 0 CA--C 1.574 1.868 0 CA-C-N 112.012 -2.358 . . . . 0.0 117.198 143.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . . . -77.04 -51.86 10.34 Favored 'General case' 0 N--CA 1.487 1.382 0 CA-C-O 126.625 3.107 . . . . 0.0 113.365 -147.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -43.91 -41.63 5.32 Favored 'General case' 0 CA--C 1.584 2.253 0 CA-C-N 109.348 -3.569 . . . . 0.0 117.591 157.371 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . . . -91.42 -2.46 57.27 Favored 'General case' 0 N--CA 1.501 2.078 1 N-CA-C 122.744 4.35 . . . . 0.0 122.744 174.77 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . . . -97.91 -3.74 37.92 Favored 'General case' 1 N--CA 1.548 4.462 1 N-CA-C 126.259 5.651 . . . . 0.0 126.259 164.032 . . . . . . . . 3 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . . . -90.48 -42.86 10.62 Favored 'General case' 1 C--N 1.232 -4.517 4 CA-C-N 102.845 -6.525 . . . . 0.0 126.962 -173.478 . . . . . . . . 3 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . . . -28.04 -88.52 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.291 -1.965 2 CA-C-N 98.062 -8.699 . . . . 0.0 119.904 110.107 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . . . -75.04 15.53 0.4 Allowed 'General case' 0 N--CA 1.534 3.73 2 O-C-N 113.994 -5.441 . . . . 0.0 120.54 -171.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . . . -93.0 -61.01 1.66 Allowed 'General case' 0 N--CA 1.502 2.162 1 CA-C-N 106.498 -4.865 . . . . 0.0 114.876 167.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . . . -48.06 -43.25 30.28 Favored 'General case' 0 N--CA 1.511 2.586 0 N-CA-C 117.002 2.223 . . . . 0.0 117.002 166.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.58 -60.16 2.37 Favored 'General case' 0 N--CA 1.495 1.781 0 CA-C-N 111.889 -2.414 . . . . 0.0 113.06 157.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.297 -1.683 0 CA-C-N 114.073 -1.422 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.561 2.926 0 CA-C-O 127.723 3.957 . . . . 0.0 114.389 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . . . -56.83 -45.6 35.3 Favored 'Trans proline' 1 CA--C 1.417 -5.363 0 CA-C-O 110.699 -3.959 . . . . 0.0 120.314 169.418 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.512 ' CA ' ' H ' ' A' ' 5' ' ' ARG . . . -101.65 51.19 0.84 Allowed 'General case' 0 C--N 1.257 -3.442 1 O-C-N 111.982 -6.699 . . . . 0.0 115.079 156.756 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -57.0 -27.87 61.95 Favored 'General case' 0 N--CA 1.521 3.092 1 N-CA-C 123.415 4.598 . . . . 0.0 123.415 110.261 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.512 ' H ' ' CA ' ' A' ' 3' ' ' THR . . . -100.35 -56.46 2.35 Favored 'General case' 0 C--N 1.282 -2.366 2 N-CA-C 124.356 4.947 . . . . 0.0 124.356 -145.709 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.536 ' O ' ' N ' ' A' ' 10' ' ' ILE . . . -38.6 -45.09 0.4 Allowed 'Isoleucine or valine' 0 C--O 1.157 -3.786 2 CA-C-N 105.654 -5.248 . . . . 0.0 111.54 126.65 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.478 ' H ' ' N ' ' A' ' 5' ' ' ARG . . . -61.41 -60.55 3.55 Favored 'General case' 2 C--O 1.143 -4.543 2 CA-C-O 140.983 9.944 . . . . 0.0 113.306 -172.65 . . . . . . . . 4 3 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -36.81 -36.74 0.12 Allowed 'General case' 1 C--N 1.22 -5.031 2 CA-C-N 102.177 -6.829 . . . . 0.0 105.558 157.141 . . . . . . . . 3 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.528 ' C ' ' HD2' ' A' ' 13' ' ' PRO . . . -90.74 -12.67 35.88 Favored 'General case' 0 CA--C 1.431 -3.632 1 N-CA-C 134.001 8.519 . . . . 0.0 134.001 151.023 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.536 ' N ' ' O ' ' A' ' 6' ' ' ILE . . . -67.61 -57.47 9.48 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.317 0 CA-C-O 127.603 3.573 . . . . 0.0 109.122 174.529 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.573 ' C ' ' H ' ' A' ' 14' ' ' GLY . . . -112.69 -27.92 7.99 Favored 'General case' 1 CA--C 1.384 -5.421 1 CA-C-N 99.256 -8.156 . . . . 0.0 121.566 -156.162 . . . . . . . . 4 3 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -101.48 19.66 0.05 OUTLIER Pre-proline 0 C--N 1.266 -3.026 0 C-N-CA 113.203 -3.399 . . . . 0.0 118.735 159.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.528 ' HD2' ' C ' ' A' ' 9' ' ' SER . 0.0 OUTLIER -53.05 -31.29 53.22 Favored 'Trans proline' 0 N--CA 1.523 3.221 2 N-CA-C 132.654 7.905 . . . . 0.0 132.654 99.487 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.573 ' H ' ' C ' ' A' ' 11' ' ' LEU . . . -59.65 -25.71 61.45 Favored Glycine 3 N--CA 1.552 6.405 1 CA-C-O 129.219 4.788 . . . . 0.0 122.444 167.453 . . . . . . . . 4 3 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . . . -107.11 -69.86 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.28 -2.444 2 CA-C-N 101.512 -7.344 . . . . 0.0 113.698 -163.217 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -27.0 -32.43 0.0 OUTLIER 'General case' 0 C--N 1.277 -2.568 0 N-CA-C 119.676 3.213 . . . . 0.0 119.676 153.515 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -85.1 -46.01 11.55 Favored 'General case' 0 C--N 1.328 -0.363 2 N-CA-C 123.334 4.568 . . . . 0.0 123.334 167.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -39.18 -57.74 1.28 Allowed 'General case' 0 N--CA 1.508 2.425 0 CA-C-O 123.249 1.499 . . . . 0.0 114.302 151.126 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . . . -81.99 -55.76 4.38 Favored 'General case' 0 CA--C 1.553 1.083 0 CA-C-O 123.32 1.533 . . . . 0.0 109.123 -140.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -48.62 -56.35 8.71 Favored 'General case' 0 CA--C 1.567 1.603 0 CA-C-N 112.728 -2.033 . . . . 0.0 115.128 162.009 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . . . -90.24 13.26 15.73 Favored 'General case' 0 N--CA 1.532 3.672 1 O-C-N 116.052 -4.155 . . . . 0.0 119.216 -178.568 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . . . -87.48 -32.72 19.31 Favored 'General case' 0 CA--C 1.427 -3.761 0 N-CA-C 121.464 3.876 . . . . 0.0 121.464 158.019 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . . . -43.52 -59.11 2.3 Favored 'General case' 0 C--N 1.253 -3.598 0 CA-C-N 108.665 -3.88 . . . . 0.0 114.804 174.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . . . -36.23 -46.14 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.26 -3.284 2 CA-C-N 102.379 -6.737 . . . . 0.0 125.261 148.161 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . . . -72.13 -14.47 61.84 Favored 'General case' 0 C--N 1.278 -2.502 1 N-CA-C 121.991 4.071 . . . . 0.0 121.991 162.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . . . -91.01 -61.56 1.64 Allowed 'General case' 0 N--CA 1.511 2.602 0 CA-C-N 110.681 -2.963 . . . . 0.0 108.375 -160.445 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . . . -49.91 -42.58 48.41 Favored 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 128.659 2.784 . . . . 0.0 118.238 157.232 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.7 -50.19 46.09 Favored 'General case' 0 N--CA 1.503 2.208 0 CA-C-O 124.159 1.933 . . . . 0.0 110.227 161.257 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.301 -1.532 0 CA-C-N 113.05 -1.886 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.562 2.978 0 N-CA-C 118.375 2.11 . . . . 0.0 118.375 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . . . -96.34 -6.85 1.31 Allowed 'Trans proline' 1 CA--C 1.606 4.089 1 C-N-CA 125.855 4.37 . . . . 0.0 120.872 -177.064 . . . . . . . . 3 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.432 ' O ' ' N ' ' A' ' 7' ' ' PHE . . . -32.77 -68.32 0.1 Allowed 'General case' 1 C--O 1.148 -4.265 2 CA-C-N 106.772 -4.74 . . . . 0.0 119.442 117.856 . . . . . . . . 4 3 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -58.47 -21.46 51.49 Favored 'General case' 0 N--CA 1.503 2.181 0 CA-C-O 127.295 3.426 . . . . 0.0 116.887 179.284 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . . . -95.0 -42.43 8.64 Favored 'General case' 0 C--N 1.296 -1.743 3 CA-C-N 103.729 -6.123 . . . . 0.0 125.905 174.684 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.428 ' O ' ' N ' ' A' ' 9' ' ' SER . . . -45.95 -51.69 3.39 Favored 'Isoleucine or valine' 0 C--O 1.192 -1.932 0 O-C-N 128.948 3.905 . . . . 0.0 106.128 136.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.436 ' O ' ' N ' ' A' ' 10' ' ' ILE . . . -45.32 -64.44 0.72 Allowed 'General case' 3 N--CA 1.561 5.098 0 O-C-N 126.551 2.407 . . . . 0.0 113.063 -155.942 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -39.38 -47.62 1.79 Allowed 'General case' 1 N--CA 1.373 -4.319 4 C-N-CA 153.271 12.628 . . . . 0.0 100.027 166.512 . . . . . . . . 3 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.523 ' O ' ' HG2' ' A' ' 13' ' ' PRO . . . -91.75 19.2 6.67 Favored 'General case' 0 N--CA 1.513 2.676 1 N-CA-C 132.711 8.041 . . . . 0.0 132.711 153.15 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.436 ' N ' ' O ' ' A' ' 7' ' ' PHE . . . -109.29 -49.65 7.09 Favored 'Isoleucine or valine' 2 CA--C 1.644 4.576 2 N-CA-C 98.912 -4.477 . . . . 0.0 98.912 -177.547 . . . . . . . . 4 3 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.507 ' C ' ' H ' ' A' ' 14' ' ' GLY . . . -62.97 -52.78 61.66 Favored 'General case' 1 CA--C 1.361 -6.297 2 C-N-CA 138.429 6.692 . . . . 0.0 126.301 -177.71 . . . . . . . . 4 3 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -95.83 -15.52 0.2 Allowed Pre-proline 0 C--N 1.248 -3.844 2 O-C-N 135.102 7.751 . . . . 0.0 112.744 -177.212 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.523 ' HG2' ' O ' ' A' ' 9' ' ' SER . 0.1 OUTLIER -54.67 -24.55 37.8 Favored 'Trans proline' 0 N--CA 1.504 2.144 1 N-CA-C 128.56 6.331 . . . . 0.0 128.56 121.467 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.507 ' H ' ' C ' ' A' ' 11' ' ' LEU . . . -85.83 -0.3 87.63 Favored Glycine 2 N--CA 1.533 5.157 1 CA-C-N 108.127 -4.124 . . . . 0.0 121.814 164.465 . . . . . . . . 4 3 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . . . -103.89 -69.36 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.642 2 CA-C-N 106.409 -4.896 . . . . 0.0 114.335 175.523 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -24.03 -41.4 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.714 0 CA-C-N 110.865 -2.88 . . . . 0.0 117.994 156.02 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.44 -81.66 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.716 1 CA-C-N 106.073 -5.058 . . . . 0.0 121.287 158.512 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -36.33 -60.12 0.59 Allowed 'General case' 0 CA--C 1.581 2.168 0 N-CA-C 117.182 2.29 . . . . 0.0 117.182 171.235 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . . . -58.69 -57.38 13.25 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 128.874 2.87 . . . . 0.0 112.347 -168.166 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -71.7 -36.48 70.58 Favored 'General case' 0 CA--C 1.574 1.893 0 C-N-CA 127.689 2.396 . . . . 0.0 115.667 -176.185 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . . . -85.88 -0.86 56.48 Favored 'General case' 0 N--CA 1.506 2.374 0 N-CA-C 117.598 2.444 . . . . 0.0 117.598 173.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . . . -104.67 -26.87 12.13 Favored 'General case' 1 N--CA 1.554 4.743 1 N-CA-C 125.376 5.325 . . . . 0.0 125.376 176.427 . . . . . . . . 3 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . . . -35.0 -68.89 0.11 Allowed 'General case' 0 C--N 1.258 -3.37 1 CA-C-N 102.823 -6.535 . . . . 0.0 118.625 146.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . . . -34.28 -41.0 0.09 OUTLIER 'Isoleucine or valine' 1 C--N 1.236 -4.335 2 CA-C-N 105.484 -5.325 . . . . 0.0 122.642 148.921 . . . . . . . . 3 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . . . -94.71 2.47 55.56 Favored 'General case' 0 C--N 1.275 -2.646 0 N-CA-C 120.837 3.643 . . . . 0.0 120.837 170.524 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . . . -91.2 -25.11 19.69 Favored 'General case' 0 CA--C 1.608 3.185 0 CA-C-N 108.552 -3.931 . . . . 0.0 113.977 169.33 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . . . -96.85 -59.3 1.83 Allowed 'General case' 0 N--CA 1.507 2.419 0 C-N-CA 131.157 3.783 . . . . 0.0 110.163 -176.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.44 23.4 0.12 Allowed 'General case' 0 N--CA 1.497 1.886 0 CA-C-N 112.195 -2.275 . . . . 0.0 114.233 141.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.316 -0.87 0 O-C-N 119.359 -2.088 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.569 3.448 0 N-CA-C 117.691 1.837 . . . . 0.0 117.691 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . . . -120.96 14.59 0.02 OUTLIER 'Trans proline' 0 CA--C 1.561 1.848 1 N-CA-C 125.474 5.144 . . . . 0.0 125.474 -164.537 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.727 ' C ' ' H ' ' A' ' 5' ' ' ARG . . . -55.56 -67.84 0.25 Allowed 'General case' 0 C--O 1.179 -2.642 2 CA-C-O 109.121 -5.228 . . . . 0.0 108.441 114.047 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -52.31 -1.14 0.02 OUTLIER 'General case' 1 N--CA 1.569 5.521 1 CA-C-O 131.128 5.251 . . . . 0.0 118.594 -147.739 . . . . . . . . 3 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.727 ' H ' ' C ' ' A' ' 3' ' ' THR . . . -93.29 -56.29 3.0 Favored 'General case' 0 C--N 1.269 -2.895 3 C-N-CA 142.114 8.166 . . . . 0.0 123.219 -176.515 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.565 ' C ' ' H ' ' A' ' 9' ' ' SER . . . -39.28 -29.77 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.435 -3.457 1 CA-C-O 110.952 -4.356 . . . . 0.0 109.516 125.494 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.503 ' H ' ' N ' ' A' ' 5' ' ' ARG . . . -72.34 -56.85 4.8 Favored 'General case' 1 N--CA 1.558 4.939 2 CA-C-O 131.312 5.339 . . . . 0.0 115.367 -173.013 . . . . . . . . 4 3 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -37.44 -49.24 1.01 Allowed 'General case' 1 C--N 1.233 -4.497 3 C-N-CA 142.179 8.192 . . . . 0.0 100.704 150.732 . . . . . . . . 3 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.565 ' H ' ' C ' ' A' ' 6' ' ' ILE . . . -102.66 -6.46 22.69 Favored 'General case' 0 N--CA 1.52 3.065 1 N-CA-C 128.829 6.603 . . . . 0.0 128.829 174.957 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.474 ' C ' ' HB2' ' A' ' 13' ' ' PRO . . . -84.85 -47.54 17.08 Favored 'Isoleucine or valine' 1 C--N 1.231 -4.562 2 CA-C-N 106.894 -4.685 . . . . 0.0 98.392 -179.455 . . . . . . . . 4 3 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.555 ' C ' ' H ' ' A' ' 14' ' ' GLY . . . -106.13 -33.38 7.87 Favored 'General case' 1 CA--C 1.378 -5.64 1 N-CA-C 123.457 4.614 . . . . 0.0 123.457 -157.276 . . . . . . . . 4 3 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -76.41 -23.1 0.44 Allowed Pre-proline 0 C--N 1.246 -3.897 2 O-C-N 130.065 4.603 . . . . 0.0 113.343 166.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.529 ' HG2' ' O ' ' A' ' 9' ' ' SER . 0.0 OUTLIER -48.34 -27.45 9.9 Favored 'Trans proline' 0 CA--C 1.476 -2.416 1 N-CA-C 129.113 6.544 . . . . 0.0 129.113 127.895 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.555 ' H ' ' C ' ' A' ' 11' ' ' LEU . . . -64.93 -21.03 67.29 Favored Glycine 2 N--CA 1.544 5.855 1 CA-C-O 128.106 4.17 . . . . 0.0 122.742 160.041 . . . . . . . . 4 3 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . . . -108.45 -68.99 0.95 Allowed 'Isoleucine or valine' 0 CA--C 1.462 -2.427 2 CA-C-N 103.262 -6.469 . . . . 0.0 111.936 -159.667 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -26.37 -32.92 0.0 OUTLIER 'General case' 0 C--N 1.269 -2.921 0 N-CA-C 119.937 3.31 . . . . 0.0 119.937 148.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -88.75 -41.46 12.53 Favored 'General case' 0 N--CA 1.466 0.326 2 N-CA-C 123.7 4.704 . . . . 0.0 123.7 167.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -39.01 -59.15 1.02 Allowed 'General case' 0 N--CA 1.511 2.593 0 CA-C-O 123.796 1.76 . . . . 0.0 114.881 148.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . . . -77.3 -56.46 4.53 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 114.714 -1.13 . . . . 0.0 108.316 -143.117 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -42.44 -45.4 4.38 Favored 'General case' 0 CA--C 1.582 2.204 0 C-N-CA 126.52 1.928 . . . . 0.0 115.741 159.684 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . . . -92.57 1.77 57.07 Favored 'General case' 0 CA--C 1.578 2.054 0 N-CA-C 119.251 3.056 . . . . 0.0 119.251 -176.015 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . . . -106.54 -15.7 14.72 Favored 'General case' 1 N--CA 1.56 5.064 1 N-CA-C 124.075 4.843 . . . . 0.0 124.075 157.521 . . . . . . . . 3 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . . . -36.68 -69.67 0.11 Allowed 'General case' 1 C--N 1.233 -4.468 0 CA-C-N 108.794 -3.821 . . . . 0.0 118.61 157.36 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . . . -35.47 -43.65 0.15 Allowed 'Isoleucine or valine' 1 C--N 1.224 -4.879 2 CA-C-N 102.526 -6.67 . . . . 0.0 123.099 149.961 . . . . . . . . 3 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . . . -92.29 1.82 57.0 Favored 'General case' 0 C--N 1.292 -1.893 0 N-CA-C 118.398 2.74 . . . . 0.0 118.398 171.163 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . . . -90.91 -32.57 15.95 Favored 'General case' 0 CA--C 1.612 3.328 0 CA-C-N 110.71 -2.95 . . . . 0.0 113.632 175.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . . . -97.05 -48.91 5.21 Favored 'General case' 0 N--CA 1.509 2.482 1 C-N-CA 131.968 4.107 . . . . 0.0 110.818 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -78.44 22.74 0.32 Allowed 'General case' 0 N--CA 1.499 1.985 0 C-N-CA 117.586 -1.646 . . . . 0.0 113.419 140.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.317 -0.807 0 O-C-N 119.622 -1.924 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.56 2.883 0 CA-C-O 119.151 -0.805 . . . . 0.0 112.022 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . . . -130.01 26.42 0.0 OUTLIER 'Trans proline' 0 N--CA 1.514 2.723 1 N-CA-C 125.119 5.007 . . . . 0.0 125.119 -163.673 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.485 ' C ' ' H ' ' A' ' 5' ' ' ARG . . . -54.92 -81.51 0.01 OUTLIER 'General case' 0 C--O 1.189 -2.109 2 CA-C-N 104.679 -5.691 . . . . 0.0 100.148 109.012 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -61.03 -10.26 5.68 Favored 'General case' 0 N--CA 1.521 3.075 0 O-C-N 127.694 3.121 . . . . 0.0 118.458 -122.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.485 ' H ' ' C ' ' A' ' 3' ' ' THR . . . -95.13 -48.8 5.79 Favored 'General case' 0 C--N 1.301 -1.542 4 C-N-CA 141.899 8.08 . . . . 0.0 128.466 -176.226 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.649 ' C ' ' H ' ' A' ' 9' ' ' SER . . . -37.16 -60.3 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.512 2.631 3 N-CA-C 89.576 -7.935 . . . . 0.0 89.576 142.834 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . . . -103.34 -32.04 9.75 Favored 'General case' 1 N--CA 1.371 -4.405 1 CA-C-O 130.934 5.159 . . . . 0.0 111.664 -128.603 . . . . . . . . 3 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -45.88 -36.27 5.22 Favored 'General case' 0 CA--C 1.446 -3.053 1 O-C-N 116.054 -4.154 . . . . 0.0 121.197 126.757 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.649 ' H ' ' C ' ' A' ' 6' ' ' ILE . . . -90.7 10.6 25.2 Favored 'General case' 0 N--CA 1.524 3.258 1 N-CA-C 125.11 5.226 . . . . 0.0 125.11 176.094 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . . . -110.99 -42.39 4.74 Favored 'Isoleucine or valine' 1 CA--C 1.651 4.855 1 CA-C-N 106.817 -4.719 . . . . 0.0 102.094 -176.364 . . . . . . . . 3 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.541 ' C ' ' H ' ' A' ' 14' ' ' GLY . . . -54.71 -59.33 4.86 Favored 'General case' 1 CA--C 1.373 -5.852 1 C-N-CA 138.069 6.548 . . . . 0.0 120.91 170.374 . . . . . . . . 4 3 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -81.89 -41.18 1.01 Allowed Pre-proline 1 N--CA 1.362 -4.857 1 CA-C-N 105.47 -5.332 . . . . 0.0 102.968 -172.42 . . . . . . . . 3 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.535 ' HD2' ' C ' ' A' ' 9' ' ' SER . 0.1 OUTLIER -37.56 -22.4 0.05 OUTLIER 'Trans proline' 0 N--CA 1.518 2.927 2 O-C-N 108.919 -6.411 . . . . 0.0 127.829 134.853 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.541 ' H ' ' C ' ' A' ' 11' ' ' LEU . . . -80.33 -7.21 88.76 Favored Glycine 2 N--CA 1.529 4.851 1 CA-C-N 108.141 -4.118 . . . . 0.0 119.886 163.045 . . . . . . . . 4 3 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . . . -105.86 -76.53 0.46 Allowed 'Isoleucine or valine' 0 C--O 1.2 -1.521 2 C-N-CA 133.1 4.56 . . . . 0.0 110.89 -166.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -21.1 -34.71 0.0 OUTLIER 'General case' 0 C--N 1.26 -3.306 0 N-CA-C 120.367 3.469 . . . . 0.0 120.367 147.001 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -83.8 -45.29 13.46 Favored 'General case' 0 N--CA 1.476 0.827 1 N-CA-C 125.246 5.276 . . . . 0.0 125.246 160.531 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -36.4 -55.42 0.82 Allowed 'General case' 0 N--CA 1.517 2.878 0 CA-C-O 125.235 2.445 . . . . 0.0 116.276 154.461 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . . . -78.07 -50.25 12.42 Favored 'General case' 0 N--CA 1.48 1.047 0 CA-C-O 124.047 1.879 . . . . 0.0 111.327 -152.057 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -37.93 -48.98 1.21 Allowed 'General case' 0 N--CA 1.413 -2.29 0 C-N-CA 131.617 3.967 . . . . 0.0 120.836 149.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . . . -87.89 7.86 28.83 Favored 'General case' 0 N--CA 1.514 2.731 0 N-CA-C 119.901 3.297 . . . . 0.0 119.901 170.53 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . . . -104.08 -30.69 10.09 Favored 'General case' 0 N--CA 1.534 3.771 1 N-CA-C 124.429 4.974 . . . . 0.0 124.429 173.572 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . . . -37.82 -59.49 0.81 Allowed 'General case' 0 C--N 1.258 -3.404 2 CA-C-N 104.18 -5.918 . . . . 0.0 121.877 152.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . . . -36.13 -47.24 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.262 -3.205 3 O-C-N 134.567 7.417 . . . . 0.0 123.071 140.259 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . . . -91.89 4.81 52.09 Favored 'General case' 0 C--N 1.269 -2.902 0 O-C-N 119.128 -2.233 . . . . 0.0 116.437 170.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . . . -96.56 -60.0 1.7 Allowed 'General case' 0 N--CA 1.521 3.112 0 CA-C-N 110.475 -3.057 . . . . 0.0 113.572 -175.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . . . -47.16 -38.4 11.69 Favored 'General case' 0 N--CA 1.51 2.564 0 CA-C-N 109.06 -3.7 . . . . 0.0 115.053 158.175 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -91.13 -83.19 0.28 Allowed 'General case' 0 N--CA 1.489 1.489 0 CA-C-O 123.36 1.552 . . . . 0.0 108.411 164.202 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.296 -1.741 0 O-C-N 121.224 -0.923 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.558 2.736 0 CA-C-O 123.645 1.692 . . . . 0.0 117.12 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . . . -65.5 -54.1 0.66 Allowed 'Trans proline' 1 CA--C 1.412 -5.587 0 CA-C-O 110.883 -3.882 . . . . 0.0 118.752 -172.021 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . . . -96.25 56.96 1.66 Allowed 'General case' 0 C--N 1.264 -3.126 2 O-C-N 111.859 -6.776 . . . . 0.0 112.104 149.558 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -75.56 -14.36 60.39 Favored 'General case' 0 N--CA 1.523 3.19 1 O-C-N 116.156 -4.09 . . . . 0.0 121.269 111.379 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . . . -97.47 -55.55 2.79 Favored 'General case' 0 N--CA 1.492 1.635 1 N-CA-C 122.161 4.134 . . . . 0.0 122.161 -155.803 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . . . -38.32 -55.09 0.35 Allowed 'Isoleucine or valine' 1 CA--C 1.418 -4.104 0 CA-C-N 108.428 -3.987 . . . . 0.0 111.262 131.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . . . -45.87 -63.27 1.01 Allowed 'General case' 3 CA--C 1.299 -8.704 0 O-C-N 127.406 2.941 . . . . 0.0 111.007 -175.001 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -35.63 -49.1 0.55 Allowed 'General case' 0 C--N 1.273 -2.733 2 C-N-CA 141.414 7.886 . . . . 0.0 104.361 167.591 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.47 ' O ' ' HG2' ' A' ' 13' ' ' PRO . . . -76.44 -13.43 60.11 Favored 'General case' 1 N--CA 1.539 4.024 2 N-CA-C 134.667 8.765 . . . . 0.0 134.667 169.0 . . . . . . . . 4 3 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . . . -103.84 -45.55 9.79 Favored 'Isoleucine or valine' 2 C--N 1.204 -5.731 2 CA-C-N 97.549 -8.932 . . . . 0.0 99.1 -161.293 . . . . . . . . 3 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.521 ' C ' ' H ' ' A' ' 14' ' ' GLY . . . -94.77 -56.6 2.72 Favored 'General case' 1 CA--C 1.397 -4.931 1 C-N-CA 135.144 5.378 . . . . 0.0 118.402 -148.135 . . . . . . . . 4 3 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -86.26 -12.89 0.19 Allowed Pre-proline 0 C--N 1.262 -3.199 2 O-C-N 135.848 8.217 . . . . 0.0 113.32 178.766 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.47 ' HG2' ' O ' ' A' ' 9' ' ' SER . 0.1 OUTLIER -56.08 -27.7 66.09 Favored 'Trans proline' 0 N--CA 1.52 3.053 2 N-CA-C 131.501 7.462 . . . . 0.0 131.501 118.579 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.521 ' H ' ' C ' ' A' ' 11' ' ' LEU . . . -77.97 -5.15 86.71 Favored Glycine 3 N--CA 1.562 7.051 2 CA-C-O 130.659 5.589 . . . . 0.0 123.301 164.845 . . . . . . . . 4 3 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . . . -105.61 -78.4 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.278 -2.514 2 C-N-CA 139.386 7.074 . . . . 0.0 117.819 179.616 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -29.6 -30.34 0.0 OUTLIER 'General case' 0 C--N 1.264 -3.139 0 N-CA-C 117.932 2.567 . . . . 0.0 117.932 152.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -53.19 -77.56 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.863 0 CA-C-N 109.21 -3.632 . . . . 0.0 120.627 150.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -33.68 -58.27 0.42 Allowed 'General case' 0 CA--C 1.571 1.788 0 N-CA-C 116.685 2.106 . . . . 0.0 116.685 169.425 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . . . -64.8 -41.37 95.85 Favored 'General case' 0 CA--C 1.552 1.04 0 CA-C-N 113.6 -1.636 . . . . 0.0 113.67 -164.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -83.43 -27.8 29.28 Favored 'General case' 0 CA--C 1.582 2.198 0 C-N-CA 129.142 2.977 . . . . 0.0 114.593 -178.317 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . . . -84.51 3.66 35.45 Favored 'General case' 0 N--CA 1.505 2.304 0 N-CA-C 120.034 3.346 . . . . 0.0 120.034 158.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . . . -103.39 -27.16 12.6 Favored 'General case' 1 N--CA 1.548 4.443 1 N-CA-C 124.534 5.012 . . . . 0.0 124.534 173.261 . . . . . . . . 3 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . . . -35.99 -67.41 0.16 Allowed 'General case' 0 C--N 1.257 -3.414 1 CA-C-N 103.779 -6.101 . . . . 0.0 119.048 149.065 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . . . -33.9 -41.86 0.09 OUTLIER 'Isoleucine or valine' 1 C--N 1.239 -4.219 2 CA-C-N 104.851 -5.613 . . . . 0.0 122.801 147.961 . . . . . . . . 3 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . . . -94.43 3.08 55.63 Favored 'General case' 0 C--N 1.274 -2.705 0 N-CA-C 120.838 3.644 . . . . 0.0 120.838 170.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . . . -90.97 -25.75 19.59 Favored 'General case' 0 CA--C 1.609 3.222 1 CA-C-N 108.381 -4.008 . . . . 0.0 113.831 169.34 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . . . -96.82 -59.11 1.87 Allowed 'General case' 0 N--CA 1.507 2.406 0 C-N-CA 131.266 3.826 . . . . 0.0 110.239 -176.264 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.14 23.62 0.1 Allowed 'General case' 0 N--CA 1.498 1.929 0 CA-C-N 112.152 -2.295 . . . . 0.0 114.225 141.353 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.316 -0.849 0 O-C-N 119.361 -2.087 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.572 3.632 0 N-CA-C 117.796 1.878 . . . . 0.0 117.796 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . . . -127.34 -7.92 0.0 OUTLIER 'Trans proline' 1 N--CA 1.538 4.106 1 N-CA-C 129.978 6.876 . . . . 0.0 129.978 -155.399 . . . . . . . . 3 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.467 ' O ' ' CA ' ' A' ' 7' ' ' PHE . . . -35.68 -61.72 0.45 Allowed 'General case' 0 C--O 1.161 -3.603 2 CA-C-N 100.892 -7.413 . . . . 0.0 110.959 119.192 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -93.54 -21.28 19.54 Favored 'General case' 0 N--CA 1.524 3.248 1 CA-C-O 129.78 4.609 . . . . 0.0 115.973 -137.223 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.516 ' CA ' ' H ' ' A' ' 7' ' ' PHE . . . -90.0 -22.43 21.9 Favored 'General case' 0 C--N 1.268 -2.95 3 N-CA-C 141.871 11.434 . . . . 0.0 141.871 136.498 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.438 ' O ' ' N ' ' A' ' 10' ' ' ILE . . . -46.01 -43.32 4.73 Favored 'Isoleucine or valine' 0 CA--C 1.465 -2.289 0 O-C-N 128.886 3.866 . . . . 0.0 106.763 126.095 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.516 ' H ' ' CA ' ' A' ' 5' ' ' ARG . . . -67.08 -61.16 2.07 Favored 'General case' 0 N--CA 1.401 -2.919 1 CA-C-O 129.405 4.431 . . . . 0.0 118.194 -133.813 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -35.1 -27.18 0.01 OUTLIER 'General case' 2 C--N 1.195 -6.132 2 N-CA-C 136.562 9.467 . . . . 0.0 136.562 130.275 . . . . . . . . 3 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.477 ' O ' ' HD2' ' A' ' 13' ' ' PRO . . . -89.35 5.59 44.39 Favored 'General case' 0 C--N 1.255 -3.502 1 N-CA-C 135.188 8.958 . . . . 0.0 135.188 140.647 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.438 ' N ' ' O ' ' A' ' 6' ' ' ILE . . . -67.7 -43.29 86.71 Favored 'Isoleucine or valine' 0 C--N 1.255 -3.503 1 CA-C-O 129.246 4.355 . . . . 0.0 118.642 162.302 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . . . -116.82 -28.85 6.21 Favored 'General case' 1 CA--C 1.406 -4.584 3 CA-C-N 98.219 -8.628 . . . . 0.0 127.937 -149.486 . . . . . . . . 3 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -76.91 -23.93 0.45 Allowed Pre-proline 1 C--N 1.244 -4.003 3 O-C-N 135.077 7.736 . . . . 0.0 122.988 150.65 . . . . . . . . 3 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.477 ' HD2' ' O ' ' A' ' 9' ' ' SER . 0.1 OUTLIER -59.36 -22.76 67.14 Favored 'Trans proline' 0 C--N 1.31 -1.486 1 N-CA-C 130.72 7.162 . . . . 0.0 130.72 128.365 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -80.66 4.91 66.75 Favored Glycine 1 N--CA 1.518 4.118 2 CA-C-N 104.567 -5.742 . . . . 0.0 120.26 159.043 . . . . . . . . 3 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . . . -113.39 -67.72 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 C-N-CA 131.127 3.771 . . . . 0.0 113.058 -174.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -26.96 -34.96 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 108.917 -3.765 . . . . 0.0 119.506 145.139 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.83 -70.4 0.21 Allowed 'General case' 0 N--CA 1.441 -0.91 2 N-CA-C 126.167 5.618 . . . . 0.0 126.167 155.335 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -38.22 -54.76 1.37 Allowed 'General case' 0 CA--C 1.583 2.232 0 N-CA-C 118.187 2.662 . . . . 0.0 118.187 163.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . . . -39.46 -56.47 1.6 Allowed 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 129.731 3.213 . . . . 0.0 115.507 174.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -80.9 -27.28 36.32 Favored 'General case' 0 CA--C 1.567 1.598 0 CA-C-N 109.998 -3.274 . . . . 0.0 113.757 -178.228 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . . . -98.49 10.52 40.73 Favored 'General case' 0 N--CA 1.525 3.297 1 N-CA-C 130.874 7.361 . . . . 0.0 130.874 160.018 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . . . -95.12 -28.37 15.11 Favored 'General case' 0 N--CA 1.538 3.934 2 N-CA-C 125.718 5.451 . . . . 0.0 125.718 157.715 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . . . -30.84 -56.75 0.22 Allowed 'General case' 2 N--CA 1.366 -4.645 2 CA-C-N 103.517 -6.22 . . . . 0.0 119.53 138.208 . . . . . . . . 3 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . . . -94.35 -8.88 9.67 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.239 0 C-N-CA 113.901 -3.12 . . . . 0.0 117.924 -171.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . . . -71.02 -14.52 62.37 Favored 'General case' 0 C--N 1.307 -1.252 1 N-CA-C 127.46 6.096 . . . . 0.0 127.46 148.531 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . . . -92.6 -48.36 6.65 Favored 'General case' 1 N--CA 1.548 4.465 0 N-CA-C 118.845 2.906 . . . . 0.0 118.845 -162.219 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . . . -46.19 -72.98 0.04 OUTLIER 'General case' 0 C--N 1.288 -2.076 1 CA-C-N 106.22 -4.991 . . . . 0.0 117.266 138.536 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -77.1 -58.77 3.09 Favored 'General case' 0 N--CA 1.493 1.712 0 CA-C-O 124.802 2.239 . . . . 0.0 111.548 -172.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.298 -1.673 0 CA-C-N 111.988 -2.369 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.557 2.685 0 CA-C-O 123.632 1.684 . . . . 0.0 115.952 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . . . -63.09 -45.4 12.62 Favored 'Trans proline' 1 CA--C 1.422 -5.101 0 N-CA-C 121.899 3.769 . . . . 0.0 121.899 -178.722 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.406 ' CA ' ' H ' ' A' ' 5' ' ' ARG . . . -95.7 47.98 1.12 Allowed 'General case' 0 C--N 1.267 -2.982 1 O-C-N 111.697 -6.877 . . . . 0.0 112.956 147.008 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -63.05 -17.92 62.78 Favored 'General case' 0 N--CA 1.521 3.116 1 N-CA-C 123.337 4.569 . . . . 0.0 123.337 117.684 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.406 ' H ' ' CA ' ' A' ' 3' ' ' THR . . . -105.92 -56.89 2.12 Favored 'General case' 0 C--N 1.298 -1.656 3 N-CA-C 124.967 5.173 . . . . 0.0 124.967 -141.292 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . . . -35.48 -61.11 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.425 -3.838 1 CA-C-N 106.682 -4.781 . . . . 0.0 114.599 113.43 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . . . -35.39 -41.01 0.17 Allowed 'General case' 3 CA--C 1.333 -7.403 2 N-CA-C 129.336 6.791 . . . . 0.0 129.336 -179.487 . . . . . . . . 3 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -57.03 -52.26 65.99 Favored 'General case' 1 N--CA 1.315 -7.192 4 O-C-N 145.693 14.37 . . . . 0.0 125.673 165.426 . . . . . . . . 3 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.447 ' O ' ' HG2' ' A' ' 13' ' ' PRO . . . -97.3 0.37 47.94 Favored 'General case' 0 N--CA 1.501 2.096 3 N-CA-C 132.805 8.076 . . . . 0.0 132.805 160.782 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . . . -62.61 -39.72 85.68 Favored 'Isoleucine or valine' 0 C--N 1.246 -3.91 2 CA-C-N 101.757 -7.019 . . . . 0.0 120.202 150.418 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.472 ' C ' ' H ' ' A' ' 14' ' ' GLY . . . -100.63 -52.58 3.3 Favored 'General case' 1 CA--C 1.416 -4.194 3 CA-C-N 99.029 -8.26 . . . . 0.0 125.736 -145.088 . . . . . . . . 4 3 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -81.29 -21.3 0.31 Allowed Pre-proline 0 N--CA 1.379 -3.99 2 O-C-N 136.935 8.897 . . . . 0.0 116.151 167.027 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.447 ' HG2' ' O ' ' A' ' 9' ' ' SER . 12.2 Cg_exo -52.53 -24.27 21.77 Favored 'Trans proline' 0 N--CA 1.51 2.474 2 N-CA-C 134.683 8.686 . . . . 0.0 134.683 118.13 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.472 ' H ' ' C ' ' A' ' 11' ' ' LEU . . . -78.41 -3.07 85.72 Favored Glycine 2 N--CA 1.543 5.793 2 CA-C-N 106.655 -4.793 . . . . 0.0 120.827 159.539 . . . . . . . . 4 3 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . . . -114.87 -77.81 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.467 -2.238 2 C-N-CA 134.852 5.261 . . . . 0.0 112.409 -169.513 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -29.29 -27.91 0.0 OUTLIER 'General case' 0 C--N 1.274 -2.71 0 N-CA-C 119.939 3.311 . . . . 0.0 119.939 150.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -57.76 -69.02 0.19 Allowed 'General case' 0 CA--C 1.549 0.923 1 N-CA-C 130.425 7.195 . . . . 0.0 130.425 145.697 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -35.54 -54.69 0.68 Allowed 'General case' 0 CA--C 1.578 2.03 0 N-CA-C 116.955 2.205 . . . . 0.0 116.955 159.648 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . . . -77.3 -55.15 5.66 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 113.653 -1.612 . . . . 0.0 111.555 -155.519 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -39.82 -41.9 1.21 Allowed 'General case' 0 CA--C 1.586 2.349 0 N-CA-C 117.522 2.415 . . . . 0.0 117.522 157.083 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . . . -95.22 14.17 23.09 Favored 'General case' 0 N--CA 1.502 2.165 1 N-CA-C 123.86 4.763 . . . . 0.0 123.86 175.031 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.416 ' C ' ' H ' ' A' ' 25' ' ' GLU . . . -101.87 -6.68 23.25 Favored 'General case' 1 N--CA 1.555 4.78 1 N-CA-C 127.42 6.082 . . . . 0.0 127.42 151.009 . . . . . . . . 4 3 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . . . -81.13 -48.2 12.45 Favored 'General case' 1 C--N 1.221 -4.988 2 CA-C-N 102.955 -6.475 . . . . 0.0 123.262 -173.019 . . . . . . . . 3 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . . . -23.71 -52.74 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.283 -2.32 3 N-CA-C 131.404 7.557 . . . . 0.0 131.404 115.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.416 ' H ' ' C ' ' A' ' 22' ' ' ARG . . . -90.66 8.81 32.46 Favored 'General case' 0 N--CA 1.521 3.097 0 O-C-N 118.12 -2.863 . . . . 0.0 117.085 169.769 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . . . -96.25 -61.8 1.38 Allowed 'General case' 0 N--CA 1.518 2.928 0 CA-C-N 108.768 -3.833 . . . . 0.0 116.215 -175.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . . . -46.34 -46.16 18.06 Favored 'General case' 0 N--CA 1.494 1.76 1 CA-C-N 108.006 -4.179 . . . . 0.0 115.431 156.547 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -91.29 -79.56 0.37 Allowed 'General case' 0 N--CA 1.484 1.258 0 CA-C-O 123.871 1.796 . . . . 0.0 108.788 166.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.297 -1.681 0 CA-C-N 114.228 -1.351 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.559 2.826 0 N-CA-C 119.032 2.373 . . . . 0.0 119.032 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . . . -130.79 -14.94 0.0 OUTLIER 'Trans proline' 0 CA--C 1.583 2.957 1 N-CA-C 124.056 4.599 . . . . 0.0 124.056 -151.069 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.492 ' O ' ' CA ' ' A' ' 7' ' ' PHE . . . -34.55 -56.62 0.53 Allowed 'General case' 0 C--O 1.182 -2.455 2 CA-C-O 106.696 -6.383 . . . . 0.0 112.697 122.583 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -96.02 -28.1 14.8 Favored 'General case' 0 N--CA 1.526 3.369 2 CA-C-O 132.009 5.671 . . . . 0.0 116.586 -141.012 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.484 ' N ' ' H ' ' A' ' 7' ' ' PHE . . . -102.92 -17.65 15.4 Favored 'General case' 0 C--N 1.262 -3.225 3 N-CA-C 138.529 10.196 . . . . 0.0 138.529 141.952 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.419 ' O ' ' N ' ' A' ' 10' ' ' ILE . . . -44.47 -49.47 2.23 Favored 'Isoleucine or valine' 0 C--O 1.184 -2.359 0 CA-C-N 109.757 -3.383 . . . . 0.0 105.485 124.157 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.492 ' CA ' ' O ' ' A' ' 3' ' ' THR . . . -63.83 -61.4 2.32 Favored 'General case' 1 CA--C 1.385 -5.401 0 O-C-N 126.679 2.487 . . . . 0.0 114.646 -140.324 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -92.46 27.34 2.3 Favored 'General case' 0 N--CA 1.398 -3.059 1 CA-C-N 106.955 -4.657 . . . . 0.0 120.449 158.857 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.413 ' O ' ' HG2' ' A' ' 13' ' ' PRO . . . -100.58 7.78 43.83 Favored 'General case' 0 CA--C 1.461 -2.466 1 N-CA-C 142.619 11.711 . . . . 0.0 142.619 120.52 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.419 ' N ' ' O ' ' A' ' 6' ' ' ILE . . . -67.79 -54.2 24.76 Favored 'Isoleucine or valine' 0 C--N 1.249 -3.802 2 CA-C-N 105.276 -5.42 . . . . 0.0 114.938 165.182 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.443 ' C ' ' H ' ' A' ' 14' ' ' GLY . . . -120.49 -26.37 5.38 Favored 'General case' 1 CA--C 1.397 -4.92 3 CA-C-N 96.754 -9.294 . . . . 0.0 130.205 -148.317 . . . . . . . . 4 3 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -90.65 -25.69 0.29 Allowed Pre-proline 1 N--CA 1.372 -4.374 2 CA-C-N 103.572 -6.195 . . . . 0.0 107.069 159.805 . . . . . . . . 3 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.413 ' HG2' ' O ' ' A' ' 9' ' ' SER . 0.1 OUTLIER -39.57 -15.72 0.04 OUTLIER 'Trans proline' 0 N--CA 1.533 3.837 3 O-C-N 104.571 -8.699 . . . . 0.0 128.305 125.829 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.443 ' H ' ' C ' ' A' ' 11' ' ' LEU . . . -86.17 9.29 70.34 Favored Glycine 1 N--CA 1.539 5.521 1 CA-C-N 105.17 -5.468 . . . . 0.0 122.646 159.701 . . . . . . . . 4 3 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . . . -115.98 -83.98 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.795 3 CA-C-N 105.051 -5.575 . . . . 0.0 112.117 -167.54 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -28.99 -26.01 0.0 OUTLIER 'General case' 0 C--N 1.248 -3.819 1 CA-C-N 107.735 -4.302 . . . . 0.0 120.974 148.333 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -70.12 -58.75 3.44 Favored 'General case' 0 C--N 1.326 -0.451 1 N-CA-C 133.463 8.32 . . . . 0.0 133.463 143.485 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -35.24 -55.85 0.62 Allowed 'General case' 0 CA--C 1.586 2.364 0 N-CA-C 116.186 1.921 . . . . 0.0 116.186 159.064 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . . . -68.23 -56.98 6.75 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 113.113 -1.858 . . . . 0.0 111.714 -168.183 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -44.09 -38.61 3.73 Favored 'General case' 0 CA--C 1.585 2.308 0 N-CA-C 117.348 2.351 . . . . 0.0 117.348 162.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . . . -95.88 1.04 52.76 Favored 'General case' 0 N--CA 1.513 2.695 1 N-CA-C 125.494 5.368 . . . . 0.0 125.494 178.434 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . . . -100.19 3.73 43.91 Favored 'General case' 1 N--CA 1.557 4.896 2 N-CA-C 125.845 5.498 . . . . 0.0 125.845 155.902 . . . . . . . . 3 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . . . -87.33 -56.04 3.54 Favored 'General case' 1 C--N 1.214 -5.308 1 CA-C-N 103.929 -6.032 . . . . 0.0 119.363 -174.215 . . . . . . . . 3 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . . . -23.79 -46.21 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.268 -2.947 2 N-CA-C 132.484 7.957 . . . . 0.0 132.484 123.017 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . . . -78.72 -8.78 59.05 Favored 'General case' 0 C--N 1.28 -2.444 0 N-CA-C 121.358 3.836 . . . . 0.0 121.358 164.365 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . . . -94.05 -46.08 7.29 Favored 'General case' 1 N--CA 1.549 4.488 0 CA-C-N 108.924 -3.762 . . . . 0.0 118.981 -157.403 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . . . -46.36 -74.1 0.04 OUTLIER 'General case' 0 C--N 1.287 -2.141 1 CA-C-N 106.516 -4.856 . . . . 0.0 117.027 135.425 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -77.7 -58.89 3.02 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-O 124.778 2.227 . . . . 0.0 111.775 -169.09 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.297 -1.717 0 CA-C-N 112.109 -2.314 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.273 0 N-CA-C 118.167 2.027 . . . . 0.0 118.167 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . . . -136.02 16.6 0.0 OUTLIER 'Trans proline' 0 CA--C 1.586 3.108 0 N-CA-C 121.739 3.707 . . . . 0.0 121.739 169.524 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.619 ' C ' ' H ' ' A' ' 5' ' ' ARG . . . -51.84 -93.84 0.0 OUTLIER 'General case' 0 C--O 1.167 -3.253 2 CA-C-O 102.211 -8.519 . . . . 0.0 107.867 97.175 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -46.56 2.0 0.0 OUTLIER 'General case' 0 N--CA 1.528 3.457 2 CA-C-N 127.276 4.58 . . . . 0.0 118.656 -146.454 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.619 ' H ' ' C ' ' A' ' 3' ' ' THR . . . -103.62 -41.51 5.93 Favored 'General case' 0 N--CA 1.5 2.072 3 N-CA-C 134.597 8.74 . . . . 0.0 134.597 167.316 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.504 ' O ' ' N ' ' A' ' 10' ' ' ILE . . . -33.24 -52.14 0.11 Allowed 'Isoleucine or valine' 1 CA--C 1.419 -4.065 1 CA-C-O 111.609 -4.043 . . . . 0.0 103.557 123.228 . . . . . . . . 4 3 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.536 ' H ' ' N ' ' A' ' 5' ' ' ARG . . . -90.94 -52.06 5.04 Favored 'General case' 1 N--CA 1.334 -6.259 1 CA-C-O 130.8 5.095 . . . . 0.0 109.806 -122.366 . . . . . . . . 4 3 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -35.07 -37.15 0.06 Allowed 'General case' 2 C--N 1.215 -5.267 1 N-CA-C 123.502 4.63 . . . . 0.0 123.502 136.888 . . . . . . . . 3 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.64 ' O ' ' HD2' ' A' ' 13' ' ' PRO . . . -90.09 16.23 8.78 Favored 'General case' 0 CA--C 1.423 -3.915 2 N-CA-C 124.994 5.183 . . . . 0.0 124.994 157.33 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.504 ' N ' ' O ' ' A' ' 6' ' ' ILE . . . -79.82 -24.15 11.99 Favored 'Isoleucine or valine' 0 CA--C 1.602 2.962 0 CA-C-O 127.433 3.492 . . . . 0.0 112.881 160.42 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.461 ' CA ' ' H ' ' A' ' 14' ' ' GLY . . . -117.32 -28.31 6.18 Favored 'General case' 1 CA--C 1.383 -5.452 3 N-CA-C 126.288 5.662 . . . . 0.0 126.288 -160.645 . . . . . . . . 4 3 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -71.57 -18.67 0.39 Allowed Pre-proline 0 C--N 1.247 -3.868 2 O-C-N 134.504 7.378 . . . . 0.0 119.404 147.7 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.64 ' HD2' ' O ' ' A' ' 9' ' ' SER . 0.1 OUTLIER -63.31 -21.51 71.76 Favored 'Trans proline' 0 C--N 1.298 -2.09 2 N-CA-C 127.64 5.977 . . . . 0.0 127.64 130.297 . . . . . . . . 4 4 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.461 ' H ' ' CA ' ' A' ' 11' ' ' LEU . . . -74.75 -3.23 66.87 Favored Glycine 2 N--CA 1.534 5.224 0 CA-C-N 108.969 -3.741 . . . . 0.0 121.372 157.833 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.406 ' C ' ' N ' ' A' ' 17' ' ' ALA . . . -113.79 -65.57 1.52 Allowed 'Isoleucine or valine' 0 CA--C 1.475 -1.907 2 C-N-CA 133.768 4.827 . . . . 0.0 112.221 -168.982 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -27.45 -33.27 0.0 OUTLIER 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 119.855 3.28 . . . . 0.0 119.855 148.201 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.406 ' N ' ' C ' ' A' ' 15' ' ' VAL . . . -90.49 -41.28 11.51 Favored 'General case' 0 CA--C 1.516 -0.364 2 CA-C-N 107.284 -4.507 . . . . 0.0 122.523 173.528 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -38.81 -62.31 0.63 Allowed 'General case' 0 CA--C 1.59 2.517 0 CA-C-O 123.015 1.388 . . . . 0.0 114.539 148.099 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . . . -77.43 -59.04 2.94 Favored 'General case' 0 CA--C 1.556 1.196 0 CA-C-O 124.443 2.068 . . . . 0.0 109.119 -143.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -41.39 -44.6 2.86 Favored 'General case' 0 CA--C 1.57 1.741 0 CA-C-N 111.5 -2.591 . . . . 0.0 115.931 160.479 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . . . -95.9 8.41 43.68 Favored 'General case' 0 N--CA 1.507 2.403 0 N-CA-C 118.794 2.887 . . . . 0.0 118.794 -174.481 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . . . -100.77 -28.21 12.94 Favored 'General case' 1 N--CA 1.551 4.603 1 N-CA-C 124.103 4.853 . . . . 0.0 124.103 160.275 . . . . . . . . 3 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . . . -39.36 -64.51 0.46 Allowed 'General case' 1 C--N 1.241 -4.138 1 CA-C-N 105.8 -5.182 . . . . 0.0 116.842 162.418 . . . . . . . . 3 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . . . -24.62 -50.92 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.252 -3.634 2 CA-C-N 104.509 -5.769 . . . . 0.0 124.642 139.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . . . -91.29 -0.22 57.63 Favored 'General case' 0 N--CA 1.505 2.317 0 N-CA-C 119.484 3.142 . . . . 0.0 119.484 170.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . . . -92.79 -37.19 12.46 Favored 'General case' 1 N--CA 1.553 4.699 0 CA-C-O 126.324 2.964 . . . . 0.0 117.33 -168.87 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . . . -93.47 -41.61 9.7 Favored 'General case' 0 N--CA 1.512 2.648 2 CA-C-N 107.295 -4.502 . . . . 0.0 111.146 171.791 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -76.56 18.9 0.29 Allowed 'General case' 0 N--CA 1.494 1.738 0 C-N-CA 117.624 -1.63 . . . . 0.0 114.253 139.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.318 -0.764 0 O-C-N 119.307 -2.121 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.556 2.611 0 N-CA-C 115.661 1.024 . . . . 0.0 115.661 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . . . -139.71 18.57 0.0 OUTLIER 'Trans proline' 0 C--N 1.384 2.398 2 N-CA-C 128.678 6.376 . . . . 0.0 128.678 -149.566 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.711 ' C ' ' H ' ' A' ' 5' ' ' ARG . . . -57.34 -61.86 2.18 Favored 'General case' 0 C--O 1.199 -1.6 1 CA-C-O 109.257 -5.163 . . . . 0.0 109.085 103.863 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -54.89 8.94 0.0 OUTLIER 'General case' 0 CA--C 1.62 3.659 0 CA-C-O 125.373 2.511 . . . . 0.0 116.461 -157.075 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.711 ' H ' ' C ' ' A' ' 3' ' ' THR . . . -101.34 -51.89 3.38 Favored 'General case' 0 N--CA 1.478 0.964 3 C-N-CA 139.347 7.059 . . . . 0.0 126.019 172.937 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.44 ' C ' ' H ' ' A' ' 9' ' ' SER . . . -38.79 -33.06 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.447 -2.999 0 CA-C-O 111.968 -3.872 . . . . 0.0 110.735 135.081 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.582 ' C ' ' H ' ' A' ' 10' ' ' ILE . . . -93.08 -41.96 9.67 Favored 'General case' 0 CA--C 1.435 -3.449 2 N-CA-C 131.122 7.453 . . . . 0.0 131.122 -156.165 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -34.68 -48.06 0.36 Allowed 'General case' 0 N--CA 1.394 -3.27 2 CA-C-N 96.899 -9.228 . . . . 0.0 107.649 127.597 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.44 ' H ' ' C ' ' A' ' 6' ' ' ILE . . . -89.56 -2.34 58.31 Favored 'General case' 0 CA--C 1.479 -1.779 0 N-CA-C 121.277 3.806 . . . . 0.0 121.277 157.749 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.582 ' H ' ' C ' ' A' ' 7' ' ' PHE . . . -67.1 -26.01 35.48 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.137 1 CA-C-O 128.737 4.113 . . . . 0.0 118.03 167.881 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.584 ' H ' ' HD2' ' A' ' 13' ' ' PRO . . . -113.29 -55.2 2.55 Favored 'General case' 0 CA--C 1.435 -3.477 2 CA-C-N 101.232 -7.258 . . . . 0.0 126.057 -127.886 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -94.3 -21.87 0.24 Allowed Pre-proline 0 N--CA 1.38 -3.941 2 O-C-N 137.692 9.37 . . . . 0.0 112.564 171.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.584 ' HD2' ' H ' ' A' ' 11' ' ' LEU . 27.7 Cg_exo -62.49 -25.64 75.93 Favored 'Trans proline' 0 N--CA 1.49 1.294 1 N-CA-C 127.106 5.772 . . . . 0.0 127.106 126.873 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -76.07 2.31 56.47 Favored Glycine 1 N--CA 1.522 4.373 3 O-C-N 130.403 4.814 . . . . 0.0 121.68 160.015 . . . . . . . . 3 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . . . -113.11 -69.36 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.973 1 CA-C-N 106.687 -4.757 . . . . 0.0 110.206 -177.03 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -27.06 -28.75 0.0 OUTLIER 'General case' 0 C--N 1.29 -2.017 0 N-CA-C 120.044 3.35 . . . . 0.0 120.044 148.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -69.9 -56.99 5.59 Favored 'General case' 0 CA--C 1.549 0.924 1 N-CA-C 121.913 4.042 . . . . 0.0 121.913 160.162 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -36.69 -60.7 0.58 Allowed 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 115.747 1.758 . . . . 0.0 115.747 155.319 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . . . -77.69 -58.32 3.33 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-O 121.929 0.871 . . . . 0.0 110.072 -150.197 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -43.77 -31.67 0.87 Allowed 'General case' 0 CA--C 1.581 2.164 0 N-CA-C 116.448 2.018 . . . . 0.0 116.448 164.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . . . -90.14 -20.44 23.11 Favored 'General case' 0 CA--C 1.569 1.684 0 N-CA-C 116.53 2.048 . . . . 0.0 116.53 -178.51 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . . . -102.25 -13.58 17.33 Favored 'General case' 1 N--CA 1.574 5.725 1 N-CA-C 124.829 5.122 . . . . 0.0 124.829 170.391 . . . . . . . . 3 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . . . -30.29 -60.76 0.17 Allowed 'General case' 1 C--N 1.225 -4.814 1 CA-C-N 107.639 -4.346 . . . . 0.0 120.498 134.244 . . . . . . . . 3 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . . . -90.05 -18.77 7.54 Favored 'Isoleucine or valine' 1 C--N 1.241 -4.13 0 CA-C-N 110.022 -3.263 . . . . 0.0 114.743 -159.554 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . . . -66.47 -18.51 65.4 Favored 'General case' 0 C--N 1.307 -1.242 1 N-CA-C 123.855 4.761 . . . . 0.0 123.855 148.821 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . . . -90.49 -62.87 1.36 Allowed 'General case' 0 N--CA 1.522 3.144 0 CA-C-N 114.229 -1.351 . . . . 0.0 109.37 -163.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . . . -48.66 -47.7 40.37 Favored 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 128.489 2.716 . . . . 0.0 116.293 157.028 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.02 -48.81 72.56 Favored 'General case' 0 N--CA 1.5 2.039 0 CA-C-O 124.324 2.011 . . . . 0.0 110.832 160.262 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.303 -1.434 0 CA-C-N 112.699 -2.046 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.617 ' C ' ' H ' ' A' ' 3' ' ' THR . . . . . . . . 0 N--CA 1.486 1.999 0 N-CA-C 111.493 -0.643 . . . . 0.0 111.493 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . . . -68.75 40.33 0.25 Allowed 'Trans proline' 0 N--CA 1.535 3.949 2 CA-C-O 131.453 4.689 . . . . 0.0 123.548 170.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.617 ' H ' ' C ' ' A' ' 1' ' ' GLY . . . -92.95 -52.04 4.78 Favored 'General case' 1 C--N 1.24 -4.183 2 CA-C-N 98.415 -8.539 . . . . 0.0 117.122 148.804 . . . . . . . . 4 3 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.407 ' N ' ' O ' ' A' ' 1' ' ' GLY . . . -38.67 -15.38 0.01 OUTLIER 'General case' 0 N--CA 1.527 3.405 3 O-C-N 112.667 -6.271 . . . . 0.0 120.093 163.797 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.692 ' N ' ' H ' ' A' ' 7' ' ' PHE . . . -101.76 -59.32 1.72 Allowed 'General case' 0 C--N 1.273 -2.751 3 CA-C-N 99.951 -7.841 . . . . 0.0 128.086 -174.68 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.748 ' C ' ' H ' ' A' ' 9' ' ' SER . . . -42.71 -36.88 0.75 Allowed 'Isoleucine or valine' 0 C--O 1.206 -1.208 1 O-C-N 129.513 4.258 . . . . 0.0 107.652 125.055 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.692 ' H ' ' N ' ' A' ' 5' ' ' ARG . . . -93.78 -1.81 54.5 Favored 'General case' 2 CA--C 1.392 -5.114 1 N-CA-C 135.918 9.229 . . . . 0.0 135.918 -171.063 . . . . . . . . 4 3 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.88 -39.21 93.65 Favored 'General case' 1 CA--C 1.389 -5.215 3 CA-C-N 94.437 -10.347 . . . . 0.0 132.684 117.779 . . . . . . . . 3 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.748 ' H ' ' C ' ' A' ' 6' ' ' ILE . . . -105.98 12.02 30.99 Favored 'General case' 0 C--N 1.253 -3.619 1 N-CA-C 125.501 5.371 . . . . 0.0 125.501 178.925 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . . . -95.03 -30.97 4.15 Favored 'Isoleucine or valine' 0 C--N 1.259 -3.35 1 CA-C-N 106.958 -4.656 . . . . 0.0 105.878 166.392 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . . . -86.65 -62.55 1.48 Allowed 'General case' 1 CA--C 1.408 -4.506 1 C-N-CA 136.424 5.89 . . . . 0.0 121.075 -158.928 . . . . . . . . 3 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -72.66 -21.65 0.48 Allowed Pre-proline 0 N--CA 1.391 -3.384 2 CA-C-N 102.198 -6.819 . . . . 0.0 113.134 167.404 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.502 ' HG2' ' O ' ' A' ' 9' ' ' SER . 0.1 OUTLIER -68.95 -20.39 38.76 Favored 'Trans proline' 0 CA--C 1.499 -1.258 1 N-CA-C 127.724 6.009 . . . . 0.0 127.724 139.567 . . . . . . . . 4 4 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -72.46 -4.39 60.61 Favored Glycine 0 N--CA 1.512 3.702 0 O-C-N 128.766 3.791 . . . . 0.0 118.368 157.066 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . . . -119.15 -56.72 3.53 Favored 'Isoleucine or valine' 0 CA--C 1.475 -1.926 0 CA-C-N 110.353 -2.924 . . . . 0.0 115.048 -161.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -26.91 -42.7 0.02 OUTLIER 'General case' 0 C--N 1.292 -1.905 1 CA-C-N 108.261 -4.063 . . . . 0.0 117.163 141.422 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.87 -73.02 0.16 Allowed 'General case' 0 CA--C 1.557 1.218 0 CA-C-N 108.461 -3.972 . . . . 0.0 118.179 172.508 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -38.69 -66.71 0.25 Allowed 'General case' 0 CA--C 1.583 2.217 0 N-CA-C 116.93 2.196 . . . . 0.0 116.93 164.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . . . -60.88 -59.98 4.52 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 128.435 2.694 . . . . 0.0 111.63 -161.281 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.33 -42.99 92.34 Favored 'General case' 0 CA--C 1.569 1.692 0 C-N-CA 126.587 1.955 . . . . 0.0 115.991 -175.63 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . . . -92.35 6.38 47.11 Favored 'General case' 0 N--CA 1.517 2.888 0 O-C-N 119.272 -2.143 . . . . 0.0 116.148 -179.284 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . . . -104.52 -30.78 9.81 Favored 'General case' 1 N--CA 1.542 4.151 1 N-CA-C 125.044 5.202 . . . . 0.0 125.044 174.517 . . . . . . . . 3 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . . . -34.9 -71.86 0.06 Allowed 'General case' 0 C--N 1.261 -3.275 2 CA-C-N 103.022 -6.444 . . . . 0.0 117.921 147.522 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . . . -25.98 -45.57 0.01 OUTLIER 'Isoleucine or valine' 1 C--N 1.234 -4.43 2 N-CA-C 124.303 4.927 . . . . 0.0 124.303 143.522 . . . . . . . . 3 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . . . -92.6 -0.76 57.27 Favored 'General case' 0 N--CA 1.505 2.315 0 N-CA-C 119.219 3.044 . . . . 0.0 119.219 170.745 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . . . -92.39 -36.22 13.26 Favored 'General case' 1 N--CA 1.55 4.551 0 CA-C-O 126.069 2.842 . . . . 0.0 117.12 -170.853 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . . . -94.36 -41.98 9.13 Favored 'General case' 0 N--CA 1.512 2.67 2 CA-C-N 107.796 -4.275 . . . . 0.0 111.014 173.377 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -77.2 19.76 0.31 Allowed 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 117.849 -1.54 . . . . 0.0 114.235 139.634 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.317 -0.821 0 O-C-N 119.333 -2.104 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.55 ' C ' ' H ' ' A' ' 4' ' ' ALA . . . . . . . . 0 CA--C 1.558 2.719 0 CA-C-O 126.904 3.502 . . . . 0.0 120.382 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . . . -105.33 -33.97 0.02 OUTLIER 'Trans proline' 0 CA--C 1.472 -2.616 1 O-C-N 113.105 -4.208 . . . . 0.0 121.355 -135.427 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.531 ' CA ' ' H ' ' A' ' 5' ' ' ARG . . . -96.23 55.45 1.52 Allowed 'General case' 0 C--O 1.183 -2.41 0 N-CA-C 119.781 3.252 . . . . 0.0 119.781 114.64 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.55 ' H ' ' C ' ' A' ' 1' ' ' GLY . . . -68.17 -9.09 44.16 Favored 'General case' 0 N--CA 1.53 3.572 1 O-C-N 113.866 -5.521 . . . . 0.0 120.458 111.513 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.588 ' N ' ' H ' ' A' ' 7' ' ' PHE . . . -105.3 -58.43 1.9 Allowed 'General case' 0 C--N 1.299 -1.596 1 CA-C-N 107.977 -4.192 . . . . 0.0 119.937 -153.422 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.501 ' O ' ' N ' ' A' ' 10' ' ' ILE . . . -39.51 -40.25 0.41 Allowed 'Isoleucine or valine' 0 C--O 1.162 -3.522 1 CA-C-O 108.079 -5.724 . . . . 0.0 111.681 127.458 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.591 ' C ' ' H ' ' A' ' 10' ' ' ILE . . . -61.57 -53.13 60.42 Favored 'General case' 1 C--O 1.15 -4.147 1 CA-C-N 127.436 4.653 . . . . 0.0 119.397 -169.478 . . . . . . . . 4 3 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -38.94 -53.86 1.7 Allowed 'General case' 1 N--CA 1.379 -4.005 4 C-N-CA 146.633 9.973 . . . . 0.0 99.128 155.279 . . . . . . . . 3 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.441 ' O ' ' HG2' ' A' ' 13' ' ' PRO . . . -85.58 2.86 43.24 Favored 'General case' 0 N--CA 1.494 1.735 1 N-CA-C 125.675 5.435 . . . . 0.0 125.675 160.758 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.591 ' H ' ' C ' ' A' ' 7' ' ' PHE . . . -80.67 -47.89 20.15 Favored 'Isoleucine or valine' 0 CA--C 1.584 2.275 0 CA-C-O 126.072 2.844 . . . . 0.0 106.286 172.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.438 ' C ' ' H ' ' A' ' 14' ' ' GLY . . . -114.02 -23.83 9.35 Favored 'General case' 0 CA--C 1.439 -3.32 2 CA-C-N 106.794 -4.73 . . . . 0.0 123.581 -147.959 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -95.21 -7.78 0.12 Allowed Pre-proline 1 N--CA 1.374 -4.257 2 CA-C-N 104.327 -5.852 . . . . 0.0 110.882 160.967 . . . . . . . . 3 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.441 ' HG2' ' O ' ' A' ' 9' ' ' SER . 0.3 OUTLIER -77.39 -10.91 17.48 Favored 'Trans proline' 0 CA--C 1.475 -2.431 2 N-CA-C 124.44 4.746 . . . . 0.0 124.44 131.464 . . . . . . . . 4 4 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.438 ' H ' ' C ' ' A' ' 11' ' ' LEU . . . -87.45 9.4 73.51 Favored Glycine 1 N--CA 1.523 4.442 2 O-C-N 132.149 5.906 . . . . 0.0 121.477 163.57 . . . . . . . . 4 3 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . . . -115.31 -78.29 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.405 -2.678 2 CA-C-N 105.273 -5.464 . . . . 0.0 111.086 -175.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -28.26 -29.83 0.0 OUTLIER 'General case' 0 C--N 1.246 -3.899 0 CA-C-N 110.996 -2.82 . . . . 0.0 118.25 152.203 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -58.29 -71.7 0.11 Allowed 'General case' 0 CA--C 1.533 0.29 1 N-CA-C 123.617 4.673 . . . . 0.0 123.617 148.773 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -33.36 -60.45 0.35 Allowed 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 115.393 1.627 . . . . 0.0 115.393 165.118 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . . . -63.49 -45.36 91.09 Favored 'General case' 0 CA--C 1.545 0.783 0 CA-C-N 114.346 -1.297 . . . . 0.0 112.134 -161.622 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -84.99 -12.14 53.9 Favored 'General case' 0 N--CA 1.418 -2.044 0 C-N-CA 127.75 2.42 . . . . 0.0 115.526 -173.774 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . . . -90.15 -22.01 21.94 Favored 'General case' 0 N--CA 1.509 2.492 0 N-CA-C 118.891 2.923 . . . . 0.0 118.891 165.112 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . . . -93.34 -27.61 16.68 Favored 'General case' 1 N--CA 1.564 5.226 1 N-CA-C 126.433 5.716 . . . . 0.0 126.433 178.039 . . . . . . . . 3 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . . . -27.34 -81.97 0.01 OUTLIER 'General case' 1 CA--C 1.417 -4.146 2 CA-C-N 102.919 -6.491 . . . . 0.0 113.152 123.75 . . . . . . . . 3 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . . . -78.09 -12.67 13.76 Favored 'Isoleucine or valine' 0 C--N 1.257 -3.451 1 C-N-CA 110.571 -4.452 . . . . 0.0 116.904 -139.761 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . . . -91.31 -1.62 57.6 Favored 'General case' 0 C--N 1.306 -1.301 2 N-CA-C 126.896 5.887 . . . . 0.0 126.896 159.032 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . . . -88.71 -57.99 2.71 Favored 'General case' 1 N--CA 1.539 4.023 0 CA-C-O 125.416 2.531 . . . . 0.0 115.98 178.073 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . . . -71.03 -52.49 19.24 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-N 108.843 -3.799 . . . . 0.0 115.043 165.597 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -81.29 22.74 0.65 Allowed 'General case' 0 N--CA 1.512 2.631 0 C-N-CA 116.069 -2.252 . . . . 0.0 112.623 148.367 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.315 -0.927 0 O-C-N 119.818 -1.801 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.563 3.069 0 N-CA-C 104.42 -3.472 . . . . 0.0 104.42 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . . . -113.49 11.43 0.05 OUTLIER 'Trans proline' 0 N--CA 1.508 2.36 0 C-N-CA 124.597 3.531 . . . . 0.0 118.922 168.721 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.74 ' C ' ' H ' ' A' ' 5' ' ' ARG . . . -49.71 -86.53 0.0 OUTLIER 'General case' 0 C--O 1.165 -3.381 2 CA-C-O 105.639 -6.886 . . . . 0.0 108.243 110.126 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -41.52 -5.57 0.0 OUTLIER 'General case' 0 N--CA 1.535 3.782 0 CA-C-N 124.19 3.177 . . . . 0.0 118.954 -154.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.74 ' H ' ' C ' ' A' ' 3' ' ' THR . . . -102.43 -54.27 2.71 Favored 'General case' 0 C--N 1.291 -1.936 4 C-N-CA 138.666 6.786 . . . . 0.0 123.523 -170.061 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.516 ' O ' ' N ' ' A' ' 10' ' ' ILE . . . -48.84 -50.92 13.2 Favored 'Isoleucine or valine' 1 C--O 1.135 -4.946 2 CA-C-N 106.808 -4.724 . . . . 0.0 106.907 137.706 . . . . . . . . 4 3 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.458 ' C ' ' H ' ' A' ' 10' ' ' ILE . . . -59.3 -55.23 37.49 Favored 'General case' 2 CA--C 1.365 -6.17 1 CA-C-O 140.191 9.567 . . . . 0.0 114.696 -163.484 . . . . . . . . 4 3 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -34.49 -43.31 0.16 Allowed 'General case' 0 N--CA 1.393 -3.298 1 CA-C-N 100.335 -7.666 . . . . 0.0 109.505 158.044 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.478 ' O ' ' HD2' ' A' ' 13' ' ' PRO . . . -88.67 -9.23 52.8 Favored 'General case' 0 CA--C 1.46 -2.502 1 N-CA-C 133.361 8.282 . . . . 0.0 133.361 152.485 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.516 ' N ' ' O ' ' A' ' 6' ' ' ILE . . . -66.47 -52.64 44.21 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.84 0 CA-C-O 126.613 3.102 . . . . 0.0 108.378 168.867 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.471 ' C ' ' H ' ' A' ' 14' ' ' GLY . . . -119.31 -25.24 6.15 Favored 'General case' 1 CA--C 1.397 -4.937 1 CA-C-N 102.956 -6.475 . . . . 0.0 120.799 -146.002 . . . . . . . . 4 3 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -100.04 16.61 0.05 OUTLIER Pre-proline 0 C--N 1.265 -3.079 1 O-C-N 130.809 5.068 . . . . 0.0 120.142 155.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.478 ' HD2' ' O ' ' A' ' 9' ' ' SER . 0.1 OUTLIER -67.3 -25.33 42.61 Favored 'Trans proline' 0 N--CA 1.509 2.406 2 N-CA-C 131.243 7.363 . . . . 0.0 131.243 105.925 . . . . . . . . 4 4 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.471 ' H ' ' C ' ' A' ' 11' ' ' LEU . . . -74.96 -0.83 61.17 Favored Glycine 3 N--CA 1.552 6.378 1 CA-C-O 129.011 4.673 . . . . 0.0 121.746 167.319 . . . . . . . . 4 3 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . . . -112.86 -67.18 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.29 -1.994 2 CA-C-N 104.462 -5.869 . . . . 0.0 116.517 -179.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -26.44 -37.03 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 119.251 3.056 . . . . 0.0 119.251 153.612 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -56.12 -79.13 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.804 1 CA-C-N 105.978 -5.101 . . . . 0.0 120.726 157.625 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -37.19 -49.49 0.91 Allowed 'General case' 0 CA--C 1.582 2.185 0 N-CA-C 117.637 2.458 . . . . 0.0 117.637 167.365 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . . . -47.81 -71.96 0.06 Allowed 'General case' 0 CA--C 1.564 1.505 0 C-N-CA 129.345 3.058 . . . . 0.0 112.942 -179.167 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -51.63 -25.53 7.22 Favored 'General case' 0 CA--C 1.571 1.783 0 CA-C-N 108.541 -3.936 . . . . 0.0 116.401 173.287 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . . . -90.78 -29.92 17.32 Favored 'General case' 0 CA--C 1.564 1.484 0 CA-C-O 115.414 -2.232 . . . . 0.0 115.696 -179.349 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . . . -100.79 -10.7 20.52 Favored 'General case' 1 N--CA 1.581 6.088 1 N-CA-C 124.797 5.11 . . . . 0.0 124.797 174.698 . . . . . . . . 3 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . . . -30.54 -67.85 0.09 Allowed 'General case' 1 C--N 1.233 -4.471 1 CA-C-N 105.582 -5.281 . . . . 0.0 118.822 125.603 . . . . . . . . 3 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . . . -88.0 7.45 2.99 Favored 'Isoleucine or valine' 1 C--N 1.238 -4.282 0 C-N-CA 113.775 -3.17 . . . . 0.0 117.929 -157.261 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . . . -87.18 -32.4 19.85 Favored 'General case' 0 C--N 1.303 -1.431 3 C-N-CA 134.484 5.114 . . . . 0.0 124.008 161.44 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . . . -87.65 -34.07 18.59 Favored 'General case' 0 N--CA 1.534 3.737 1 CA-C-N 106.87 -4.695 . . . . 0.0 116.553 -172.457 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . . . -95.97 -38.79 10.08 Favored 'General case' 0 N--CA 1.511 2.613 2 C-N-CA 131.994 4.118 . . . . 0.0 110.008 173.174 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -77.35 16.6 0.59 Allowed 'General case' 0 N--CA 1.499 1.989 0 C-N-CA 116.909 -1.917 . . . . 0.0 114.287 139.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.315 -0.895 0 O-C-N 119.096 -2.253 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.546 1.997 0 N-CA-C 116.648 1.419 . . . . 0.0 116.648 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . . . -113.96 -20.76 0.02 OUTLIER 'Trans proline' 0 N--CA 1.522 3.203 1 N-CA-C 122.776 4.106 . . . . 0.0 122.776 -150.217 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . . . -32.51 -49.63 0.22 Allowed 'General case' 0 C--N 1.252 -3.657 2 CA-C-N 100.52 -7.582 . . . . 0.0 121.231 126.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.482 ' C ' ' H ' ' A' ' 7' ' ' PHE . . . -92.47 -29.42 16.25 Favored 'General case' 0 N--CA 1.5 2.045 2 C-N-CA 132.834 4.454 . . . . 0.0 114.851 -163.259 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.656 ' N ' ' H ' ' A' ' 7' ' ' PHE . . . -103.11 -39.16 6.99 Favored 'General case' 0 C--N 1.293 -1.868 3 C-N-CA 139.836 7.254 . . . . 0.0 128.237 171.739 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . . . -39.89 -58.49 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.426 -3.819 2 CA-C-N 107.144 -4.571 . . . . 0.0 103.878 125.587 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.656 ' H ' ' N ' ' A' ' 5' ' ' ARG . . . -46.2 -41.29 12.55 Favored 'General case' 0 N--CA 1.492 1.672 2 N-CA-C 125.387 5.328 . . . . 0.0 125.387 -144.035 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -90.85 -40.38 11.79 Favored 'General case' 1 N--CA 1.372 -4.359 3 C-N-CA 150.495 11.518 . . . . 0.0 110.151 -162.129 . . . . . . . . 3 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.482 ' O ' ' HD2' ' A' ' 13' ' ' PRO . . . -70.95 -14.09 62.24 Favored 'General case' 0 CA--C 1.458 -2.559 1 N-CA-C 128.96 6.652 . . . . 0.0 128.96 140.43 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . . . -74.02 -23.52 18.84 Favored 'Isoleucine or valine' 0 C--N 1.253 -3.591 1 CA-C-O 129.335 4.397 . . . . 0.0 117.52 169.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . . . -110.92 -55.61 2.47 Favored 'General case' 1 CA--C 1.407 -4.524 1 CA-C-N 102.425 -6.716 . . . . 0.0 119.462 -138.666 . . . . . . . . 3 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -76.78 -21.78 0.4 Allowed Pre-proline 0 C--N 1.254 -3.553 2 O-C-N 132.958 6.411 . . . . 0.0 115.823 163.159 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.482 ' HD2' ' O ' ' A' ' 9' ' ' SER . 1.4 Cg_exo -60.58 -17.87 51.27 Favored 'Trans proline' 0 CA--C 1.479 -2.271 1 N-CA-C 128.007 6.118 . . . . 0.0 128.007 131.667 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -59.69 -22.46 57.01 Favored Glycine 2 N--CA 1.535 5.273 0 CA-C-O 126.199 3.11 . . . . 0.0 119.255 154.203 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.414 ' N ' ' H ' ' A' ' 17' ' ' ALA . . . -119.54 -49.26 3.54 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.617 1 CA-C-N 106.441 -4.88 . . . . 0.0 118.811 -144.165 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -28.72 -52.8 0.1 Allowed 'General case' 0 C--N 1.298 -1.673 2 CA-C-N 106.808 -4.724 . . . . 0.0 114.34 135.309 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.414 ' H ' ' N ' ' A' ' 15' ' ' VAL . . . -77.22 -52.42 9.27 Favored 'General case' 0 CA--C 1.56 1.334 1 CA-C-N 107.495 -4.412 . . . . 0.0 112.563 -157.895 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -36.72 -66.46 0.22 Allowed 'General case' 0 CA--C 1.585 2.307 0 CA-C-N 110.83 -2.895 . . . . 0.0 115.324 146.38 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . . . -46.91 -61.29 1.93 Allowed 'General case' 0 N--CA 1.514 2.727 0 CA-C-O 125.243 2.449 . . . . 0.0 113.777 -159.368 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -77.72 -14.75 59.52 Favored 'General case' 0 CA--C 1.567 1.598 0 C-N-CA 129.405 3.082 . . . . 0.0 116.244 -174.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . . . -92.27 -24.47 18.98 Favored 'General case' 0 N--CA 1.523 3.184 0 N-CA-C 117.942 2.571 . . . . 0.0 117.942 174.236 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . . . -96.01 -27.25 15.21 Favored 'General case' 1 N--CA 1.561 5.106 1 N-CA-C 126.158 5.614 . . . . 0.0 126.158 179.723 . . . . . . . . 3 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . . . -27.89 -80.32 0.01 OUTLIER 'General case' 0 CA--C 1.423 -3.941 2 CA-C-N 103.064 -6.425 . . . . 0.0 113.338 123.459 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . . . -79.66 -12.35 13.11 Favored 'Isoleucine or valine' 0 C--N 1.254 -3.554 1 C-N-CA 110.693 -4.403 . . . . 0.0 116.552 -139.287 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . . . -91.42 1.52 57.06 Favored 'General case' 0 C--N 1.308 -1.219 2 N-CA-C 127.287 6.032 . . . . 0.0 127.287 157.186 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . . . -89.71 -62.17 1.53 Allowed 'General case' 0 N--CA 1.538 3.926 0 CA-C-O 125.323 2.487 . . . . 0.0 115.752 176.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . . . -57.26 -61.48 2.44 Favored 'General case' 0 N--CA 1.494 1.768 0 CA-C-N 109.257 -3.61 . . . . 0.0 115.705 157.78 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -79.99 22.28 0.52 Allowed 'General case' 0 N--CA 1.517 2.883 0 C-N-CA 115.388 -2.525 . . . . 0.0 112.322 155.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.317 -0.829 0 O-C-N 119.928 -1.732 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.556 2.656 0 CA-C-O 123.613 1.674 . . . . 0.0 117.061 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . . . -95.27 -40.31 0.02 OUTLIER 'Trans proline' 0 N--CA 1.503 2.058 1 O-C-N 112.802 -4.368 . . . . 0.0 121.396 -126.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . . . -102.42 46.92 0.91 Allowed 'General case' 0 C--N 1.28 -2.429 1 N-CA-C 122.097 4.11 . . . . 0.0 122.097 127.058 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -70.54 -8.45 51.49 Favored 'General case' 0 N--CA 1.536 3.859 1 N-CA-C 122.196 4.147 . . . . 0.0 122.196 130.071 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.679 ' N ' ' H ' ' A' ' 7' ' ' PHE . . . -111.29 -55.1 2.54 Favored 'General case' 0 C--N 1.286 -2.18 2 CA-C-N 105.272 -5.422 . . . . 0.0 117.621 -140.062 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.502 ' C ' ' H ' ' A' ' 9' ' ' SER . . . -37.12 -38.19 0.15 Allowed 'Isoleucine or valine' 2 CA--C 1.364 -6.179 1 CA-C-N 106.264 -4.971 . . . . 0.0 112.735 126.729 . . . . . . . . 4 3 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.679 ' H ' ' N ' ' A' ' 5' ' ' ARG . . . -67.6 -60.35 2.62 Favored 'General case' 0 CA--C 1.423 -3.907 1 CA-C-O 137.041 8.067 . . . . 0.0 111.338 -173.343 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -36.26 -43.61 0.37 Allowed 'General case' 0 N--CA 1.407 -2.579 2 CA-C-N 100.51 -7.586 . . . . 0.0 105.36 159.694 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.51 ' C ' ' HD2' ' A' ' 13' ' ' PRO . . . -106.49 1.7 25.68 Favored 'General case' 0 CA--C 1.464 -2.345 1 N-CA-C 130.056 7.058 . . . . 0.0 130.056 176.356 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.426 ' N ' ' O ' ' A' ' 6' ' ' ILE . . . -91.93 -46.12 14.33 Favored 'Isoleucine or valine' 0 CA--C 1.621 3.695 2 N-CA-C 96.796 -5.261 . . . . 0.0 96.796 177.192 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.487 ' C ' ' H ' ' A' ' 14' ' ' GLY . . . -112.91 -27.59 8.04 Favored 'General case' 1 CA--C 1.402 -4.726 1 N-CA-C 122.222 4.156 . . . . 0.0 122.222 -152.415 . . . . . . . . 4 3 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -99.78 14.58 0.05 OUTLIER Pre-proline 0 C--N 1.256 -3.48 1 O-C-N 130.19 4.681 . . . . 0.0 120.791 154.273 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.51 ' HD2' ' C ' ' A' ' 9' ' ' SER . 0.0 OUTLIER -71.57 -22.13 24.84 Favored 'Trans proline' 0 N--CA 1.507 2.289 2 N-CA-C 130.215 6.967 . . . . 0.0 130.215 110.115 . . . . . . . . 4 4 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.487 ' H ' ' C ' ' A' ' 11' ' ' LEU . . . -82.32 2.28 85.2 Favored Glycine 2 N--CA 1.541 5.668 1 CA-C-O 127.849 4.027 . . . . 0.0 120.619 168.582 . . . . . . . . 4 3 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . . . -111.95 -64.3 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.71 2 CA-C-N 106.391 -4.905 . . . . 0.0 114.157 179.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -23.67 -42.32 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 111.56 -2.564 . . . . 0.0 117.612 152.519 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -56.8 -83.8 0.01 OUTLIER 'General case' 0 CA--C 1.556 1.201 1 CA-C-N 106.837 -4.71 . . . . 0.0 119.54 158.293 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -36.21 -60.8 0.54 Allowed 'General case' 0 CA--C 1.58 2.125 0 N-CA-C 118.615 2.82 . . . . 0.0 118.615 172.27 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . . . -52.65 -54.66 30.3 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 128.421 2.688 . . . . 0.0 112.824 -172.751 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.51 -53.06 61.32 Favored 'General case' 0 N--CA 1.399 -2.982 0 CA-C-N 112.693 -2.049 . . . . 0.0 111.602 173.117 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . . . -95.42 34.34 1.46 Allowed 'General case' 0 N--CA 1.518 2.96 0 N-CA-C 120.401 3.482 . . . . 0.0 120.401 175.337 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . . . -107.73 -5.71 17.23 Favored 'General case' 0 N--CA 1.533 3.714 0 N-CA-C 121.068 3.729 . . . . 0.0 121.068 141.444 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . . . -63.3 -55.02 28.13 Favored 'General case' 0 C--N 1.246 -3.897 0 N-CA-C 118.529 2.788 . . . . 0.0 118.529 -179.728 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . . . -28.18 -52.09 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.266 -3.063 4 CA-C-N 100.903 -7.408 . . . . 0.0 124.073 131.39 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . . . -92.29 7.52 42.39 Favored 'General case' 0 N--CA 1.519 2.98 0 N-CA-C 117.36 2.356 . . . . 0.0 117.36 171.478 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . . . -96.5 -60.97 1.5 Allowed 'General case' 0 N--CA 1.511 2.587 0 CA-C-N 109.317 -3.583 . . . . 0.0 110.699 179.077 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . . . -48.42 -38.61 20.14 Favored 'General case' 0 N--CA 1.503 2.209 0 C-N-CA 126.567 1.947 . . . . 0.0 115.937 162.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -76.54 -59.79 2.62 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-O 123.795 1.76 . . . . 0.0 110.639 160.491 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.299 -1.628 0 CA-C-N 114.127 -1.397 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.434 ' C ' ' H ' ' A' ' 4' ' ' ALA . . . . . . . . 0 CA--C 1.576 3.879 0 N-CA-C 119.964 2.746 . . . . 0.0 119.964 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . . . -97.9 -18.89 0.18 Allowed 'Trans proline' 0 CA--C 1.503 -1.053 0 N-CA-C 121.676 3.683 . . . . 0.0 121.676 -148.19 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.529 ' CA ' ' H ' ' A' ' 5' ' ' ARG . . . -99.94 55.38 0.93 Allowed 'General case' 0 C--O 1.188 -2.139 0 N-CA-C 119.545 3.165 . . . . 0.0 119.545 115.287 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.434 ' H ' ' C ' ' A' ' 1' ' ' GLY . . . -66.36 -5.25 10.07 Favored 'General case' 0 N--CA 1.528 3.433 1 O-C-N 113.554 -5.716 . . . . 0.0 120.271 113.843 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.529 ' H ' ' CA ' ' A' ' 3' ' ' THR . . . -106.72 -60.48 1.66 Allowed 'General case' 0 C--N 1.306 -1.298 1 O-C-N 129.72 4.388 . . . . 0.0 119.713 -147.419 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.434 ' O ' ' N ' ' A' ' 10' ' ' ILE . . . -38.1 -50.09 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.434 -3.51 1 CA-C-O 111.572 -4.061 . . . . 0.0 112.732 125.902 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . . . -48.03 -62.15 1.62 Allowed 'General case' 2 CA--C 1.387 -5.311 1 CA-C-O 132.597 5.951 . . . . 0.0 112.98 178.499 . . . . . . . . 3 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -37.77 -46.19 0.89 Allowed 'General case' 0 N--CA 1.4 -2.943 2 CA-C-N 102.314 -6.766 . . . . 0.0 106.153 168.044 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.574 ' O ' ' HG2' ' A' ' 13' ' ' PRO . . . -92.95 3.07 56.39 Favored 'General case' 0 CA--C 1.469 -2.158 1 N-CA-C 129.292 6.775 . . . . 0.0 129.292 166.522 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.434 ' N ' ' O ' ' A' ' 6' ' ' ILE . . . -93.78 -41.23 12.33 Favored 'Isoleucine or valine' 1 C--N 1.238 -4.275 0 N-CA-C 102.213 -3.254 . . . . 0.0 102.213 178.592 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.446 ' C ' ' H ' ' A' ' 14' ' ' GLY . . . -111.29 -28.6 8.17 Favored 'General case' 1 CA--C 1.421 -4.016 1 N-CA-C 122.245 4.165 . . . . 0.0 122.245 -153.249 . . . . . . . . 4 3 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -82.46 -24.12 0.36 Allowed Pre-proline 0 C--N 1.256 -3.494 2 O-C-N 131.63 5.581 . . . . 0.0 114.064 158.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.574 ' HG2' ' O ' ' A' ' 9' ' ' SER . 0.1 OUTLIER -56.21 -16.89 18.57 Favored 'Trans proline' 0 CA--C 1.476 -2.38 1 N-CA-C 128.107 6.156 . . . . 0.0 128.107 129.9 . . . . . . . . 4 4 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.446 ' H ' ' C ' ' A' ' 11' ' ' LEU . . . -59.3 -24.03 58.49 Favored Glycine 2 N--CA 1.536 5.35 0 CA-C-O 127.05 3.583 . . . . 0.0 121.727 155.391 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.41 ' N ' ' H ' ' A' ' 17' ' ' ALA . . . -120.03 -50.84 3.58 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.843 1 CA-C-N 104.187 -6.007 . . . . 0.0 118.236 -142.646 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -28.69 -52.45 0.1 Allowed 'General case' 0 CA--C 1.476 -1.879 2 CA-C-N 105.697 -5.228 . . . . 0.0 115.114 135.213 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.41 ' H ' ' N ' ' A' ' 15' ' ' VAL . . . -74.49 -59.78 2.58 Favored 'General case' 0 CA--C 1.553 1.09 1 CA-C-N 107.272 -4.513 . . . . 0.0 110.848 -161.571 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -35.16 -56.41 0.6 Allowed 'General case' 0 CA--C 1.574 1.872 0 CA-C-N 110.604 -2.998 . . . . 0.0 115.992 157.34 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . . . -43.37 -53.7 5.16 Favored 'General case' 0 N--CA 1.508 2.441 0 C-N-CA 128.18 2.592 . . . . 0.0 114.975 -167.573 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -80.51 -33.34 36.49 Favored 'General case' 0 N--CA 1.421 -1.905 0 C-N-CA 130.976 3.71 . . . . 0.0 114.439 -173.348 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . . . -90.31 -0.41 57.62 Favored 'General case' 0 N--CA 1.529 3.514 0 N-CA-C 117.039 2.237 . . . . 0.0 117.039 170.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . . . -88.87 -35.87 16.3 Favored 'General case' 1 N--CA 1.555 4.794 1 N-CA-C 123.619 4.674 . . . . 0.0 123.619 167.607 . . . . . . . . 3 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . . . -37.75 -64.49 0.39 Allowed 'General case' 0 C--N 1.26 -3.309 2 CA-C-N 102.513 -6.676 . . . . 0.0 114.969 167.068 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . . . -25.09 -51.02 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.268 -2.957 2 CA-C-N 104.354 -5.839 . . . . 0.0 124.695 142.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . . . -92.26 -2.73 56.28 Favored 'General case' 0 C--N 1.274 -2.679 0 N-CA-C 119.831 3.271 . . . . 0.0 119.831 170.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . . . -87.84 -24.24 23.76 Favored 'General case' 0 CA--C 1.609 3.241 0 CA-C-N 110.581 -3.009 . . . . 0.0 113.821 179.818 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . . . -96.09 -53.41 3.66 Favored 'General case' 0 N--CA 1.501 2.12 1 C-N-CA 132.831 4.453 . . . . 0.0 110.986 -178.672 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.03 22.06 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.918 0 CA-C-N 111.757 -2.474 . . . . 0.0 115.442 139.469 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.319 -0.746 0 O-C-N 119.518 -1.988 . . . . 0.0 . . . . . . . . . . 0 0 . 1 stop_ save_